Instrument	Activation Date	Guidance Measure	Guidance High Value	Guidance Low Value	Guidance Text	The Doc Type
POOL.OQ	2022-10-20T11:00:00Z	Revenue	5932537920	5808943380	I mean you've had years of successful capacity creation and this recent inflation taking things to a higher price level.	Transcript
POOL.OQ	2023-02-16T11:00:00Z	EBIT			In view of the potential for flat to slightly lower sales, gross margin compression and inflationary pressures on expenses, we would anticipate operating margin to decline as much as 100 to 150 basis points compared to 2022 full year results. We believe we can achieve a 15% operating margin even under these reduced sales expectations by continuing an intense focus on expense management and the crisp operating execution we have demonstrated consistently over time.	Transcript
CHRW.OQ	2022-05-25T10:55:00Z	Revenue			I mean throughout the balance of this year, should we expect to see volume grow at a rate ahead of head count growth? That would be the goal as we get through kind of with the Q3, Q4 into next year.	Transcript
CHRW.OQ	2023-04-26T17:00:00Z	EBITDA			As you would expect, the cash that we used to reduce debt generally reduces the amount of cash available for share repurchases.	Transcript
CHRW.OQ	2022-07-27T17:00:00Z	EBIT			And so while the market will undoubtedly shift from this point over time, we've got a clear view on what it's going to take to deliver against that 40% operating margin target through the cycle, both in terms of the components of volume, AGP per transaction and just our overall cost structure.	Transcript
AJG.N	2023-04-27T16:15:10Z	Revenue			"We expect insurance and reinsurance pricing increases to continue throughout 2023 and beyond. Our talented team will leverage our expertise, data and I believe we are very well positioned for the remainder of 2023!" insights to help clients with these challenging insurance market conditions.	Press Release
AJG.N	2023-01-26T17:15:00Z	Revenue			So as I sit here today, '23 could be another fantastic year with brokerage organic growth nicely in the 7% to 9% range.	Transcript
AJG.N	2023-04-27T17:15:00Z	Revenue			And then in terms of the organic outlook, still kind of keeping the 7% to 9% range for the year, can you just give us a sense of kind of what you're embedding in there for the economy as well as pricing when you think about -- or are you just expecting, in general, a stable environment over the next few quarters compared to what we saw in Q1?	Transcript
AJG.N	2023-04-27T17:15:00Z	Revenue			And then in terms of the organic outlook, still kind of keeping the 7% to 9% range for the year, can you just give us a sense of kind of what you're embedding in there for the economy as well as pricing when you think about -- or are you just expecting, in general, a stable environment over the next few quarters compared to what we saw in Q1?	Transcript
AJG.N	2023-04-27T17:15:00Z	Revenue			And then in terms of the organic outlook, still kind of keeping the 7% to 9% range for the year, can you just give us a sense of kind of what you're embedding in there for the economy as well as pricing when you think about -- or are you just expecting, in general, a stable environment over the next few quarters compared to what we saw in Q1?	Transcript
AJG.N	2023-01-26T17:15:00Z	EBITDA			Another year of double-digit growth and margin expansion would be another terrific year. Flipping to Page 7. The Risk Management adjusted EBITDAC margin of 19.3% in the quarter and 18.5% for the full year. Looking forward, full year '23 organic should be pushing 10% and adjusted EBITDAC margins should be around 19%. Moving on to our Risk Management segment, Gallagher Bassett. The way I look at the math, it might say that an additional $773 million of free cash, combined maybe another $70 million of recurring EBITDAC at that 10 to 11x multiple, which would then have a nice arbitrage for our current trading multiple. We see a nice step-up in '23 with margins around 19% even as we continue to make investments to enhance the client experience and in analytics and tools to drive better claim outcomes.	Transcript
AJG.N	2022-01-27T17:15:00Z	EBIT			And to be clear, all of these comments are before the impact of the acquisition of Willis Re. Then by 2023, we could be back to that pre-pandemic view that margin expansion might occur at a 4% or so organic level.	Transcript
AJG.N	2023-04-27T17:15:00Z	EBITDA			I think the accounting and the deferred revenue from 606 in the fourth quarter, plus maybe the life cases, I mean we have -- so as more life cases come in pretty lumpy, those probably cost us 50 basis points, the combination of the 2, and full year organic something like that. So you can see here, this quarter was up, fueled about 90 basis points.	Transcript
AJG.N	2023-04-27T17:15:00Z	EBITDA			As we look forward, we're seeing the rest of the year organic in that 12% to 13% range and full year margins now finishing a bit above 19%.	Transcript
AJG.N	2023-04-27T17:15:00Z	EBITDA			As we look forward, we're seeing the rest of the year organic in that 12% to 13% range and full year margins now finishing a bit above 19%.	Transcript
CNP.N						
AMCR.N						
WM.N	2023-03-16T08:00:00Z	EBITDA	20781390000	20485920000	And in '23, we're expecting 13% more EBITDA than we generated in '17. Can you just help us understand, is recycling a bundled offering with your waste collection business? What are the roadblocks to getting to 100% fee-for-service?	Transcript
WM.N	2023-04-27T10:00:00Z	Revenue	5975000000	5825000000	For the full year, we continue to expect flat overall volumes at the midpoint of our guidance. Our collection volumes were down modestly in the quarter, driven by intentional steps we continue to take to price every contract to achieve acceptable returns. This has led to some non-regrettable volume losses in our residential and commercial business. With profitability improving in each line of business and contract wins with healthy price increases, we're pleased to see our differentiated service and disciplined approach yield benefits.	Transcript
WM.N	2023-03-16T08:00:00Z	EBIT			Can you kind of just expand on some of those cost levers and what you can do to drive operating margin?	Transcript
WM.N	2023-03-08T08:40:00Z	EBITDA			And I know that if you look at your margins, they probably are under a little bit of pressure in the first half, but we kind of get back to that point where we reach that inflection. But if I just look at my core business and taking margins up by kind of -- if today it's going to be kind of 28.5% to 29%, taking it solidly through 30% on the core side through what she talked about on cost controls, and efficiencies and using data and analytics. But the idea here is this is a business that should be able to at least meet its cost inflation and hopefully a little bit more? There is a lot going on with commodities and stuff going on in the margins.	Transcript
BA.N	2022-10-26T10:30:00Z	Revenue			On the 87 program, we delivered 9 airplanes in the quarter and have 115 airplanes in inventory. We still anticipate delivery of the first 777-9 airplane in 2025 and continue to coordinate with the FAA to prioritize resources across our development programs.	Transcript
BA.N	2023-01-25T10:30:00Z	Revenue			On the commercial delivery front, 737 deliveries are unchanged and between 400 and 450 airplanes, 787 deliveries are unchanged between 70 and 80 airplanes, and we've added a couple of items on the expense front. On the services side, so we had a big year for the services business.	Transcript
BA.N	2023-04-26T10:30:00Z	Revenue			The work will impact the timing of our deliveries over the next several months.	Transcript
BA.N	2023-01-25T10:30:00Z	EBIT			Yes, sure.	Transcript
BA.N	2023-03-22T06:35:00Z	EBIT			So we see all that in front of us, that will get us to a point where margins will look more familiar to what you've seen in the past.	Transcript
BA.N	2023-04-26T10:30:00Z	EBIT			And of course, as Dave mentioned, by the time we get to '25, '26, we still see a path to get BCA back to the double-digit margins that you all recognize. But as we move into the back half of the year, the margins will improve. Maybe how do we think about BCA margins going forward?	Transcript
FOX.OQ	2023-05-09T08:30:00Z	Revenue			And so with another sort of 1/3 of our book due for renewal in fiscal '24 and a touch under 30% during fiscal '25, we feel pretty confident that we can continue to deliver pricing gains in subscribers. If the subscriber rate of attrition stays at the same level, we expect to post ongoing affiliate revenue growth for the company.	Transcript
FOX.OQ	2022-11-01T08:30:00Z	EBITDA			Last year, we sort of across -- TUBI across the whole year was in the low 200s in terms of EBITDA deficit for the company.	Transcript
LIN.N	2023-02-07T09:00:00Z	Revenue			And then I'd welcome any thoughts on non-China, Asia as well, taking into account your ExxonMobil project start-up in Singapore. Sanjiv, would you comment on your expectations for China as they emerge from the Lunar New Year holiday?	Transcript
WY.N	2023-01-27T10:00:00Z	Revenue			Turning to our full year harvest plan.	Transcript
WY.N	2023-04-28T10:00:00Z	Revenue			For our lumber business, we expect higher production and sales volumes in the second quarter and moderately lower unit manufacturing costs as operating rates at our Northwest mills return to a more normalized level, reliability improves across the system and inflationary pressures continue to ease.	Transcript
WY.N	2023-01-27T10:00:00Z	Revenue			Turning to our full year harvest plan.	Transcript
WY.N	2023-01-27T10:00:00Z	EBITDA			As Devin mentioned, HBU demand has moderated somewhat in response to broader macroeconomic concerns. Turning to our Real Estate, Energy and Natural Resources segment.	Transcript
WY.N	2023-04-28T10:00:00Z	EBITDA			For the full year, we continue to anticipate adjusted EBITDA of approximately $300 million for the segment.	Transcript
MCD.N	2023-04-25T08:30:00Z	Revenue			So I think certainly, you can kind of see a path forward where operating margin could come up a little bit from where our guidance is today if we continue to see that strong top line result over the course of the rest of the year, but there are several ifs there.	Transcript
MCD.N	2022-05-16T06:00:03Z	Revenue			* excluding the closure of all restaurants in russia, the company expects: * net restaurant unit expansion will contribute about 1.5% to 2022 systemwide sales growth in constant currencies	Press Release
MCD.N	2023-04-25T08:30:00Z	EBIT			And so I think our outlook for inflation for the year, I'll kind of break that into a couple of pieces.	Transcript
HD.N	2022-02-22T09:00:00Z	Revenue	154254940000	149532850000	So Michael, we've established a goal of $200 billion in sales. So if you could just get into that real quick, that would be great.	Transcript
HD.N	2023-05-16T09:00:00Z	EBIT	22058456000	20934599000	And anything else you'd highlight there?	Transcript
SPG.N	2023-05-02T17:00:00Z	Revenue			And looking at the guidance raise, how much of that property -- core property NOI versus maybe other factors? I'm guessing it's not that straightforward. If we have an uptick in sales, we'll do better. Just maybe can you give us an update how you're thinking about that number for the rest of the year? So the outlook on that front is very positive and unchanged since our commentary at the -- certainly, at the beginning of this year and fourth quarter of last year as well. So wondering if you could discuss that rent maturity and mark-to-market outlook?	Transcript
SPG.N	2022-11-01T08:30:00Z	EBIT			Absolutely. I have a question, a follow-up for you on the leasing.	Transcript
HBAN.OQ	2023-05-09T04:45:00Z	Revenue			And so those are going to be the core sources of growth here in the back half of the year.	Transcript
QRVO.OQ	2023-05-03T17:00:00Z	Revenue			For the full year, fiscal '24, we forecast revenue will be above fiscal '23 and expect to benefit from strong dollar content growth at our largest customers.	Transcript
QRVO.OQ	2022-05-23T13:50:00Z	EBIT			Yes. It's certainly is.	Transcript
LVS.N	2023-01-25T16:04:04Z	Revenue			"In Singapore, we were pleased to see the robust recovery continue at Marina	Press Release
LVS.N	2022-04-25T16:30:00Z	EBITDA			Any place there's very large-scale buildings that can create large EBITDA. If our business returns in Singapore, like we anticipate, -- and then behind that comes to Macao, we get back to $4 billion or $5 billion, $6 billion EBITDA.	Transcript
CTRA.N						
AIG.N	2023-05-05T08:30:00Z	Revenue			In future state, we expect a redefined AIG parent expense structure to be approximately 1% to 1.5% of premiums, which today is roughly $250 million to $350 million.	Transcript
AIG.N	2023-05-05T08:30:00Z	Revenue			In future state, we expect a redefined AIG parent expense structure to be approximately 1% to 1.5% of premiums, which today is roughly $250 million to $350 million.	Transcript
AIG.N	2022-02-17T08:30:00Z	EBIT			Although there are several opposite forces that work, such as economic and social inflation, my sense is that the 2022 market will continue to produce tight terms and conditions and strong pricing to sustain additional margin expansion into calendar 2023.	Transcript
AIZ.N	2023-05-02T16:15:00Z	EBITDA	984886000	965762000	single-digits, with results improving as the year progresses, led by improved the segment.	Press Release
AIZ.N	2023-05-03T08:00:00Z	Revenue			And what is the magnitude of those swings? We do expect to see progress in auto, over the balance of the year in '23.	Transcript
AIZ.N	2023-05-02T16:15:00Z	EBITDA			single-digits, with results improving as the year progresses, led by improved the segment.	Press Release
AIZ.N	2022-05-04T08:00:00Z	EBITDA			For this segment, we continue to expect adjusted EBITDA growth in the low double digits for 2022 with average annual growth of 10% in 2023 and 2024.	Transcript
AIZ.N	2022-08-03T08:00:00Z	EBITDA			Or I guess, what is the likelihood that EBITDA growth over the next couple of years could accelerate sufficiently to get it kind of back in that original range?	Transcript
CARR.N	2023-03-21T06:35:00Z	Revenue	4390010000	4390010000	But we're not seeing signs of that yet. First of all, residential HVAC is a really good business. We have a leading position in the U.S. in residential HVAC.	Transcript
CARR.N	2022-02-24T09:10:00Z	Revenue	768250000	768250000	Last year, we picked up something like 350 bps of market share, high-margin business.	Transcript
CARR.N	2023-05-10T12:30:00Z	Revenue	3080000000	3080000000	Just how do you think that, that relationship is going to look for you going forward?	Transcript
CARR.N	2023-05-23T12:30:00Z	Revenue			And it's the mix up. And so it's not a one-for-one reduction and that's why we expect also from an overall company point for Viessmann we expect attractive revenue growth rates going forward. And so it's not like, for example, in Asia, in some countries. The boiler business is actually still growing in parts of the world.	Transcript
CARR.N	2023-05-23T12:30:00Z	Revenue			And it's the mix up. And so it's not a one-for-one reduction and that's why we expect also from an overall company point for Viessmann we expect attractive revenue growth rates going forward. And so it's not like, for example, in Asia, in some countries. The boiler business is actually still growing in parts of the world.	Transcript
CARR.N	2023-02-07T08:00:00Z	EBIT			And then any sort of weighting on things like the productivity savings -- that just trying to understand where you get the offset in that HVAC margin, if there's a mix headwind and a TCC margin headwind as well. So we're comfortable with those 15% margins for the full year. . We expect the HVAC segment operating margin to be similar in 2022 despite absorbing about 100 bps of pressure from the consolidation of Toshiba, and expect operating margin expansion in Refrigeration and Fire & Security.	Transcript
CARR.N	2023-02-07T08:00:00Z	EBIT			And then any sort of weighting on things like the productivity savings -- that just trying to understand where you get the offset in that HVAC margin, if there's a mix headwind and a TCC margin headwind as well. So we're comfortable with those 15% margins for the full year. . We expect the HVAC segment operating margin to be similar in 2022 despite absorbing about 100 bps of pressure from the consolidation of Toshiba, and expect operating margin expansion in Refrigeration and Fire & Security.	Transcript
CARR.N	2023-02-07T08:00:00Z	EBIT			And then any sort of weighting on things like the productivity savings -- that just trying to understand where you get the offset in that HVAC margin, if there's a mix headwind and a TCC margin headwind as well. So we're comfortable with those 15% margins for the full year. . We expect the HVAC segment operating margin to be similar in 2022 despite absorbing about 100 bps of pressure from the consolidation of Toshiba, and expect operating margin expansion in Refrigeration and Fire & Security.	Transcript
CARR.N	2023-04-27T07:30:00Z	EBITDA			We expect approximately EUR 700 million of EBITDA on EUR 4 billion of sales in 2023.	Transcript
CARR.N	2023-02-23T10:20:00Z	EBIT			And the team is driving, and I think that as we go through the year, we'll continue to drive, hopefully, upside to that.	Transcript
COST.OQ	2023-04-05T08:00:00Z	Revenue			In terms of regional and merchandising categories, the general highlights were as follows: U.S. regions with the strongest comparable sales were the Northeast, Southeast and Midwest.	Transcript
COST.OQ	2023-03-02T17:00:00Z	EBIT			While I can't give guidance, certainly, we and everybody who has cash benefit from earning more money on their cash right now.	Transcript
MCO.N	2022-02-10T11:30:00Z	Revenue	5905440000	5741400000	Historically, pricing has contributed 3% to 4% to overall revenue growth.	Transcript
MCO.N	2023-04-25T12:30:00Z	EBIT	2657448000	2526216000	I don't know if this is for Mark, but just can we go back to the margins?	Transcript
MCO.N	2022-02-10T11:30:00Z	Revenue			Historically, pricing has contributed 3% to 4% to overall revenue growth.	Transcript
MCO.N	2023-04-25T12:30:00Z	Revenue			And that's, again, based on our expectation for market volatility to partially abate in the latter half of 2023. We now expect first half MIS revenue to decline in the mid- to high single-digit percent range and second half MIS revenue growth in the mid- to high teens percent range. We're also pleased to reaffirm our expectation for full year 2023 MA revenue to increase by approximately 10%.	Transcript
MCO.N	2022-10-25T12:30:00Z	Revenue			But we think that the rate of declines have probably bottomed out here in the third or fourth quarter, and we'll start to see gradual improvement throughout the balance of next year. Even though we've got -- so we've got a tough comp in the first quarter of next year from an issuance perspective. So if you could just be a little more specific what you meant when you think fourth and third quarter is likely to be a trough for debt issuance, noting that we still have unfavorable mix in the fourth quarter, like when would you expect MIS revenue to start to improve? So what I really meant was that the year-over-year quarterly declines in revenue in MIS, we would expect a trough in the third, fourth quarter of this year.	Transcript
MCO.N	2022-05-02T11:30:00Z	EBIT			And finally, just to sort of close out this one, our path to our medium-term MA margin target of mid-30s, it's not expected to be linear, especially as we continue to make opportunistic investments as time goes on.	Transcript
MCO.N	2022-02-10T11:30:00Z	EBIT			As such, over the coming 5 years, we project Moody's revenue to grow by at least 10% on an average annualized basis and adjusted operating margin to stabilize in the low 50s percent range.	Transcript
MCO.N	2023-04-25T07:00:00Z	EBIT			The First Quarter 2023 Earnings Release and other earnings materials can be	Press Release
MCO.N	2023-04-25T07:00:00Z	EBIT			(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.sec.gov&esheet=53386996&newsitemid=20230425005437&lan=en-US&anchor=www.sec.gov&index=2&md5=3144734c28bda75e6503516ef7afe021)	Press Release
MCO.N	2023-04-25T07:00:00Z	EBIT			(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.sec.gov&esheet=53386996&newsitemid=20230425005437&lan=en-US&anchor=www.sec.gov&index=2&md5=3144734c28bda75e6503516ef7afe021)	Press Release
DIS.N	2023-02-08T16:30:00Z	Revenue	91282050000	89607150000	And in terms of our current outlook, as we sit here today, we still expect that revenue and segment operating income growth for this fiscal year will be in the high single-digit percentage range, and we look forward to updating you on our progress as we move forward. As we have said before, sub growth will vary quarter-to-quarter, and we expect to see higher core subscriber growth towards the end of the fiscal year.	Transcript
DIS.N	2023-02-08T16:30:00Z	EBIT	13211890000	12969470000	Although, as I have mentioned before, our expectations are built on certain assumptions around subscriber additions based on the attractiveness of our future content, churn expectations, the financial impact of the Disney+ ad tier and price increases, our ability to quickly execute on cost rationalization while preserving revenue and macroeconomic conditions, all of which, while based on extensive internal analysis as well as recent experience, provide a layer of uncertainty in our outlook. And in terms of our current outlook, as we sit here today, we still expect that revenue and segment operating income growth for this fiscal year will be in the high single-digit percentage range, and we look forward to updating you on our progress as we move forward. And like Bob said, we are reaffirming our guidance that Disney+ will achieve profitability by the end of fiscal 2024.	Transcript
PAYX.OQ	2022-06-29T09:30:00Z	EBITDA	4980636000	4980636000	Adjusted EBITDA margin is expected to be another stellar 44%.	Transcript
PAYX.OQ	2023-03-29T08:30:00Z	Revenue	2191479840	2171188360	* Management Solutions revenue is now anticipated to grow by approximately 8%;	Press Release
PAYX.OQ	2022-09-28T08:30:00Z	EBIT	2042060760	1973807600	Martin Mucci, Chairman and CEO, commented, â€œWe are off to a good start for fiscal 2023, achieving double-digit growth in revenue and earnings. The value	Press Release
PAYX.OQ	2023-03-29T09:30:00Z	EBIT			Guidance for margins and effective tax rates are unchanged, but we do anticipate being on the higher end of the range for operating margin and the lower end of the range for effective tax rate.	Transcript
AMD.OQ	2023-01-31T17:00:00Z	Revenue			And so we are expecting a softer first half and then a stronger second half, but we feel very good about our market share position and opportunity to grow with Data Center.	Transcript
AMD.OQ	2023-05-02T17:00:00Z	Revenue			Looking at the year, we continue to expect the PC TAM to be down approximately 10% for 2023 to approximately 260 million units.	Transcript
AMD.OQ	2023-01-31T17:00:00Z	Revenue			And so we are expecting a softer first half and then a stronger second half, but we feel very good about our market share position and opportunity to grow with Data Center.	Transcript
AMD.OQ	2022-02-14T08:35:51Z	EBIT			transaction. The acquisition, originally announced on October 27, 2020,	Press Release
AMD.OQ	2023-01-31T17:00:00Z	Revenue			And so we are expecting a softer first half and then a stronger second half, but we feel very good about our market share position and opportunity to grow with Data Center.	Transcript
REG.OQ	2023-02-10T11:00:00Z	Revenue			And second, we are also anticipating lower noncash revenues of $36 million at the midpoint in 2023 compared to $47 million in 2022. First, we are anticipating lower COVID collections of $3 million in 2023 compared to $20 million last year. Please note that we increased our full year noncash revenue guidance from $30 million a quarter ago to account for new information, including an assumption that we will continue converting tenants to accrual accounting in 2023, as well as the likelihood that we will recognize accelerated below-market rent amortization triggered by the potential for bankruptcy-related store closures.	Transcript
REG.OQ	2023-05-18T08:30:00Z	EBIT			And then maybe can you just comment on the mark-to-market opportunity in the portfolio. And then that low 7s cap rate you cited, is that a fully loaded mark-to-market on everything? Just bigger picture, higher level.	Transcript
DHI.N	2023-04-20T08:30:00Z	Revenue	33000000000	31500000000	For the third quarter, we expect our rental revenues to be similar to our first and second quarters.	Transcript
TRV.N	2023-04-19T09:00:00Z	Revenue			We expect renewal premium change to be modestly higher than this level throughout the remainder of 2023. We expect renewal premium change to remain at this elevated level through the end of the year. We've shared previously that we expect written pricing in auto to be adequate in states representing the majority of our premium by midyear.	Transcript
BIO.N	2023-03-02T11:45:00Z	Revenue	2850000000	2750000000	That's more a mid- and long-term kind of internal targets.	Transcript
BIO.N	2023-05-17T15:35:00Z	Revenue	684000000	632500000	But again, as Andy mentioned, fundamentally, our growth drivers are still there in terms of the Droplet Digital PCR, the process chromatography, diagnostics that we actually upped our guidance for later this year. So we have a lot of upcoming kind of strategy that we believe is going to continue to play well for us, and it's all kind of baked in the kind of nice growth trajectory, still it's 8 years -- 8% for the 2021 to 2025 CAGR, which is still pretty nice profile, which is definitely higher than the historical kind of growth profile for Bio-Rad.	Transcript
BIO.N	2023-05-04T17:00:00Z	EBITDA			And full year adjusted EBITDA margin is expected to be about 23%, versus 25% in our prior guidance. For the first half of the year, we expect adjusted EBITDA margin to be about 21%, and in the second half of the year to be about 25%.	Transcript
BIO.N	2023-05-04T17:00:00Z	EBIT			For the first half of the year, we expect operating margin to be about 14% and reaching 21% for the second half of 2023.	Transcript
BIO.N	2023-05-04T16:15:00Z	EBITDA			approximately 8.0 percent between 2021 and 2025, and an adjusted EBITDA margin	Press Release
MOS.N	2023-05-04T11:00:00Z	Revenue			In Brazil, first quarter results reflected the impact of declining prices and inventory destocking. In the second quarter, 90% of those tonnes are already committed and priced.	Transcript
MOS.N	2023-02-23T11:00:00Z	EBIT			But for the full year, we do expect distribution margins to be back within our normal range.	Transcript
BWA.N	2023-05-09T09:00:00Z	EBIT	17900000000	17100000000	The same would probably be true here for the R&D, right, because this is largely program-specific application engineering.	Transcript
BWA.N	2023-02-16T09:30:00Z	Revenue	1855000000	1705000000	And then in 2023, we're looking at a number that implies at least 8% growth over market.	Transcript
BWA.N	2023-05-04T09:30:00Z	Revenue			Second, as I previously mentioned, we expect our end markets to be flat to up 3% for the year, which contributes to the organic net sales change you see on the slide.	Transcript
BWA.N	2023-05-04T06:30:07Z	EBIT			Adjusted Operating Income and Adjusted Operating Margin Guidance Full-Year 2023 Guidance	Press Release
BWA.N	2023-05-04T06:30:07Z	EBIT			Adjusted Operating Income and Adjusted Operating Margin Guidance Full-Year 2023 Guidance	Press Release
BWA.N	2023-05-04T06:30:07Z	EBIT			Adjusted operating margin 10.0 % 10.4 %	Press Release
WDC.OQ	2023-01-31T16:30:00Z	Revenue			Before I go over guidance for the fiscal third quarter, I'll discuss the business outlook and the financial impact associated with the actions we are taking to rightsize our cost structure. We expect bit growth to resume in the fiscal fourth quarter.	Transcript
VTR.N	2023-02-10T10:00:00Z	Revenue			It is important to note that 80% of our revenue growth in 2023 will be driven by the RevPOR growth, much of which has already been realized as over half of our resident population have already received the rent increases. This, in combination with improved care pricing, rising street rates and typical resident attrition, results in about 6% expected RevPOR growth in 2023. We anticipate year-over-year revenue growth of approximately 8% at the midpoint of the same-store cash NOI guidance range driven by continued strong rate growth and occupancy growth of 130 to 170 basis points. We are projecting unprecedented organic growth in our portfolio, once again driven by SHOP, and complemented by the positive compounding contributions of our office business led by Pete.	Transcript
VTR.N	2023-05-09T10:00:00Z	EBIT			We completed 13 of the 15 planned NOI-generating CapEx projects in this portfolio in the fourth quarter of 2022. With the right investments and strategic focus, we believe that we have an extraordinary opportunity to drive NOI recovery in the SHOP portfolio that Debbie mentioned with the potential to generate over $1 billion in NOI when the portfolio reaches 88% occupancy and a 30% margin.	Transcript
IVZ.N	2023-01-24T09:00:00Z	Revenue			At current AUM levels, we would expect the ratio to trend towards the higher end of the range for 2023.	Transcript
ZBRA.OQ	2022-11-01T08:30:00Z	Revenue	5665380000	5434140000	But yes, we would expect again, steady improvement from the second half run rate as we go into next year.	Transcript
ZBRA.OQ	2023-05-24T08:40:00Z	EBITDA	1246383600	1195510800	And that's with still about 70 bps impact from supply chain costs as well over the last 2 years, we've had a 150 basis point headwind in FX. Can we be in that 48%, even despite some of the pressure top line? I think the one thing I'd say just in terms of broader margin, if you look at where we ended our guide for the year at 22% EBITDA, it's about a 50 basis points increase from where we were in 2019. So I think both from OpEx leverage as well as the underlying gross margin of the business remains healthy, and we just -- once we get past the supply chain, and again, we feel like there's, again, continued opportunity to expand, particularly as we grow other parts of the portfolio that have an inherently higher margin such as machine vision and software. So let's jump into margins. So supply chain costs have come down materially. You're one of the few that have split out kind of the supply chain cost, made it easy for us analysts, but talk about -- how do we think about margins in the range for this year?	Transcript
ZBRA.OQ	2023-05-02T08:30:00Z	EBITDA			We expect full year adjusted EBITDA margin of approximately 22%, which is the low end of our previous outlook.	Transcript
AMAT.OQ	2023-02-28T12:00:00Z	Revenue			It's relatively small, but we expect this to grow over the years and I would say, medium-term years.	Transcript
STX.OQ	2023-04-20T09:00:00Z	Revenue			To that end, we have not let up on executing our HAMR-based product road map to preserve our significant time-to-market advantage. We are confident in Seagate's ability to translate areal density leadership into the most advantaged TCO across a broad range of customers from the highest capacity drives used in cloud data centers to lower and mid-cap drives more typically used by enterprise and VIA customers. We are tracking well to our stated plans and achieved the key milestone last week of shipping initial qualification units to a cloud launch partner, and we expect to recognize initial revenue from 30-plus terabyte platforms this quarter as part of our Corvault system solutions. We currently expect the high-volume ramp to begin in early calendar 2024, depending on customer qualification time lines and prevailing macro conditions at that time.	Transcript
STX.OQ	2022-07-21T17:00:00Z	EBIT			We will continue to focus on managing costs and balancing supply with demand to position the company to expand operating margin back into the target range of 18% to 22% when top line growth resumes, which we believe could begin later in the fiscal year.	Transcript
STX.OQ	2022-01-26T16:30:00Z	EBIT			As a result, we are raising our long-term target non-GAAP operating margin range to 18% to 22% of revenue compared with our prior range of 15% to 20% of revenue.	Transcript
FDS.N	2023-05-09T05:45:00Z	EBIT	2100000000	2080000000	And going forward, how do we think about that as in terms of your target setting there?	Transcript
FDS.N	2022-09-22T11:00:00Z	Revenue	735000000	707000000	They're fully equipped to go out and really kind of communicate the value of FactSet's proposition -- value proposition. We expect 2/3 of our top line acceleration to come from existing clients with low double-digit expansion offset by normal erosion plus increases in price realization.	Transcript
FDS.N	2023-03-23T11:00:00Z	Revenue			The decline is offset by the $10 million addition of CUSIP and remains within our medium-term outlook of 8% to 9% organic ASV growth.	Transcript
FDS.N	2023-03-23T07:00:00Z	EBIT			Annual Business Outlook	Press Release
FDS.N	2023-03-23T07:00:00Z	EBIT			services growth of 7% - 9%, adjusted operating margin of 34%-35%, and adjusted	Press Release
FDS.N	2023-03-23T11:00:00Z	EBIT			And in the first half of the year, I would note our capitalization was $35 million. As a result of these measures, we are maintaining adjusted margin guidance of 34% to 35%, consistent with our Investor Day commitment of 50 to 75 basis points of adjusted margin expansion on average per year. Travel is prioritized for essential trips, primarily around Helen's sales team.	Transcript
SYK.N	2022-10-31T16:30:00Z	Revenue			Again, I'm not asking for specific guidance, but maybe some qualitative comments on these variables. So that's one positive tailwind.	Transcript
SYK.N	2022-09-08T14:35:00Z	Revenue			And at the time you did the deal, you said double-digit top line growth for the next few years, something along those lines, right? And so that's what you've seen so far? And we have a pathway in terms of looking at our current businesses, looking at our product pipeline. I think we'll demonstrate that this year. I think what I will say is growth at the high end of med tech is still on the table, and we haven't really backed away from that. So is there a framework to think about 2023 that you can offer? That is what we are seeing. We have a lot of exciting new products that are coming out next year that I think will help drive the top line. Yes.	Transcript
VRSN.OQ	2023-04-27T16:30:00Z	Revenue	1505000000	1490000000	Revenue is now expected to be in the range of $1.490 billion to $1.505 billion.	Transcript
VRSN.OQ	2023-04-27T16:30:00Z	EBIT	1050000000	990000000	Operating income is now expected to be between $990 million and $1.05 billion.	Transcript
TECH.OQ	2022-11-01T09:00:00Z	Revenue			With the toughest comp of the year now in our rearview mirror, we anticipate a return to double-digit organic growth for the remainder of the fiscal year.	Transcript
TECH.OQ	2023-05-03T09:00:00Z	Revenue			We'll get back to you as we get a plan.	Transcript
TECH.OQ	2022-11-17T12:00:00Z	EBITDA			I mean, frankly -- I mean, Will, you and Chuck, and John Wilson will probably talk 3 times a week as it is already.	Transcript
TECH.OQ	2022-09-14T12:50:00Z	EBIT			But that doesn't include the Wilson Wolf. I think a lot of people -- that 40% number for Techne is such a targeted number and you put out the 40% plus.	Transcript
TECH.OQ	2023-03-06T14:10:00Z	EBIT			All strong for us, the lowest op margin business we have at least 30%. It's a matter of decision on investment.	Transcript
NVR.N						
BBWI.N	2023-02-23T08:30:00Z	EBIT	7560000000	7182000000	Did you put a time frame around that? Time frame is difficult to say. Yes.	Transcript
LOW.N	2023-05-23T09:00:00Z	Revenue	89000000000	87000000000	My question is, first, I'm trying to sort out the guidance.	Transcript
LOW.N	2023-05-23T09:00:00Z	EBIT	12104000000	11658000000	We now expect adjusted operating margin in the range of 13.4% to 13.6% for the full year driven by PPI initiatives across the company, partly offset by planned wage investments and lower sales volumes.	Transcript
LOW.N	2023-03-01T09:00:00Z	EBIT			So the bulk of the 60 to 80 basis points of EBIT expansion that's reflected in the guide is coming from SG&A leverage, and it's being largely driven by our productivity initiatives.	Transcript
BSX.N	2023-04-26T08:00:00Z	Revenue	14013610000	13759970000	Last week, the Population Health Research Institute announced the IDE approval of [LOUS 4], which is a collaborative research study with Boston Scientific that will continue to expand our LAAC clinical evidence. Our first quarter performance exceeded our expectations across all business units and regions, which is a testament to the winning spirit of our global team and the relentless focus on innovation and execution, and we also launched more than 70 new products globally in 2022.	Transcript
BSX.N	2022-07-27T08:00:00Z	Revenue	3699593040	3632632080	While the macroeconomic environment continues to be challenging, we remain committed to our long-term financial goals, continuing to grow sales faster than underlying markets, operating margin expansion, double-digit adjusted EPS growth and strong adjusted free cash flow.	Transcript
BSX.N	2023-04-26T08:00:00Z	EBIT			I think that puts us right in place to achieve that 26.4% for the year.	Transcript
SYY.N	2023-05-02T10:00:00Z	Revenue	75499760000	75499760000	It's not as much about the local independent versus the chain or multiunit as much as it is good operators innovating on their menu, offering fresh, local, customizable offerings that map to the end consumer. So part of it is accidentally there, we got a mixed message between the marketplace which means all businesses and then Cisco specific.	Transcript
SYY.N	2022-08-09T10:00:00Z	EBITDA			The midpoint of our guidance also translates to adjusted EBITDA of approximately $4 billion in the year.	Transcript
SYY.N	2021-11-09T10:00:00Z	EBIT			Aaron, I'll toss to you for any additional comments. And those 2 levers in combination is what expands the EBIT margin. But sales growth and cost reductions, not for margin rate growth. I do not believe that, that growth will come primarily from product margin expansion. I would just add, in support of Kevin's point, that I am also excited by elements of our merchandising and our supply chain transformation that, over time, as we work through this very inflationary period, should provide us with new opportunities. If you think about look out to '24, '25 take a longer-term view, are you more confident in gross margin being better than it's been historically? In particular, I'm excited with the work that's underway in connection with Sysco's private label brand and other elements that will be supportive of our overall financial profile. It's going to come from continued disciplined expense optimization by taking structural costs out and investing in capabilities that drive the top line. John, what we've articulated is we're really bullish on our EBIT margin expanding that we will move that needle. Or that the cost structure of the business will be less, right, in light of some -- a lot of the macro dynamics we're seeing today? So to answer your question, while the short term certainly were challenged from a -- or it's lower than we would have hoped, from a gross margin perspective because of the impact of inflation over the longer term, the 24% and the 25%, we are quite bullish. So why the EBIT margin grows is, a, the top line will be accelerating; b, we'll be taking structural costs out of the business. Then maybe the second question, right? Which 1 of those 2 is more likely to drive higher long-term profit margins?	Transcript
FCX.N	2023-04-21T10:00:00Z	Revenue	12500000000	12500000000	On Slide 10, we provide an update of our 3-year outlook for sales volumes.	Transcript
FCX.N	2021-07-22T10:00:00Z	EBITDA			What you see here on these graphs, we would generate EBITDA in the range of over $12.5 billion per annum for '22 and '23 on average at $4 copper to $17 billion per annum at $5 copper.	Transcript
MAS.N	2023-02-22T13:50:00Z	Revenue	7812000000	7812000000	And so as we think about the consumer cooling off, it's natural when you see that kind of outsized growth that kind of reverts a little bit more to the mean. So going into the pandemic, it was a nice solid piece of our Plumbing business, but we've seen enormous growth in that business during the course of the pandemic. What could that impact kind of look like this year and sort of just how that's kind of playing into the 10% to 14%...	Transcript
MAS.N	2023-03-07T08:05:00Z	Revenue	1171800000	1171800000	Yes.	Transcript
MAS.N	2023-04-26T08:00:00Z	EBIT			As Keith also mentioned, we do expect volumes to be pressured this year. As a result, all else equal, operating profit dollars remain neutral from cost recovery pricing actions, the results in margin compression. At this time, currency is projected to have a minimal impact on our 2023 results. For Masco overall, we are planning for volumes to be down in the low double-digit range, partially offset by low single-digit pricing. I mean 15.8% margin in the first quarter, 2Q and 3Q are generally well above the first quarter and the full year outlook is 15%. So with overall, our 10% guide to the top line being down, I think that weighs on it.	Transcript
MAS.N	2023-04-26T08:00:00Z	EBIT			As Keith also mentioned, we do expect volumes to be pressured this year. As a result, all else equal, operating profit dollars remain neutral from cost recovery pricing actions, the results in margin compression. At this time, currency is projected to have a minimal impact on our 2023 results. For Masco overall, we are planning for volumes to be down in the low double-digit range, partially offset by low single-digit pricing. I mean 15.8% margin in the first quarter, 2Q and 3Q are generally well above the first quarter and the full year outlook is 15%. So with overall, our 10% guide to the top line being down, I think that weighs on it.	Transcript
MAS.N	2023-04-26T08:00:00Z	EBIT			As Keith also mentioned, we do expect volumes to be pressured this year. As a result, all else equal, operating profit dollars remain neutral from cost recovery pricing actions, the results in margin compression. At this time, currency is projected to have a minimal impact on our 2023 results. For Masco overall, we are planning for volumes to be down in the low double-digit range, partially offset by low single-digit pricing. I mean 15.8% margin in the first quarter, 2Q and 3Q are generally well above the first quarter and the full year outlook is 15%. So with overall, our 10% guide to the top line being down, I think that weighs on it.	Transcript
BEN.N	2022-11-01T11:00:00Z	Revenue			I think what we're seeing globally is that the adoption of alt, a more significant portion of the portfolio is occurring in every region we operate in.	Transcript
BEN.N	2022-11-01T11:00:00Z	EBIT			35% to 40% of our adjusted expense base is variable with the market, but we're also very focused, Jenny asked me to do this in sort of one of my new roles here is to be very focused on the other 60% to 65%. And I think we do expect the margin to go a little bit down before it comes back up. And as I mentioned, we expect to absorb all of that into our cost base. And how much do you have wiggle room in order to continue to grind that down through the year as we work through this very, very challenging environment. And obviously, it's an inflationary environment that you've got Alcentra. And we're finding other places within Franklin Templeton to be more efficient so that we end up with an attractive expense base given the very difficult market conditions. But how much is Alcentra adding into that 3.95 to 4 base? By absorb it, I don't mean cut it. I think what you're sort of getting at in a way is the margin. I'll just point to a couple of important things. So I want to make that clear. So on Alcentra, it's approximately $100 million. So this is how -- this is where scale can matter where we can find other places to be more efficient across the platform. We're not cutting costs over in London in the company we just acquired. Yes. Thanks, Brennan. You helped us sort of quantify the -- what your expectation is for an uplift to T&E.	Transcript
META.OQ	2023-04-26T17:00:00Z	Revenue			As Mark noted, we have seen a 24% increase in overall time spent on Instagram from our ranking improvements since launching Reels globally. However, the overall economics of Reels will be determined by a combination of our ability to continue growing monetization per time on Reels and our ability to drive incremental engagement from Reels. We continue to expect that Reels will become neutral to overall revenue by end of this year or early next year.	Transcript
META.OQ	2023-04-26T17:00:00Z	EBIT			We continue to expect Reality Labs operating losses to increase year-over-year in 2023.	Transcript
EVRG.OQ	2022-08-04T09:00:00Z	EBIT			SPP did recently increase their reserve margin to 15% from 12%, and that will go in effect next year.	Transcript
EXPD.OQ						
PAYC.N	2023-05-02T17:00:00Z	Revenue	1715000000	1713000000	For fiscal 2023, we are raising our outlook and now expect revenue in the range of $1.713 billion to $1.715 billion or approximately 25% year-over-year growth at the midpoint of the range. In 2023, we project Paycom will generate greater than $1.7 billion in revenues, over $700 million in adjusted EBITDA and strong operating cash flow, all of which continue to grow. On May 1, the Board of Directors approved a quarterly dividend program that we expect to initiate in mid-May.	Transcript
PAYC.N	2023-05-02T17:00:00Z	EBITDA	702000000	700000000	In 2023, we project Paycom will generate greater than $1.7 billion in revenues, over $700 million in adjusted EBITDA and strong operating cash flow, all of which continue to grow. On May 1, the Board of Directors approved a quarterly dividend program that we expect to initiate in mid-May. We expect adjusted EBITDA in the range of $717 million to $719 million, representing an adjusted EBITDA margin of approximately 42% at the midpoint of the range.	Transcript
PAYC.N	2023-05-02T17:00:00Z	EBITDA			In 2023, we project Paycom will generate greater than $1.7 billion in revenues, over $700 million in adjusted EBITDA and strong operating cash flow, all of which continue to grow. On May 1, the Board of Directors approved a quarterly dividend program that we expect to initiate in mid-May. We expect adjusted EBITDA in the range of $717 million to $719 million, representing an adjusted EBITDA margin of approximately 42% at the midpoint of the range.	Transcript
EXPE.OQ	2023-05-04T16:30:00Z	Revenue			Looking ahead, given the strength we continue to see in our business, we are reiterating our full year outlook of double-digit top line growth with margin expansion.	Transcript
EXPE.OQ	2023-02-09T16:30:00Z	EBITDA			And we think as we're starting to demonstrate when we're getting these lifetime value customers, if we can get more efficient as we have started to do in the year with our marketing spend, and we're driving the top line of the levels that we're seeing that it's accelerated through to Q4 and it's coming in even stronger in 2023.	Transcript
EXPE.OQ	2022-11-03T16:30:00Z	EBIT			And if you look even through the third quarter today, we're at 30% margin, which is over 400 basis points over 2019 levels.	Transcript
RJF.N	2023-01-25T17:00:00Z	Revenue			What we're not going to do is force our stretch for growth, but we will continue to provide -- have our advisers provide excellent advice for their clients.	Transcript
CL.N	2023-04-28T08:30:00Z	Revenue	19045020000	18506010000	I expect as we kind of look out through the remainder of the year, it's going to come down slightly.	Transcript
CL.N	2023-01-27T08:30:00Z	Revenue			So overall, it will be another year of good investment, a good share growth id expected and obviously good top line growth coming through the P&L.	Transcript
CL.N	2023-03-16T12:00:00Z	EBIT			But when you've got double-digit inflation in Europe, you see it in Latin America, by country, it varies widely. Commodities are still up. I mean, can you just maybe talk about what you're seeing from a pricing environment perspective? I mean, maybe kind of building on that, right? I mean, there's a lot of discussion around pricing. So let me start with the macro view and then yes, we could take it down to North America. So we've taken price through '22, including at the fourth quarter.	Transcript
CE.N	2023-02-20T16:30:00Z	EBITDA			The expansion provides approximately 35 percent incremental EVA capacity approximately $10 million per year in additional operating EBITDA across the integrated acetyl value chain with the earnings contributions ramping across starting in the first quarter of 2023. The project is expected to deliver the second quarter.	Press Release
CE.N	2022-01-28T10:00:00Z	Revenue			And I suspect we'll see others in the industry doing so, but I will say it's still into a very tight market. And I think this is a market -- these are markets that will all continue to be very tight for the next, I'm going to say, at least 4 to 5 years. And I think we called out some VAM expansions. And I think what that means is, even with higher natural gas prices, because the marginal capacity in acetic acid is coming out of China, which is coal priced, you'll continue to see prices that support good margins in the Acetyl Chain as we go forward over the next few years. And so especially in Europe, we're just seeing a demand, quite frankly, that the industry can't keep up with right now. And then if you go into our downstream products like emulsions and RDP, I would say the demand is huge right now. And then maybe as a follow-up, since you get at acetic acid from kind of all 3 of the carbon starting points, can you talk about what's happening to the cost curve for acetic acid with all the different energy price moves we've seen in the last half year? And we make some systems that are made of -- if you think about kind of 5 layers of emulsions and RDP powders to make thermal insulation systems for putting on the externals of buildings. And where do you think either you or the industry might make some announcements around new capacity in that chain over the next couple of years? But again, in the first quarter, we see it being really tight again as we have some outages, especially in China, for turnarounds as well as some maintenance downtime. But we do have some new capacity coming on sometime in the next few months with the second phase of Huayi Guangxi. First question is just on the Acetyl Chain. I think as we've called out before, acetic acid, any major expansions will take a while. I would say VAM has been around 100% utilization for some time now. I would say the entire view of the chain is pretty tight right now. It was a little bit better in the fourth quarter. Just look at utilization, acetic acid had been pretty close to 100%. Now that did moderate a little bit in the fourth quarter, but still 85% to 90% utilization in acetic acid. Other than our old Clear Lake capacity that will come on first half of 2022 -- 2023, sorry, I get the wrong -- right year, 2023. So I do think we'll see some expansion. So I think VAM is going to continue to be very tight. So I'd say those utilization rates are definitely at 100% and staying that way. There's been a few other ones, but I think the demand in VAM continues to grow quite rapidly. There's some really interesting things happening in the market now around increased energy efficiency requirements. VAM is very tight. We see that being about the same this quarter and maybe tightening a little bit as we go through the year. We're at least 4 to 5 years out from any other expansions there. We're making -- we are looking to expand RDP as well. We've announced some expansions in VAM. We've called out some VAE expansions. What will '22 look like different than '21 from a cost curve standpoint? When you look at the different steps from acetic acid down to VAM and some of the other derivatives, where do you see the supply demand being the tightest over the next couple of years?	Transcript
CE.N	2022-02-18T08:30:00Z	Revenue			And then some years, it may be a little bit lower, but we really do believe that 5% is a sustainable growth level. And then, Scott, maybe on slide 15 where you had the 5% sales CAGR. And what are the other constituents that led to the 5%? Can you just give us a bit more color on that dynamic? From a revenue standpoint, the steel business has some more volatility to that, but more kind of historically low single digits, largely driven by price, at least over the last decade as opposed to volume. How much of that is sort of driven by just cyclicality in some of the currently challenged end markets like auto OEM recover? So we bring this business in to Engineered Materials, we expect that revenue growth again to be kind of more in that mid- to high single-digit range overall. So when we kind of blend that together that 5%, we think, is kind of over time where we'll land on average kind of with the blended portfolio. Some years, it's going to be higher than that, and we do expect we have that opportunity here over the next several years.	Transcript
CE.N	2022-03-31T17:00:00Z	EBIT			Celanese Engineered Materials business. Celanese expects the restructuring of	Press Release
CE.N	2021-03-25T06:00:00Z	EBIT			Engineered Materials is expected to deliver adjusted EBIT of $700 to $750 The Acetyl Chain is expected to deliver adjusted EBIT of $900 to $1,000	Press Release
CE.N	2021-03-25T06:00:00Z	EBIT			Engineered Materials is expected to deliver adjusted EBIT of $700 to $750 The Acetyl Chain is expected to deliver adjusted EBIT of $900 to $1,000	Press Release
CE.N	2021-03-25T06:00:00Z	EBIT			Engineered Materials is expected to deliver adjusted EBIT of $700 to $750 The Acetyl Chain is expected to deliver adjusted EBIT of $900 to $1,000	Press Release
UNH.N	2023-01-13T05:55:00Z	Revenue	360000000000	357000000000	UnitedHealth Group affirmed the 2023 growth and performance objectives	Press Release
UNH.N	2022-10-14T08:45:00Z	Revenue			Can you remind us, I guess, how much revenue coverage you have for next year at this point? So the impact there and how that comes in.	Transcript
ARE.N	2023-04-24T16:10:05Z	Revenue			Key Assumptions Low High Low High Key Changes Straight-line rent revenue $ 130 $ 145 $ 130 $ 145	Press Release
ARE.N	2023-04-24T16:10:05Z	EBIT			$119.0 million to fund construction spending over time and to accrete its	Press Release
UAA.N	2023-05-09T06:55:03Z	Revenue	5962672360	5903636000	Fiscal 2024 Outlook Versus fiscal 2023, key points related to Under Armour's fiscal year 2024 freight costs, partially offset by mix impacts related to higher off-price revenue and higher promotions expected in the company's direct-to-consumer	Press Release
UAA.N	2023-05-09T08:30:00Z	EBIT	330000000	310000000	This translates to an expectation that operating income will reach $310 million to $330 million.	Transcript
GEN.OQ	2023-03-06T12:50:00Z	Revenue			Just a rough breakdown of what that looks like?	Transcript
GEN.OQ	2023-02-02T17:00:00Z	Revenue			Beyond Q4, we remain focused on our long-term objectives and are still targeting to achieve $3 annualized EPS exiting fiscal year 2025 with the following underlying key assumptions: our Cyber Safety business continues to grow mid-single digits, post-synergy structure of 60%-plus operating margin, free cash flow deployed towards debt paydown and share buyback, the SOFR curve trends indicate rates below 3% exiting fiscal year 2025 and our diluted share count expected to be around pre-Avast merger levels.	Transcript
GEN.OQ	2023-03-06T12:50:00Z	EBIT			And it's going to be exactly what we're going after, and how we prioritize is exactly how we guide to you guys, long term, mid-single-digit rate of growth.	Transcript
LLY.N	2023-05-10T13:00:00Z	Revenue	31700000000	31200000000	But even over the last years, and we saw in Q1, we continue to outperform the market in the U.S. We saw volume growth globally of 27%.	Transcript
LLY.N	2022-12-13T09:00:00Z	EBIT			However, we remain committed to expanding operating margin over time, excluding IPR&D and development milestone charges.	Transcript
LLY.N	2022-11-01T09:00:00Z	EBIT			We look forward to sharing more details on our 2023 guidance call on December 13. While these investments will slow our operating margin expansion in 2023, they are critical to maximizing pipeline and new launch opportunities to help sustain top-tier revenue growth and operating margin expansion over the mid- to long term.	Transcript
CDAY.N	2023-02-08T17:00:00Z	Revenue	1500000000	1480000000	And so if I look towards the Bureau kind of run for the year, the makeup effectively is the remaining North American payroll and fiscal 2023 is like $1.5 million to $2 million.	Transcript
CDAY.N	2023-05-03T17:00:00Z	Revenue	379000000	366000000	And as such, we expect to exit 2023 with an ARR in the range of $14 million to $16 million.	Transcript
CDAY.N	2023-05-03T17:00:00Z	EBITDA			Of note, we continue to expect conversion of full year adjusted EBITDA to operating cash flows of about 50%. On the heels of improving efficiency across the organization, we are raising our adjusted EBITDA outlook for the year by $6 million at the low end and $4 million at the high.	Transcript
CDAY.N	2023-02-08T17:00:00Z	EBIT			And I think that growth trend will continue for some time. But I would expect the profitability of that business to obviously improve. But again, it's a small business today, growing well over 100% year-over-year. In terms of the margins, the margins obviously go up as the scale of the business actually goes up as well.	Transcript
CDAY.N	2023-02-08T17:00:00Z	EBITDA			Adjusted EBITDA is expected to be in the range of $360 million to $375 million or margins of 25% at the midpoint. This provides an excellent setup for 2023 as evidenced by our strong 2023 fiscal year guidance of Dayforce recurring revenue ex float growth at constant currency of 25% to 27% and adjusted EBITDA of 24% to 25%. Turning to fiscal year '23 guidance.	Transcript
GRMN.N	2023-05-03T10:30:00Z	Revenue	5000000000	5000000000	In the last quarter, you guys talked about the kind of guidance revenue by segment.	Transcript
GRMN.N	2023-05-03T10:30:00Z	Revenue	1015000000	1015000000	In the last quarter, you guys talked about the kind of guidance revenue by segment.	Transcript
GRMN.N	2023-05-03T10:30:00Z	EBIT			In the last quarter, you guys talked about the kind of guidance revenue by segment. Just curious if there's any update on that. Just maybe you can unpack if there's any change to the segment guidance for this year. So we would expect gross margins from the segment to gravitate towards the high double digits -- high teens, rather, 19%, 20% operating margin and then gross margin and then operating margin would be more in line with the mid- to high single digits.	Transcript
GRMN.N	2023-02-22T10:30:00Z	Revenue			For 2023, we expect revenue to be down approximately 5% in the segment as it stabilizes and as we anticipate the benefit of new product introductions.	Transcript
NWL.OQ	2023-04-28T07:00:00Z	Revenue	8400000000	8400000000	and divestitures) and comparing to 2023 reported sales.	Press Release
NWL.OQ	2023-02-10T08:30:00Z	EBITDA	806400000	806400000	Or is it potentially even superior to that now just given some of the programs that you've announced?	Transcript
NWL.OQ	2023-04-28T07:00:00Z	EBIT			Outlook for Second Quarter and Full Year 2023 full year 2023 outlook.	Press Release
ISRG.OQ	2023-04-18T16:30:00Z	Revenue			On our last call, we forecasted full year 2023 procedure growth within a range of 12% to 16%. This range continues to reflect the uncertainty associated with the course of the pandemic and macroeconomic risks. We are now increasing our forecast and expect full year 2023 procedure growth of 18% to 21%. We expect the impact of this decision to be an increase in revenue and operating profit of approximately $100 million in 2023.	Transcript
ISRG.OQ	2023-04-18T16:30:00Z	EBIT			We expect the impact of this decision to be an increase in revenue and operating profit of approximately $100 million in 2023.	Transcript
AVB.N	2023-02-09T13:00:00Z	Revenue			The combination of the 2 reflects a projected 80 basis point headwind from net bad debt for the full year 2023. We expect our East Coast regions to produce revenue growth slightly above the portfolio average, while the West Coast markets are projected to fall below the portfolio average.	Transcript
AVB.N	2022-07-28T13:00:00Z	EBITDA			So could you provide an update there?	Transcript
AVB.N	2023-02-09T13:00:00Z	EBIT			In 2023, we're projecting an additional $11 million of incremental NOI from these initiatives and, looking further out, expect meaningful contributions in 2024 and beyond. In aggregate, we're expecting an additional $11 million in NOI from these 3 strategic priorities in 2023 with a lot more to come in future years from these initiatives and others.	Transcript
PVH.N	2022-12-01T09:00:00Z	Revenue	9385168000	9294926000	Demand in our future order books across brands continue to hold with the spring 2023 season firming up to be high single-digit growth on top of double-digit growth in spring this past year.	Transcript
PVH.N	2022-08-31T09:00:00Z	Revenue	938520000	929490000	We are very focused on making sure that we execute on the PVH+ drivers, the 5-plus drivers, on winning more with product, winning even more with consumer engagement, winning in the digitally led marketplace and getting to that demand-driven supply chain and investing behind that growth and driving efficiencies.	Transcript
PVH.N	2023-05-31T16:15:00Z	EBIT			* Full year outlook * Operating margin is projected to be approximately 10%. * Operating margin:Â Reaffirms outlook approximately 10% 2023 Outlook: Full Year 2023 Guidance	Press Release
TPR.N	2022-08-18T08:00:00Z	Revenue	6700000000	6700000000	On a reported basis, we anticipate revenue in the area of $6.9 billion, which represents growth of 3% to 4% and includes roughly 300 basis points of FX headwinds from the significant appreciation of the U.S. dollar. Our guidance assumes balanced growth with all brands and channels contributing to constant currency top line gains for the year. Specifically, we expect revenue and earnings growth versus prior year to be back half weighted, helped by the sequential improvement planned in China as we move throughout the year. We are increasingly confident in the brand's opportunity to achieve $2 billion in revenue and a high-teens operating margin over our planning horizon.	Transcript
TPR.N	2023-05-11T06:45:00Z	Revenue			basis, revenue is expected to grow approximately 3% versus last year;	Press Release
TPR.N	2022-05-12T08:30:00Z	Revenue			Importantly, given the success, we expect to approach $950 million in revenue this fiscal year, closing in on our near-term target to reach $1 billion in sales.	Transcript
TPR.N	2022-08-18T08:00:00Z	EBIT			We are increasingly confident in the brand's opportunity to achieve $2 billion in revenue and a high-teens operating margin over our planning horizon.	Transcript
TPR.N	2022-11-10T08:00:00Z	EBIT			In addition, we anticipate a year-over-year operating margin decline of over 70 basis points, which now incorporates the expectation for FX pressure of roughly 120 basis points compared to our prior outlook for 100 basis points of impact. This contemplates gross margin relatively in line with, to slightly below prior year, reflecting the benefit of moderating freight costs as well as AUR increases across all brands. We expect the majority of this FX headwind to flow through the gross margin line. We expect these tailwinds to be offset by the previously anticipated rising input costs for materials as well as the negative impact of FX, as mentioned.	Transcript
CBRE.N	2023-02-23T08:30:00Z	Revenue	2719570000	2661080240	Within our REI segment, we expect SOP in the mid-$300 million range with roughly equal contributions from development and investment management.	Transcript
CBRE.N	2023-02-23T08:30:00Z	Revenue			Within our REI segment, we expect SOP in the mid-$300 million range with roughly equal contributions from development and investment management.	Transcript
CBRE.N	2023-05-04T00:02:15Z	Revenue			service provider. TÃœV Rheinland has around 21,000 employees in more than total of five portfolio properties with 1,350 residential units in	Press Release
CBRE.N	2022-02-24T08:30:00Z	EBIT			Our overall margin is expected to gradually increase over this period even with considerable growth from our lower-margin GWS segment. The GWS margin itself should also improve over time as higher-margin project management accounts for a larger share of our GWS revenue base. We envision solid organic revenue and earnings growth across our 3 business segments.	Transcript
CBRE.N	2023-02-23T08:30:00Z	EBIT			All major client sectors are expected to grow notably in health care and technology, where the changing use of real estate is driving increased demand for outsourcing services that we believe CBRE is best positioned to deliver.	Transcript
CBRE.N	2023-04-27T06:55:00Z	EBIT			Global Workplace Solutions business, loan servicing, property management, The cyclically resilient elements of CBREâ€™s business include its entire companyâ€™s business segment operating profit this year, a record high.	Press Release
CINF.OQ	2023-02-07T11:00:00Z	Revenue			I'm thinking about the guidance for 8% plus premium growth in 2023.	Transcript
CINF.OQ	2022-11-01T11:00:00Z	Revenue			Personal auto insurance for the industry, including our book of business, generally needs higher premium rates to achieve profitability.	Transcript
SEE.N	2022-02-23T13:00:00Z	Revenue	6100000000	5850000000	And specifically to the operating model, what we mentioned in the past is we typically would grow over time, 3% to 5%. Maybe that's a good segue in to -- I'll talk about our operating model, which is a little bit more of the longer-term financial objectives that we see based on the markets that we serve. So we're profiling out our 2025 estimates of greater than $750 million organically and potentially over $1 billion with M&A. We actually bumped that up to 5% to 7%, coming off a favorable 6% organic growth last year, and I'll get to what the drivers are in terms of why we made that change.	Transcript
SEE.N	2023-05-02T10:00:00Z	Revenue	1300000000	1250000000	SEE automation revenue continues to fuel our growth. We expect net sales to be in the range of $5.85 billion to $6.1 billion, which at the midpoint assumes mid-single-digit growth on a reported basis and low single-digit growth organically.	Transcript
SEE.N	2023-05-02T10:00:00Z	EBITDA			We expect full year adjusted EBITDA to be in the range of $1.25 billion to $1.3 billion, which assumes adjusted EBITDA margins of approximately 21%.	Transcript
SEE.N	2023-05-02T10:00:00Z	EBITDA			We expect full year adjusted EBITDA to be in the range of $1.25 billion to $1.3 billion, which assumes adjusted EBITDA margins of approximately 21%.	Transcript
WMB.N	2023-05-04T09:30:00Z	EBITDA	6800000000	6400000000	However, as I mentioned in my commentary, I forecast -- our current forecast does show that we do not need any additional EBITDA from Sequent this year to make the midpoint of our guidance. No change to our consolidated adjusted EBITDA guidance of $6.4 billion to $6.8 billion or any of our other consolidated financial performance metrics.	Transcript
WMB.N	2023-05-03T16:15:00Z	EBITDA			(Dollars in millions, except per-share amounts and coverage ratio) Â  Low Â  Mid Â  High 2023 Guidance Reconciliation of Net Income (Loss) to Modified EBITDA, Non-GAAP Adjusted	Press Release
EA.OQ	2023-05-09T17:00:00Z	Revenue	7700000000	7300000000	But in terms of the mobile growth for next year, our expectations are that mobile business in aggregate will be down year-on-year after FY '23, a large part of that related to the decision to sunset the Apex mobile title, and so that obviously is in the comparable for '23. I missed the first part of it. I'll start there and then I sort of missed the first part of your second question, so if you could repeat that here in a second. Let me address your first question.	Transcript
EA.OQ	2023-05-09T17:00:00Z	EBIT			And I would say that the comp is just quite a bit higher.	Transcript
CPRI.N	2023-05-31T06:45:00Z	Revenue	5700000000	5700000000	For Michael Kors, the Company expects the following:	Press Release
CPRI.N	2023-02-08T08:30:00Z	Revenue	957000000	957000000	Excluding Asia, we expect retail revenue to increase in the mid-single-digit range driven by our strategic initiatives.	Transcript
CPRI.N	2023-02-08T08:30:00Z	Revenue			Now I would like to discuss our expectations regarding the cadence of fiscal '24 revenue and earnings between the first and second half of the year.	Transcript
CPRI.N	2023-05-31T06:45:00Z	Revenue			For Michael Kors, the Company expects the following:	Press Release
CPRI.N	2023-05-31T06:45:00Z	Revenue			For Michael Kors, the Company expects the following:	Press Release
CPRI.N	2023-05-31T06:45:00Z	Revenue			For Michael Kors, the Company expects the following:	Press Release
CPRI.N	2023-02-08T08:30:00Z	Revenue			Now I would like to discuss our expectations regarding the cadence of fiscal '24 revenue and earnings between the first and second half of the year.	Transcript
CPRI.N	2023-05-31T06:45:00Z	EBIT			For Jimmy Choo, the Company expects the following: For Versace, the Company expects the following:	Press Release
CPRI.N	2023-02-08T08:30:00Z	EBIT			Relative to prior year, this will result in lower margins in the first half of fiscal '24 with margin expansion expected in the back half of the year.	Transcript
CPRI.N	2022-06-01T08:30:00Z	EBIT			Long term, we are confident in our ability to resume double-digit revenue increases as we move beyond the impact of current macro headwinds. The power of Versace, Jimmy Choo and Michael Kors, as well as the proven resilience of the luxury market, reinforce our optimism for the future and our ability to achieve $7 billion in revenue and a 20% operating margin over time. The power of Versace, Jimmy Choo and Michael Kors, as well as the proven resilience of the luxury market, reinforces our optimism for the future and our ability to achieve $7 billion in revenue and a 20% operating margin over time.	Transcript
CPRI.N	2023-05-31T06:45:00Z	EBIT			Fiscal Year 2024 Outlook	Press Release
CPRI.N	2023-05-31T06:45:00Z	EBIT			For Jimmy Choo, the Company expects the following: For Versace, the Company expects the following:	Press Release
CPRI.N	2023-05-31T06:45:00Z	EBIT			For Jimmy Choo, the Company expects the following: For Versace, the Company expects the following:	Press Release
TMUS.OQ	2023-02-28T09:40:00Z	Revenue	29200000000	28800000000	So despite anticipating the industry to go down, we do believe we're going to continue to take a bigger share of the pie with the value proposition, the network and again, really leveraging these underpenetrated markets.	Transcript
TMUS.OQ	2023-04-27T16:30:00Z	EBITDA			This is up 10% year-over-year at the midpoint based on higher service revenues and merger synergies, of course, excludes leasing revenues of approximately $300 million as we transition substantially all remaining customers off device leasing by year-end.	Transcript
CB.N						
TXN.OQ	2022-02-03T11:00:00Z	EBIT			On your specific question, again, we don't manage to gross margins, right?	Transcript
MDLZ.OQ	2023-02-21T15:00:00Z	Revenue	34621400000	34621400000	As a result, we are now increasing from 3% to 5% more revenue per sales goal. For example, more than 1 million stores around the globe now have access to our automated intelligence enabled suggested other function, which frees up our reps to engage 45% of more time in robust selling rather than administrative tasks. To take our performance to the next level, we are digitalizing our sales force to enable even more precise customer targeting and delivery.	Transcript
MDLZ.OQ	2022-10-25T16:05:00Z	Revenue			additional $600 million through 2030, for a total $1 billion investment since the start of the program, with the goal to increase cocoa volume at scale and work with about 300,000 farmers in the program by 2030.Â Â  With this	Press Release
MDLZ.OQ	2022-06-01T10:00:00Z	EBIT			Yes.	Transcript
BRO.N	2023-04-25T08:00:00Z	Revenue			While we anticipate National Programs will have a good 2023, we do expect lower organic growth in the second half of this year as compared to the second half of last year.	Transcript
BRO.N	2023-04-25T08:00:00Z	Revenue			And do you have a targeted leverage ratio that you're looking to get to? Now keep in mind that the revenue from the captives, right, will start to level out. Yes, I think we're just trying to estimate right now, it will -- we're anticipating to move back and forth a little bit.	Transcript
BRO.N	2022-07-26T08:00:00Z	Revenue			We're anticipating total revenues for July 2022 through June 2023 to be in the range of $375 million to $400 million and we've also provided the projections by segment.	Transcript
BALL.N	2023-05-04T11:00:00Z	Revenue			For the full year and incorporating year-to-date trends, our customer mix and excluding Russia, we now estimate low single-digit global volume growth for Ball, with North America being slightly down, South America volume up mid-single digits, EMEA volume up mid-single digits plus and our other non-reportable beverage business volumes up mid- to high single digits. Looking ahead, the breadth of retail summer promotional activity across our customer mix in North America, and the continuing successful ramp-up of our two new facilities in EMEA, will be the key drivers of our ultimate 2023 shipment growth.	Transcript
BALL.N	2023-02-02T11:00:00Z	EBIT			Including the $86 million Russian operating earnings headwind, comparable operating earnings should increase over $200 million in full year 2023, comparable D&A will likely be in the range of $560 million.	Transcript
BALL.N	2022-11-03T11:00:00Z	EBIT			And north of 15% next year is what we're looking at. And so maybe '23 to '25, do you expect kind of 10% to 15% EBIT growth for that business? And then on aerospace, our understanding is that '22 is kind of a transition year to the next, say, 2- or 3-year range of backlog. Is that right? Or how should we think about aerospace? Over that period, yes. We'll do 1 more question.	Transcript
PFG.OQ	2023-03-01T16:15:00Z	Revenue			2023 and long-term guidance Life Insurance Premium and fees(11) $923 $914 0-3% 1-4% table below and illustrated further in Exhibit 1.	Press Release
PFG.OQ	2023-03-01T16:15:00Z	Revenue			2023 and long-term guidance Life Insurance Premium and fees(11) $923 $914 0-3% 1-4% table below and illustrated further in Exhibit 1.	Press Release
PFG.OQ	2023-03-01T16:15:00Z	Revenue			2023 and long-term guidance Life Insurance Premium and fees(11) $923 $914 0-3% 1-4% table below and illustrated further in Exhibit 1.	Press Release
PFG.OQ	2023-03-02T10:00:00Z	Revenue			Additionally, in 2023, we expect $30 million to $40 million of lower gross performance fees compared to 2022 as they are expected to normalize after being elevated for several years. Long term, we expect growth in China and Brazil to contribute to margin expansion. PGI's revenue growth and margin are expected to be pressured in 2023 as we entered the year with lower AUM levels, the results of the macroeconomic headwinds in 2022.	Transcript
PFG.OQ	2023-03-01T16:15:00Z	Revenue			2023 and long-term guidance Life Insurance Premium and fees(11) $923 $914 0-3% 1-4% table below and illustrated further in Exhibit 1.	Press Release
PFG.OQ	2023-03-02T10:00:00Z	EBIT			In RIS, LDTI is negatively impacting the margin by about 1% and the underperformance of equity and fixed income markets in 2022 is pressuring growth in revenue and margin in 2023.	Transcript
PFG.OQ	2023-03-01T16:15:00Z	EBIT			excluding table below and illustrated further in Exhibit 1.	Press Release
PFG.OQ	2022-03-02T10:00:00Z	EBIT			In RIS-Spread, we expect the margin to improve relative to our prior guidance as our mix of business is shifting to higher-margin products.	Transcript
PFG.OQ	2023-03-01T16:15:00Z	EBIT			excluding table below and illustrated further in Exhibit 1.	Press Release
PFG.OQ	2023-03-01T16:15:00Z	EBIT			2023 and long-term guidance Guidance measure 2022 revenue, 2022 revenue, 2023 revenue Long-term amounts reflecting LDTI and excluding significant variances as shown in the significant variances(3) table below and illustrated further in Exhibit 1.	Press Release
PFG.OQ	2023-03-01T16:15:00Z	EBIT			excluding table below and illustrated further in Exhibit 1.	Press Release
KEYS.N	2023-05-16T16:30:00Z	Revenue			I mean, as I said, I think we largely think -- albeit at a lower level, we think -- we largely see things as stable here as we move from the first half into the second half, right?	Transcript
KEYS.N	2021-12-01T14:00:00Z	EBIT			And kind of on top of that, appreciating that you have a lot of internal attributes with your manufacturing and your supply chain, but there are inflationary pressures on component costs and stuff. And so our goal is to not just maintain margins, but over the long term, we've been on a nice run of expanding margins. How has that been managed by the company? That's a great overview. What have you done there and the stickiness of those price increases to the customers as you, I'm assuming you've invoked some.	Transcript
SEDG.OQ	2023-05-03T16:30:00Z	Revenue			We expect this momentum to continue in the coming quarters as we are still increasing capacity of backup inverters to deliver on the significant backlog and the strong demand for this product.	Transcript
SEDG.OQ	2022-12-01T12:30:00Z	EBIT			And I think that this is a very important point to mention because this industry has been an industry of losing companies.	Transcript
RL.N	2023-05-25T09:00:00Z	Revenue	6636908000	6508036000	For fiscal '24, we are guiding constant currency revenues to increase low single digits and foreign currency to benefit reported revenues by about 20 basis points. Importantly, we expect to deliver both revenue growth and margin expansion this year. We currently expect growth to be led by Asia, up double digits followed by low single-digit growth in Europe and a low single-digit decline in North America based on softer spring trends and Q1 wholesale timing shifts.	Transcript
RL.N	2023-05-25T09:00:00Z	Revenue			For fiscal '24, we are guiding constant currency revenues to increase low single digits and foreign currency to benefit reported revenues by about 20 basis points. Importantly, we expect to deliver both revenue growth and margin expansion this year. We currently expect growth to be led by Asia, up double digits followed by low single-digit growth in Europe and a low single-digit decline in North America based on softer spring trends and Q1 wholesale timing shifts.	Transcript
RL.N	2022-09-19T08:01:00Z	EBIT			rate of mid- to high-single digits in constant currency. Operating profit to at least 15% by Fiscal 2025 in constant currency, driven by a combination	Press Release
RL.N	2022-09-19T08:01:00Z	Revenue			Company expects an acceleration in revenue growth to a compound annual growth	Press Release
JPM.N	2023-02-15T15:20:00Z	Revenue			And I guess within -- just going back to -- you mentioned halfway into the quarter, a lot could change. For the rest of the macro franchise, again, very robust in starting. We believe that in commodities, the opportunity, particularly in energy, will last more than just last year.	Transcript
INFO.N^B22	2021-12-16T10:30:00Z	Revenue			1% y/y, to 23.4 million units, as supply chain shortages choke off market 15.1 million units. "For 2022, the pace of sales is expected to quicken in the 2019. 2022 demand is set at 15.0m units (+7.8%), according to IHS Markit. 2022, up from an estimated 15.7 million this year. For the North American COVID-19, but the new year might struggle to deliver meaningful improvement to German-based production. The 2021 Western and Central European demand forecast IHS Markit (NYSE: INFO), a world leader in information, analytics and In Greater China, IHS Markit forecasts modest growth for 2022 of 1.6 percent, In Mainland Chinaâ€”for 2021, IHS Markit analysts foresee the market down by Looking at 2022, US sales volumes are expected to reach nearly 15.5 million Markit. The European auto industry looks set for a bleak mid-winter as widening virus above pre-crisis levels to 26.9 million, up by 11.3% y/y. assuming the ongoing availability of effective vaccines and apart from any challenged. Tentative demand recovery will continue across most regions, concerns combine with ongoing supply chain woes, with concerns for continue to be restrained next year as the semiconductor supply chain remains current forecasts remains at nearly 15.2 million units; this reflects growth foresees 13.9 million units, just scraping into growth territory, up 0.2% y/y. further 10% y/y increase, and comfortably above pre-pandemic output levels of growth. Near-term risks are balanced, and 2022 is currently set at 24.2 in 2022, up 3.7%. IHS Markit projects the industry will finish out 2021 with is forecast to support vehicle output levels of 90.6 million units for 2023, a major impacts from the Omicron variant. million (+3.3% y/y), with more meaningful recovery expected for 2023â€”back nearly 79.4 million light vehicles sold, and industry demand levels will new car sales levels,â€ said Couchman. of just over 2.2 million units year over year. A more normalized supply chain project significant demand recovery in the first half of 2022. But we expect region, momentum is improving heading into 2022, though our outlook based on second half of the year. Given current inventory conditions, it's difficult to setting the stage for better volume outlooks into 2023 and 2024,â€ according solutions, forecasts new light vehicle sales of nearly 82.4 million globally to 24.3 million units. Europe is expected to produce 18.5 million units in to Chris Hopson, manager, North American light vehicle sales forecast, IHS to exit 2022 with a pace of sales more recognizable to pre-COVID levels, units, up an estimated 2.6% from the projected 2021 level of approximately â€œEuropean car consumers are expected to hunker down for a second winter of	Press Release
INFO.N^B22	2021-03-23T08:00:00Z	Revenue			Lance, I was hoping you could help just provide some of the key takeaways from CERAWeek, when you look out over the next couple of years or maybe 3 to 5 years, and there's obviously a lot of movement.	Transcript
TTWO.OQ	2023-05-17T16:30:00Z	Revenue	5470000000	5370000000	We expect GAAP net revenue to range from $5.37 billion to $5.47 billion and cost of revenue to range from $2.51 billion to $2.54 billion.	Transcript
TTWO.OQ	2023-05-17T16:05:00Z	EBITDA	479000000	427000000	* EBITDA (Non-GAAP) is expected to range from $427 to $479 million EBITDA Â  $427 to $479 GAAP Non-GAAP compensation deferred net	Press Release
CDW.OQ	2023-04-18T16:05:00Z	Revenue			expect the US IT market to decline at a high single-digit rate in 2023, recognizing that a number of wildcards may impact this view as the year	Press Release
CDW.OQ	2023-02-08T08:30:00Z	EBIT			We expect our full year non-GAAP operating income margin to be in the mid- to high 8% range.	Transcript
RMD.N	2023-04-27T16:30:00Z	Revenue			However, looking forward, we expect negligible revenue from COVID-related demand.	Transcript
LNT.OQ						
CMG.N	2023-04-25T16:30:00Z	Revenue			And this brings me to expanding access convenience with a long-term target of 7,000 restaurants in North America. The expansion of Chipotlanes adds additional convenience by adding our unique order pick-up channel, which comes with a larger digital penetration driven by the order ahead business. We remain on track to grow new restaurants 8% to 10% per year for the foreseeable future with at least 80% including a Chipotlane.	Transcript
CMG.N	2022-02-08T16:30:00Z	EBIT			And it's a combination of the sales growth and, obviously, pricing where we need to, when we need to. And just kind of the go forward, if you could kind of give any kind of color as we go through the year, what that margin trajectory looks like and related -- as it relates to that long-term algorithm you provided, if there's any change there or if it's kind of consistent with what you've messaged prior. And then we've got a lot of initiatives going on, make sure that we're as efficient as possible. I guess both for kind of the 1Q, I think Jack and Brian, you talked to, I think, low to mid-23 sort of underlying. So long term, we've got 100% confidence in what we can achieve. To answer your question, the long-term algorithm, we still believe we will achieve it. Wanted to focus a little bit more on the margin. Wondering if you could just talk a little bit more about what goes into that.	Transcript
PCAR.OQ	2023-01-24T12:00:00Z	Revenue			But we also see more and more benefits of the used truck centers that we have been developing and opening over the recent years. In 2023, we expect used truck prices to moderate but remain historically strong. Past dues are low, less than 1.5%. So yes, customers continue to pay their bills and the finance company continues to benefit from that. The 2023 U.S. and Canadian Class 8 truck market deliveries are forecast to be in a range of 270,000 to 310,000 vehicles.	Transcript
PCAR.OQ	2023-01-24T08:00:02Z	Revenue			environment.â€ U.S. and Canada Class 8 truck industry retail sales are estimated to be in a range of 270,000-310,000 trucks in 2023.	Press Release
GNRC.N	2023-02-15T10:00:00Z	Revenue	4290852780	4108263300	Global interest in our C&I products and services has never been stronger and is well positioned to continue growing in 2023.	Transcript
GNRC.N	2023-05-03T10:00:00Z	Revenue	772353550	698404760	Additionally, this outlook does not assume a prolonged deep recessionary environment that meaningfully impacts consumer spending during 2023. Having said that, demand for our home standby products tends to be driven more by power outages rather than overall macroeconomic conditions.	Transcript
GNRC.N	2023-05-03T10:00:00Z	EBITDA			Given these gross margin and operating expense expectations, adjusted EBITDA margins before deducting for noncontrolling interests are still expected to be approximately 17% to 18% for the full year.	Transcript
GNRC.N	2023-02-15T10:00:00Z	Revenue			Global interest in our C&I products and services has never been stronger and is well positioned to continue growing in 2023.	Transcript
CHTR.OQ	2023-01-27T08:30:00Z	Revenue			But that year-over-year growth should moderate in the second half of 2023.	Transcript
CHTR.OQ	2023-02-28T12:10:00Z	EBITDA			And that's really what gives us the ability to make the decisions that we've made to take some of that capital that we have now and invest it in future growth to generate continued growth in the long term on that already growing cash flow base.	Transcript
PWR.N	2023-05-04T09:00:00Z	Revenue	19100000000	18600000000	Our segment revenue expectations are unchanged, but we now expect full year margins to range between 7% and 7.5%. Regarding our Renewable segment, given the strength of the first quarter and increased project awards, we are raising our full year revenue expectations for the segment by $200 million, ranking between $4.5 billion and $4.7 billion.	Transcript
PWR.N	2023-05-04T06:55:08Z	EBITDA	1951300000	1838200000	Full Year Ending	Press Release
PWR.N	2023-05-04T09:00:00Z	Revenue			Our segment revenue expectations are unchanged, but we now expect full year margins to range between 7% and 7.5%. Regarding our Renewable segment, given the strength of the first quarter and increased project awards, we are raising our full year revenue expectations for the segment by $200 million, ranking between $4.5 billion and $4.7 billion.	Transcript
PWR.N	2023-05-04T09:00:00Z	Revenue			Our segment revenue expectations are unchanged, but we now expect full year margins to range between 7% and 7.5%. Regarding our Renewable segment, given the strength of the first quarter and increased project awards, we are raising our full year revenue expectations for the segment by $200 million, ranking between $4.5 billion and $4.7 billion.	Transcript
PWR.N	2023-05-04T09:00:00Z	Revenue			Our segment revenue expectations are unchanged, but we now expect full year margins to range between 7% and 7.5%. Regarding our Renewable segment, given the strength of the first quarter and increased project awards, we are raising our full year revenue expectations for the segment by $200 million, ranking between $4.5 billion and $4.7 billion.	Transcript
PWR.N	2023-05-04T09:00:00Z	EBIT			From a segment perspective, we continue to see Electric segment revenues between $10 billion and $10.1 billion for the year, with full year margins between 10.7% and 11.3%. Our segment revenue expectations are unchanged, but we now expect full year margins to range between 7% and 7.5%.	Transcript
PWR.N	2023-05-04T09:00:00Z	EBIT			From a segment perspective, we continue to see Electric segment revenues between $10 billion and $10.1 billion for the year, with full year margins between 10.7% and 11.3%. Our segment revenue expectations are unchanged, but we now expect full year margins to range between 7% and 7.5%.	Transcript
PWR.N	2023-05-04T09:00:00Z	EBIT			From a segment perspective, we continue to see Electric segment revenues between $10 billion and $10.1 billion for the year, with full year margins between 10.7% and 11.3%. Our segment revenue expectations are unchanged, but we now expect full year margins to range between 7% and 7.5%.	Transcript
PWR.N	2023-05-04T06:55:08Z	EBITDA			Estimated Range range between $1.70 billion and $1.82 billion and adjusted EBITDA (a non-GAAP	Press Release
PWR.N	2023-02-23T09:00:00Z	EBITDA			Just the $580 million that -- for 3 deals is actually a fairly large amount for you guys when you usually do kind of more smaller bolt-on ones per quarter. So maybe you could just give a little bit of guidance around the revenue and EBITDA contribution in 2023 from that incremental M&A? These segment operating ranges support our expectation for 2023 annual consolidated revenues of $18.4 billion to $18.9 billion and adjusted EBITDA of between $1.8 billion and $1.9 billion.	Transcript
CCL.N	2023-03-27T10:00:00Z	Revenue	4100000000	3900000000	We now expect capacity growth for the full year 2023 to be 4.5% when compared to 2019.	Transcript
CCL.N	2023-03-27T10:00:00Z	EBITDA			Putting all these factors together, we expect $3.9 billion to $4.1 billion of adjusted EBITDA for the full year 2023.	Transcript
CCL.N	2022-06-24T10:00:00Z	EBITDA			Thank you, Arnold. We're looking forward to your leadership.	Transcript
PM.N	2023-02-22T11:00:00Z	Revenue			And that is translating of course in a very strong growth at the level of the revenue and with the guidance that we gave for 2023. We would be further -- three year in a row growing above 7% organic our revenue so fast growing company, both at the level of volume and at the level of revenue. Well, with a target that we are for 2023, we would be growing for the third year in a row the total volumes and of course, that doesn't take into account here the additional growth in volume that Swedish Match is going to bring to us.	Transcript
PM.N	2023-02-09T09:00:00Z	Revenue			If favorable, the difference to our forecasted 2023 excise payment would increase our net revenue by around 1% and adjusted diluted EPS growth by around 3 points, thereby increasing our forecast currency-neutral growth range to plus 10% to plus 12%.	Transcript
PM.N	2023-04-20T09:00:00Z	EBIT			Therefore, and as explained previously, we expect a progressive improvement in our gross profit and OI margin notably weighted towards H2 as headwinds subside and the underlying driver of our transformation accelerate.	Transcript
COO.N	2023-06-01T16:15:00Z	Revenue	3569000000	3512000000	Fiscal Year 2023 Financial Guidance The Company updated its fiscal year 2023 financial guidance. Details are to 9%) * CVI revenue of $2,365 - $2,400 million (organic growth of 8% to 10%)	Press Release
COO.N	2023-06-01T16:15:00Z	Revenue			Fiscal Year 2023 Financial Guidance The Company updated its fiscal year 2023 financial guidance. Details are to 9%) * CVI revenue of $2,365 - $2,400 million (organic growth of 8% to 10%)	Press Release
COO.N	2023-06-01T16:15:00Z	Revenue			Fiscal Year 2023 Financial Guidance The Company updated its fiscal year 2023 financial guidance. Details are to 9%) * CVI revenue of $2,365 - $2,400 million (organic growth of 8% to 10%)	Press Release
COO.N	2023-03-21T13:30:00Z	EBIT			And so we're going to drive operating margin expansion incrementally year-after-year, but we'll want to reinvest in our business to make sure that we're driving that durable top line growth. That's critical.	Transcript
COO.N	2023-03-21T13:30:00Z	Revenue			I mean, implied in the midpoint of our guidance on a consolidated basis is revenues of 7.5% to 8% growth on a constant -- on an organic basis.	Transcript
SNA.N						
UAL.OQ	2023-04-19T10:30:00Z	Revenue			While further return to corporate business will help profitability in all quarters, we're not assuming that will occur in our 2023 revenue outlook.	Transcript
UAL.OQ	2023-02-23T09:45:00Z	EBIT			And for a good reason, we've got more leverage than we did going into the pandemic. And so you combine that balance sheet that has been relatively protected and the margins that we think we're going to deliver and are -- we're going to grow into our debt and the balance sheet is going to I think if you deliver 9% margin and a 14% margin in '20, the debt that we have is quite manageable. Yes, I'll try to come back to that, Brandon.	Transcript
ESS.N	2023-02-07T16:15:00Z	Revenue			Estimated Same-Property Portfolio Growth based on 50,064 Apartment Homes Midpoint Cash-Basis Midpoint GAAP-Basis Revenues 3.25% to 4.75% 4.00% 4.40%	Press Release
ESS.N	2023-04-27T16:15:00Z	EBIT			Midpoint	Press Release
KHC.OQ	2023-02-15T09:00:00Z	Revenue	6363180000	6243120000	And when you detailed this, I guess, at CAGNY, a year ago, you sort of, I think, said it would take multiple years to reach this level of growth.	Transcript
KHC.OQ	2023-05-03T09:00:00Z	EBITDA			We are so confident that we are raising our guidance on EBITDA and earnings.	Transcript
JBHT.OQ	2023-05-18T11:20:00Z	Revenue			Or is there other costs involved in that.	Transcript
JBHT.OQ	2023-05-23T08:35:00Z	EBIT			But in general, we're going to be within that guidance range. Darren, you have 10% to 12%, right?	Transcript
CMI.N	2023-05-02T10:00:00Z	EBITDA	33688800000	32285100000	We have also revised our forecast for EBITDA to be in the range of 15% to 15.7% from our previous guidance of 14.5% to 15.2%, reflecting very strong incremental margins while we continue to invest for the future within our core business and Accelera.	Transcript
CMI.N	2023-05-02T10:00:00Z	EBITDA	5289141600	4842765000	2023 EBITDA is projected to be in the range of 13.8% to 14.5% of sales flat with previous guidance.	Transcript
CMI.N	2023-05-02T10:00:00Z	EBITDA			2023 EBITDA is projected to be in the range of 13.8% to 14.5% of sales flat with previous guidance.	Transcript
CMI.N	2023-05-02T10:00:00Z	Revenue			For Accelera, we are expecting full year sales to be $350 million to $400 million, consistent with our prior guidance.	Transcript
CMI.N	2023-05-02T07:30:00Z	Revenue			separation of the Filtration business. Within the Components Segment, Cummins	Press Release
CMI.N	2022-11-15T12:15:00Z	Revenue			I think $50 million to $100 million of revenue this year.	Transcript
CMI.N	2023-05-02T10:00:00Z	EBITDA			2023 EBITDA is projected to be in the range of 13.8% to 14.5% of sales flat with previous guidance.	Transcript
CMI.N	2023-02-06T07:30:00Z	EBITDA			million included in the overall guidance for that segment. to $4.7 billion, and EBITDA to be in the range of 10.3 to 11.0 percent of	Press Release
CMI.N	2023-05-02T10:00:00Z	EBIT			Components, we expect total 2023 revenues to increase between 32% and 37%, up 4% from prior year guidance and EBIT margin to be in the range of 14.1% to 14.8%, unchanged from 3 months ago.	Transcript
CMI.N	2023-02-06T07:30:00Z	EBIT			our New Power segment in 2023.â€	Press Release
CMI.N	2023-05-02T10:00:00Z	EBITDA			2023 EBITDA is projected to be in the range of 13.8% to 14.5% of sales flat with previous guidance.	Transcript
CMI.N	2023-05-02T07:30:00Z	EBITDA			separation of the Filtration business. Within the Components Segment, Cummins to $4.9 billion, an increase from $4.5 billion to $4.7 billion previously, and	Press Release
CMI.N	2023-02-06T10:00:00Z	EBITDA			I guess, I would have thought margins would have been a little better in implied guide just given maybe price cost going away, China improving.	Transcript
PNR.N	2022-10-25T09:00:00Z	Revenue	4121800000	4039364000	And third, we believe the diversity of our portfolio will be demonstrated and create resiliency.	Transcript
PNR.N	2022-03-03T08:30:00Z	EBITDA	842490000	819513000	As discussed, we expect this deal will be meaningfully accretive to adjusted EPS and will add significant sales growth, EBITDA margin expansion and cash flow.	Transcript
PNR.N	2022-03-03T08:30:00Z	EBIT			With this acquisition, we will be creating a combined commercial water solutions food service platform of approximately $700 million in sales with an operating margin of around 25% in 2023.	Transcript
CRL.N	2022-02-16T08:30:00Z	Revenue	4154982700	4055581200	We're very pleased with the mid-teens growth rate forecast for 2022 and expect the Manufacturing segment will achieve its 2024 target of approaching 20% growth once the benefit of the high-growth CDMO business is fully reflected in the organic growth rate and the CDMO scale continues to increase.	Transcript
CRL.N	2022-01-11T10:30:00Z	Revenue			And manufacturing is approaching at 20% for 2024 now. And manufacturing is slightly below in the mid -- but also in the mid-teens, but that should pick up and accelerate over the next couple of years as the CDMO business really comes into its own. As I said, we're below that right now, but cell and gene therapy should drive us there. DSA is above those targets in the mid-teens. DSA segment 2024 goal was around 10% growth and at least mid-20s operating margin. So I want to remind you of our 2024 goals, which were RMS mid-to-high single digits and operating margins in the high 20s, where we're knocking all those numbers now.	Transcript
CRL.N	2022-06-08T10:00:00Z	Revenue			I talked about double-digit organic growth rate.	Transcript
CRL.N	2023-03-20T18:46:03Z	Revenue			this year and reduce revenue growth by 200 to 400 basis points. As a result,	Press Release
CRL.N	2022-11-02T09:00:00Z	Revenue			So we have to call it right now -- so we're building space in that right now.	Transcript
CRL.N	2022-01-11T10:30:00Z	Revenue			And manufacturing is approaching at 20% for 2024 now. And manufacturing is slightly below in the mid -- but also in the mid-teens, but that should pick up and accelerate over the next couple of years as the CDMO business really comes into its own. As I said, we're below that right now, but cell and gene therapy should drive us there. DSA is above those targets in the mid-teens. DSA segment 2024 goal was around 10% growth and at least mid-20s operating margin. So I want to remind you of our 2024 goals, which were RMS mid-to-high single digits and operating margins in the high 20s, where we're knocking all those numbers now.	Transcript
CRL.N	2022-01-11T10:30:00Z	EBIT			And the cell and gene therapy, CDMOs are the third major part is growing faster than the other 2 parts of this business. We -- our long-term guidance is that we're going to be slightly below that or around mid-30s.	Transcript
CRL.N	2022-01-11T10:30:00Z	EBIT			The most significant demand that we've seen for our products and services across the board.	Transcript
CRL.N	2022-02-16T08:30:00Z	EBIT			And we still believe in the long-term targets for 2024, another 150 basis points if you take this year and the next couple of years. On a segment basis, the DSA operating margin is expected to be the primary contributor to the margin improvement in 2022 as leverage from higher revenue growth is expected to drive the operating margin towards its longer-term target in the mid-20% range. We are also confident in our ability to achieve our 2024 financial targets, including approximately 150 basis points of operating margin expansions from the 2021 level.	Transcript
CRL.N	2023-02-22T08:30:00Z	EBIT			Based on our expectations for the CDMO business, we believe the Manufacturing operating margin will improve meaningfully in 2023 to above the 30% level.	Transcript
CRL.N	2022-11-02T09:00:00Z	EBIT			You have that roughly 22.5% off-margin target for 2024.	Transcript
DPZ.N	2023-02-23T07:30:04Z	Revenue			(versus 2022) ((1)) Fiscal 2023 Guidance Impact of changes in foreign currency exchange rates on international $(2.0) - $(6.0) million Market basket pricing change (versus 2022) ((1)) + 3% - + 5% franchise royalty revenues	Press Release
DPZ.N	2023-04-27T10:00:00Z	Revenue			Changes in foreign currency rates could have a $2 million to $6 million negative impact on international royalty revenues in 2023.	Transcript
DPZ.N	2023-02-23T10:00:00Z	EBIT			If foreign currency remains at current levels, or increase as a headwind going forward, we expect that this will be a barrier to recovering to our prepandemic operating income margins.	Transcript
DPZ.N	2023-02-23T10:00:00Z	EBITDA			So I think in terms of franchise EBITDA, we expect '23 to be improved versus 2022, for sure, given the pricing changes that we made towards the back half of the year and the lowering pressure from food basket and costs that we anticipate in '23.	Transcript
AGN.N^E20						
HPQ.N	2022-11-22T17:00:00Z	Revenue			But we do expect some improvement in our revenue trajectory in the second half of '23. For FY '23, we expect to be within that range in aggregate. Furthermore, normal, quarterly sequential seasonality does not apply for FY '23, given the dynamic macro environment.	Transcript
HPQ.N	2023-02-28T17:00:00Z	Revenue			What is it you see in the data? You obviously just guided the PC market a little weaker than you communicated 3 months ago.	Transcript
HPQ.N	2023-03-06T11:35:00Z	Revenue			I think what is probably important to highlight is, we see what we call sellouts or shipments for sales to real customers, virtual shipments to the channel have been stronger because the channel is being reduced which means that real and customer demand is stronger than what the current numbers are reflected.	Transcript
HPQ.N	2023-05-30T17:00:00Z	EBIT			For FY '23, we expect margins to be solidly in our target range driven by the gradual improvement in PC revenue in the back half of the year and increasing Future Ready transformation savings. We expect Print margins to be above the high end of our 16% to 18% target range for H2 '23, driven by disciplined pricing and cost management and continued progress on rebalancing our system profitability.	Transcript
HPQ.N	2022-11-22T17:00:00Z	EBIT			The Poly integration is going well so far with the business performing better than expected. We are well positioned to accelerate our peripheral growth, and we expect Poly to be accretive to non-GAAP operating profit and EPS in fiscal year '23.	Transcript
HPQ.N	2023-02-28T17:00:00Z	EBIT			Another really strong quarter. Do you expect to be above that range for the full year?	Transcript
HPQ.N	2023-05-30T17:00:00Z	EBIT			For FY '23, we expect margins to be solidly in our target range driven by the gradual improvement in PC revenue in the back half of the year and increasing Future Ready transformation savings. We expect Print margins to be above the high end of our 16% to 18% target range for H2 '23, driven by disciplined pricing and cost management and continued progress on rebalancing our system profitability.	Transcript
LW.N	2023-04-06T10:00:00Z	Revenue	5350000000	5250000000	And in Retail, we expect the year-over-year growth rate in price/mix will also decelerate as we continue to lap last year's pricing actions, although this will be tempered by a recent price increase that took effect towards the end of the third quarter.	Transcript
LW.N	2023-04-06T10:00:00Z	Revenue	1210000000	1180000000	And in Retail, we expect the year-over-year growth rate in price/mix will also decelerate as we continue to lap last year's pricing actions, although this will be tempered by a recent price increase that took effect towards the end of the third quarter.	Transcript
LW.N	2023-04-06T10:00:00Z	Revenue			And in Retail, we expect the year-over-year growth rate in price/mix will also decelerate as we continue to lap last year's pricing actions, although this will be tempered by a recent price increase that took effect towards the end of the third quarter.	Transcript
LW.N	2023-04-06T10:00:00Z	EBITDA			The additional $100 million to $115 million increase in our full year EBITDA target reflects our strong results in our fiscal third quarter, and our expected strong sales and earnings growth in the fourth quarter.	Transcript
LW.N	2022-10-05T10:00:00Z	Revenue			We're well positioned to deliver at the upper end of our financial target ranges for the year, and we're making the necessary investments in our production capacity and operating infrastructure to support long-term growth and create value for our shareholders.	Transcript
TGT.N	2022-05-18T06:30:03Z	Revenue	1000000000	1000000000	confidence in our long-term financial algorithm, which anticipates mid-single costs, driven by a number of factors, resulting in profitability that came in dedicated to our guests and serving their needs, giving us continued digit revenue growth, and an operating margin rate of 8 percent or higher over growth of nearly 4 percent. Throughout the quarter, we faced unexpectedly high time. Despite these near-term challenges, our team remains passionately time." well below our expectations, and well below where we expect to operate over	Press Release
TGT.N	2023-05-17T08:00:00Z	EBIT			We expect to grow our full year operating income by $1 billion or more, and we expect our business to generate full year GAAP and adjusted EPS of $7.75 to $8.75.	Transcript
TGT.N	2023-05-17T06:30:04Z	EBIT			As we look ahead, we now expect shrink will reduce this year's profitability by more than $500 million compared with last year. While there are many	Press Release
NTAP.OQ	2023-02-22T17:00:00Z	Revenue	6043900000	5853040000	And how much of it was, I don't know, the proverbial back office versus revenue-focused headcount? And then do you see the resumption of growth happening in '24 as you go forward? And there was no predictable pattern in terms of what types of customers. And we feel good about the fact that we continue to broaden the number of use cases and customer value propositions we can address that should benefit us moving forward with a more focused route-to-market approach for cloud as well. Even though the impact in the quarter from there being acquired is lower, we had -- we saw no changes to the churn in our cloud storage business, but we did see optimization, meaning movement of capacity from higher cost, more high-performance levels to lower cost, lower performance levels. I think that we see the impact of a tough macro environment on customer spending. We remain confident in our long-term Public Cloud gross margin goal of 75% to 80% as the business scales and an increasing percentage of our Public Cloud revenue is driven by cloud and software solutions.	Transcript
NTAP.OQ	2023-02-22T17:00:00Z	Revenue			And how much of it was, I don't know, the proverbial back office versus revenue-focused headcount? And then do you see the resumption of growth happening in '24 as you go forward? And there was no predictable pattern in terms of what types of customers. And we feel good about the fact that we continue to broaden the number of use cases and customer value propositions we can address that should benefit us moving forward with a more focused route-to-market approach for cloud as well. Even though the impact in the quarter from there being acquired is lower, we had -- we saw no changes to the churn in our cloud storage business, but we did see optimization, meaning movement of capacity from higher cost, more high-performance levels to lower cost, lower performance levels. I think that we see the impact of a tough macro environment on customer spending. We remain confident in our long-term Public Cloud gross margin goal of 75% to 80% as the business scales and an increasing percentage of our Public Cloud revenue is driven by cloud and software solutions.	Transcript
NTAP.OQ	2023-05-31T16:01:00Z	EBIT			The Company provided the following financial guidance for the full fiscal year	Press Release
NTAP.OQ	2023-05-31T16:01:00Z	EBIT			The Company provided the following financial guidance for the full fiscal year	Press Release
OXY.N	2023-02-28T13:00:00Z	Revenue			We expect 2023 to be another strong year by historical standards, though it is unlikely to match 2022.	Transcript
OXY.N	2023-05-10T13:00:00Z	EBITDA			For example, our new OxyChem projects are expected to contribute $300 million to $400 million in incremental annual EBITDA, with benefits expected to start in late 2023 and full project benefits expected in early 2026.	Transcript
IR.N	2023-03-08T09:40:00Z	Revenue	6626256000	6507930000	Now I would say other than some of those longer cycle projects, that visibility may be where you typically walk into your U.S. visibility for a portion of Q1, you've got visibility more of it into Q2. The MQLs are the marketing qualified leads, this is really a kind of an output and the construct of our demand generation engine.	Transcript
IR.N	2023-05-03T16:30:00Z	Revenue	1710000000	1660000000	FX Impact(3) (~1%) ~ Flat	Press Release
IR.N	2023-05-04T08:00:00Z	EBITDA			This will imply delivering an approximately 45% of our adjusted EBITDA in the first half of the year and 55% in the second half, which generally means that the balance of our adjusted EBITDA guidance raised, in addition to the Q1 outperformance, will fall into the second half of the year. Total adjusted EBITDA for the company is expected to be in the range of $1.66 billion and $1.71 billion, which is up 5% versus our initial guidance.	Transcript
IR.N	2023-05-04T08:00:00Z	EBITDA			This will imply delivering an approximately 45% of our adjusted EBITDA in the first half of the year and 55% in the second half, which generally means that the balance of our adjusted EBITDA guidance raised, in addition to the Q1 outperformance, will fall into the second half of the year. Total adjusted EBITDA for the company is expected to be in the range of $1.66 billion and $1.71 billion, which is up 5% versus our initial guidance.	Transcript
TER.OQ	2023-04-27T08:30:00Z	Revenue			Our strategy is to address this market with an expanding range of applications for our robots and a focused distribution strategy that we expect to yield an average 20% to 30% annual growth over the midterm. So second half, I think you asked about SOC revenue in the second half.	Transcript
TER.OQ	2023-04-27T08:30:00Z	Revenue			Our strategy is to address this market with an expanding range of applications for our robots and a focused distribution strategy that we expect to yield an average 20% to 30% annual growth over the midterm. So second half, I think you asked about SOC revenue in the second half.	Transcript
TER.OQ	2022-10-26T08:30:00Z	Revenue			And that alone would add significantly to the growth that we saw in 2022 because that was like a 10-point headwind to where we are. Balancing these balloons are a few anchors. Beyond that, we do expect significant impact from new products, both from UR and from MiR in 2023. Could those be sort of impactful enough for your growth to accelerate in '23? I realize it's hard to predict what 2023 could look like. So in other words, we are expecting these new things to help out with growth. So overall, they're going to have a greater impact on growth in 2023 than they had in 2022.	Transcript
TER.OQ	2023-01-26T08:30:00Z	EBIT			IA profitability is planned to be in the range of 5% to 15% profit level on higher volume.	Transcript
TER.OQ	2023-04-27T08:30:00Z	EBIT			In 2023, we expect profitability of UR to be in that 10% to 15% range.	Transcript
WAB.N	2022-03-09T06:30:00Z	Revenue	9000000000	8700000000	strategy, margin expansion drivers, and capital allocation plans. Wabtecâ€™s	Press Release
WAB.N	2023-05-09T10:55:00Z	Revenue			And the core growth of the rail industry or rail and transit, the industries that we participate in, not huge, right? And when looking at your a 5-year outlook.	Transcript
WAB.N	2023-02-15T08:30:00Z	EBIT			I think you saw some of my comments when it comes down to visibility into '24 and '25.	Transcript
WAB.N	2022-02-16T08:30:00Z	Revenue			Excluding near-term supply chain challenges, we estimate that transit sales would have been up on a year-over-year basis. Looking forward, we expect our service long-term orders to normalize in 2022. This year's backlog growth was driven by an unusually high number of long-term service contracts. We believe the medium and long-term outlook for this segment remains positive as infrastructure spendings for green initiatives continue. We expect long-term revenue growth in the majority of our end markets.	Transcript
FBIN.N	2023-05-09T16:05:00Z	EBITDA	4486850000	4392390000	for 2023. We believe we will be able to deliver this strong near-term	Press Release
FBIN.N	2023-04-26T17:00:00Z	EBITDA	897370000	834554100	We are mindful of the ongoing uncertainties inherent in the external macro environment, and we continue to expect full year net sales to be down in the range of 5% to 7%, operating margins to be between 16% and 17%, and EBITDA margins to be between 19% and 20%.	Transcript
FBIN.N	2023-04-26T17:00:00Z	EBIT	762764500	702782400	So that's how the company and the portfolio is geared towards that 25% to 30% decremental.	Transcript
NOW.N	2023-04-26T16:10:00Z	Revenue			($ millions)((3)) GAAP Guidance Margin (%) ((2))	Press Release
NOW.N	2023-04-26T17:00:00Z	Revenue			We are raising our subscription revenue outlook by $25 million at the midpoint to a range of $8.47 billion and $8.52 billion, representing 23% to 23.5% year-over-year growth on both a reported and constant currency basis.	Transcript
NOW.N	2023-04-26T16:10:00Z	EBIT			December 31, 2023	Press Release
NOW.N	2023-04-26T17:00:00Z	EBIT			We expect subscription gross margin of 84%, operating margin of 26%, a free cash flow of 30%. With that in mind, let's turn to our 2023 guidance.	Transcript
EXC.OQ	2023-02-14T06:50:00Z	Revenue			allowed ROE of 7.85%, reflecting the monthly average yields for 30-year	Press Release
EXC.OQ	2022-11-03T10:00:00Z	Revenue			Is that a fair way to interpret that specific language you used? So we're doing all the things we can to control cost heading into '23.	Transcript
EXC.OQ	2022-08-03T10:00:00Z	EBIT			The net results in our operating -- or opportunity to invest the $29 billion of capital over the next 4 years for our customers with an annualized 6% to 8% operating earnings growth through 2025, and we expect to pay out 60% of those operating earnings each year to our stakeholders -- shareholders.	Transcript
BR.N	2023-05-22T08:40:00Z	Revenue	6222919000	6051646000	And that has been very healthy.	Transcript
BR.N	2023-03-07T12:10:00Z	Revenue			And you mentioned a couple of times this morning that free cash flow conversion will return to historical levels by fiscal '24 as you lap the development and testing costs, et cetera, that are starting to come down.	Transcript
EMN.N	2023-04-28T08:00:00Z	Revenue			And Mark, just on Fibers. And that's due to the conversation we've just had around the weakness in the market on the demand front being pretty substantial. What -- we're really excited about it.	Transcript
EMN.N	2023-04-28T08:00:00Z	Revenue			And Mark, just on Fibers. And that's due to the conversation we've just had around the weakness in the market on the demand front being pretty substantial. What -- we're really excited about it.	Transcript
EMN.N	2023-04-27T16:15:00Z	EBIT			$200 million for the year, net of inflation. We also delivered strong allowing us to substantially recover our margins as we realize lower raw with our pricing discipline, which we expect will continue through the year,	Press Release
EMN.N	2022-03-17T10:30:00Z	EBITDA			$100 million, $125 million. So when I do the numbers, I get about $100 million in EBITDA.	Transcript
AZO.N	2023-05-23T10:00:00Z	Revenue			We will, as always, be transparent about what we are seeing and provide color on our markets and performance as trends emerge.	Transcript
AZO.N	2023-02-28T10:00:00Z	EBIT			Higher debt levels and expected continuing higher borrowing costs are driving this increase. We're planning interest in the $72 million range for the third quarter of fiscal 2023 versus $42 million in last year's third quarter.	Transcript
TEL.N	2023-01-25T08:30:00Z	Revenue			We now expect the full year impact to be roughly half of this number at the current exchange rates.	Transcript
TEL.N	2023-04-26T08:30:00Z	Revenue			And I think it shows where we position the business. And I think we talked about last quarter, our industrial equipment market showed some plateauing in some areas. And also, we do expect this year in excess of $2 billion of our automotive revenue will be from electric vehicles. I think you get into the industrial businesses, we have 3 markets that still remember, remain strong. Now the one thing we do have this year and our growth of content is the benefit from the pricing that we put in to offset inflation. So that's about 300 basis points more on the growth than we would normally have.	Transcript
TEL.N	2023-04-26T08:30:00Z	EBIT			Communications should remain in the mid-teens at the expected volume levels that Terrence mentioned.	Transcript
TEL.N	2023-01-25T08:30:00Z	EBIT			We expect adjusted operating margins to improve sequentially into quarter 2 and get back to the high teens in the second half of this year, as we mentioned last quarter.	Transcript
TEL.N	2023-04-26T06:00:08Z	EBIT			half of the year, driven by further margin improvement in our Transportation	Press Release
FRT.N	2023-02-08T17:00:00Z	Revenue			A big driver of our growth in 2022 was the continued stabilization of a large portion of our redevelopment and expansion pipeline.	Transcript
FRT.N	2022-11-03T17:00:00Z	EBIT			I know you raised the guidance, but just curious on what the fourth quarter implied expectation is with the upward (inaudible) provide us guidance to think about a number for 2023? In terms of capital needed for our large development projects, we have less than an incremental $225 million to go. Just curious on the guidance for same-store NOI and what has been delivered year-to-date and kind of what the exit implied is for the ex any term fees noise that's caused there. Our year-to-date number is 8.8%, which I mentioned, and we provided 7% to 8% for the year. So the 3% to 5% is what is implied in the fourth quarter is what is implied with the overall guidance. The number that we report, which is -- includes the headwinds from term fees and prior period rents, in the fourth quarter, should be about, call it, 3% to 5%, in line with what we did this quarter at 3.7%. Those projects alone will be contributing an incremental $40 million in operating income in years to come.	Transcript
DUK.N	2023-02-09T10:00:00Z	Revenue			But the upside in industrial as easing supply chain constraints fuel a continued rebound for certain large manufacturers. In 2023, total retail load growth is projected to be roughly 0.5%. This illustrates the robust customer growth experienced in our territories, which we expect to continue in 2023. We expect load growth in the commercial class to moderate this year following 2 years of significant growth.	Transcript
DUK.N	2022-08-04T10:00:00Z	EBITDA			Like what is EBITDA for that business? So we've had some relief via AVCBD there. We also, in the last call, said we see a trending more in line with that for '23, because despite the favorable executive action, the delay and uncertainty that was created during that period of time really pushed execution of projects from '23 into '24.	Transcript
KMI.N	2022-07-20T16:05:00Z	Revenue	7700000000	7700000000	and into the next. Earnings in the quarter also benefited from gain on the contract, our average charter rate will improve through the end of this year lower, albeit improving, rate environment. Based on firm charters under	Press Release
KMI.N	2023-04-19T16:30:00Z	EBITDA			Our current backlog is $3.7 billion, up $400 million quarter-to-quarter and had an aggregate EBITDA multiple of 3.5x. Second, the backlog projects are attractive returns in aggregate, well above our cost of capital.	Transcript
DVN.N						
RCL.N	2023-05-04T10:00:00Z	Revenue			As you can see on Page 5, we are more than doubling our full year yield growth expectations to 6.75% to 7.75% on increased expectations for ticket and onboard revenues. Looking to the rest of 2023, we expect to deliver amazing vacation experiences to over 8 million guests a record yields as we deploy our best-in-class fleet across the best global itineraries. Silversea will welcome Silver Nova this summer, the first of the new evolution class. Since all 3 of these ships will be delivered in the second half of this year, they will be a key yield driver next year. These ships are sure to continue elevating vacation experiences for our guests and will continue to further drive the competitive advantage and deliver very attractive financial returns.	Transcript
RCL.N	2023-05-04T10:00:00Z	EBITDA			Our cost outlook for the year reflects our commitment to enhancing profitability while focusing on delivering the best vacation experiences.	Transcript
RCL.N	2022-11-03T10:00:00Z	EBIT			In addition, the benefits from actions taken during the pandemic to improve margins continue to materialize, and we expect them to ramp up in the fourth quarter and into 2023. We expect these actions to partially mitigate the inflationary pressures we expect to continue to weigh on our cost through the first half of '23.	Transcript
VTRS.OQ	2023-02-27T08:30:00Z	Revenue	16000000000	15500000000	Developed Markets grew by 1% in 2022 on the strength of European growth, offsetting the decline in North America. In North America, despite the solid performance of Yupelri, the business declined by 4% as we navigated the competitive headwinds on key products like Wixela and loss of exclusivity on Miacalcin and Perforomist. Recall that our previous guidance included full year contribution from biosimilar business. These market dynamics will be the primary reasons for our expectation of an approximate 3% decline in 2023. We anticipate strong volume growth to the continue for our key brands for '23.	Transcript
VTRS.OQ	2023-05-08T08:30:00Z	Revenue	5400000000	5000000000	We continue to expect total revenue to be higher in the second half due to ramp and launch of new products, including Breyna, our generic version of Symbicort, as well as normal product seasonality, particularly in Europe.	Transcript
VTRS.OQ	2023-04-27T02:00:06Z	EBIT			balance of Â£3.5 million will be recognised in other operating income in 2023. million of that upfront payment was recorded in other operating income and the recorded in other operating income in 2022 and Â£3.5 million will be	Press Release
VTRS.OQ	2023-05-08T08:30:00Z	EBITDA			While foreign exchange continues to be dynamic, based on current rates, we have assumed a slight headwind in Q2 and minimal to neutral impact for the full year.	Transcript
CAH.N	2022-05-25T08:30:00Z	Revenue			Do you -- when you look at the pharma growth long term, it doesn't really imply much in terms of margin change, meaning it sounds like the top -- your EBIT growth is going to match your -- the revenue growth. Is that a fair way to think about it? Just by the nature of the brand, margins are lower and that will be a higher revenue growing impact.	Transcript
CAH.N	2022-11-04T08:30:00Z	Revenue			And specifically, for the second quarter, we expect segment profit dollars to be similar to the first quarter.	Transcript
CAH.N	2022-11-04T08:30:00Z	Revenue			And specifically, for the second quarter, we expect segment profit dollars to be similar to the first quarter.	Transcript
CAH.N	2022-05-25T08:30:00Z	EBIT			But is there a thought that maybe we're going to reestablish some new longer-term targets once you get through the 2023 guidance?	Transcript
CAH.N	2022-08-11T08:30:00Z	EBIT			We plan to grow Cardinal Health brand sales by a compounded annual growth rate of at least 3%, which will generate $75 million or more of incremental segment profit over the next 3 years.	Transcript
CAH.N	2022-11-30T08:50:00Z	EBIT			That makes sense.	Transcript
AAL.OQ	2023-04-27T08:30:00Z	Revenue			And on the MAXs, we have 17 remaining. We continue to expect the full year impact of all anticipated labor agreements to be approximately 3 points of CASMx.	Transcript
AAL.OQ	2023-03-14T10:30:00Z	EBITDA			So that then leads us into a position where, on some important metrics like debt -- net debt to adjusted EBITDAR over time, we're going to find ourselves in a position where we have some of the best metrics that we've had even lower than we found ourselves at the time of the merger way back in 2017.	Transcript
MKC.N	2022-01-27T08:00:00Z	Revenue	6795035000	6668025000	And just a few months ago, we began our expansion of FONA's footprint to increase our Americas flavor manufacturing capacity, an investment we planned as part of our acquisition model, enabling us to deliver the future growth we expect. For FONA, we are on track to achieve our targeted $7 million by the end of 2023. We are also achieving revenue synergies as expected.	Transcript
MKC.N	2023-01-26T06:30:05Z	Revenue	967680000	950400000	incentive compensation expenses given the expected improvement in underlying	Press Release
MKC.N	2023-01-26T08:00:00Z	EBIT			However, we expect to see positive benefits in our results going forward.	Transcript
MKC.N	2023-03-28T06:30:03Z	EBIT			Operating income in 2023 is expected to grow by 10% to 12% from $864 million in 2022. The Company anticipates approximately $50 million of special charges in 2023 that relate to previous organizational and streamlining actions.	Press Release
IEX.N	2023-04-26T16:30:00Z	Revenue	3396000000	3326000000	Acquire Iridian Spectral Technologies, a Global Leader in Thin-film Dielectric IDEX Corporation Continues Strategic Capital Deployment with Agreement to	Press Release
IEX.N	2023-04-27T10:30:00Z	Revenue	946000000	915000000	Iridian expects fiscal 2023 revenues of CAD 36 million and EBITDA margin in the low-30s range.	Transcript
IEX.N	2023-04-27T10:30:00Z	EBITDA			We expect full year organic revenue growth of 0% to 3% and adjusted EBITDA margin to range between 27.5% and 27.9%.	Transcript
IEX.N	2023-04-26T16:30:00Z	EBITDA			30s. Acquire Iridian Spectral Technologies, a Global Leader in Thin-film Dielectric IDEX Corporation Continues Strategic Capital Deployment with Agreement to Privately held and based in Ottawa, Ontario, Canada, Iridian expects fiscal year 2023 sales of approximately CAD 36 million and EBITDA margin in the low	Press Release
IEX.N	2023-04-27T10:30:00Z	EBITDA			We expect full year organic revenue growth of 0% to 3% and adjusted EBITDA margin to range between 27.5% and 27.9%.	Transcript
VLO.N	2023-01-26T10:00:00Z	Revenue			With respect to the Renewable Diesel segment, we expect sales volumes to be approximately 1.2 billion gallons in 2023.	Transcript
VLO.N	2023-01-26T06:30:00Z	EBIT			Refinery optimization projects that are expected to reduce costs and improve margin capture are progressing on schedule. The Port Arthur Coker project is	Press Release
VLO.N	2022-01-27T10:00:00Z	EBIT			BlackRock and Navigator's large-scale carbon sequestration project is also progressing on schedule and is still expected to begin start-up activities in late 2024. Valero is expected to be the anchor shipper with 8 ethanol plants connected to this system, which should provide a higher ethanol product margin.	Transcript
LH.N	2023-04-25T06:53:08Z	Revenue	15496000000	15123500000	of (0.2%), previous 2023 Guidance was (0.2)%	Press Release
LH.N	2023-04-25T06:53:08Z	Revenue			of (0.2%), previous 2023 Guidance was (0.2)%	Press Release
LH.N	2023-04-25T09:00:00Z	Revenue			But at the same time, we're not seeing any significant changes to the trends of what's happened in the past. But in terms of payers, we have very good conversations with the payers, very constructive. Patrick, I'll start, and I'll ask Glenn to give some specifics. So I feel good about price and price mix as we go through this year to next year. So top line growth, LaunchPad savings, not having the constraints will drive the margin improvement. We expect Enterprise revenue to grow 1.5% to 4% compared to 2022.	Transcript
LH.N	2022-02-10T09:00:00Z	Revenue			We expect Diagnostics Base Business organic revenue to grow at a 2.5% to 4.5% CAGR compared to 2021.	Transcript
LH.N	2023-02-16T09:00:00Z	EBIT			It will never get to our average margins because the hospital business margins never get as high as our average diagnostic testing, but it certainly will improve as we go through this year and into next year and beyond. That was obviously a positive benefit to the company.	Transcript
LH.N	2023-04-25T09:00:00Z	EBIT			We also continue to expect that the drug development margin will increase slightly in 2023 compared to 2022. We expect Diagnostics Base Business margin to be up in 2023 versus 2022, including the unfavorable mix impact from Ascension.	Transcript
LH.N	2023-04-25T09:00:00Z	EBIT			We also continue to expect that the drug development margin will increase slightly in 2023 compared to 2022. We expect Diagnostics Base Business margin to be up in 2023 versus 2022, including the unfavorable mix impact from Ascension.	Transcript
DRI.N	2023-03-23T08:30:00Z	Revenue	10500000000	10450000000	We now expect total sales of $10.45 billion to $10.5 billion, same restaurant sales growth of 6.5% to 7%, approximately 55 new restaurant openings, capital spending between $550 million to $575 million; total inflation of 7% to 7.5% and annual pricing of 6% to 6.5%.	Transcript
DRI.N	2023-05-04T08:30:00Z	Revenue			When you look at the fine dining segment, sales have outperformed relative to pre-COVID, and that is expected to continue.	Transcript
DRI.N	2022-09-22T08:30:00Z	EBITDA			And part of that is the shrinking gap between pricing and inflation. And then as we get to the back half, we expect to be higher than last year. And then as we look at the full year, do we still expect restaurant level margins to be better than pre-COVID? So the question is, do you still expect those store level margins to exceed pre-COVID levels for the full year? Where are we from an EBIT margin? Yes, that's what's embedded in our guidance for the full year.	Transcript
DRI.N	2022-06-23T08:30:00Z	Revenue			And we have said throughout COVID that we expect our off-premise sales as a percent to be higher than they were pre-COVID and probably higher than the 20%. And we want to make sure that we get to equilibrium before we kind of give a new goal. But I will say that we expect it to be higher than it was pre-COVID, and we expect it to be higher than that initial kind of 20% goal, mainly because of the investments that we've made, and what a great job our team members do to make sure that their guests get their food on time and it's accurate. But before COVID, you guys were saying that Olive Garden could be a 20%-plus off-premise sales mix. Do you think just given the recent stickiness and strength of that, that it's more likely we'll see this hang in around 25% plus? Finally, turning to our financial outlook for fiscal 2023. My first question, Rick, is just around off-premise, that this is the fourth quarter now where you guys are running off-premise around a 25% to 30% sales range, holding on quite strong and quite sticky as the dine-in business rebounds. We are running at 25% plus now at Olive Garden. We expect total sales of $10.2 billion to $10.4 billion, representing growth of 6% to 8% from last year; same restaurant sales growth of 4% to 6% and 55 to 60 new restaurants; capital spending of $500 million to $550 million; total inflation of approximately 6%, and we plan to continue underpricing total inflation with annual pricing of approximately 5%. We're still not quite at equilibrium yet. Yes, Andrew.	Transcript
MAA.N	2023-02-02T10:00:00Z	Revenue			Based on this, effective rent growth for the year is projected to be a solid 7% at the midpoint of our range, with total Same Store revenues expected to grow 6.25%, slightly diluted from the other revenue items, primarily reimbursement in fee income, which grew at a more modest pace.	Transcript
MAA.N	2023-04-26T16:15:09Z	EBIT			MAA Same Store Portfolio: NOI growth 5.30% to 7.30% 6.30 % No Change N/A	Press Release
JNJ.N	2023-01-24T08:30:00Z	Revenue			ERLEADA, which is now in different indications in metastatic and nonmetastatic prostate cancer will have some readouts of studies in high-risk localized prostate cancer in 2023, providing an additional leg of growth. In Consumer Health, we anticipate continued growth in line with the markets that we compete in. In MedTech, we expect second half operational sales growth to be higher than the first half of the year, as we anticipate ongoing procedure recovery to improve as the year progresses. Our INVEGA SUSTENNA franchise in the U.S. as well as our pulmonary artery hypertension franchise with UPTRAVI and OPSUMIT that has been affected by COVID-19, but that we expect that will continue to deliver growth. So that is the mainstay of our growth prospects towards 2025, and I will go later about the disconnect. We also expect to continue to utilize strategic price increases across the portfolio to minimize the impact of ongoing inflationary pressures within the supply chain.	Transcript
JNJ.N	2023-04-26T07:00:05Z	Revenue			press release dated Feb. 16, 2023.	Press Release
JNJ.N	2023-01-24T08:30:00Z	Revenue			ERLEADA, which is now in different indications in metastatic and nonmetastatic prostate cancer will have some readouts of studies in high-risk localized prostate cancer in 2023, providing an additional leg of growth. In Consumer Health, we anticipate continued growth in line with the markets that we compete in. In MedTech, we expect second half operational sales growth to be higher than the first half of the year, as we anticipate ongoing procedure recovery to improve as the year progresses. Our INVEGA SUSTENNA franchise in the U.S. as well as our pulmonary artery hypertension franchise with UPTRAVI and OPSUMIT that has been affected by COVID-19, but that we expect that will continue to deliver growth. So that is the mainstay of our growth prospects towards 2025, and I will go later about the disconnect. We also expect to continue to utilize strategic price increases across the portfolio to minimize the impact of ongoing inflationary pressures within the supply chain.	Transcript
JNJ.N	2023-04-18T08:30:00Z	EBIT			We are maintaining the guidance we provided in January for our adjusted pretax operating margin, other income and expense, interest expense and tax rate.	Transcript
JNJ.N	2022-11-01T08:00:00Z	Revenue			The transaction will accelerate pro forma MedTech and Johnson & Johnson enterprise revenue growth. Turning to the financial benefits for Johnson & Johnson. We view this as an exciting opportunity to help patients, create value for shareholders, and to accelerate top line and earnings growth, and we intend to invest accordingly to drive this long-term growth. While we have not yet provided guidance for 2023, you should expect the transaction, considering the impact of financing, to be slightly dilutive to neutral to Johnson & Johnson's adjusted earnings per share in the first year and then accretive by approximately $0.05 in 2024 and increasingly accretive thereafter.	Transcript
ABC.N	2023-02-01T06:30:00Z	EBIT	257673966500	252902226400	percent. Expectations for segment operating income growth excluding COVID-19	Press Release
ABC.N	2023-02-01T06:30:00Z	EBIT	3384870100	3321601500	Fiscal Year 2023 Expectations	Press Release
ABC.N	2022-09-14T11:45:00Z	Revenue			And so I think also what I was getting at, too, is as we think about 2023 and the key drivers that are embedded in your underlying 8% EPS growth, that's excluding the COVID dynamics.	Transcript
ABC.N	2023-05-02T08:30:00Z	EBIT			We are raising our consolidated operating income guidance to a range of 2% to 4% growth from the previous range of 0% to 3% growth to reflect the strong core performance in the U.S. Healthcare Solutions segment.	Transcript
ABC.N	2022-06-01T16:30:00Z	EBIT			As the Company executes on its strategic imperatives and benefits from its	Press Release
ABC.N	2022-06-01T16:30:00Z	EBIT			* Adjusted operating income growth in the range of 5-8%; * International Healthcare Solutions adjusted operating income growth in the As the Company executes on its strategic imperatives and benefits from its growth drivers over the long term, it expects: range of 5-8%;	Press Release
ABC.N	2022-08-03T08:30:00Z	EBIT			As a reminder, we expect about $0.60 of contribution in the U.S. segment and around $0.10 in the International segment. Our segment-level COVID contribution expectations remain unchanged for fiscal 2022.	Transcript
ABC.N	2022-08-03T08:30:00Z	EBIT			As a reminder, we expect about $0.60 of contribution in the U.S. segment and around $0.10 in the International segment. Our segment-level COVID contribution expectations remain unchanged for fiscal 2022.	Transcript
SHW.N	2023-04-25T11:00:00Z	EBIT	22148900000	21041455000	And that's how we're going to drive that operating margin back to where we expect it to be. But similar -- what are maybe a couple of the top drivers that we get you back into that near $10 range on EPS? I know there are several things that you can probably mention, John. Is it mainly lower -- a better affordability environment driving higher housing turnover? So instead of a headwind with the macro environment becomes a tailwind, and then we grow -- I keep going back to '08 and '09 because I believe it's a similar environment and the similar dynamics. So we expect to grow not 1 to 2x the market, but 2 to 2.5 to 3x the market. We expect these actions will benefit segment margin over time as we drive a return to our high teens, low 20s adjusted margin target.	Transcript
SHW.N	2023-01-26T11:00:00Z	EBIT			We expect operating margin to modestly improve year-over-year, excluding restructuring and impairment costs and acquisition-related amortization expense.	Transcript
GD.N	2023-01-25T09:00:00Z	Revenue	41300000000	41200000000	And we continue to invest prudently when we see the need for more service capacity.	Transcript
GD.N	2023-01-25T09:00:00Z	Revenue	4501700000	4490800000	And we continue to invest prudently when we see the need for more service capacity.	Transcript
GD.N	2023-02-22T08:35:00Z	Revenue			But that's just -- again, it's a shipyard environment, and it takes time to make that happen.	Transcript
GD.N	2023-01-25T09:00:00Z	Revenue			And we continue to invest prudently when we see the need for more service capacity.	Transcript
GD.N	2023-01-25T09:00:00Z	Revenue			And we continue to invest prudently when we see the need for more service capacity.	Transcript
GD.N	2023-01-25T09:00:00Z	EBIT			As a result, the group's revenue for 2023 will remain essentially flat at $10.9 billion as well their operating margin rate at 8.1%. Continuing the better-than-expected performance in 2022, we expect the group to hold steady again in '23 with revenue of $7.3 billion and operating margin once again towards the high end of their reliable 14% to 15% range at 14.7%.	Transcript
GD.N	2023-01-25T09:00:00Z	EBIT			As a result, the group's revenue for 2023 will remain essentially flat at $10.9 billion as well their operating margin rate at 8.1%. Continuing the better-than-expected performance in 2022, we expect the group to hold steady again in '23 with revenue of $7.3 billion and operating margin once again towards the high end of their reliable 14% to 15% range at 14.7%.	Transcript
GD.N	2023-01-25T09:00:00Z	EBIT			As a result, the group's revenue for 2023 will remain essentially flat at $10.9 billion as well their operating margin rate at 8.1%. Continuing the better-than-expected performance in 2022, we expect the group to hold steady again in '23 with revenue of $7.3 billion and operating margin once again towards the high end of their reliable 14% to 15% range at 14.7%.	Transcript
GD.N	2023-01-25T09:00:00Z	EBIT			As a result, the group's revenue for 2023 will remain essentially flat at $10.9 billion as well their operating margin rate at 8.1%. Continuing the better-than-expected performance in 2022, we expect the group to hold steady again in '23 with revenue of $7.3 billion and operating margin once again towards the high end of their reliable 14% to 15% range at 14.7%.	Transcript
SBAC.OQ	2023-05-01T16:01:00Z	Revenue	2726000000	2686000000	(in millions, except per share amounts) Â  Full Year 2023 Â  Outlook ((7)) Â  Excluding FX Site leasing revenue Â  $ 2,481.0 Â  to $ 2,501.0 Total revenues Â  $ 2,686.0 to $ 2,726.0 Â  $ 12.0 Â  $ 5.0 measurement for the full year 2023: year.	Press Release
SBAC.OQ	2023-05-01T16:01:00Z	Revenue	1875000000	1855000000	(in millions, except per share amounts) Â  Full Year 2023 Â  Outlook ((7)) Â  Excluding FX Site leasing revenue Â  $ 2,481.0 Â  to $ 2,501.0 Total revenues Â  $ 2,686.0 to $ 2,726.0 Â  $ 12.0 Â  $ 5.0 measurement for the full year 2023: year.	Press Release
SBAC.OQ	2023-05-01T17:00:00Z	Revenue			Domestically, churn was in line with our prior quarter projections, and our full year churn expectations remain the same as we provided last quarter, including $25 million to $30 million of Sprint merger-related churn.	Transcript
SBAC.OQ	2022-03-07T11:15:00Z	EBIT			So, equivalent tower gross profit, we'll call it. We'll say gross 8%. What will same-store NOI growth be for your property sector overall, not your company in 2023?	Transcript
SBAC.OQ	2023-05-01T16:01:00Z	EBITDA			Outlook	Press Release
SBAC.OQ	2023-03-07T13:00:00Z	Revenue			They are varied by customer, as you would expect. Yes. They're generally busy in the aggregate, which supports our $72 million organic growth number domestically in 2023.	Transcript
MPWR.OQ	2023-02-08T17:00:00Z	Revenue			MPS's first advanced data converter products for high precision industrial and medical applications were made commercially available during 2022, and we expect to have an initial revenue ramp in 2023.	Transcript
COP.N	2023-03-13T10:59:00Z	Revenue			continues to review the ROD and will advance internal approval processes federal government, the state of Alaska and North Slope Borough communities.	Press Release
ORCL.N	2023-03-09T17:00:00Z	Revenue			Approximately 48% of total RPO is expected to be recognized as revenue over the next 12 months.	Transcript
ORCL.N	2022-12-12T17:00:00Z	Revenue			As all of these differentiators come together and our business continues to accelerate, we expect organic growth for our fiscal year 2023 cloud revenues will be over 30% in constant currency.	Transcript
ORCL.N	2023-03-09T17:00:00Z	EBIT			And by the way, I actually expect this year, FY 2023, the one we are closing out in 1 more quarter, will be the trough year for operating margins and percentages as our margin improvement initiatives play out.	Transcript
AMP.N	2022-07-27T09:00:00Z	Revenue			Based upon our current assumptions, the interest rate benefit will increase further in 2023.	Transcript
AMP.N	2023-04-24T16:08:00Z	Revenue			benefits going forward.	Press Release
AMP.N	2022-10-26T09:00:00Z	EBIT			In 2022, spread earnings will increase by over $600 million versus the prior year, and we expect this trend to continue into 2023.	Transcript
AMP.N	2023-04-24T16:08:00Z	EBIT			adjusted operating margin remained in our target range at 31 percent. translation and net outflows, as well as lower performance fees. Net pretax	Press Release
NXPI.OQ	2023-05-22T08:40:00Z	Revenue			So we did do better than we originally had anticipated versus our Q1 original guidance.	Transcript
NXPI.OQ	2023-03-07T11:00:00Z	Revenue			So our -- as you remember, in November of '21, we -- at our Analyst Day, we provided our growth outlook and we said that automotive would grow at 9% to 14% 3-year CAGR from '21 to '24.	Transcript
CPRT.OQ	2022-09-08T11:00:00Z	EBITDA			Sure.	Transcript
TXT.N	2023-01-25T08:00:00Z	Revenue	14000000000	14000000000	At Bell, the December 2022 FLRAA contract, award has solidified the long-term outlook for the segment and should provide an increasing revenue stream that we expect will drive growth well into the future. At Industrial, we're expecting segment revenues of about $3.6 billion and margin to be in the range of about 5% to 6%. At Systems, we're expecting mid-single-digit revenue growth across our businesses. Moving to segment outlook on Slide 11 and beginning with Textron Aviation.	Transcript
TXT.N	2023-01-25T08:00:00Z	Revenue			At Bell, the December 2022 FLRAA contract, award has solidified the long-term outlook for the segment and should provide an increasing revenue stream that we expect will drive growth well into the future. At Industrial, we're expecting segment revenues of about $3.6 billion and margin to be in the range of about 5% to 6%. At Systems, we're expecting mid-single-digit revenue growth across our businesses. Moving to segment outlook on Slide 11 and beginning with Textron Aviation.	Transcript
TXT.N	2023-01-25T08:00:00Z	Revenue			At Bell, the December 2022 FLRAA contract, award has solidified the long-term outlook for the segment and should provide an increasing revenue stream that we expect will drive growth well into the future. At Industrial, we're expecting segment revenues of about $3.6 billion and margin to be in the range of about 5% to 6%. At Systems, we're expecting mid-single-digit revenue growth across our businesses. Moving to segment outlook on Slide 11 and beginning with Textron Aviation.	Transcript
TXT.N	2023-04-27T08:00:00Z	Revenue			But with the FLRAA protest now cleared, how does this change the trajectory of Bell profit?	Transcript
TXT.N	2023-04-27T06:30:00Z	Revenue			resolution of the FLRAA contract protest earlier this month, which allowed us	Press Release
TXT.N	2023-04-27T08:00:00Z	EBIT			So FLRAA is going to roll in consistent with how we had seen Bell in terms of the $3.3 billion of revenue and [8.25%, 9.25%], not guidance.	Transcript
TXT.N	2023-01-25T08:00:00Z	EBIT			Lastly, at finance, we're forecasting a profit of about $15 million. Segment margin is expected to be in a range of approximately 12% to 13%. We're forecasting a margin in a range of 8.25% to 9.25%.	Transcript
TXT.N	2022-01-27T08:00:00Z	EBIT			But on the other side of that coin, when you see some of the ramp downs, it's more pressured to be in that range, and that's where you see us today. But we've been saying for a very long time that we expect Bell sort of a 10% to 12% margin business. I won't go beyond probably 2022 guidance. Is there a path back to a 12% sell margin in the next few years? Maybe on Bell, with the program roll off and with FLRAA, if you win that contract, upside is really further down the line. We've obviously been well above that as we had a lot of strong multiyear production programs where we could drive efficiencies and gain the benefits of that.	Transcript
TXT.N	2023-01-25T08:00:00Z	EBIT			Lastly, at finance, we're forecasting a profit of about $15 million. Segment margin is expected to be in a range of approximately 12% to 13%. We're forecasting a margin in a range of 8.25% to 9.25%.	Transcript
TXT.N	2023-01-25T08:00:00Z	EBIT			Lastly, at finance, we're forecasting a profit of about $15 million. Segment margin is expected to be in a range of approximately 12% to 13%. We're forecasting a margin in a range of 8.25% to 9.25%.	Transcript
TXT.N	2023-01-25T08:00:00Z	EBIT			Lastly, at finance, we're forecasting a profit of about $15 million. Segment margin is expected to be in a range of approximately 12% to 13%. We're forecasting a margin in a range of 8.25% to 9.25%.	Transcript
T.N	2023-05-22T17:10:00Z	Revenue	42708950000	42708950000	One, you just hit one of them right on the head, profitability, customer metrics, customer growth, ARPU growth, EBITDA growth, the profitability of our largest business, the guide that we've given on EBITDA growth of 3% or better, those are all going to drive real improvements in cash flow as we move through the year. That's going to result in money in the coffers and improve the performance of the business in '23 versus '22.	Transcript
T.N	2023-04-20T08:30:00Z	EBITDA			And as we reduce our copper services footprint and related legacy infrastructure, we expect to consistently improve our margins, grow EBITDA and, ultimately, improve our capital efficiency.	Transcript
MTCH.OQ	2023-05-23T11:30:00Z	Revenue	3507727300	3348285150	And then in Q3, as a result of those payer -- as a result of those price changes and the impact on payers. Now we're rolling out those price changes into an additional 5 international markets. So just to make sure kind of people understand the dynamics of this. We're going to test and see.	Transcript
MTCH.OQ	2022-03-07T13:55:00Z	EBITDA			But is that 40% or at least 40% number still in play? We're getting benefits from marketing.	Transcript
MTCH.OQ	2023-05-03T08:30:00Z	EBIT			In terms of full year 2023 AOI margin, we continue to target flat or better than the 35% we achieved last year.	Transcript
NDAQ.OQ	2022-07-20T08:00:00Z	Revenue			We remain confident in our ability to improve our organic growth through the remainder of 2022 and into 2023.	Transcript
NDAQ.OQ	2023-01-25T08:00:00Z	Revenue			And I think, Owen, one thing we did point out because embedded in that 5% annual growth in expenses is about -- 1 percentage point of that is really the continued investment we're making in our digital assets business as we kind of get closer to launching that business hopefully in the first half of this year.	Transcript
NDAQ.OQ	2022-06-01T10:00:00Z	Revenue			And as we think about sort of moving forward in scalability, one of the things as part of our strategic pivot that we did coming into 2017, we were investing in the higher-growth areas, but we are also expanding the portion of our business that is SaaS related, which, over time, is a more scalable model. And so our ambition there is to grow 6% to 9%, on average, over the medium term. Coming out of the first quarter, we were at 34%. Our ambition is to get to 40% to 50% by 2025. So before we started the pivot, we were in the mid-20s SaaS revenues as a percentage of our annualized recurring revenues. So when we think about our revenue ambitions, we think about it in the context of that 2/3 of our business is the solutions segment business. So when we think about the solutions segments that we talked about, sort of starting off, as well as the Market Services business, a lot of beta factors go into market services.	Transcript
NDAQ.OQ	2022-06-09T11:00:00Z	Revenue			And then on Market Technology, the third segment of Corporate Solutions, so I think, certainly, the pandemic impacted sort of the run rate, what you could do in regards to providing technology to global clients. And we have really great dialogue with new and existing clients as we're coming in through 2022. Or what's the environment?	Transcript
FFIV.OQ	2022-12-07T12:50:00Z	Revenue	2830637250	2749761900	And so we expected that to be relatively flat in terms of growth in our guidance and that -- getting that to the 15% to 20% software growth rate that we anticipated. And that's what we were experiencing in Q4.	Transcript
FFIV.OQ	2023-04-19T17:00:00Z	EBIT	849191180	824928570	Based on current visibility and our earlier-than-anticipated systems recovery, we expect to see lower systems revenue in Q3 and Q4 than in Q2.	Transcript
FFIV.OQ	2023-01-24T16:30:00Z	EBIT			As Francois noted, we continue to expect non-GAAP earnings growth in the low to mid-teens for FY '23. We now expect Global Services growth of mid-single digits, which is up from low to mid-single digits growth we forecasted previously.	Transcript
LEN.N	2023-03-15T11:00:00Z	Revenue			Additionally, we are targeting delivery volume for the full year to be between 62,000 and 66,000 homes as we drive volume and pick up market share and build margins back up through reconciliation of construction and land costs while carefully managing SG&A. And the fact that we are projecting a flattish number of deliveries in 2023 versus 2022 displays the strength of our strategy. Finally, once again, given market volatility, we're providing boundaries for deliveries only first full year 2023 as we did last quarter, as Stuart mentioned, this delivery range should be 62,000 to 66,000, which is an increase of our previous range of 60,000 to 65,000. We maintain our volume to move through the limited legacy land that we have, which is at legacy prices, while keeping our production machine working efficiently and rationalizing costs.	Transcript
CDNS.OQ	2023-02-13T17:00:00Z	Revenue	4070000000	4030000000	And as you can see from the outlook, we're expecting that last year, the 85-15 split in recurring revenue to upfront revenue mix, we expect that to continue. And if you look over 3 years for our revenue CAGR, that's mid-teens to '22, and we're guiding to mid-teens for '23. Can you just help reconcile that mid-teens growth with the implied outlook for recurring revenue?	Transcript
CDNS.OQ	2023-05-18T14:15:00Z	Revenue	1709400000	1652300000	I would expect to get back to more normal lead times by the middle of the year, which I think is important because it sets us up for a stronger second half if we have demo machines in place and we have that capacity in the cloud infrastructure to show how good these systems are to drive more sales in the second half.	Transcript
CDNS.OQ	2023-04-24T17:00:00Z	EBIT			With that in mind, our updated outlook for fiscal 2023 is: revenue in the range of $4.03 billion to $4.07 billion; GAAP operating margin in the range of 30% to 31%; non-GAAP operating margin in the range of 41% to 42%; GAAP EPS in the range of $3.26 to $3.34; non-GAAP EPS in the range of $4.96 to $5.04; operating cash flow in the range of $1.3 billion to $1.4 billion.	Transcript
CDNS.OQ	2023-04-24T17:00:00Z	EBIT			With that in mind, our updated outlook for fiscal 2023 is: revenue in the range of $4.03 billion to $4.07 billion; GAAP operating margin in the range of 30% to 31%; non-GAAP operating margin in the range of 41% to 42%; GAAP EPS in the range of $3.26 to $3.34; non-GAAP EPS in the range of $4.96 to $5.04; operating cash flow in the range of $1.3 billion to $1.4 billion.	Transcript
NVDA.OQ	2022-09-20T13:00:00Z	Revenue			We also have Orin designed into about 40 different cars and companies.	Transcript
WELL.N	2023-05-03T09:00:00Z	EBIT			As our guidance outlines, we expect the MOB portfolio to deliver between 2% to 3% same-store NOI growth in 2023. Underlying this FFO guidance is an increased estimate of total portfolio year-over-year same-store NOI growth of 9% to 13%, driven by subsegment growth of outpatient medical, 2% to 3%; long-term post-acute, 3% to 4%; senior housing triple net, 13%; and finally, increased senior housing operating growth of 17% to 24% year-over-year.	Transcript
WELL.N	2023-05-03T09:00:00Z	Revenue			The midpoint of which is driven by better-than-expected expense trends to start the year, along with year-over-year growth expectations of revenue approximately 9.5%. Underlying this revenue growth is an expectation of approximately 230 basis points of year-over-year average occupancy increase and rent growth of approximately 6.3%.	Transcript
WELL.N	2023-05-02T16:06:03Z	EBIT			* Long-Term/Post-Acute Care approximately 3% to 4% * Outpatient Medical approximately 2% to 3% * Same Store NOI: We continue to expect average blended SSNOI growth of 9% to * Seniors Housing Operating approximately 17% to 24% * Seniors Housing Triple-net approximately 1% to 3% 13%, which is comprised of the following components:	Press Release
WELL.N	2023-05-02T16:06:03Z	EBIT			* Long-Term/Post-Acute Care approximately 3% to 4% * Outpatient Medical approximately 2% to 3% * Same Store NOI: We continue to expect average blended SSNOI growth of 9% to * Seniors Housing Operating approximately 17% to 24% * Seniors Housing Triple-net approximately 1% to 3% 13%, which is comprised of the following components:	Press Release
PLD.N	2023-04-18T12:00:00Z	Revenue			We are maintaining our forecast for net promote income of $380 million. We expect the pace to remain slow in the second quarter, putting the bulk of the activity into the second half. We had a few Development Starts in the quarter, a reflection of our discipline, but our pipeline is deep, and we are maintaining our guidance of $2.5 billion to $3 billion for the year.	Transcript
PLD.N	2023-04-18T12:00:00Z	Revenue			We expect G&A to range between $380 million and $390 million and strategic capital revenues, excluding promotes, to range between $515 million and $530 million.	Transcript
PLD.N	2023-01-18T12:00:00Z	EBIT			Given these assumptions, we believe our lease mark-to-market will be sustained or even increased over '23, ending the year between 65% and 70% and providing visibility to an incremental $2.9 billion of NOI after the more than $300 million that will become realized over the course of this year. I just want to make sure on the mark-to-market, numbers that are embedded in your same-store NOI growth of 8% to 9% GAAP and 8.5% to 9.5% cash. I think leasing spreads next year are going to be in the high 70s to low 80s on a net effective basis. So clearly, everything that will roll next year is going to be above the 67% reporting today. You clearly laid out the building blocks of your same store NOI growth of 8.5% to 9.5% in 2023, where you have a high level of visibility.	Transcript
PLD.N	2022-01-19T12:00:00Z	Revenue			We expect net promote income of $0.55 per share for the year, almost all of which will occur in the third quarter and is driven by our PELF venture. While a record, given the significant increase in rents and valuations, we would expect to see similar or higher promote levels in 2023.	Transcript
ROST.OQ	2022-11-17T16:15:00Z	Revenue	19630620000	19069750000	Or is there any change to your thinking on dd's, given the environment?	Transcript
ROST.OQ	2023-02-28T16:15:00Z	EBIT	2100480000	1964180000	This reflects the resetting of the baseline for incentive compensation, higher wages, the deleveraging effect on flattish same-store sales and lower freight costs.	Transcript
MRK.N	2023-04-27T09:00:00Z	Revenue	58900000000	57700000000	We expect strong underlying revenue growth of 8% to 10%, offset by the decline in LAGEVRIO and an approximate 2 percentage point negative impact from foreign exchange using mid-April rates.	Transcript
MRK.N	2023-05-10T11:40:00Z	Revenue			And we've been seeing exceptional revenue growth from the product.	Transcript
MRK.N	2023-04-27T06:30:00Z	Revenue			Financial Outlook	Press Release
MRK.N	2023-05-10T11:40:00Z	EBIT			And then just showing that with respect to P&L growth. How do you think about like the balance of adding new assets in the form of BD or just M&A? So that's priority number one. Underlying operating margin in the year 2025 was greater than 43%. We have the roll-off of some royalties, specifically on GARDASIL and KEYTRUDA. We're focused on making sure that we maximize the opportunities from these business development transactions we've done to ensure we're investing the appropriate amount in R&D to see those assets hopefully come to their full potential.	Transcript
MRK.N	2023-02-02T08:00:00Z	Revenue			And we expect continued growth, strong growth in our Animal Health business. Our guidance reflects confidence in continued strong growth across oncology, vaccines and Animal Health.	Transcript
WEC.N	2023-02-02T14:00:00Z	Revenue			Overall, we are projecting relatively flat electric and gas sales year-over-year.	Transcript
MSCI.N	2023-01-31T06:45:00Z	EBITDA	995000000	965000000	Adjusted EBITDA Expense $965 to $995 million	Press Release
MSCI.N	2023-04-25T11:00:00Z	Revenue			In climate, we continue to see good momentum and very engaging discussions across client segments, although some of the factors impacting ESG sales did, to a smaller degree, also impact climate sales. Our climate subscription run rate growth across all products was 68%, which was roughly the same as the Climate ABF growth rate. We see strong engagement from our clients as they look for insights into the highly dynamic market, including around climate and income risk, although we did see some pickup in cancels from smaller clients in the quarter.	Transcript
MSCI.N	2022-11-30T12:00:00Z	EBIT			And I think a lot of it boils down to, leaving aside some of the FX factors at play, capitalization factors at play, broader expense actions at play, it boils down to our, what we call our internal capital allocation process and where we are prioritizing investments, and so areas like Index, like ESG and Climate, we are very much prioritizing reinvesting the growth in the business to fuel longer-term growth. And does that margin comment pertain to all divisions or simply just the Index divisions as there is [not] expecting margin expansion? And given the size of the Analytics segment and the cost base, that can help lead to the overall MSCI margin expansion. And there are some areas like Analytics where we're not investing as heavily. I mean, you can see from the long-term targets, there are some areas where we are expecting some margin expansion over time. You've seen it most notably in the Analytics segment.	Transcript
MSCI.N	2022-04-26T11:00:00Z	EBIT			As a reminder, the margin also reflects the integration of RCA, which is a lower-margin business. For the full year, we expect to drive continued high 50% margins on a consolidated basis, which is in line with our long-term target.	Transcript
MSCI.N	2022-11-30T12:00:00Z	EBIT			And I think a lot of it boils down to, leaving aside some of the FX factors at play, capitalization factors at play, broader expense actions at play, it boils down to our, what we call our internal capital allocation process and where we are prioritizing investments, and so areas like Index, like ESG and Climate, we are very much prioritizing reinvesting the growth in the business to fuel longer-term growth. And does that margin comment pertain to all divisions or simply just the Index divisions as there is [not] expecting margin expansion? And given the size of the Analytics segment and the cost base, that can help lead to the overall MSCI margin expansion. And there are some areas like Analytics where we're not investing as heavily. I mean, you can see from the long-term targets, there are some areas where we are expecting some margin expansion over time. You've seen it most notably in the Analytics segment.	Transcript
TMO.N	2023-04-26T08:30:00Z	Revenue	45300000000	45300000000	Since the beginning of the year, the macro environment has become slightly more challenging.	Transcript
TMO.N	2023-05-10T11:00:00Z	Revenue	10826700000	10781400000	This year, we're expecting 7% core growth in pharma and biotech likely around that as well in terms of the outlook.	Transcript
TMO.N	2023-01-10T10:30:00Z	EBIT			That there's not a 100% guarantee, but it was highly certain.	Transcript
TMO.N	2023-04-26T08:30:00Z	EBIT			Guidance assumes adjusted operating margins for 2023 to be in the range of 23.8% to 23.9% for the year.	Transcript
F.N	2023-05-22T06:00:00Z	EBIT	11000000000	9000000000	e.	Press Release
F.N	2023-05-02T17:00:00Z	Revenue			It sounds as though Blue is guided to be negative for the full year as incentive spend picks up.	Transcript
F.N	2023-05-02T17:00:00Z	EBIT			And EBT for Ford Credit is anticipated to be around $1.3 billion.	Transcript
F.N	2023-03-23T07:00:00Z	EBIT			* Reaffirms full-year 2023 adjusted EBIT guidance of $9 billion to $11 billion; Ford Model e; and EBIT approaching $6 billion for Ford Pro, nearly twice its a modest improvement from last year; a full-year loss of about $3 billion for provides segment-level outlooks; plans to share more information at Capital	Press Release
F.N	2023-05-02T17:00:00Z	EBIT			And EBT for Ford Credit is anticipated to be around $1.3 billion.	Transcript
LYB.N	2023-02-03T11:00:00Z	EBITDA			Based on expected volumes and margins, we estimate that lost production associated with all of this maintenance downtime will impact 2023 EBITDA by approximately $290 million. We remain confident that our value enhancement program can achieve recurring annual EBITDA of $150 million by the end of 2023 through the execution of about 1,000 projects.	Transcript
LYB.N	2023-04-28T11:00:00Z	EBITDA			Nonetheless, we expect to continue converting approximately 80% of EBITDA to cash over the longer term, as we have done in the past.	Transcript
LYB.N	2023-02-03T11:00:00Z	Revenue			As our new world-scale PO/TBA plant ramps up, we expect to produce and sell about half of the asset's nameplate capacity in 2023.	Transcript
LYB.N	2022-04-27T11:00:00Z	EBIT			Are you going to be able to capture these pretty phenomenal numbers? How should we think about your margin capture potential in Q2? I know you're selling -- or you're closing the refinery at the end of '23, but right now, refining margins are pretty phenomenal looking at $30 Gulf Coast cracks, $70 diesel cracks. Listen, for refining, yes, we're seeing very strong margins. Or is there a reason to be cautious on just overall margin capture? So to answer your question just very shortly, yes, we expect to be able to capture that margin uplift. So we're operating the assets very well, very high utilization rates. Thanks, Matthew, for the question. The Maya 2-1-1 today is over $60, very strong diesel cracks, gasoline cracks strongest since 2015, inventories are low.	Transcript
LYB.N	2023-02-03T11:00:00Z	EBITDA			From a portfolio point of view, we estimate APS will shift approximately $200 million of annual EBITDA between O&P Americas and O&P EAI segments fairly equally.	Transcript
LYB.N	2023-02-03T11:00:00Z	EBITDA			From a portfolio point of view, we estimate APS will shift approximately $200 million of annual EBITDA between O&P Americas and O&P EAI segments fairly equally.	Transcript
IBM.N	2023-04-19T17:00:00Z	Revenue			As a result, we expect 2023 infrastructure revenue to decline, with pretax margin in the low teens. To provide some perspective, Infrastructure should impact IBM's overall revenue growth by over 1 point.	Transcript
IBM.N	2023-05-23T11:30:00Z	Revenue			So in the same way that we built a Red Hat business, we're going to build a watsonx business within IBM Consulting.	Transcript
IBM.N	2022-09-14T10:30:00Z	Revenue			And so consulting within the technology space has seen a lot of demand over the last few years in the market.	Transcript
IBM.N	2023-04-19T17:00:00Z	EBIT			We still expect this action to pay back by the end of the year.	Transcript
IBM.N	2022-03-09T14:30:00Z	Revenue			And obviously, the software business is a big part of that goal to get to sustained mid-single-digit revenue growth. And so just walk through how you would plan to achieve that, and particularly how you achieve sustainable growth, even though there is some cyclicality in parts of the software business like TPP. And then I get about 2 points from the rest of software. But I do have the negative headwind of our TP software, which is predicted to decline in the mid- to high single digits. But getting back to your point, we've promised and I promised with investors back in October that we get mid-single digits in the midterm, which is 22 to 24. But the combination of 4 plus 2 minus 1 gets me to mid-single-digit growth in the midterm. Didn't do that in the fourth quarter. It was certainly an easy compare. One of the, I think, most strategic things from an investor standpoint that Arvind did was to shift away from the focus on earnings towards sustainable revenue growth and free cash flow. That gives me about 4 points of tailwind to the software business. That's really a combination of Red Hat. We think that was a onetime event. We've seen great success with Red Hat thus far, grew 21% all in, in the fourth quarter. You say, well, what is that adds up to 6.	Transcript
IQV.N	2022-02-15T09:00:00Z	Revenue	15400000000	15150000000	I wanted to come back to -- you guys made the comment that you expect your R&DS revenue growth this year, I think, to be in the upper teens if you ignore COVID work, which is a very impressive number.	Transcript
IQV.N	2023-04-27T07:00:00Z	Revenue	3695000000	3625000000	represents 9 to 11 percent revenue growth at constant currency excluding	Press Release
IQV.N	2023-05-24T10:00:00Z	Revenue			So while AI/ML approaches will be able to present an equivalent of the scorecard, the experience of decades of clinical development will allow experts to communicate with their customers and align the AI/ML outcomes with aspects such as the customers' risk appetite, funding situation and other key considerations, which may be difficult to encode within an AI/ML model.	Transcript
IQV.N	2022-02-24T11:00:00Z	EBIT			And maybe the last one, just on the margin side, just the COVID impact on margins. And then we put out some implied margin guidance from our -- in our '20 by '25 plan, and it's not annually as strong as that. Can you just remind us, obviously with the pass-through impact, I know it wasn't the most profitable business. I think if you take the midpoint of our guidance, it's a little bit under 100 basis points of margin expansion there. I want to say, if you did the math on it, it comes to 20 to 30 basis points of margin expansion per year. The revenue comes down, but maybe the margin holds in as COVID fades, maybe just talk through that impact on the margin side.	Transcript
IQV.N	2022-09-13T11:10:00Z	EBITDA			But if you kind of back into what the implied margin expansion is from our revenue and EBITDA guidance, it is 20 to 30 basis points per year. Is it something in that 30 bps ZIP code the right way to think about it?	Transcript
IQV.N	2023-04-27T09:00:00Z	EBITDA			We're also reaffirming our guidance on adjusted EBITDA of $3.625 billion to $3.695 billion, and that represents year-over-year growth of 8.3% to 10.4%.	Transcript
VRTX.OQ	2023-05-09T12:20:00Z	Revenue			So with that strong and steady and consistent performance.	Transcript
DXCM.OQ	2023-04-27T16:30:00Z	Revenue	3515000000	3400000000	We are raising our full year 2023 revenue guidance to a range of $3.4 billion to $3.515 billion.	Transcript
DXCM.OQ	2023-04-27T16:30:00Z	EBITDA	913900000	884000000	For margins, we are reaffirming our prior full year guidance of gross profit margins in the range of 62% to 63%, operating margins of approximately 16.5% and adjusted EBITDA margins of approximately 26%.	Transcript
DXCM.OQ	2023-04-27T16:30:00Z	EBIT	579975000	561000000	For margins, we are reaffirming our prior full year guidance of gross profit margins in the range of 62% to 63%, operating margins of approximately 16.5% and adjusted EBITDA margins of approximately 26%.	Transcript
CERN.OQ^F22	2021-02-10T16:30:00Z	Revenue			And then also federal is the bridge to 2021? And then how should we think about the federal opportunity in 2022? But what I would say is that we previewed the federal, once it got to around $1 billion, would grow at a mid-teens CAGR for the next several years, and end of the year, just under $1 billion. So that will put you in the mid-hundreds as far as contribution to the growth. They are the 1, 2, 3 by 2023 work to be done to build a $1 billion health network business by 2025. We don't necessarily break out the guidance at that level of detail. We're getting to about $150 million to $200 million, just want to make sure we're in the ballpark. When we think about the top line guidance, can you quantify for us the contribution from federal.	Transcript
CERN.OQ^F22	2021-10-29T09:00:00Z	EBIT			So in summary, we've made good progress at improving margins this year and plenty of opportunities remain to help us achieve our goal of mid-20% adjusted operating margin by 2024.	Transcript
PEP.OQ	2023-02-09T08:15:00Z	Revenue			Or are you assuming more pricing in 2023?	Transcript
AOS.N	2023-04-27T10:00:00Z	Revenue	3830000000	3680000000	We reaffirm our guidance that our sales in China will grow 3% to 5% in local currency in 2023.	Transcript
AOS.N	2023-04-27T10:00:00Z	Revenue			We reaffirm our guidance that our sales in China will grow 3% to 5% in local currency in 2023.	Transcript
AOS.N	2023-04-27T06:55:04Z	Revenue			2022 2023 Outlook revised outlook for the full year 2023 projects our sales to be flat year-over-year at the mid-point, +/- 2%. We raised our expected full year	Press Release
AOS.N	2023-04-27T10:00:00Z	EBIT			So we'll see margins lower in the back half.	Transcript
AOS.N	2023-04-27T10:00:00Z	EBIT			So we'll see margins lower in the back half.	Transcript
BLK.N						
ABMD.OQ^L22	2022-08-04T07:00:01Z	Revenue	1170000000	1130000000	FISCAL YEAR 2023 OUTLOOK fiscal year 2022. reported revenue of $1.13 to $1.17 billion or 10% to 14% growth compared to to 24%. Based on current foreign exchange rates, the company now expects	Press Release
ABMD.OQ^L22	2022-04-28T07:00:01Z	Revenue	280800000	259900000	*ABOUT NON-GAAP FINANCIAL MEASURES	Press Release
ABMD.OQ^L22	2022-08-04T08:00:00Z	EBIT			We are also maintaining our full year operating margin guidance of 23% to 24%.	Transcript
HII.N	2023-02-09T09:00:00Z	Revenue			For Mission Technologies, we expect 2023 revenue of approximately $2.5 billion, organic growth of approximately 5% year-over-year.	Transcript
HII.N	2023-02-09T09:00:00Z	Revenue			For Mission Technologies, we expect 2023 revenue of approximately $2.5 billion, organic growth of approximately 5% year-over-year.	Transcript
HII.N	2023-05-04T07:15:00Z	Revenue			* Expect FY23 Mission Technologies revenue of approximately $2.5 billion,	Press Release
HII.N	2023-05-04T07:15:00Z	Revenue			* Expect FY23 Mission Technologies revenue of approximately $2.5 billion,	Press Release
HII.N	2023-05-04T07:15:00Z	EBITDA			Mission Technologies segment operating margin(2) between 2.5% and 3.0%, and	Press Release
HII.N	2023-05-04T07:15:00Z	EBIT			Mission Technologies EBITDA margin(2Â )between 8.0% and 8.5% Operating FAS/CAS Adjustment ($68M) Shipbuilding Operating Margin (2) 7.7% - 8.0%	Press Release
HII.N	2023-02-09T09:00:00Z	EBIT			For 2023, we expect Shipbuilding operating margin between 7.7% and 8% as we continue to target incremental margin improvement but acknowledge the current challenges have tempered the pace of that progress.	Transcript
HII.N	2023-02-09T09:00:00Z	EBITDA			As we look -- going forward, right, EBITDA margin stay flat from '21 to '22, we're foreshadowing some margin expansion into '23. For Mission Technologies, we expect 2023 revenue of approximately $2.5 billion, organic growth of approximately 5% year-over-year. We expect operating margins of between 2.5% and 3% and EBITDA margins of between 8% and 8.5%.	Transcript
HII.N	2023-05-04T07:15:00Z	EBIT			FY23 Outlook	Press Release
CVS.N	2022-11-02T08:00:00Z	Revenue	338590350000	332141010000	And we expect that the economics on vaccines and diagnostic testing will change, following expiration of the public health emergency which we project will happen in the early part of the first quarter of 2023. In PSS, we are targeting mid-single-digit growth over our baseline. In addition to those specific adjustments, we are projecting that our Retail LTC segment will have over $3 billion of revenues in 2022 from COVID, which have a robust margin profile. It is not prudent to anticipate a similar level of COVID-based revenues going forward.	Transcript
CVS.N	2023-01-10T11:15:00Z	Revenue			Our specialty pharmacy business is expected to generate top line revenue growth of more than 20% in 2022, creating strong momentum that will allow us to continue to unlock the value to customers and drive results in 2023 and beyond.	Transcript
CVS.N	2022-11-02T08:00:00Z	Revenue			And we expect that the economics on vaccines and diagnostic testing will change, following expiration of the public health emergency which we project will happen in the early part of the first quarter of 2023. In PSS, we are targeting mid-single-digit growth over our baseline. In addition to those specific adjustments, we are projecting that our Retail LTC segment will have over $3 billion of revenues in 2022 from COVID, which have a robust margin profile. It is not prudent to anticipate a similar level of COVID-based revenues going forward.	Transcript
CVS.N	2023-02-08T08:00:00Z	EBIT			Overall, for the Retail/LTC segment, we expect 2023 adjusted operating income to decline from 2022 to between $5.95 billion and $6.05 billion.	Transcript
CVS.N	2023-05-03T08:00:00Z	EBIT			In the Pharmacy & Consumer Wellness segment, our new adjusted operating income guidance is a range of $5.73 billion to $5.83 billion, reflecting lower-than-expected COVID volumes as well as the impact of resegmentation.	Transcript
PH.N	2023-02-23T10:30:00Z	Revenue	18000000000	18000000000	So we like the long-term trajectory of what aerospace can do from a growth standpoint.	Transcript
PH.N	2023-03-22T09:05:00Z	EBITDA	4200000000	4200000000	So my predecessor, Tom Williams, would tell you that this is his favorite slide, and obviously, there's a reason for that. There's a lot to be proud of here.	Transcript
PH.N	2023-05-04T11:00:00Z	Revenue	4083810000	4013700000	By FY '27, we will have approximately 85% of the company in long cycle end markets or industrial aftermarket. This mix shift is further reason why we will grow differently in the future, and it is why we are committed to our FY '27 target of 4% to 6% organic growth over the cycle.	Transcript
PH.N	2023-05-04T11:00:00Z	Revenue			Obviously, we increased our guidance this morning. So that will help us with the future year guidance. We'll come back to you in August with the full year guidance.	Transcript
PH.N	2023-03-07T11:00:00Z	EBITDA			We will get Meggitt to 30% adjusted EBITDA margins.	Transcript
PH.N	2023-02-02T11:00:00Z	EBIT			As I mentioned earlier, we're on track to achieve the $60 million in synergies by the end of this fiscal year.	Transcript
PH.N	2023-02-02T11:00:00Z	EBIT			And I just wanted to note that $0.25 of that is due to the less bad currency rates. And just as a reminder, we mentioned this last quarter, we do expect Meggitt to be just slightly dilutive to overall margins in this first stub-years as we generate those synergies that Jenny just spoke to. We are increasing segment operating income by $0.35 for the remainder of the second half.	Transcript
PH.N	2019-03-05T10:55:00Z	EBITDA			So we updated our goals early and said that by fiscal year '23, it's our goal to continue to grow 150 basis points more than Industrial Production Index over the cycle, that our segment operating margins will reach 19%, that our EBITDA margin will reach 20%, that we'll continue to generate free cash flow greater than net income over the cycle and all of that will result in earnings per share growth of 10% or more a year. We measure ourselves in this with a goal of wanting to grow 150 basis points faster than the Industrial Production Index over the cycle.	Transcript
PH.N	2023-05-04T11:00:00Z	EBIT			We now are forecasting 22.5% for the full year. When you look at adjusted segment operating margins, we've increased our full year guide by 40 basis points.	Transcript
NSC.N	2023-01-25T08:45:00Z	Revenue			You can expect in 2023 that the quarterly year-over-year growth will be around double what you see here, meaning that the full year impact will be a step-up in the $40 million to $50 million range.	Transcript
MSFT.OQ	2023-02-07T17:30:00Z	Revenue			Simply put, the new Bing and the new Edge will drive revenue growth through increased volume and increased rates.	Transcript
MSFT.OQ	2023-01-24T17:30:00Z	EBIT			As a result, when excluding the Q2 charge and favorable impact from the change in accounting estimate, we expect full year operating margins to be down roughly 1 point in constant currency and roughly 2 points in USD, even with the headwinds from materially lower OEM revenue and higher energy costs.	Transcript
MSFT.OQ	2022-10-25T17:30:00Z	EBIT			At the total company level, we continue to expect double-digit revenue and operating income growth on a constant currency basis.	Transcript
HWM.N	2023-05-02T10:00:00Z	EBITDA	6325000000	6200000000	The balance sheet was improved with debt reductions of $176 million, and net leverage will now continue towards the 2x net debt to EBITDA in the balance of 2023, given both the reduction in debt and the improved EBITDA.	Transcript
HWM.N	2023-05-02T10:00:00Z	Revenue	1435000000	1400000000	So I don't think you should be expecting anything, given what has been a really, really great first quarter, maybe I shouldn't say it myself, but it was good.	Transcript
HWM.N	2023-02-14T10:00:00Z	EBIT			We look forward to above-trend growth in '23, '24 and '25, and that will be reflected in additional profits and cash coming from the business.	Transcript
HWM.N	2023-05-02T07:00:00Z	EBITDA			Adj. EBITDA(* 1) $359M $362M $365M Â  $1.400B $1.415B $1.435B	Press Release
BAX.N	2022-05-25T09:00:00Z	Revenue	15415260000	15264130000	acquisition. These synergies are captured in Baxterâ€™s 2022â€“2025 financial	Press Release
BAX.N	2022-09-14T10:35:00Z	Revenue	2442260800	2266950000	But I was listening to a competitor yesterday talk about just significant pent-up demand in this market, given some of the issues that have happened in infusion pumps over the last couple of years. Maybe just to move over to NOVUM for a moment, but you got the syringe pump approval, and the large volume pump is expected in 2023. So for me, I look at it and say, sure, there could be some short-term pent-up of demand that we're able to support. What I would say in general is we would expect overall infusion pump sales next year of the LVP to be north of $100 million.	Transcript
BAX.N	2022-06-14T13:40:00Z	EBIT			And again, you also have the Hillrom synergies in there, but it's a lot of, I realize, change. I want to kind of transition this to just talking about margins and margin aspirations.	Transcript
BAX.N	2023-04-27T08:30:00Z	EBIT			We now expect full year adjusted operating margin to be between 15.5% and 16%.	Transcript
HUM.N	2023-04-26T09:00:00Z	Revenue	102700000000	100700000000	For the full year, we have updated our consolidated adjusted revenue expectations to a range of $100.7 billion to $102.7 billion while updating our Insurance segment adjusted revenue expectations to a range of $97.5 billion to $99 billion. These changes reflect the removal of the Employer Group commercial medical business results, which are being adjusted out for non-GAAP reporting purposes, partially offset by the impact of our previously announced increased individual Medicare Advantage membership growth estimates for the full year of at least 775,000 members.	Transcript
HUM.N	2023-04-26T09:00:00Z	Revenue			For the full year, we have updated our consolidated adjusted revenue expectations to a range of $100.7 billion to $102.7 billion while updating our Insurance segment adjusted revenue expectations to a range of $97.5 billion to $99 billion. These changes reflect the removal of the Employer Group commercial medical business results, which are being adjusted out for non-GAAP reporting purposes, partially offset by the impact of our previously announced increased individual Medicare Advantage membership growth estimates for the full year of at least 775,000 members.	Transcript
HUM.N	2023-02-01T09:00:00Z	EBIT			In summary, we are guiding to insurance segment income from operations in the range of $3.2 billion to $3.5 billion for 2023, an increase of more than 12% over 2022 at the midpoint of the range.	Transcript
HUM.N	2023-02-01T09:00:00Z	EBITDA			For our CenterWell segment, we expect EBITDA in the range of $1.3 billion to $1.45 billion for 2023, a slight decrease from 2022.	Transcript
ZBH.N	2023-04-18T10:15:00Z	Revenue	7356294000	7286895000	but I just want to highlight a couple of things about innovation that I think you might have seen in the Academy.	Transcript
ZBH.N	2023-05-10T13:40:00Z	Revenue			And do you think that could be in a growth driver next year?	Transcript
ZBH.N	2021-01-11T15:40:00Z	EBIT			On the longer-term, we remain confident in that 30% operating margin profile in 2023.	Transcript
ZBH.N	2023-05-02T08:30:00Z	EBIT			So Suky, I want to ask you a question about margins.	Transcript
TDY.N	2023-04-26T11:00:00Z	EBIT	5730000000	5730000000	And is it biased towards Digital Imaging? January, you're perfectly correct. So what are the kind of the main parts of the change? We're taking some guidance down in instrumentation from January to today.	Transcript
TDY.N	2023-04-26T11:00:00Z	Revenue			On revenue, specifically, we continue to see total 2023 growth of approximately 5% or sales of approximately $5.73 billion with the second quarter being roughly $1.4 billion.	Transcript
TDY.N	2023-04-26T11:00:00Z	EBIT			And is it biased towards Digital Imaging? January, you're perfectly correct. So what are the kind of the main parts of the change? We're taking some guidance down in instrumentation from January to today.	Transcript
TDY.N	2023-04-26T11:00:00Z	EBIT			And is it biased towards Digital Imaging? January, you're perfectly correct. So what are the kind of the main parts of the change? We're taking some guidance down in instrumentation from January to today.	Transcript
TDY.N	2023-04-26T11:00:00Z	EBIT			And is it biased towards Digital Imaging? January, you're perfectly correct. So what are the kind of the main parts of the change? We're taking some guidance down in instrumentation from January to today.	Transcript
GILD.OQ	2023-04-27T16:02:00Z	Revenue	11600000000	11000000000	Guidance and Outlook billion, unchanged from prior guidance.	Press Release
GILD.OQ	2023-04-27T16:30:00Z	Revenue			We believe this is a more appropriate level of investment for a company with a broad late-stage clinical portfolio that is targeting attractive opportunities and sustainable revenue growth.	Transcript
GILD.OQ	2023-04-27T16:02:00Z	EBIT			Projected operating income GAAP to non-GAAP reconciliation:	Press Release
GILD.OQ	2023-04-27T16:30:00Z	EBIT			Overall, there is no change to our expectations for non-GAAP operating income in the range of $11 billion to $11.6 billion.	Transcript
EPAM.N	2023-05-05T08:00:00Z	Revenue	5000000000	4950000000	And then just as a follow-up, it seems like while financials and travel seem to put up pretty solid growth numbers ex Russia, I was a little bit more surprised to see the Life Sciences and, to a lesser degree, Hi-tech experienced a bit of a slowdown.	Transcript
EPAM.N	2023-05-05T08:00:00Z	EBIT	825000000	767250000	We expect GAAP income from operations to continue to be in the range of 11.5% to 12.5% and non-GAAP income from operations to continue to be in the range of 15.5% to 16.5%.	Transcript
EPAM.N	2023-05-05T08:00:00Z	EBIT			We expect GAAP income from operations to continue to be in the range of 11.5% to 12.5% and non-GAAP income from operations to continue to be in the range of 15.5% to 16.5%.	Transcript
CMA.N	2023-04-20T08:00:00Z	Revenue			We continue to expect growth in most businesses, but plan to be appropriately selective supporting opportunities most aligned with our target credit, pricing and relationship strategy. We expect momentum, especially in our Commercial Real Estate and National Dealer Services business, to drive average 2023 loan growth of 8% to 9%.	Transcript
NOC.N	2023-01-26T09:00:00Z	Revenue	38432100000	38066080000	And similar to our cadence in 2022, we expect first quarter sales of approximately 24% of our full year estimate, with sales ramping again throughout the year. And we continue to expect flattish sales at both Aeronautics and Defense Systems. Now turning to 2023 guidance, our revenue expectations have increased from our prior estimates, with the midpoint representing nearly 4.5% growth on top of the strong level in 2022. We enter 2023 with a backlog of more than 2x our annual sales. We expect Aeronautics and Defense Systems to return to growth in 2024. Why does the growth rate slow that much in '23?	Transcript
NOC.N	2023-01-26T09:00:00Z	Revenue	4400000000	4300000000	And similar to our cadence in 2022, we expect first quarter sales of approximately 24% of our full year estimate, with sales ramping again throughout the year. And we continue to expect flattish sales at both Aeronautics and Defense Systems. Now turning to 2023 guidance, our revenue expectations have increased from our prior estimates, with the midpoint representing nearly 4.5% growth on top of the strong level in 2022. We enter 2023 with a backlog of more than 2x our annual sales. We expect Aeronautics and Defense Systems to return to growth in 2024. Why does the growth rate slow that much in '23?	Transcript
NOC.N	2023-02-15T09:15:00Z	EBIT			That's the environment we'd expect to see normalize over the next couple of years and lead to that mitigating increased opportunity in our margins.	Transcript
NOC.N	2023-02-15T09:15:00Z	Revenue			And then '24, '25, things should move north?	Transcript
NOC.N	2023-01-26T09:00:00Z	Revenue			And similar to our cadence in 2022, we expect first quarter sales of approximately 24% of our full year estimate, with sales ramping again throughout the year. And we continue to expect flattish sales at both Aeronautics and Defense Systems. Now turning to 2023 guidance, our revenue expectations have increased from our prior estimates, with the midpoint representing nearly 4.5% growth on top of the strong level in 2022. We enter 2023 with a backlog of more than 2x our annual sales. We expect Aeronautics and Defense Systems to return to growth in 2024. Why does the growth rate slow that much in '23?	Transcript
NOC.N	2023-01-26T09:00:00Z	Revenue			And similar to our cadence in 2022, we expect first quarter sales of approximately 24% of our full year estimate, with sales ramping again throughout the year. And we continue to expect flattish sales at both Aeronautics and Defense Systems. Now turning to 2023 guidance, our revenue expectations have increased from our prior estimates, with the midpoint representing nearly 4.5% growth on top of the strong level in 2022. We enter 2023 with a backlog of more than 2x our annual sales. We expect Aeronautics and Defense Systems to return to growth in 2024. Why does the growth rate slow that much in '23?	Transcript
NOC.N	2023-01-26T09:00:00Z	EBIT			And it's kind of perceived to be kind of a 10% business, I think, is what we've talked about in the past and looking to a second year in the mid-9s here in 2023. The margin guidance came down there, margin rate guidance came down there a couple of times during the year. We're forecasting a rate just above that level that we operated at in '22 as we now look at '23.	Transcript
NOC.N	2023-01-26T06:38:52Z	EBIT			relations website at http://investor.northropgrumman.com.	Press Release
NOC.N	2023-01-26T06:38:52Z	EBIT			Corporation (NYSE: NOC) has released its fourth quarter and full-year 2022 FALLS CHURCH, Va., Jan. 26, 2023 (GLOBE NEWSWIRE) -- Northrop Grumman companyâ€™s Form 8-K filing and is also available on the company's investor financial results. A copy of the earnings release has been furnished in the relations website at http://investor.northropgrumman.com.	Press Release
NOC.N	2023-01-26T06:38:52Z	EBIT			Corporation (NYSE: NOC) has released its fourth quarter and full-year 2022 FALLS CHURCH, Va., Jan. 26, 2023 (GLOBE NEWSWIRE) -- Northrop Grumman companyâ€™s Form 8-K filing and is also available on the company's investor financial results. A copy of the earnings release has been furnished in the relations website at http://investor.northropgrumman.com.	Press Release
NOC.N	2023-01-26T09:00:00Z	EBIT			I wonder if you could talk a little bit about the profitability in the Space business. Margins are expected to remain solid in the 11.3% to 11.5% range. On LRIP, we haven't baked any margin or cash in that part of the program into our multiyear outlook or our '23 guide. So what sort of offsets that to get to that 50 basis points of expansion? You mentioned B-21 EMD program, will -- a portion of the contract will continue for a number of years.	Transcript
NOC.N	2023-01-26T09:00:00Z	EBIT			I wonder if you could talk a little bit about the profitability in the Space business. Margins are expected to remain solid in the 11.3% to 11.5% range. On LRIP, we haven't baked any margin or cash in that part of the program into our multiyear outlook or our '23 guide. So what sort of offsets that to get to that 50 basis points of expansion? You mentioned B-21 EMD program, will -- a portion of the contract will continue for a number of years.	Transcript
NOC.N	2023-01-26T09:00:00Z	EBIT			I wonder if you could talk a little bit about the profitability in the Space business. Margins are expected to remain solid in the 11.3% to 11.5% range. On LRIP, we haven't baked any margin or cash in that part of the program into our multiyear outlook or our '23 guide. So what sort of offsets that to get to that 50 basis points of expansion? You mentioned B-21 EMD program, will -- a portion of the contract will continue for a number of years.	Transcript
PNW.N	2023-05-04T12:00:00Z	Revenue			As previously discussed, our 2023 sales growth is driven by several large customers expanding and ramping up their usage.	Transcript
BFb.N	2021-06-09T10:00:00Z	Revenue	1312360000	1288280000	Our business model remains excellent with nearly a 34% operating margin and an approximately 20% ROIC, both industry-leading metrics.	Transcript
BFb.N	2021-06-09T10:00:00Z	EBIT			In summary, while fiscal 2021 was filled with rapidly changing market dynamics and twists and turns at every corner, we delivered strong top line growth, consistent with our long-term aspiration. Our business model remains excellent with nearly a 34% operating margin and an approximately 20% ROIC, both industry-leading metrics.	Transcript
DE.N	2022-02-18T10:00:00Z	Revenue			Starting with the goal to reach 10% recurring revenue by 2030. Thanks, Jill.	Transcript
DE.N	2023-05-19T10:00:00Z	EBIT			As noted last quarter, we expect price realization to moderate in the latter half of the fiscal year relative to our reported first 6 months.	Transcript
DE.N	2023-02-17T10:00:00Z	Revenue			Let's turn to our 2023 construction and forestry industry outlook on Slide 10.	Transcript
DE.N	2022-08-19T10:00:00Z	Revenue			Ag & Turf products typically in the 30% to 35% range, and Construction & Forestry products historically have been in the 20% to 25% range, and that would be our targeting goal as we think about 2023. While the industry continues to be constrained by supply, demand remains robust and our guidance assumes a heavier back-end loaded year for industry retail.	Transcript
DE.N	2023-02-17T10:00:00Z	EBIT			Operating margin is expected to be in the range of 17% to 18%. The segment's operating margin is projected between 14.5% and 15.5%.	Transcript
DE.N	2022-11-23T10:00:00Z	EBIT			For the segment's operating margin, our full year forecast is between 22% and 23%.	Transcript
DE.N	2023-05-19T10:00:00Z	EBIT			As noted last quarter, we expect price realization to moderate in the latter half of the fiscal year relative to our reported first 6 months.	Transcript
DE.N	2023-05-19T10:00:00Z	EBIT			As noted last quarter, we expect price realization to moderate in the latter half of the fiscal year relative to our reported first 6 months.	Transcript
HSY.N	2023-04-27T08:00:00Z	Revenue	11252837520	11252837520	As a result of our strong start and increased visibility into customer demand and supply chain costs for the remainder of the year, we are increasing our sales and earnings outlook for the year.	Transcript
GL.N	2023-05-04T11:00:00Z	Revenue			For the year, we expect health premium revenue to grow around 3%, at the midpoint of our guidance, we expect health underwriting margin as a percent of premium to be in the range of 28% to 30%.	Transcript
GL.N	2023-05-04T11:00:00Z	Revenue			For the year, we expect health premium revenue to grow around 3%, at the midpoint of our guidance, we expect health underwriting margin as a percent of premium to be in the range of 28% to 30%.	Transcript
GL.N	2023-05-04T11:00:00Z	Revenue			For the year, we expect health premium revenue to grow around 3%, at the midpoint of our guidance, we expect health underwriting margin as a percent of premium to be in the range of 28% to 30%.	Transcript
GL.N	2023-05-04T11:00:00Z	EBIT			As we've discussed on prior calls, underwriting margin is different under the new LDTI accounting rules. The increase in our expectations for 2023 is largely due to the impact of lower share price and slightly higher life margins as a result of lower policy obligations than previously anticipated.	Transcript
GL.N	2023-05-04T11:00:00Z	EBIT			As we've discussed on prior calls, underwriting margin is different under the new LDTI accounting rules. The increase in our expectations for 2023 is largely due to the impact of lower share price and slightly higher life margins as a result of lower policy obligations than previously anticipated.	Transcript
GL.N	2023-05-04T11:00:00Z	EBIT			As we've discussed on prior calls, underwriting margin is different under the new LDTI accounting rules. The increase in our expectations for 2023 is largely due to the impact of lower share price and slightly higher life margins as a result of lower policy obligations than previously anticipated.	Transcript
SLB.N	2023-04-21T09:30:00Z	Revenue			Consequently, this year, we expect to post our highest revenue ever in the Middle East, putting us on track to achieve our multiyear growth aspiration. Taken together, we expect the strong international growth to offset any weakness in North America, keeping our full year ambitions intact with year-on-year growth in excess of 15%, which should support adjusted EBITDA growth in the mid-20s.	Transcript
SLB.N	2022-01-21T09:30:00Z	EBITDA			So as the year develop, we believe that these attributes: our foundation, operating leverage, our performance that differentiate the execution give us a premium, our market mix, our technology adoption, success with customer and finally pricing, giving a tailwind to this, will drive and further expand our margin to the 2025, the 25% margin expansion.	Transcript
AWK.N	2023-02-16T09:00:00Z	Revenue			Recent new revenue in Pennsylvania, New Jersey and Illinois, together with infrastructure surcharge mechanisms account for a significant majority of the $1.10 to $1.20 per share revenue increase in 2023 shown on this slide.	Transcript
PKG.N	2023-04-25T09:00:00Z	Revenue			It looks like maybe this next quarter where we should see another down double-digit type of volume year-over-year. Yes, George.	Transcript
PKG.N	2023-04-25T09:00:00Z	Revenue			It looks like maybe this next quarter where we should see another down double-digit type of volume year-over-year. Yes, George.	Transcript
PKG.N	2022-07-26T09:00:00Z	EBITDA			Down?	Transcript
PKG.N	2023-04-24T17:00:00Z	Revenue			will be lower as a result of the previously published domestic containerboard	Press Release
FLT.N	2023-05-03T17:30:00Z	Revenue	3860000000	3820000000	So we're revising full year revenue and cash EPS guidance up by our Q1 beat, so revenue at the midpoint now of $3.840 billion and cash EPS at the midpoint now, $17.15.	Transcript
FLT.N	2023-03-03T08:45:00Z	Revenue	2483994250	2483994250	And where is your sales effort focused for '23? Or do you think that the bulk of the growth is going to be driven from rising the customer base?	Transcript
FLT.N	2023-03-14T13:50:00Z	EBITDA			And we think that there's a lot of targets for us to continue to do that. We think that the M&A pipeline is robust as it's ever been for us.	Transcript
ADI.OQ	2023-06-01T15:30:00Z	Revenue			So those things will enable us to, I think, over a sustainable period of time to grow 10% plus, we have a growth expectation in the automotive business to be able to grow kind of low double digits, kind of 12%, 13%. We play in kind of mid high-end systems.	Transcript
ADI.OQ	2022-04-05T16:15:00Z	EBIT			CAGR and Adjusted Operating Margin Target to 42-50%	Press Release
MMC.N	2022-07-21T08:30:00Z	Revenue	21963200000	21963200000	The higher the levels of growth that we see next year or the year after, the more we'll be able to think about margins.	Transcript
MMC.N	2023-04-20T08:30:00Z	EBIT			I would also note that while our current outlook contemplates margin expansion in the second quarter, we expect it will be more modest than in the other quarters, reflecting the talent investments we continue to make last year, timing of the annual raises and the continued rebound in expenses such as T&E relative to last year.	Transcript
IT.N	2023-05-02T08:00:00Z	Revenue	5900000000	5900000000	Overall, we've increased our revenue outlook by $35 million. Research revenue guidance is up modestly from February. The non-subscription part of the business faces tough compares and has more direct exposure to tech vendor spending. There is seasonality to the business based on the conferences calendar, which is different than the historical pattern. We have increased our outlook for Conferences by $25 million.	Transcript
IT.N	2023-05-02T08:00:00Z	Revenue	1330000000	1330000000	Overall, we've increased our revenue outlook by $35 million. Research revenue guidance is up modestly from February. The non-subscription part of the business faces tough compares and has more direct exposure to tech vendor spending. There is seasonality to the business based on the conferences calendar, which is different than the historical pattern. We have increased our outlook for Conferences by $25 million.	Transcript
IT.N	2023-05-02T08:00:00Z	Revenue	1106000000	1106000000	Overall, we've increased our revenue outlook by $35 million. Research revenue guidance is up modestly from February. The non-subscription part of the business faces tough compares and has more direct exposure to tech vendor spending. There is seasonality to the business based on the conferences calendar, which is different than the historical pattern. We have increased our outlook for Conferences by $25 million.	Transcript
IT.N	2023-05-02T08:00:00Z	Revenue			Overall, we've increased our revenue outlook by $35 million. Research revenue guidance is up modestly from February. The non-subscription part of the business faces tough compares and has more direct exposure to tech vendor spending. There is seasonality to the business based on the conferences calendar, which is different than the historical pattern. We have increased our outlook for Conferences by $25 million.	Transcript
IT.N	2023-05-02T08:00:00Z	EBIT			We expect margins to increase modestly over time, and we generate significant free cash flow well in excess of net income.	Transcript
IT.N	2023-05-02T06:00:00Z	EBIT			(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Finvestor.gartner.com&esheet=53391287&newsitemid=20230502005358&lan=en-US&anchor=https%3A%2F%2Finvestor.gartner.com&index=1&md5=f51618be8d52c53a48e81b0b11e5166a) information regarding the Companyâ€™s results as well as an updated 2023	Press Release
IT.N	2023-05-02T08:00:00Z	EBITDA			As I mentioned in the last quarter, we've taken a prudent approach to planning for 2023. If revenue is stronger than our outlook, we expect upside to EBITDA. This applies to revenue, operating expenses and free cash flow. We now expect full year EBITDA of at least $1.33 billion, up $70 million from our prior guidance and an increase in our margin outlook as well.	Transcript
IT.N	2023-03-16T15:15:00Z	EBITDA			Can you help us understand the bridge from nearly 27% to 21.5%? So margins were almost 27% in '22 despite a significant ramp in hiring to catch up with sales.	Transcript
ECL.N	2023-02-14T13:00:00Z	Revenue			Healthcare being one of the examples because it's $1 billion business, that's not making much money as we know.	Transcript
ECL.N	2023-05-09T08:30:00Z	Revenue			That's been true for 30 years, and it's not going to change anytime soon. That's where we're going to be as well, which is why I believe that's the objective that we've set years back of 6% to 8% top line growth, 20% OI margin and 15% EPS growth are probably more true than they've ever been since we launched those targets 30 years ago as a campaign.	Transcript
ECL.N	2023-05-02T08:00:02Z	EBIT			continued robust sales growth, easing delivered product cost inflation, and	Press Release
ECL.N	2023-05-09T08:30:00Z	EBIT			That's where we're going to be as well, which is why I believe that's the objective that we've set years back of 6% to 8% top line growth, 20% OI margin and 15% EPS growth are probably more true than they've ever been since we launched those targets 30 years ago as a campaign.	Transcript
BXP.N	2022-10-26T10:00:00Z	Revenue			And as Owen described, we currently have the Avant residential building under contract. In total, we project sales for the year of $864 million, which we expect will reduce our portfolio NOI by $28 million to $30 million in 2023.	Transcript
BXP.N	2023-04-26T10:00:00Z	EBIT			So the $0.04 increase in our full year guidance includes $0.03 of improvement in our portfolio NOI that is comprised of $0.02 of lower expenses and $0.01 of better-than-projected revenues. This includes our assumption that same-property NOI growth from 2022 will be flat at the midpoint of our range.	Transcript
GE.N	2023-01-24T08:00:00Z	Revenue	4800000000	4200000000	And we expect LEAP engine deliveries to grow about 50% in '23. Underpinning this outlook is a higher services concentration in our portfolio as well as our confidence in the strength of GE Aerospace as the worldwide commercial aviation industry, airlines and airframers alike, continues its post-pandemic recovery. We also anticipate Military revenue growth, thus yielding significant profit growth for GE Aerospace in '23. With Commercial Engines growing at about 20% and services at high teens to about 20%, plus Military growing at a high single-digit rate, we expect total Aerospace revenue to be in the mid-to-high teens.	Transcript
GE.N	2023-01-24T08:00:00Z	Revenue			And we expect LEAP engine deliveries to grow about 50% in '23. Underpinning this outlook is a higher services concentration in our portfolio as well as our confidence in the strength of GE Aerospace as the worldwide commercial aviation industry, airlines and airframers alike, continues its post-pandemic recovery. We also anticipate Military revenue growth, thus yielding significant profit growth for GE Aerospace in '23. With Commercial Engines growing at about 20% and services at high teens to about 20%, plus Military growing at a high single-digit rate, we expect total Aerospace revenue to be in the mid-to-high teens.	Transcript
GE.N	2022-07-26T08:00:00Z	Revenue			And perhaps stating the obvious, with so much in flux right now, around the world, I think it's going to be important for us to see how the next 6 months unfold and at this point, expect to provide an outlook on '23 in the usual time frame at earnings -- at fourth quarter earnings. And we do expect earnings to be a bigger contributor in the sort of the 2023 improvement. It will start off a lower 2022 base, but it will still be the main part of improvement for 2023. So what that means basically is that we still expect to see the same drivers as we shared in March, but we're monitoring the volatility as Larry spoke about. We still expect to deliver significant year-over-year improvement in both profit and cash, but below our prior view. We're just starting our annual strategy and budgeting cycle for 2023. With the world evolving so quickly, we have to see how the next 6 months unfold and expect to provide you our 2023 outlook in the usual time frame at fourth quarter earnings. Yes.	Transcript
GE.N	2023-04-25T08:00:00Z	Revenue			Should we expect sort of second quarter to be around breakeven-ish and common with prior years?	Transcript
GE.N	2023-04-25T08:00:00Z	Revenue			Should we expect sort of second quarter to be around breakeven-ish and common with prior years?	Transcript
GE.N	2023-04-25T08:00:00Z	Revenue			Should we expect sort of second quarter to be around breakeven-ish and common with prior years?	Transcript
GE.N	2022-05-12T12:10:00Z	Revenue			I think you called out 7 to 8 points of growth in the Healthcare business that was impacted.	Transcript
GE.N	2023-01-24T08:00:00Z	EBIT			We continue to have, I think, a lot of optimism about the LEAP program and the opportunity to improve margins both with new units and in the aftermarket as we go forward. We had a very strong finish as you saw, margins up to nearly 19%. We'll do a better job, I'm sure, as we go forward. Well, we're delighted to talk about Aerospace, so let me jump in. You'll see that both in the P&L and I think in the cash flow statement.	Transcript
GE.N	2023-01-24T08:00:00Z	EBIT			We continue to have, I think, a lot of optimism about the LEAP program and the opportunity to improve margins both with new units and in the aftermarket as we go forward. We had a very strong finish as you saw, margins up to nearly 19%. We'll do a better job, I'm sure, as we go forward. Well, we're delighted to talk about Aerospace, so let me jump in. You'll see that both in the P&L and I think in the cash flow statement.	Transcript
GE.N	2023-01-10T06:30:00Z	EBIT			The Company expects full year 2023 results as follows:	Press Release
GE.N	2023-04-25T08:00:00Z	EBIT			All 3 businesses saw strong top line growth with continued productivity gains in the first quarter, and we remain on track to achieve modest profitability for the full year.	Transcript
GE.N	2023-04-25T08:00:00Z	EBIT			And for Power, we expect revenue and profit to be slightly down year-over-year, really with the second half loaded outage and Aeroderivatives shipments. And then sort of 2 specific drivers I was curious about. How do you see that playing out the balance of the year? Should we expect sort of second quarter to be around breakeven-ish and common with prior years?	Transcript
GE.N	2023-01-24T08:00:00Z	EBIT			We're expecting organic revenue growth in the high single-digit range; $1.60 to $2 for adjusted EPS, which includes about $4.2 billion to $4.8 billion of adjusted profit; and a range of $3.4 billion to $4.2 billion for free cash flow.	Transcript
ED.N						
ALLE.N	2022-05-02T13:20:00Z	Revenue	3713606500	3648168500	And so what you saw in the last cycle is we have above-market growth from the tailwinds of this electromechanical conversion. This is not an industry where like the foot phone becomes the smartphone, and we all have a smartphone within 4 years.	Transcript
ALLE.N	2023-04-26T08:00:00Z	Revenue			Maybe help us understand kind of what's the split between price and volume versus your prior assumption? Maybe just a first question around that nonresidential Americas outlook and sort of an update there.	Transcript
ALLE.N	2023-05-09T13:50:00Z	Revenue			And so are we expected then to continue to see very positive pricing over the course at least over the next 12 months because of how you spec into these projects? And so what you have in 2023 is you do have some lapping of previous year where we had multiple price increases. And that is really where we're going to put our investments to drive market outgrowth and shareholder return.	Transcript
ALLE.N	2022-04-20T08:00:00Z	EBITDA			Following the completion of the transaction, the net debt to adjusted EBITDA is expected to be approximately (inaudible).	Transcript
ALLE.N	2022-04-20T08:00:00Z	EBIT			We expect $9 million in net run rate EBIT synergies annually achievable by the end of 2024, with 2/3 of that associated with net revenue synergies and the remainder to come from optimized procurement, production and shared administration functions, which will be partially offset by additional stand-alone costs and investments.	Transcript
ALLE.N	2023-02-22T08:00:00Z	EBIT			Adjusted operational earnings are expected to increase 9% to 12%, driven by volume leverage and price and productivity exceeding inflation and investments.	Transcript
ALLE.N	2023-04-26T08:00:00Z	EBIT			So if you look at margins for the year, I expect our margins to be up, say, 50 to 100 basis points full year.	Transcript
OTIS.N	2022-02-15T06:05:01Z	Revenue	14100000000	13900000000	* Organic Service sales up mid single digits	Press Release
OTIS.N	2022-02-15T06:05:01Z	Revenue	2300000000	2200000000	* Organic Service sales up mid single digits	Press Release
OTIS.N	2023-04-26T08:30:00Z	Revenue			Turning to Otis' 2023 financial outlook. We now expect net sales to be in the range of $13.9 billion to $14.2 billion, up 2.5% to 4.5% versus the prior year, which is a 75-basis-point improvement from the prior outlook at the midpoint, driven by FX.	Transcript
OTIS.N	2022-04-23T08:30:00Z	Revenue			As a result, we now expect EMEA sales to be up low to mid-single digits for 2022. While the backlog in EMEA is up more than 5%, our customers are requesting postponement of deliveries due to a broader slowdown in building construction activity, pushing shipments from 2022 to 2023.	Transcript
OTIS.N	2023-02-01T08:30:00Z	EBIT			We expect roughly 50 basis points of margin expansion.	Transcript
OTIS.N	2023-02-01T08:30:00Z	EBIT			We expect roughly 50 basis points of margin expansion.	Transcript
OTIS.N	2023-04-26T08:30:00Z	EBIT			Turning to Otis' 2023 financial outlook.	Transcript
OTIS.N	2023-04-26T06:12:01Z	EBIT			2023 Outlook(1) adjusted effective tax rate and free cash flow on a forward-looking basis, a	Press Release
WFC.N	2023-01-13T12:00:00Z	Revenue			And just looking at what the guide implies a step down -- a little bit of a step down from thereafter. And so as you look at the key things, you look at stick loan growth, we've got -- we're expecting kind of low to mid-single-digit loan growth throughout the year. And then obviously, also the timing of when we expect to realize some of those matters as well. And then we would expect the betas to continue to move up a little from here. Can you just kind of walk us through just how you expect the betas to move through and then like what doesn't necessarily follow through from here in terms of some of the moving parts? However, this benefit is expected to be partially offset by continued deposit runoff and mix shift to higher-yielding products with these declines, partially offset by modest loan growth. Mike, just a follow-up on the NII outlook for the year. So not super fast pace, but at a moderate pace of loan growth. So you obviously had a good high end to the year at 13.5% FTE. This reduction is expected to be partially offset by an increase in trading gains and noninterest income, so the impact to revenue is currently expected to be small. We also expect a headwind for lower CIB Markets net interest income due to higher funding costs. We are expecting some moderate declines across the deposit base, stabilizing later in the year, but some moderate declines as we look over the next few quarters.	Transcript
WFC.N	2022-07-15T10:00:00Z	Revenue			Our deposit pricing has been stable, but we expect deposit betas to increase over time. Turning to our operating segments, starting with Consumer Banking and Lending on Slide 10.	Transcript
CTVA.N	2023-02-02T09:00:00Z	Revenue	18750000000	18750000000	But as we look at it, it's -- we're expecting the market organic growth to be in the mid-single digits, call it, 4% to 7% with biologicals outstripping that. But as you begin to look at new products, yes, we had a great year, finishing up about $1.9 billion for the year in the sales of those products. Or what could go wrong in '23?	Transcript
CTVA.N	2023-05-18T09:30:00Z	Revenue	3650000000	3650000000	But 2 things.	Transcript
CTVA.N	2023-05-18T09:30:00Z	EBITDA			We work in rationalize the business just the first year, we were starting to see, how much of -- how much fruits of your labor are you seeing this year?	Transcript
CTVA.N	2022-12-05T11:00:00Z	EBITDA			It represents a 12x multiple based on Stoller's '22 expected EBITDA. This is an important strategic shift for Corteva, which aligns with our purpose, core values and formula to create long-term value for both farmers and our shareholders. We have built a simple but straightforward plan to deliver approximately $4.4 billion in operating EBITDA at the midpoint by 2025, with margins in the 21% to 23% range. We're assuming the close on the transaction sometime in the -- call it the first quarter to early second quarter of the year, obviously, subject to regulatory approval.	Transcript
CTVA.N	2023-05-18T09:30:00Z	EBITDA			We work in rationalize the business just the first year, we were starting to see, how much of -- how much fruits of your labor are you seeing this year?	Transcript
FTV.N	2023-03-21T09:55:00Z	Revenue	6100000000	6000000000	I think the strength of the portfolio at Fluke that was that -- the longer-term view of Fluke is over 25 years, as you know, is a great franchise. Maybe we can talk about Fluke.	Transcript
FTV.N	2023-05-25T07:00:00Z	Revenue	1567258940	1514682000	billion to $6.1 billion, diluted net earnings per share of $2.33 to $2.44, and	Press Release
FTV.N	2023-02-23T08:00:00Z	EBIT			Again, longer-term target is 75 basis points a year. I think inflation is still out there. So let's talk about margins for a second. So we're probably matching that. When they do, you could see some upside. Yes, Andy, I think I'll take that.	Transcript
FTV.N	2023-04-26T12:00:00Z	EBIT			Adjusted operating profit is expected to increase 6% to 10%, with margins in the range of 25% to 25.5%.	Transcript
AEE.N	2023-02-16T10:00:00Z	Revenue			Turning to Illinois. We expect our weather-normalized kilowatt-hour sales, including energy efficiency, to be relatively flat over our 5-year plan.	Transcript
AEE.N	2022-06-27T12:00:00Z	Revenue			250 jobs at peak construction. Once operational in late 2024, the project is Ameren Missouri meet its goal of net-zero carbon emissions by 2045 as well as Developed by EDF Renewables, Huck Finn Solar is expected to create more than communities in both Audrain and Ralls Counties. This new generation will help expected to generate more than $14 million in revenue for the local goals. provide new clean energy options to help customers meet their clean energy	Press Release
PRU.N	2023-05-03T11:00:00Z	Revenue			And and also higher reinvestment rates. And we also like the additive mix that the Life business brings, particularly the longevity and mortality balance.	Transcript
PRU.N	2023-05-24T07:15:00Z	EBIT			million.	Press Release
PRU.N	2023-05-03T11:00:00Z	EBIT			And last, we expect other items to increase adjusted operating income by $25 million, primarily due to the seasonally elevated expenses in the first quarter.	Transcript
DLTR.OQ	2023-03-01T09:00:00Z	Revenue	30500000000	30000000000	Consolidated net sales for the full year fiscal 2023 are expected to range from $29.9 billion to $30.5 billion. While our outlook assumes minimal profit contribution from Family Dollar this year, we believe there is tremendous opportunity to improve Family Dollar sales productivity and margins and we are confident this opportunity will realize and produce meaningful profits in the years ahead.	Transcript
DLTR.OQ	2023-05-25T09:00:00Z	Revenue			Consolidated sales for the full fiscal year are now expected to range from $30 billion to $30.5 billion. With respect to full year fiscal 2023 guidance, recall that fiscal 2023 has a 53rd week.	Transcript
DLTR.OQ	2023-03-01T09:00:00Z	EBIT			Based on the confluence of these factors, we anticipate year-over-year gross and operating margins will decline in the first half of 2023, followed by growth in the second half.	Transcript
DLTR.OQ	2023-03-01T09:00:00Z	EBIT			Based on the confluence of these factors, we anticipate year-over-year gross and operating margins will decline in the first half of 2023, followed by growth in the second half.	Transcript
CF.N	2023-05-02T11:00:00Z	Revenue			We expect this to be an active fertilizer season -- application season in 2023 with corn acres in the U.S. expected to be up about 5% and wheat acres up around 9% compared to 2022.	Transcript
CF.N	2023-05-17T08:45:00Z	EBITDA			And it could be one barge of 1,500 tons and everyone's trading on that for a every hour.	Transcript
NEE.N	2022-01-25T09:00:00Z	Revenue			And then maybe if I could pivot in brief, any thoughts or comments you'd like to share around some of the headlines pertaining to FPL here? And we believe that, that will enable us to grow rate base in the range of 8% to 9% on a compound annual growth rate basis, assuming all of the investments that were anticipated in the settlement agreement, ultimately, we're able to successfully bring into service. Feel free to opine any more on the '25 guidance. For customers in Northwest Florida, typical customer bills are projected to decline over the next 4 years. I know that this is probably preempting a little bit the June Analyst Day, regardless. I know there's been a lot of back and forth, and perhaps there's a lot of context to provide there. I would say the key parts that we think about, first on Florida Power & Light Company, we've got the outcome from the 4-year settlement agreement. So we can continue that for the next couple of years. That is now the -- how we expect to operate for the next couple of years, and that creates the opportunity to continue investing in the business and executing on the strategy that's been so successful for customers over quite a number of years looking back.	Transcript
NEE.N	2023-04-25T09:00:00Z	Revenue			And I think the 2 gigawatts that we added to the backlog is a great sign of that and it's a mix of wind, solar and battery storage in that portfolio and the conversations that we continue to have both with customers in the power sector, as well as customers outside of the power sector remain quite robust. So we continue to see a very strong renewables development environment.	Transcript
NEE.N	2023-04-03T08:30:08Z	EBITDA			year-end 2023.	Press Release
NEE.N	2023-04-25T09:00:00Z	EBITDA			NextEra Energy Partners continues to expect run rate contributions for adjusted EBITDA and cash available for distributions from its forecasted portfolio at December 31, 2023, to be in the ranges of $2.22 billion to $2.42 billion and $770 million to $860 million, respectively.	Transcript
FMC.N	2023-05-09T08:00:00Z	Revenue	6150000000	6150000000	But in general, I'd say, overall, a solid quarter. So we have outperformed our guidance. We've never done formulaic price increases. What we've done is taken more value through pricing on products that create very strong value for growers, where we have differentiation such that given the nature of our supply chain and the complex very fragmented buy of inputs that we have.	Transcript
FMC.N	2023-05-18T08:00:00Z	EBITDA	1530000000	1530000000	I think they are good numbers in terms of growth of the industry. On November 16, we have our next Investor Day where we're going to roll out a more longer-term plan as we're reaching the end of this planning period.	Transcript
FMC.N	2023-03-01T13:50:00Z	EBITDA			The intent is to get FMC back to 27% EBITDA margin as we come out at the back end of this cycle. Trailing 12-month basis.	Transcript
ILMN.OQ	2023-02-07T17:00:00Z	Revenue	5042400000	4904880000	GRAIL expects this exciting momentum to continue and to translate into an expected revenue CAGR of 60% to 90% over the next 5 years. We expect full year 2023 core Illumina revenue to grow 6% to 9% to approximately $4.83 billion to $4.96 billion.	Transcript
ILMN.OQ	2023-02-07T17:00:00Z	Revenue	403392000	392390400	GRAIL expects this exciting momentum to continue and to translate into an expected revenue CAGR of 60% to 90% over the next 5 years. We expect full year 2023 core Illumina revenue to grow 6% to 9% to approximately $4.83 billion to $4.96 billion.	Transcript
ILMN.OQ	2023-05-01T15:00:00Z	Revenue			Illumina revenue growth of 6% to 9% and GRAIL revenue in the range of $90	Press Release
ILMN.OQ	2023-02-07T17:00:00Z	EBIT			We expect core Illumina sequencing instrument growth of approximately 9% year-over-year, driven by the NovaSeq X upgrade cycle and continued momentum in mid-throughput.	Transcript
ILMN.OQ	2023-02-07T17:00:00Z	EBIT			We expect consolidated non-GAAP operating margin of approximately 8% in core Illumina non-GAAP operating margin of approximately 22% for 2023.	Transcript
ILMN.OQ	2023-04-25T17:00:00Z	EBIT			We continue to expect non-GAAP earnings per diluted share in the range of $1.25 to $1.50 for 2023, including a consolidated non-GAAP operating margin of approximately 8% and Core Illumina non-GAAP operating margin of approximately 22%. We continue to expect operating margins to improve in the second half of 2023 as revenue ramps and we scale our production of NovaSeq X and leverage the fixed cost of the manufacturing base.	Transcript
KLAC.OQ	2022-10-26T17:00:00Z	Revenue			But with that set-up, we're in pretty good shape. If you overlay those 2 components do you still expect your Process Control revenue to outperform WFE next year?	Transcript
KLAC.OQ	2021-10-27T17:00:00Z	EBIT			While operating expenses are trending higher, going forward, we will make the necessary investments to scale our business, while we continue to size the company based on our target operating model, which delivers 40% to 50% incremental operating margin leverage on revenue growth over a normalized time horizon.	Transcript
AME.N	2023-02-23T07:00:00Z	Revenue	6642572400	6458056500	And can you remind us of maybe the rough portion of the portfolio exposed to the aerospace and defense markets, some of the major programs you're on there and your outlook going forward? So a nice healthy balance. This year, we expect it to be our fastest-growing market.	Transcript
XLNX.OQ^B22	2021-04-20T09:00:02Z	Revenue			2025(1). According to industry reports, the SOM market is growing at roughly 11 percent annually and total market revenue is expected to reach $2.3 billion by	Press Release
XLNX.OQ^B22	2020-06-15T12:00:00Z	EBIT			And I think the ability to leverage the work that we've done so far on 7-nanometer in the next few years will allow us to pursue that and then that will allow growth in the top line of the company to normalize the level of spending that we have in the business. And more recently, they had jumped up into the high 20s, low 30s. And so we do not expect -- even if some of the end markets that we pursue have different margin structures than the end markets that we've had over time, we did not expect to have a decline in the operating margin environment relative to where Xilinx has been in the past. And then lastly, on the operating model, the operating margins 10 years ago, they were in kind of in the low 20s. And then we expect to be able to leverage that platform through multiple families and derivatives over time. I'll just kind of double-click on what I said earlier. Long term, is Xilinx a high 20s, low 30s operating margin company or a mid-20s, like where we are right now? So that's our goal and our target. This last fiscal year, understandably, due to lower top line expectations for some of the macro events, they kind of dropped into the 26% range. We're in the front end of the 7-nanometer development phase. Yes, keyword there being long-term as we work through this equation.	Transcript
NUE.N	2023-04-20T14:00:00Z	Revenue			Our raw materials segment is expected to continue to improve on higher shipment volumes.	Transcript
D.N	2022-08-08T10:00:00Z	Revenue			For the latter few years of our 5-year plan, we expect slightly lower sales growth due to the transmission capacity constraints until new infrastructure can be placed into service.	Transcript
SJM.N	2022-11-21T07:00:00Z	Revenue	8638812000	8638812000	As a result, we expect to see double-digit growth in both volume and sales for the remainder of the year.	Transcript
SJM.N	2022-11-21T07:00:00Z	Revenue			As a result, we expect to see double-digit growth in both volume and sales for the remainder of the year.	Transcript
SJM.N	2023-02-08T16:35:02Z	Revenue			approximately $1.5 billion for the fiscal year ended April 30, 2023, which are business. The Company expects these brands to generate net sales of primarily reported in the U.S. Retail Pet Foods segment.	Press Release
SJM.N	2022-09-06T14:15:00Z	Revenue			And construction of our new plant in McCullough, Alabama is on track with operations expected to begin in calendar 2025, enabling the Uncrustables brand to continue on its path to $1 billion in annual sales.	Transcript
SJM.N	2022-06-07T09:00:00Z	EBIT			We will be short of that for the fiscal year.	Transcript
SJM.N	2022-08-23T07:00:00Z	EBIT			Despite the reduction in SKUs, we expect profit growth for fruit spreads in the fiscal year as we increase focus on our core Smucker's fruit spreads items. We also expect margin improvement throughout the year.	Transcript
SJM.N	2021-06-03T07:30:00Z	Revenue			On a 2-year basis, our full year guidance reflects net sales, excluding divestitures, to grow at a 3% to 4% CAGR and modest adjusted earnings per share growth at the midpoint of the guidance range.	Transcript
EMR.N	2022-10-31T08:00:00Z	Revenue			Automation Solutions backlog was reduced by $400 million in the quarter, but remains robust at $5.8 billion and supports our sales outlook for 2023.	Transcript
EMR.N	2023-01-17T08:30:00Z	Revenue			After lowering its 2022 revenue guidance at the end of April, just 3 months later, NI guided to a mid-teens top line growth rate and adjusted its 2023 margin improvement to 3x larger than its prior guidance.	Transcript
EMR.N	2023-03-13T09:00:03Z	Revenue			leverage advanced predictive technologies to reduce operational complexity and minimize project risk through its DeltaVâ„¢ distributed control and safety	Press Release
EMR.N	2023-01-17T08:30:00Z	EBIT			After lowering its 2022 revenue guidance at the end of April, just 3 months later, NI guided to a mid-teens top line growth rate and adjusted its 2023 margin improvement to 3x larger than its prior guidance.	Transcript
EMR.N	2022-10-31T08:00:00Z	EBITDA			And then secondly, just AspenTech, I'd be curious, I think the implied, I guess, the EBITDA from this quarter was roughly, call it, $80 million, $85 million.	Transcript
EMR.N	2023-05-03T08:00:00Z	EBITDA			We now expect AspenTech's adjusted segment EBITA to be slightly below 40% for the year.	Transcript
DVA.N	2022-02-10T17:00:00Z	Revenue	1625000000	1475000000	But at the same time, you're also kind of saying your growth rate of 2021 hasn't changed. I just try to think directionally, how should we think about 2023 versus your prior comments?	Transcript
DVA.N	2023-05-10T16:40:00Z	Revenue			And I think we will continue to look for and I expect we will find opportunities to bridge that gap with a variety of things associated with cost savings in other areas like pharmaceuticals, like capacity utilization or other ways to get our revenue up even if our rates aren't increasing through mix or other opportunities.	Transcript
DVA.N	2023-05-08T17:00:00Z	EBIT			Therefore, we are revising our adjusted operating income range of $1.4 billion to $1.6 billion to a range of $1.475 billion to $1.625 billion and revising our adjusted earnings per share range of $5.45 to $6.95 to a range of $6.20 to $7.30.	Transcript
DVA.N	2023-02-22T17:00:00Z	EBIT			For IKC, we expect OI to be flat to slightly down in 2023 relative to 2022.	Transcript
DVA.N	2023-03-14T15:05:00Z	EBIT			Maybe one other question on -- one final question here, just to touch on a little bit.	Transcript
CMS.N						
HPE.N	2023-03-02T16:05:00Z	Revenue	30490720000	29920800000	* ARR((2)): Reiterates our 2022 HPE Securities Analyst Meeting ARR guidance of 35%-45% Compounded Annual Growth Rate from fiscal 2022 to fiscal 2025	Press Release
HPE.N	2023-05-30T16:05:00Z	Revenue	3237820000	3207560000	35%-45% Compounded Annual Growth Rate from fiscal 2022 to fiscal 2025	Press Release
HPE.N	2022-06-01T17:00:00Z	EBIT			Compute operating profit margins at well above 13%, well above our long-term guidance, have also been better than what our main competitor in that space, Dell, has delivered for their total ISG margins that include compute, storage and networking.	Transcript
HPE.N	2022-11-29T17:00:00Z	EBIT			In HPC & AI, revenue fell 11% year-over-year solely as a result of the Frontier deal slipping into fiscal year '23, which also impacted our operating margin in this segment. Our operating margin of 13.3% was up 2.4% annually, though down 3.2% sequentially with FX being the biggest contributor to the sequential decline. We are on track to close that deal in Q1 and have factored that into our guidance. We continue to expect our Edge business to grow and perform like a Rule of 40 business moving forward. We continue to have orders for HPC & AI solutions of about $3 billion to be delivered in upcoming quarters.	Transcript
RHI.N	2023-04-26T17:00:00Z	Revenue			Revenue was just slightly changed in Q1 relative to Q4 of last year, but the gross margin ended up declining sequentially as did the operating margin. Their pipeline is very good.	Transcript
BDX.N	2023-02-02T08:00:00Z	Revenue	19300000000	19200000000	Second, regarding FX.	Transcript
BDX.N	2023-02-02T08:00:00Z	Revenue			Second, regarding FX.	Transcript
BDX.N	2023-05-09T11:00:00Z	Revenue			Like I said, organic growth, 6%, fairly ratable in the second half. You do have a dynamic where we're going to cycle over the Parata acquisition, so I think ratable on an organic basis.	Transcript
BDX.N	2023-05-09T11:00:00Z	Revenue			But you're going to have a little bit of a lift still on total base revenues from Parata, and then that normalizes in Q4.	Transcript
BDX.N	2023-05-09T11:00:00Z	EBIT			So should we expect -- like as revenue comes in, if revenue comes in higher over the course of the year, more of that could flow through absent any FX moves?	Transcript
BDX.N	2022-06-16T11:00:00Z	EBIT			And I'm wondering if that's a good starting point for us, or if there are puts and takes you'd want us to think about.	Transcript
BDX.N	2023-02-02T08:00:00Z	Revenue			Second, regarding FX.	Transcript
BDX.N	2022-03-07T09:50:00Z	Revenue			So we learned a lot at the Investor Day and then your team did -- we felt did a great job kind of laying out the road map and the drivers of a 6% to 7% organic revenue target for the Life Sciences business.	Transcript
AAP.N	2023-05-31T06:30:00Z	Revenue	11300000000	11200000000	Prior FY 2023 Outlook Â  Updated FY 2023 Outlook	Press Release
AAP.N	2023-05-31T06:30:00Z	EBIT	951200000	889200000	($ in millions, except per share data) Low Â  High Â  Low Â  High Prior FY 2023 Outlook Â  Updated FY 2023 Outlook	Press Release
AAP.N	2023-02-28T08:00:00Z	EBIT			And then for 2023, could you talk about your expectations for the LIFO benefit and also the transformation costs that you're embedding in the outlook today? And when you think about your historical non-GAAP margin goal of 10.5% to 12.5%, can you walk through what that would equate to on a GAAP basis? Got it. Yes, sure.	Transcript
MGM.N	2023-01-26T10:00:00Z	EBITDA			I wouldn't set that expectation as a mainstream one, we'll see, but I think the bigger piece is going to be obviously coming on the positive from gaming. Obviously, from an EBITDA perspective, if you thought the full year was going to be positive, you would have stated that.	Transcript
MGM.N	2023-05-01T17:00:00Z	Revenue			Based on results thus far, BetMGM remains on track to hit fiscal '23 revenue guidance of $1.8 billion to $2 billion.	Transcript
MGM.N	2023-05-01T17:00:00Z	EBIT			But overall, I do believe that we will be able to maintain our margin in the high-20s. First, on Macau, how would you say that the margin should trend over time? I know there was some benefit of hold in the quarter, but would you say you're fully ramped in terms of where you need to be and there should be a lot of leverage as we go forward? I think last time you guys talked about high-20s as an exit rate for this year, but it seems like we're tracking above that. Or is there additional head count that you'd look to add? So in the second half of this year, I think that the labor costs will increase because we have to fill some vacancies to address service issues.	Transcript
MGM.N	2022-11-02T17:00:00Z	EBITDA			BetMGM is firing on all cylinders, demonstrating tremendous growth and remains on track to achieve profitability during 2023.	Transcript
ALGN.OQ	2023-02-01T16:41:00Z	Revenue			For 2023, Align provides the following business outlook:	Press Release
ALGN.OQ	2023-05-10T12:20:00Z	EBIT			So is that exactly what you just said, still some of that uncertainty, you moving in the right direction, but not quite there yet to have 12 months of visibility?	Transcript
ALGN.OQ	2023-04-26T16:01:00Z	EBIT			2023 Non-GAAP operating margin to be slightly above 20%.	Press Release
SRE.N	2022-02-25T12:00:00Z	Revenue			Let me just start with a little bit of context. You also have cost of capital coming.	Transcript
SRE.N	2023-03-20T16:05:01Z	EBITDA			approximately $1.55 billion. Sempra's share of the above estimates would be its share of average adjusted EBITDA after full commercial operations to be	Press Release
SRE.N	2022-02-25T12:00:00Z	EBITDA			So the earnings for -- the earnings you see in our guidance range for '22 and '23 assumes the proportional amount of earnings.	Transcript
REGN.OQ	2023-05-04T08:30:00Z	Revenue			As a result, we now expect 2023 other revenue to be higher than 2022 other revenue. For modeling purposes, second quarter 2023 other revenue is expected to be the lowest of the 2023 quarters, with the vast majority of the remaining other revenue to be recorded in the second half of this year.	Transcript
EFX.N	2022-10-20T08:30:00Z	Revenue	5375000000	5275000000	Core mortgage outperformance, predominantly in EWS, drove the remainder of organic constant dollar revenue growth. That is, obviously, going to be important to us. The new products that we talked about, the acquisition synergies and growth going into 2023. What else would you add, John?	Transcript
EFX.N	2022-07-21T08:30:00Z	Revenue	1789200000	1789200000	As a reminder, new products rolled out in '21 and '22 will drive top line growth in 2023 and beyond as they mature in the marketplace. We continue to be confident in our long-term framework of 8% to 12% revenue growth, our goal of $7 billion of revenue in 2020 -- or by 2025, our ability to expand our margins 500 basis points between 2022 and 2025, and 50 basis points per year of margin expansion longer term.	Transcript
EFX.N	2022-06-09T13:00:00Z	Revenue			Embedded in that is 1 to 2 percentage points of growth from acquisitions, so delivering 7% to 10% organic revenue growth. The businesses we expect to drive that growth in our Workforce Solutions business is our highest growing business at 13% to 15% expected annual growth in terms of organic revenue growth. USIS growing on the order of 6% to 8% and international growing 7% to 9%.	Transcript
EFX.N	2022-12-19T16:30:00Z	Revenue			And when you say EPS accretive in year 1, just hoping for some kind of quantification of how accretive.	Transcript
EFX.N	2023-04-20T08:30:00Z	Revenue			And International adjusted EBITDA margins at 23.5% were better than our expectations due to the stronger revenue growth and good execution against their 2023 cost reduction plans.	Transcript
EFX.N	2023-04-20T08:30:00Z	Revenue			And International adjusted EBITDA margins at 23.5% were better than our expectations due to the stronger revenue growth and good execution against their 2023 cost reduction plans.	Transcript
EFX.N	2023-04-20T08:30:00Z	Revenue			And as mentioned earlier, given our strong performance in the quarter, our ability to continue to outperform our underlying markets and deliver on our planned 2023 spending reductions, we've reaffirmed our 2023 guidance for revenue and adjusted EPS. John will provide more detail on the overall mortgage market and our second quarter and full year guidance shortly. The combined market impact in '22 and '23 is expected to reduce Equifax revenue by over $900 million.	Transcript
EFX.N	2023-04-20T08:30:00Z	EBITDA			Adjusting for the incremental stock-based compensation expense incurred in the quarter, adjusted EBITDA margins would have been approximately 31%, which is the baseline of which we expect to grow to 36% in the fourth quarter from revenue growth and our $120 million cost savings plan. Also, we'll be making certain forward-looking statements, including second quarter and full year 2023 guidance, to help you understand Equifax and its business environment (inaudible). And we're executing against our spending reduction plans that will deliver $200 million of savings in 2023 with run rate savings of over $250 million in 2024 that will expand our margins to 36% and EPS to over $2 per share as we exit the year, which positions us for an uncertain economic environment while reducing the capital intensity of our business. We also continue to expect to deliver adjusted EBITDA margins of over 36% in the fourth quarter, which is a very important stepping-off point for 2024.	Transcript
EFX.N	2023-02-09T08:30:00Z	EBITDA			Slide 18 provides the specifics of our 2022 full year guidance that Mark discussed in detail.	Transcript
EFX.N	2022-02-10T08:30:00Z	EBITDA			And continuing to execute our cloud data and tech transformation at these revenue levels could deliver 39% EBITDA margins by 2025. Beyond 2025, we expect to see revenue expansion of 8% to 12% and deliver margin expansion of, on average, 50 basis points per year, reflecting our significant operating leverage and high variable margins.	Transcript
EFX.N	2022-10-20T08:30:00Z	EBIT			And then just as we think about those margins, I appreciate -- I know you're not providing '23 guidance, but I appreciate you giving us EWS margin outlook of above 50%.	Transcript
EFX.N	2023-02-09T08:30:00Z	EBITDA			Slide 18 provides the specifics of our 2022 full year guidance that Mark discussed in detail.	Transcript
EFX.N	2023-03-16T11:55:00Z	EBITDA			And again, we're assuming by 2025, that we're not in a recessionary environment that it's a more normal environment.	Transcript
EFX.N	2023-02-09T08:30:00Z	EBITDA			Slide 18 provides the specifics of our 2022 full year guidance that Mark discussed in detail.	Transcript
EFX.N	2023-02-09T08:30:00Z	EBITDA			Slide 18 provides the specifics of our 2022 full year guidance that Mark discussed in detail.	Transcript
USB.N	2023-04-19T10:00:00Z	Revenue	30500000000	28500000000	Total revenue as adjusted is now expected to be in the range of $28.5 million to $30.5 billion, inclusive of approximately $350 million of full year purchase accounting accretion.	Transcript
USB.N	2022-07-15T09:00:00Z	EBIT			We believe our digital capabilities and our complete payments ecosystem are competitive advantages that will drive meaningful profit and return differentiation for our company over the next several years.	Transcript
HCA.N	2023-05-16T09:00:00Z	Revenue	64500000000	62500000000	And I think that's part of our operational learnings that we're going to continue to harness and push through the balance of the year. But there's a formula there that would make sense, and I think some of our facilities do that better than others. It's a great question. We've said we believe we can manage overall labor costs as a percent of revenue in '23, consistent with '22.	Transcript
HCA.N	2023-04-21T10:00:00Z	EBITDA	12700000000	12100000000	I will mention that our updated capital spending guidance is based on opportunities we believe exist to continue to invest growth agenda, and it also considers some land acquisitions we are planning for future development. We're 93% of the way there.	Transcript
AVGO.OQ	2023-03-02T17:00:00Z	Revenue			Sequentially, wireless was flattish compared to Q4.	Transcript
AVGO.OQ	2022-05-26T07:00:09Z	EBITDA			based on the closing price of Broadcom common stock on May 25, 2022. In	Press Release
DHR.N	2023-01-24T08:00:00Z	Revenue	10007778000	9818952000	In light of these dynamics, we now anticipate COVID-19-related vaccine and therapeutic revenue will be approximately $150 million for the full year of 2023, down from approximately $800 million in 2022 and lower than our previous expectation of $500 million.	Transcript
DHR.N	2023-01-10T16:30:00Z	Revenue			So what gives you confidence that you're able to reach that $500 million next year?	Transcript
DHR.N	2023-05-10T13:00:00Z	Revenue			Well, I mean, we have to start with -- it's hard to believe, but in the fourth quarter, we shipped 20 million tests still at Cepheid.	Transcript
DHR.N	2023-05-10T13:00:00Z	Revenue			Well, I mean, we have to start with -- it's hard to believe, but in the fourth quarter, we shipped 20 million tests still at Cepheid.	Transcript
DHR.N	2023-04-25T08:00:00Z	EBIT			Additionally, we expect a full year adjusted operating profit margin of approximately 30%, which reflects the previously mentioned efforts to adjust our cost structure and capacity in response to COVID-19 transitioning to an endemic state.	Transcript
DHR.N	2022-01-11T11:15:00Z	EBIT			And then also, you're shifting of production as you move away from COVID eventually? As we think about kind of margins beyond 2022, how do you think about kind of unaffected margins post-COVID? As we think about margin profiles here, Tycho, we've been running at higher levels of margin profiles, certainly from a mix perspective and a volume perspective, but also because operating costs just haven't been what they were historically in relation to the lack of travel and conferences and so forth. But we used to run at about 30% to 35% VCM. So we don't believe that those variable contribution margins are going to sustain at these very high rates. We do think that we're going to be at a higher VCM here between the 35% and 40% for the long term. We have been higher than that at 40%, 45%, sometimes even a little higher.	Transcript
DHR.N	2023-01-10T16:30:00Z	EBITDA			And on the right, you'll see our anticipated long-term performance of mid-single-digit core revenue growth, recurring revenues of over 50% and adjusted EBITDA margins of 25% with very strong cash flow.	Transcript
DHR.N	2022-07-21T08:00:00Z	EBITDA			But if we don't have any extra new headwinds that show up, I just think the normal VCM of 35% to 40% is the place to be.	Transcript
NWSA.OQ	2022-08-08T17:00:00Z	Revenue			As a reminder, over 75% of Dow Jones revenues are recurring or subscription-based, the majority digital, with a strong margin, and we feel confident of its growth trajectory leading into 2023. At News Media, we still expect higher content licensing revenue from our platform deals as we implement elements of the broader Google partnership, such as Subscribe with Google, and also benefit from our expanded Apple relationship.	Transcript
NWSA.OQ	2023-02-09T17:00:00Z	Revenue			BINGE reached nearly 1.4 million paying subscribers in the quarter, and we'll be launching an advertising tier later this fiscal year as we seek to maximize Foxtel's revenue potential.	Transcript
NWSA.OQ	2022-08-08T17:00:00Z	Revenue			As a reminder, over 75% of Dow Jones revenues are recurring or subscription-based, the majority digital, with a strong margin, and we feel confident of its growth trajectory leading into 2023. At News Media, we still expect higher content licensing revenue from our platform deals as we implement elements of the broader Google partnership, such as Subscribe with Google, and also benefit from our expanded Apple relationship.	Transcript
NWSA.OQ	2022-08-08T17:00:00Z	EBIT			Our faith in its prospects has been shown by the acquisitions of Investor's Business Daily, OPIS and Base Chemicals, all of which we expect will contribute to revenue and profitability in the years ahead.	Transcript
NWSA.OQ	2023-02-09T17:00:00Z	EBIT			Profitability will be skewed to the fourth quarter as we expect third quarter cost to be higher in local currency compared to the prior year given the contractual escalators and expanded content from the AFL and NRL. We are very encouraged by the year-to-date performance and continue to expect the Foxtel Group's profitability in local currency for the full year to be relatively stable.	Transcript
RTX.N	2022-06-08T12:10:00Z	Revenue	73000000000	72000000000	Rocket motors is another area that we've been talking about quite a bit. So that will return to sort of net growth line at Pratt next year, but we're also seeing some of the legacy programs at Pratt and the aftermarket just be down low.	Transcript
RTX.N	2023-04-25T08:30:00Z	EBIT			Looking ahead, on a full year basis, we continue to expect Collins' sales to grow low double digits and operating profit of between $750 million and $825 million increase versus 2022.	Transcript
RTX.N	2023-04-25T08:30:00Z	Revenue			I think first and foremost, given the strength of our backlog and the continued end market demand, we, as a team, remain extremely confident we can deliver our '23 guidance and our 2025 commitments.	Transcript
RTX.N	2022-11-08T09:30:00Z	Revenue			So I do expect the GTF aftermarket to be -- in next year. So good, healthy activity in the aftermarket there. They're everywhere in our business, but I think show up pretty quickly in the defense businesses just given the accounting models that we use for revenue recognition. We don't want to talk about '23, but I'll ask about '25 because you guys put out your targets and just maybe how this is mapping to that. Yes, that will just keep going up.	Transcript
RTX.N	2023-04-25T08:30:00Z	EBIT			Looking ahead, on a full year basis, we continue to expect Collins' sales to grow low double digits and operating profit of between $750 million and $825 million increase versus 2022.	Transcript
RTX.N	2023-02-22T09:10:00Z	EBIT			We'll see operating segment profit growth at all 4 of the businesses this year, based on all the backdrop that Greg just talked about in terms of the growing backlog, the commercial aero recovery in particular.	Transcript
RTX.N	2023-04-25T08:30:00Z	EBIT			Looking ahead, on a full year basis, we continue to expect Collins' sales to grow low double digits and operating profit of between $750 million and $825 million increase versus 2022.	Transcript
RTX.N	2023-04-25T08:30:00Z	EBIT			Looking ahead, on a full year basis, we continue to expect Collins' sales to grow low double digits and operating profit of between $750 million and $825 million increase versus 2022.	Transcript
AAPL.OQ	2022-10-27T17:00:00Z	Revenue			We're not providing guidance for the reasons that we've explained.	Transcript
CME.OQ	2022-06-09T10:30:00Z	Revenue			We had some mega changes at the CME over the years in the electronic -- the conversion to electronics.	Transcript
MRO.N	2023-02-16T09:00:00Z	EBITDA			For 2023, we expect equity income and EBITDA to decline largely due to assume significantly lower commodity prices, especially for natural gas and the already referenced planned turnaround during the second quarter. The outlook beyond 2023, however, is robust as we expect to realize significant EG earnings and cash flow improvement in 2024 on the back of an increase in our global LNG price exposure.	Transcript
MRO.N	2022-11-03T09:00:00Z	EBITDA			The cash consideration paid for the asset is attractive at just 3.4x 2023 EBITDA with a 17% 2023 free cash flow yield, highly accretive relative to Marathon Oil's stand-alone metrics at the same price deck.	Transcript
ADM.N	2022-05-18T09:30:00Z	EBITDA			And already in the first quarter, we upgraded the guidance to 20%. And we have settled to say long term, we're going to grow 15%. And you need to continue to grow EBITDA margin on sales, and they have done that. So you've seen OP growth year-over-year of 30% to 40%.	Transcript
ADM.N	2023-01-26T09:00:00Z	Revenue			I want to take a moment to expand on our view of Nutrition in 2023. Nutrition is expected to continue on a positive growth trajectory for full year 2023, including 10-plus percent profit growth and a similar level of revenue growth. Resilient food demand should drive higher volumes and margins in starches, sweeteners and wheat milling. We see continued strong demand for ethanol, including positive discretionary blending economics.	Transcript
ADM.N	2023-04-25T09:00:00Z	Revenue			As noted, we expect this growth to be significantly weighted to the back half of the year, as we manage through some destocking impacts in beverage, lower margins in amino acids and the broader demand fulfillment challenges, we discussed in the last quarter. Nutrition's growth trajectory for the year remains on course with a double-digit increase in our human Nutrition pipeline compared to this point in 2022.	Transcript
ADM.N	2023-05-17T09:30:00Z	EBIT			I guess for us, when we look at it very closely, there's a lot of volatility through the year in the markets and the operating environment. We remain confident that the growth will be back half loaded. We've guided that, that business should generate 10% growth for this full year.	Transcript
ADM.N	2022-09-07T15:45:00Z	EBIT			Again, as you said, we put a goal out there to make $1 billion in operating profit and we are again thinking that we're going to deliver that next year. And if you also could elaborate a little bit on some of the most recent partnerships and agreements, Benson Hill, New Culture and how they're going to play a role within nutrition to get this beyond $1 billion? Now one of the other things and you've also had in your operating remarks, obviously, the nutrition business and all the investments into human as well as animal nutrition, it's now, I think, you said three quarters of a billion. So definitely on track to get to the $1 billion that you've once laid out a few years back. Yes. Listen, it's been an incredible journey, the creation of this Nutrition division.	Transcript
ADM.N	2023-04-25T09:00:00Z	EBIT			Of note, we also recognized a $50 million benefit from a biofuel producer tax credit in the prior year quarter. Our most recent implementation Cedar Rapids is already generating millions of dollars in efficiencies in just the first few months, confirming the double-digit returns, we expect to see from these proceeds.	Transcript
ADM.N	2023-04-25T09:00:00Z	EBIT			Of note, we also recognized a $50 million benefit from a biofuel producer tax credit in the prior year quarter. Our most recent implementation Cedar Rapids is already generating millions of dollars in efficiencies in just the first few months, confirming the double-digit returns, we expect to see from these proceeds.	Transcript
APD.N	2023-03-20T08:00:00Z	EBIT			That's definitely a helpful overview to think about it.	Transcript
FANG.OQ						
WRB.N	2022-01-27T16:10:00Z	Revenue			underwriting income in the quarter reflected year-over-year margin improvement	Press Release
AXP.N	2022-12-06T10:40:00Z	Revenue	61848540000	60791300000	How does all this translate into better than 10% revenue growth beyond 2023?	Transcript
CLX.N	2022-08-03T17:00:00Z	Revenue	7249140000	7178070000	So we have to lap that in addition to some moderating consumer behaviors.	Transcript
CLX.N	2023-05-02T17:00:00Z	Revenue			Actually, it's a good lead in. Based on our strong performance, we're raising our fiscal year outlook. Just in response to, I think, to Lauren's question earlier on volume growth, Kevin, your response, if I heard it correctly, you emphasized stabilization of volumes. Maybe it's a progression over the course of '24, but just -- so I don't walk away with the wrong impression.	Transcript
CLX.N	2023-05-02T17:00:00Z	Revenue			But if it delivers below our expectations, I think that would be a reason why we'd be towards the lower end of the range for the fourth quarter. So my question refers more on the quarter coming in better than anticipated. You called out Kingsford being one that you potentially have to work out the price gaps.	Transcript
CLX.N	2023-02-23T14:00:00Z	EBIT			Now in terms of EBIT margin, we have not delivered on our goal. So to your point, Jason, as we rebuild that I'd expect to see accelerated EBIT margin expansion until we get back to a more normalized P&L and then get back to that more normal cadence of 25 to 50 bps. The financial goals we've set is to grow top line 3% to 5%, expand EBIT margins annually 25 to 50 basis points and then continue to generate very strong cash flow, which we define as 11% to 13% of sales. This year looks like it's a year where you're going to exceed the long-term target on the recovery. We have seen margins contract over the last year specifically. We've taken multiple rounds of pricing, including our most recent round we just took in December.	Transcript
CLX.N	2022-08-03T17:00:00Z	Revenue			So we have to lap that in addition to some moderating consumer behaviors.	Transcript
CLX.N	2022-08-03T17:00:00Z	Revenue			So we have to lap that in addition to some moderating consumer behaviors.	Transcript
DOV.N	2023-04-26T09:00:00Z	Revenue			We project flat organic growth for the year in Pumps and Process Solutions.	Transcript
DOV.N	2023-04-26T09:00:00Z	Revenue			We project flat organic growth for the year in Pumps and Process Solutions.	Transcript
DOV.N	2023-04-26T09:00:00Z	Revenue			We project flat organic growth for the year in Pumps and Process Solutions.	Transcript
DOV.N	2023-04-26T09:00:00Z	Revenue			We project flat organic growth for the year in Pumps and Process Solutions.	Transcript
DOV.N	2023-05-09T08:00:00Z	EBIT			And then we would expect the headwinds that we had, from a comp point of view for that to dissipate in the second half. It seems like, this year, your second half margins are expected to be, call it, 100 to 150 basis points better than your first half margins. Last few years have been pretty tremendous, right? So arguably, we've had a little bit of a head start here. We feel good that -- we were talking about inventory drawdown in biopharma a year before anybody else was. We'll see how much that picks up, but we would expect that to sequentially increase with, hopefully, a really good '24 coming our way.	Transcript
DOV.N	2023-03-14T08:50:00Z	EBITDA			Everybody understands that business as being the refrigeration case. We would expect over the next 3 years, depending on the cycle, get 60-40, maybe 50-50.	Transcript
DOV.N	2022-11-08T08:55:00Z	Revenue			I mean, what do you think is structurally different at Dover now versus, say, the pre-COVID era? Maybe one last question around this. Well, I mean, I can't -- I don't think it's worth talking about pre-2018, not just because I became the CEO then, but that was the period when Dover had a much larger exposure to oil and gas, which, as we know, highly cyclical.	Transcript
MTB.N	2023-04-17T11:00:00Z	Revenue			And based on where the first quarter loan balances ended, just the averaging effect of that should carry a little bit of growth through the second quarter. And really, the -- I think the challenge that you're seeing is pipelines have been robust, but they're starting to slow down a little bit, and we're managing them to focus our liquidity on our best customers and our relationship customers. And then we expect things to kind of flatten out a little bit as we go through the back half of the year.	Transcript
MTB.N	2023-01-19T11:00:00Z	Revenue			Commercial mortgage banking revenues are expected to rebound in 2023, and we will return to a gain on sale residential mortgage banking model in 2023. Turning to expenses. We continue to expect deposit mix to shift toward higher cost deposits with declines expected in demand deposits and growth in time deposits as well as on balance sheet sweeps. We expect service charges on deposit accounts to be 3% to 6% higher than 2022 and anticipate trust income to be 8% to 10% higher in 2023.	Transcript
FDX.N	2022-12-20T17:30:00Z	Revenue			As we look to the second half of the year, we expect volume declines to begin moderating in Express and Ground by the end of the third quarter with comparisons easing further in the fourth quarter as we lap the onset of softer volumes.	Transcript
FDX.N	2023-03-16T17:30:00Z	Revenue			And actually, when we're thinking about Express, we think that trend will continue into Q1 as well.	Transcript
FDX.N	2022-06-23T17:00:00Z	EBIT			And kind of the cadence of what we should expect over the course of fiscal '23 for this segment as the margin expansion has been nothing short of impressive 500 basis points plus quarter-over-quarter and year-over-year. So that was certainly most prevalent in the first half of the year.	Transcript
FDX.N	2022-09-22T17:30:00Z	EBIT			As we go through the year, the savings build and we expect then that the pressures relative to Q2 will mitigate as we go through -- be less as we go through the year.	Transcript
TROW.OQ						
DRE.N^J22						
JKHY.OQ	2023-05-02T16:37:19Z	EBIT	2055000000	2048000000	per share data)	Press Release
JKHY.OQ	2023-05-02T16:37:19Z	Revenue	464000000	460000000	GAAP to Non-GAAP GUIDANCE (In Millions, except Annual FY23* Growth 5.5 % 5.9 % Low High REVENUE (GAAP) $ 2,050 $ 2,057 per share data)	Press Release
JKHY.OQ	2023-05-02T16:37:19Z	Revenue			GAAP to Non-GAAP GUIDANCE (In Millions, except Annual FY23*	Press Release
JKHY.OQ	2023-05-02T16:37:19Z	EBIT			OPERATING INCOME (GAAP) $ 470 $ 474	Press Release
JKHY.OQ	2023-05-02T16:37:19Z	EBIT			OPERATING INCOME (GAAP) $ 470 $ 474	Press Release
JKHY.OQ	2023-05-02T16:37:19Z	EBIT			per share data)	Press Release
O.N	2023-05-03T16:05:18Z	Revenue			Prior 2023 Guidance Revised 2023 Guidance Same store rent growth Over 1.25% Over 1.25%	Press Release
MLM.N	2023-05-04T10:00:00Z	Revenue	6815000000	6600000000	As such, we expect a slowdown in product shipments to the light nonresidential sector later this year. With respect to the light nonresidential end market, we've yet to experience any notable weakness in this segment as shipments due in-process projects continue. With that said, new projects may have more difficulty accessing capital if commercial lending conditions meaningfully tighten.	Transcript
MLM.N	2023-05-04T10:00:00Z	EBITDA	1900000000	1800000000	In brief, the results we've reported over the recent past, including the first quarter results announced today, are a tribute to our team's disciplined execution of our strategic plan and gives us confidence that we will deliver 2023 adjusted EBITDA of $1.9 billion, consistent with the high end of our previously announced guidance range.	Transcript
MLM.N	2023-02-15T10:00:00Z	EBIT			We believe our multiple commercial actions enacted in 2022, coupled with broad customer support of our January 1, 2023 price increases, will drive meaningful pricing acceleration and margin expansion in 2023.	Transcript
RVTY.N	2023-03-21T14:15:00Z	Revenue	2940000000	2900000000	What's the read on that or your view there?	Transcript
RVTY.N	2022-11-08T08:00:00Z	Revenue	882000000	882000000	I think, look, there's obviously puts and takes across the portfolio. So I think speaking maybe overall to the academic and government portfolio that we'll have for the remaining business.	Transcript
RVTY.N	2023-05-11T06:00:00Z	Revenue			For the full year 2023, the Company now forecasts total revenue of $2.90-$2.94 no additional contribution from COVID related revenues.	Press Release
RVTY.N	2023-03-21T14:15:00Z	Revenue			But what's kind of the refresh on 2023 outlook, Steve?	Transcript
RVTY.N	2022-01-11T11:15:00Z	Revenue			As a result of this, as this business continues to transition and our recent acquisitions become part of our core, we expect our organic growth to continue to improve over the next few years and be in the high single-digit range as we get into 2023 and beyond. Now let's move to our Discovery & Analytical Solutions segment, where the growth profile is just as exciting as we continue to transform the portfolio with the expansion of our life sciences business.	Transcript
RVTY.N	2023-02-14T08:00:00Z	EBIT			Diagnostics will be slightly below, and then you'll have about 2 to 3 points of headwind just from our corporate expenses. So the way I would think about the margin composition of our Life Sciences and Diagnostics business in 2023 is our Life Sciences business should be above the company average. Yes. Matt.	Transcript
RVTY.N	2023-01-10T11:15:00Z	EBIT			Maybe just shifting over to framework for 2023.	Transcript
RVTY.N	2023-03-21T14:15:00Z	EBIT			We are a market-leading organic growth company on the top line.	Transcript
RVTY.N	2023-02-14T08:00:00Z	EBIT			Diagnostics will be slightly below, and then you'll have about 2 to 3 points of headwind just from our corporate expenses. So the way I would think about the margin composition of our Life Sciences and Diagnostics business in 2023 is our Life Sciences business should be above the company average. Yes. Matt.	Transcript
TWTR.N^J22	2022-03-01T09:15:00Z	Revenue	6346852500	6194528040	And we said we're going to be lapping tough comps, and you'll see mDAU growth in the low double digits in Qs 2, 3 and 4 of 2021. I believe we iterated your mDAU '23 target of 315 million. So can you can walk through kind of some of the ways that led to some of those lead -- key lead indicators? Well, you just walked into my next question, which is you ended the year, as you noted, with 217 million mDAUs. What gives you comfort that you reiterated that target?	Transcript
L.N						
QCOM.OQ	2023-05-03T16:45:00Z	Revenue			Automotive revenues of $447 million grew 20% year-over-year, driven by the adoption of our Snapdragon digital chassis and are aligned with our long-term revenue target.	Transcript
QCOM.OQ	2022-04-27T16:45:00Z	Revenue			In closing, we are pleased with our financial results and strong execution as we manage to supply constraints in the current macroeconomic environment. Our QCT handset revenues are on track to grow by greater than 50% in fiscal '22. Our strong forecast for QCT is driven by the same factors which benefited our second quarter, including gains in handset premium tier volume, strong demand in IoT and automotive and supply improvements.	Transcript
QCOM.OQ	2022-02-23T09:08:00Z	EBITDA			Asia Pacific region. NRRWF is now in the early stages of its deployment, with NRRWF at over $1 billion. NRRWF has a pipeline of about 15,000 potential sites NRRWF plans to roll out to at least 10,000 mobile telecom sites in Africa over a long runway of growth in the months ahead. in Africa, and is also targeting similar contracts in Latin America and the the next 5 years, which is expected to generate $220 million annual revenues with $110 million EBITDA. At typical multiples in the sector, this could value	Press Release
PENN.OQ	2023-05-04T09:00:00Z	EBITDA	6810000000	6370000000	Regarding EBITDAR, our 2023 guidance of $1.875 billion to $2 billion is unchanged given first quarter performance and our expectation for Barstool Sports EBITDA to be breakeven for the year.	Transcript
PENN.OQ	2023-05-04T09:00:00Z	Revenue	2000000000	1875000000	Now regarding overall company guidance, our new revenue range is $6.37 billion to $6.81 billion, up from the prior $6.15 billion to $6.58 billion and assumes revenues of roughly $220 million to $230 million from Barstool for the year from the time of the 100% acquisition on February 17.	Transcript
PENN.OQ	2023-05-04T09:00:00Z	EBITDA			For our Interactive segment, we expect the fourth quarter to be profitable, while the second and third quarters should look very similar to each other.	Transcript
PENN.OQ	2022-05-05T09:00:00Z	EBIT			These structural advantages are already proving themselves out real time and we'll deliver what we believe will be best-in-class margins over the long term. We don't lead with discounts.	Transcript
PENN.OQ	2023-05-04T09:00:00Z	EBITDA			For our Interactive segment, we expect the fourth quarter to be profitable, while the second and third quarters should look very similar to each other.	Transcript
IPG.N	2023-05-22T08:00:00Z	Revenue			Whether that was a client sector, in our case, tech, where -- and we were probably over-indexed relative to peers, and it was our second largest sector coming into the year, and what's been going on in that industry, which is macro influenced or at least we see it as sort of a bit of a -- it's not like either employment or the cost focus that you're seeing in tech is something that the marketing function within those companies is immune to.	Transcript
IPG.N	2023-04-27T08:30:00Z	EBIT			As indicated earlier, we remain comfortable with our growth outlook for the year, along with our expectation for margin expansion. As we continue to evolve the portfolio and transform our businesses, we expect severance will remain elevated in our second quarter and that we will increasingly see the benefits of these actions on margins as we move forward through the year. Is there any upside to EBITA margin guidance? You beat our estimate on operating margin, I think, probably ahead of what you were kind of pointing people towards.	Transcript
PHM.N						
ANSS.OQ	2023-05-04T08:30:00Z	Revenue	2322000000	2242000000	However, as I've mentioned in the past, quarterly dynamics can be volatile.	Transcript
ANSS.OQ	2022-02-24T08:30:00Z	Revenue	975240000	919220000	Our ongoing broad-based business momentum and our strong customer relationships give us even greater confidence for our prospects in 2022 and beyond.	Transcript
ANSS.OQ	2023-02-23T08:30:00Z	EBIT			This brings me to our operating margin guidance. We expect our full year operating margin to be in the range of 41% to 42%.	Transcript
PBCT.OQ^D22						
ULTA.OQ	2023-05-25T16:05:00Z	Revenue	11100000000	11000000000	Net sales Â  Â  $10.95 billion to $11.05 billion Â  $11.0 billion to $11.1 billion The Company has updated its outlook for fiscal 2023.	Press Release
ULTA.OQ	2023-05-25T16:30:00Z	EBIT	1642800000	1595000000	We have increased our expectations for gross margin deleverage from our original outlook to include the impact of higher shrink and a more competitive and promotional environment. We now expect operating margin for the full year will be between 14.5% and 14.8% of sales, primarily reflecting an updated view of gross margin.	Transcript
KO.N	2023-05-25T02:00:10Z	Revenue			above our 5-6% average growth target and organic EBIT growth at the top end of our -3% to +3% range for the year.	Press Release
KO.N	2023-05-25T02:00:10Z	EBIT			We remain confident that we will achieve the guidance for 2023, as set out at above our 5-6% average growth target and organic EBIT growth at the top end of	Press Release
FISV.OQ	2023-03-21T08:00:00Z	Revenue	17947110000	17779380000	And this initial guide is in line with your medium-term framework, so hypothetically -- and maybe this question has now become more topical in the last couple of weeks, but if the macro environment does really become more challenging for everybody than anticipated, how would Fiserv approach potential trade-offs between revenue and margin if it comes down to that? First, from an overall margin standpoint, you're right. So we were in the high 20s in the last couple of years, 25%, 26%, 27%; right in line to hit that $3.5 billion for 2025; and in good shape to hit $10 billion for the overall merchant segment by '25. That's now up and running; and will provide growth for us in '23, '24 and beyond. We continue to have great opportunities in the international space, again both from a Clover standpoint as well as overall merchant.	Transcript
FISV.OQ	2023-04-25T08:00:00Z	Revenue			Even as year-over-year comparisons get tougher in the second half, we still expect 2023 growth to be at the high end of the segment's guidance range for the full year.	Transcript
FISV.OQ	2023-04-25T08:00:00Z	Revenue			We continue to see organic growth in this segment within the guidance range.	Transcript
FISV.OQ	2022-05-12T10:00:00Z	EBIT			It's not to drive to a target of 95% to 100%, it's to get the best possible OI outcome to continue to expand margins, which we have deeply. We think we have a tremendous business that will be built go over the next 3 to 5 years in the data space, put real use cases and revenue growth with tremendous margin.	Transcript
FISV.OQ	2022-02-08T08:00:00Z	Revenue			Maybe I'd say 1 or 2 other things.	Transcript
FISV.OQ	2023-03-14T11:40:00Z	Revenue			And I was like, well, we had 7% to 9% with a mild recession. And we got to take a deep breath and see what happens this week. But we did say, without a mild recession, we thought about the opportunity to be at minimum on the high end, if not, do something else. Just touch on the assumptions you built into that again. Putting it all together, when we think about the guidance you gave, I mean, I think it was 7% to 9% organic revenue growth, 20 -- 12% to 14% EPS growth, right? We weren't battening down the hatches and preparing for offense.	Transcript
CSCO.OQ	2022-08-24T12:00:00Z	Revenue	56970485000	56712100000	And I think customers are seeing the benefit of that operationally as well as economically. And I think that's the area for very significant growth going forward. And so I think that will be a very significant growth driver for the business going forward. And that has also, I think, grown along with our expectations, in line with our expectations. But can you give us a quick update on how Acacia is doing, especially tell us a little bit about what you guys are seeing in China? I guess, Acacia is doing really well because Chuck has highlighted Acacia on the last 4 earnings call. I think it was a very big move for Cisco to decide we're going to support that segment of the business, and it's helped us to make sure that we meet the commitments to Cisco. Now switching topics to the optical side or the coherent side of the business. So things must be going great. The other important assumption was that we're going to grow the Cisco piece of that business as well through things like routed optical networking and adoption of pluggable ZR and ZR+ pluggables into our routers. We do expect to influence customers around this routed optical networking architecture.	Transcript
WTW.OQ	2022-10-27T09:00:00Z	Revenue	9397960000	9220640000	Maybe an update on the magnitude of book settlements you might expect in 4Q and beyond because I know you've maintained the organic growth outlook for 2022, but you faced a difficult compare with the $74 million in book sales from 4Q '21. WTW's operations in Russia, which were almost entirely within our Risk and Broking segment, comprised approximately 1% of consolidated revenue for 2021 and were highly profitable. We do not anticipate that level to repeat this year. We'll share a more detailed outlook for 2023 next quarter, and we continue to believe we will deliver on our long-term organic growth and margin expansion expectations.	Transcript
WTW.OQ	2022-04-26T07:00:00Z	Revenue			Overall, our outlook for Risk and Broking remains positive with mid-single-digit revenue growth expected over the longer term. We continue to expect that the actions we have taken will enable us to narrow the growth gap over the course of the year, with pace accelerating in the second half of 2022 as the impacts of our actions build and headwinds subside.	Transcript
WTW.OQ	2023-04-27T06:00:31Z	EBIT			* Expect to deliver adjusted operating margin expansion for the full year 2023 2023 Outlook Based on current and anticipated market conditions, the Company's full-year targets for 2023 are as follows:	Press Release
ANET.N	2023-05-23T13:55:00Z	Revenue	5470000000	5470000000	I mean we do have some revenue today coming from AI use cases.	Transcript
ANET.N	2022-11-15T15:00:00Z	EBIT			We talked about 40%, plus or minus for 2023 and reserving the right that over time, right, if there are investments that we can make that help to support and continue to grow into the future that we would do that with kind of a 38% plus or minus operating margin as a longer-term target.	Transcript
ES.N	2023-02-14T09:00:00Z	Revenue			Installation of the South Fork subsea transmission cable will begin later this quarter, and installation of the foundations, wind turbines and offshore substation will begin this summer off the coast of Massachusetts.	Transcript
CTAS.OQ	2022-12-21T10:00:00Z	Revenue	8800000000	8740000000	However, we expect these rates to be pressured in the second half of the fiscal year as the business faces increasingly challenging comparisons. Uniform Direct Sale organic revenue growth rates have been very strong year-to-date.	Transcript
CTAS.OQ	2023-03-29T10:00:00Z	Revenue	1800000000	1770000000	We are increasing our financial guidance.	Transcript
CTAS.OQ	2023-03-29T10:00:00Z	EBIT			Fiscal '23 operating income is expected to be in the range of $1.77 billion to $1.80 billion compared to $1.55 billion in fiscal '22 after excluding the gains.	Transcript
CTAS.OQ	2022-09-28T10:00:00Z	EBITDA			But basically, what type of expenses have you been able to adjust so that you can stay at this mid-20s EBITDA level. If I look back about 2 years ago, your EBITDA margin like really meaningfully stepped up to mid-20s. We think it's very, very important, which gives us an advantage in the marketplace. You see that -- certainly, energy is a big subject today, but we've talked about our smart truck proprietary routing technology that's helping us reduce idle time and drive time, which obviously helps with our energy spend, but it helps with CO2 emissions as well. You've really been able to keep it at that level.	Transcript
GPN.N	2023-05-01T08:00:00Z	EBITDA	8735000000	8635000000	I'm pleased to report that we currently have executable plans to achieve the run rate EBITDA synergy target of at least $125 million within 2 years that we committed to at the time of the announcement.	Transcript
GPN.N	2023-05-01T08:00:00Z	Revenue			We are pleased with how our business is positioned following our first quarter performance, and we are raising our financial outlook for the year. We now expect reported adjusted net revenue to range from $8.635 billion to $8.735 billion, reflecting growth of 7% to 8% over 2022, an increase from 6% to 7% previously.	Transcript
GPN.N	2023-05-16T11:00:00Z	Revenue			And I expect the vast majority next year would be kind of GAAP earnings. And so why don't we come back to that because with the acquisitions and divestitures in those last couple of years, the free cash flow and sort of GAAP versus non-GAAP earnings profile of Global Payments has taken a little bit of a hit. And that reflects the 3 things that we announced last year that just closed this year. And we, by and large, expect to hit that guidance this year ex selling that spend, which is -- we said it's like 4 to 5 points. How should investors think about now that you've completed the transactions you were off the pandemic. I expect that to continue to trend up because we don't expect to do meaningful deals in the immediate term. It was our expectation this year and revenues high single digits. So I think we're in a good place. So as we look forward, what is your outlook or how do you think about the role of improving those 2 measures? The first thing is merchants should grow at 10%, 11%, 12%. This year, it's going to be close to 16% is what we said because we've got the EVO thing coming in but EVO is growing on its own organically low double digits, right? When you think about the building box post these acquisitions and dispositions, merchants 3/4 of the company and issuer B2B is 25% of the company.	Transcript
GPN.N	2023-02-10T08:00:00Z	EBIT			Finally, while the disposition of our Consumer Solutions business is naturally expected to be a headwind for the full year, this transaction enhances the overall growth and adjusted operating margin profile of the business going forward. First, while we expect foreign exchange rates to be roughly neutral for the full year, we anticipate the currency headwind to adjusted net revenue of up to 200 basis points in the first quarter and a headwind of up to 100 basis points in the second quarter. In terms of quarterly phasing, there are several items to note. We anticipate adjusted operating margin for the Issuer business to expand up to 60 basis points as we continue to benefit from operating leverage in the business as growth continues to accelerate, offset somewhat by faster growth in our lower-margin B2B businesses.	Transcript
GPN.N	2023-05-01T08:00:00Z	EBIT			We anticipate this impact to be mitigated by synergy realization as the year progresses. We continue to expect more than 100 basis points of adjusted operating margin expansion from the existing Global Payments merchant business excluding dispositions in 2023, which again is ahead of our cycle guide. We expect this expansion will be more than offset beginning in the second quarter with the absorption of the lower-margin profile of EVO Payments.	Transcript
GPN.N	2023-05-17T08:00:00Z	EBIT			I think we've done a fantastic job scaling our business over a long period of time, making investments in higher-margin businesses that have better growth trajectories.	Transcript
RSG.N	2023-04-27T17:00:00Z	Revenue	14800000000	14650000000	And you just noted on 2024. Yes. Look, we remain committed to pricing ahead of our cost inflation to allow us to expand margins across the business.	Transcript
RSG.N	2023-02-15T17:00:00Z	EBITDA	4325000000	4275000000	These headwinds are more than offset by margin expansion in the underlying business of 80 basis points.	Transcript
RSG.N	2023-02-15T17:00:00Z	EBITDA			These headwinds are more than offset by margin expansion in the underlying business of 80 basis points.	Transcript
MCK.N	2023-05-08T16:30:00Z	EBIT	301614990000	287779440000	Excluding the impact of these COVID-19-related items from fiscal '23 results, we anticipate operating profit to increase 11% to 15% year-over-year. This year-over-year decrease includes a loss of operating profit contribution from businesses and transactions we've closed to date and that we expect to close during fiscal '24. When excluding the impact of COVID-19 vaccine distribution from fiscal 2023, we anticipate operating profit to increase 5% to 8%.	Transcript
MCK.N	2023-05-08T16:30:00Z	Revenue	4536960000	4347920000	I'd like to dig into the increase in long-term op profit growth targets and specifically pharma. We do not anticipate the higher price increases that we saw in fiscal '23 to repeat in fiscal '24. You have operating income kind of growing in line but yet for fiscal '24, if we back out the COVID benefit, it's below.	Transcript
MCK.N	2023-05-08T16:30:00Z	EBIT			Excluding the impact of these COVID-19-related items from fiscal '23 results, we anticipate operating profit to increase 11% to 15% year-over-year. This year-over-year decrease includes a loss of operating profit contribution from businesses and transactions we've closed to date and that we expect to close during fiscal '24. When excluding the impact of COVID-19 vaccine distribution from fiscal 2023, we anticipate operating profit to increase 5% to 8%.	Transcript
MCK.N	2023-05-08T16:30:00Z	EBIT			Excluding the impact of these COVID-19-related items from fiscal '23 results, we anticipate operating profit to increase 11% to 15% year-over-year. This year-over-year decrease includes a loss of operating profit contribution from businesses and transactions we've closed to date and that we expect to close during fiscal '24. When excluding the impact of COVID-19 vaccine distribution from fiscal 2023, we anticipate operating profit to increase 5% to 8%.	Transcript
MCK.N	2023-05-08T16:30:00Z	EBIT			Excluding the impact of these COVID-19-related items from fiscal '23 results, we anticipate operating profit to increase 11% to 15% year-over-year. This year-over-year decrease includes a loss of operating profit contribution from businesses and transactions we've closed to date and that we expect to close during fiscal '24. When excluding the impact of COVID-19 vaccine distribution from fiscal 2023, we anticipate operating profit to increase 5% to 8%.	Transcript
HLT.N	2023-04-26T06:00:00Z	Revenue	2950000000	2875000000	Full Year 2023	Press Release
HLT.N	2023-04-26T10:00:00Z	EBITDA			We forecast adjusted EBITDA of between $2.875 billion and $2.95 billion.	Transcript
HLT.N	2023-04-26T06:00:00Z	EBITDA			(in millions) (unaudited) HILTON WORLDWIDE HOLDINGS INC. Year Ending	Press Release
NFLX.OQ	2023-04-18T18:00:00Z	Revenue			You've seen us make moves in the space before.	Transcript
NFLX.OQ	2023-04-18T16:00:01Z	EBIT			has released its first-quarter 2023 financial results by posting them to its	Press Release
NFLX.OQ	2022-10-18T18:00:00Z	EBIT			And so we really anticipate that this is going to be a pro-consumer model that will be more attractive, bring more members in because the consumer basic price is low.	Transcript
RF.N	2023-04-21T10:00:00Z	Revenue	7788960000	7644720000	Looking forward, we continue to expect 2023 ending loan growth of approximately 4%.	Transcript
RF.N	2022-09-14T08:15:00Z	Revenue			And we don't expect it to continue. Yes.	Transcript
RF.N	2022-07-22T10:00:00Z	EBIT			If you think about just reaching the NII run rate and assuming no further growth, that would give you about 8% revenue growth into next year.	Transcript
WMT.N	2023-04-05T09:00:00Z	Revenue	25340060000	25340060000	Our capital structure and our cash flow generation are a competitive advantage.	Transcript
WMT.N	2023-05-18T08:00:00Z	Revenue			Over time, we expect revenue growth across a diversified set of drivers, improved category mix and increasingly accretive business mix, coupled with improved unit economics. This is all fueled by supply chain investments with attractive payback cycles. We expect the outcome will be operating income growing faster than sales.	Transcript
WMT.N	2023-02-21T08:00:00Z	EBIT			And it's good to speak with you. But again, I would just point you to the fact that there's just a lot that we don't know. But as noted, our business composition, or the things like our initiatives, advertising, Walmart fulfillment services, those are contributing to a larger share of our overall business, which has less of an impact as we look at this fiscal year. So the EBIT structure related to the U.S. business, there's a couple of factors there.	Transcript
WMT.N	2023-04-05T09:00:00Z	EBIT			So it's kind of how we think about that.	Transcript
AMGN.OQ	2023-05-09T11:00:00Z	Revenue	27300000000	26200000000	Second, based on that strong volume growth, we raised our '23 guidance to $26.2 billion to $27.3 billion in revenues, non-GAAP EPS up to $17.60 to $18.70.	Transcript
AMGN.OQ	2022-11-09T15:50:00Z	Revenue			And you see that in the face of a number of generics for Otezla, for ENBREL and for others. But I'm going to jump in with a financial question to start with. So those 5 strata really make up what we call the mountain and get us to that single -- mid-single-digit revenue growth guidance through 2030 and get us to the EPS growth that we talked about at the business review.	Transcript
AMGN.OQ	2023-04-27T16:30:00Z	EBIT			We expect the 2023 operating margin as a percent of product sales to be roughly 50% and expect our second quarter operating margin to also be roughly 50%.	Transcript
KIM.N	2023-04-27T06:50:00Z	Revenue			full year to $4 million to $6 million from the previous level of $14 million to $16 million. All other assumptions for 2023 provided with the companyâ€™s	Press Release
KIM.N	2023-04-27T08:30:00Z	EBIT			But I was hoping you guys could talk a little bit about the cadence for same-store NOI growth this year.	Transcript
PXD.N	2022-10-28T10:00:00Z	Revenue			Could you speak to your macro views on in-basin gas prices for 2023 and if (inaudible) tightness could lead to shut in for some of your peers?	Transcript
DG.N	2022-09-07T12:15:00Z	Revenue	39737106150	39169433210	And then finally, the volumes, we're excited about. We believe we can get $1.7 million to $2 million out of these boxes over the long term, like the margins exceeding 40% and believe it can be accretive to the total Dollar General portfolio.	Transcript
DG.N	2023-03-16T06:55:00Z	EBIT			also providing for investments intended to drive long-term sustainable growth.	Press Release
XRAY.OQ	2023-05-03T08:30:00Z	EBITDA	3950000000	3900000000	Given the better-than-expected organic sales performance to start the year, we're also raising our full year adjusted EPS outlook by $0.05 on the low-end, which brings our adjusted EPS range to $1.85 to $2.	Transcript
XRAY.OQ	2022-11-14T08:30:00Z	Revenue	711000000	693000000	And are you expecting some moderation in overall end-market demand?	Transcript
XRAY.OQ	2023-05-03T08:30:00Z	Revenue			In addition, foreign currency exchange rates are largely unchanged compared to our prior outlook.	Transcript
XRAY.OQ	2022-05-10T08:30:00Z	EBIT			And when we get to '23 guidance, we'll articulate it then. In my opinion, it is only sort of modestly stepping down, especially with the 8% of the sales in China and Russia, but the OI is much more impacted in the big decline year-over-year. Maybe I'll go back to the 2022 revenue outlook. So we'll certainly provide updated guidance for '23 when we get to the end of the year. There's obviously a lot of moving pieces in the macro right now that everyone is dealing with, and we're no different. We expect to end the year at around 20% op margin as we mentioned earlier.	Transcript
XRAY.OQ	2023-02-28T08:30:00Z	EBIT			Turning to Slide 22.	Transcript
XRAY.OQ	2023-02-28T08:30:00Z	EBITDA			For 2023, we expect our EBITDA margin to be greater than 18% which is a decline of 140 basis points from the prior year, but above our fourth quarter run rate of 17.4%.	Transcript
EQR.N	2023-02-10T11:00:00Z	Revenue			And if you put kind of all of that into the blender and you think about like 2023 and our expectations, right now in our portfolio, we kind of normalized concessions to the 2022 level so we expect to continue to see some elevated concessions in the shoulder periods. As Michael mentioned, the midpoint of our same-store revenue guidance assumes a 90-basis point reduction in revenue growth due to the impact of bad debt. The contribution of this blended rate growth to revenue will be approximately half as we capture it over the 2023 leasing season.	Transcript
EQR.N	2022-09-13T14:10:00Z	Revenue			And the most important part of that really, as far as most investors are concerned, is the setup for next year.	Transcript
EQR.N	2023-05-30T16:34:00Z	EBIT			Same store NOI Â  $ 0.04	Press Release
URI.N	2023-04-27T11:00:00Z	Revenue	14200000000	13700000000	And what's kind of embedding in the midpoint of the guide for the full year?	Transcript
URI.N	2023-04-27T11:00:00Z	EBITDA	6850000000	6600000000	Our adjusted EBITDA range remains $6.6 billion to $6.85 billion.	Transcript
TDG.N	2023-05-09T11:00:00Z	Revenue	6500000000	6410000000	As noted in our earnings release, we are increasing our full fiscal year '23 sales and EBITDA as defined guidance to reflect our strong second quarter results, the recent acquisition of Calspan and our current expectations for the remainder of the year. Moving to our outlook for fiscal year '23. On the last call, you pointed out volumes were 85% below 2019 levels, implying price of about 25% since 2019, Kevin. Or is the shortage of new planes? We still -- there are still flight activity that has not returned that we anticipate will over the coming year or so.	Transcript
TDG.N	2023-05-09T11:00:00Z	EBITDA	3290000000	3230000000	This guidance includes about a 50 basis points of margin dilution from the DART Aerospace acquisition and just over 50 basis points of margin dilution from the recent Calspan acquisition.	Transcript
TDG.N	2023-05-09T07:15:04Z	EBITDA			EBITDA As Defined $3,230 to $3,290 $3,060 to $3,160 $150 GUIDANCE MID-POINT	Press Release
CNC.N	2023-04-25T08:30:00Z	Revenue	146500000000	144500000000	First of all, there's a slight shift in mix due to growth in Marketplace, which has a structurally lower HBR. With respect to the Medicaid HBR, as you will recall, we were originally expecting to be around 89.9% in 2023.	Transcript
CNC.N	2022-11-17T16:01:02Z	EBITDA			* Evolent anticipates continued expansion in Adjusted EBITDA margin in 2023 vs. YTD 2022 result, before accretive impact from NIA.	Press Release
CNC.N	2023-02-07T08:30:00Z	EBIT			Third, our Marketplace business is $3 billion larger than we had previously assumed, and we expect performance in the target margin zone in both 2023 and 2024.	Transcript
NKE.N	2022-09-29T16:15:00Z	Revenue			and create value like only NIKE can."**	Press Release
NKE.N	2022-06-27T17:00:00Z	Revenue			As we look ahead to fiscal '23 and our guidance were flat to declining 50 bps, we're planning for mid-single-digit price increases. In fiscal '22, Express Lane drove approximately 25% of total NIKE Brand revenue with higher profitability. We expect to benefit from mid-single-digit pricing actions and continued gains from our shift to a more direct business, offset by another 100 basis points headwind from elevated ocean freight costs, increased product costs, discrete supply chain investments and normalization of historically low markdown rates. We expect to build Express Lane into a larger portion of our business in fiscal '23 and beyond.	Transcript
NKE.N	2022-09-29T17:00:00Z	EBIT			Headwinds from foreign exchange have also shifted significantly in the last 90 days as the trend of U.S. dollar strengthening has accelerated.	Transcript
AES.N	2023-02-27T10:00:00Z	Revenue	2900000000	2600000000	As I'll discuss later, we do not expect an opportunity of the same scale to recur this year and anticipate lower PTC from MCAC in 2023. Based on the drivers discussed, we expect our 2023 earnings to be significantly second half weighted with approximately 3 quarters recognized in the second half of the year.	Transcript
AES.N	2023-05-08T06:00:06Z	EBITDA			* Initiating 2023 Adjusted EBITDA(2) guidance of $2,600 to $2,900 million normalization of LNG prices and the roll-off of a gas supply contract, and	Press Release
ELV.N	2022-05-09T17:40:00Z	EBITDA			I'd say when you look at the -- and a lot of you know this, when you look at the overall opportunity in services outside of sort of you exclude pharmacy and manufacturing side of things and you look at your services, you're talking about $350 billion of EBITDA that's going to be created over the next several years.	Transcript
ELV.N	2023-01-25T08:30:00Z	Revenue			As we had stated, we're not expecting that to close until later in (technical difficulty) 2023 will not be material, really than the line items. I think that, that relationship on the Medicaid side will term at the beginning of 2024. It does not include M&A. So it's an incremental 1.6 million members. So that's really about the high-level economics that we would expect to endure in 2024.	Transcript
ELV.N	2023-01-25T08:30:00Z	EBIT			And then specifically, hoping to clarify the enrollment expectations there. As John referenced, we plan to grow between 75,000 and 125,000. Our guidance reflects double-digit growth in operating earnings in each of our health benefits and Carelon businesses that will be driven by the focused execution of our enterprise strategy, to optimize our health benefits business, invest in high-growth opportunities and accelerate capabilities and services. With respect to our earnings seasonality, we are projecting similar profitability patterns to historical ranges and expect to earn slightly more than 55% of our full year adjusted earnings per share in the first half of the year with slightly more than half of that in the first quarter, consistent with current consensus modeling of seasonality.	Transcript
ELV.N	2023-01-25T06:00:00Z	EBIT			CarelonRx Â  Â  Â  Unchanged	Press Release
ELV.N	2023-01-25T08:30:00Z	EBIT			And then specifically, hoping to clarify the enrollment expectations there. As John referenced, we plan to grow between 75,000 and 125,000. Our guidance reflects double-digit growth in operating earnings in each of our health benefits and Carelon businesses that will be driven by the focused execution of our enterprise strategy, to optimize our health benefits business, invest in high-growth opportunities and accelerate capabilities and services. With respect to our earnings seasonality, we are projecting similar profitability patterns to historical ranges and expect to earn slightly more than 55% of our full year adjusted earnings per share in the first half of the year with slightly more than half of that in the first quarter, consistent with current consensus modeling of seasonality.	Transcript
GWW.N	2022-09-21T09:15:01Z	Revenue	16800000000	16200000000	* Net sales between $19 and $20 billion, representing 8% to 10% compounded Assuming normal economic growth, delivering on these expectations would result annual growth compared to the mid-point of 2022 guidance of $15.1 billion in total Company full year 2025 performance targets, including:	Press Release
GWW.N	2023-04-27T08:00:15Z	EBIT	2637600000	2462400000	below, including an increased outlook for diluted EPS, operating cash flow and	Press Release
GWW.N	2023-04-27T11:00:00Z	Revenue			Endless Assortment is trending slightly lower. However, we expect daily sales for this segment to be up low double digits, which is a couple of hundred basis points higher when translated to constant currency.	Transcript
GWW.N	2023-02-02T11:00:00Z	Revenue			On top of a 1% to 5% market, we expect to continue executing against our strategic growth engines to achieve 400 to 500 basis points of U.S. market outgrowth in 2023.	Transcript
GWW.N	2023-04-27T08:00:15Z	EBIT			below, including an increased outlook for diluted EPS, operating cash flow and	Press Release
GWW.N	2022-07-29T11:00:00Z	EBIT			We anticipate that the business will return to more normal operating margins in 2023.	Transcript
GWW.N	2022-07-29T11:00:00Z	EBIT			We anticipate that the business will return to more normal operating margins in 2023.	Transcript
GWW.N	2023-04-27T08:00:15Z	EBIT			below, including an increased outlook for diluted EPS, operating cash flow and	Press Release
GWW.N	2023-02-02T08:00:11Z	EBIT			2023 Company Guidance High-Touch Solutions N.A. 16.3% - 16.8% Segment Operating Margin	Press Release
K.N	2023-05-04T09:30:00Z	Revenue	2042660000	2005180000	So Latin America continues to perform well.	Transcript
K.N	2023-02-22T08:00:00Z	Revenue			So we've got a great portfolio.	Transcript
K.N	2023-05-04T09:30:00Z	EBIT			It will be led by snacks, but also by growth in cereal, with both supported by strong innovation and relevant brand news. So both of our emerging markets regions are showing current momentum to go with their outstanding long-term prospects. We also expect Latin America to improve its profit margins this year, and it plans to do all this while working on separating its Caribbean cereal business as part of the spin-off.	Transcript
GOOGL.OQ	2022-10-25T17:00:00Z	Revenue			And then in commerce with FEMSA Digital in Mexico, we're bringing together solutions across Ads, Cloud, Maps, Waze and beyond to bolster its data and analytics capabilities so it can better reach and retain its beverage and retail customers. First, a transformative partnership with Transion, the #1 OEM in Africa and Pakistan, will help to close the digital divide by doubling annual activations by 2025 and build helpful products for the next billion users. In terms of how we're helping our partners innovate, I'll share 2 highlights.	Transcript
GM.N	2023-01-31T08:30:00Z	Revenue	13000000000	11000000000	On the revenue side of the equation, we expect the new products in key segments will continue to support profitable growth. This includes the Chevrolet Corvette E-Ray, our first electric supercar and the quickest production Corvette in history; our new midsized Chevrolet Colorado and GMC pickups; our new Chevrolet Silverado and GMC Sierra heavy-duty pickups; and the all-new Chevrolet Trax, which is the best entry-level Chevrolet we ever built. We expect volume and mix combined to be a slight tailwind, with volumes up 5% to 10% year-over-year and mix partially offsetting as we continue to increase production in the sedan, small SUV and crossover segments, along with GM International volume growth.	Transcript
GM.N	2023-01-31T08:30:00Z	Revenue			On the revenue side of the equation, we expect the new products in key segments will continue to support profitable growth. This includes the Chevrolet Corvette E-Ray, our first electric supercar and the quickest production Corvette in history; our new midsized Chevrolet Colorado and GMC pickups; our new Chevrolet Silverado and GMC Sierra heavy-duty pickups; and the all-new Chevrolet Trax, which is the best entry-level Chevrolet we ever built. We expect volume and mix combined to be a slight tailwind, with volumes up 5% to 10% year-over-year and mix partially offsetting as we continue to increase production in the sedan, small SUV and crossover segments, along with GM International volume growth.	Transcript
GM.N	2023-04-25T08:30:00Z	Revenue			And while we continue to experience parts availability and logistics challenges as we did in Q1, we expect these issues to gradually improve over the next few quarters and are, therefore, still expecting 2023 year-over-year wholesale volume to increase 5% to 10%.	Transcript
GM.N	2022-11-17T15:00:03Z	EBIT			* GM expects to earn low- to mid-single-digit EBIT-adjusted margins on its EV portfolio in 2025, before the positive impact of clean energy tax credits.	Press Release
GM.N	2023-01-31T08:30:00Z	EBIT			At GM Financial, the strong credit performance in historically high used vehicle prices resulted in extraordinary results over the last 2 years. For 2023, we expect earnings to normalize in the mid-$2 billion range.	Transcript
GM.N	2023-04-25T08:30:00Z	EBIT			Given the strong Q1 results and our current outlook, we are increasing our full year guidance to EBIT-adjusted in the $11 billion to $13 billion range, EPS diluted adjusted to the $6.35 to $7.35 range and adjusted automotive free cash flow in the $5.5 billion to $7.5 billion range.	Transcript
CCI.N	2023-04-20T10:30:00Z	Revenue	4494000000	4449000000	As we discussed last quarter, we expect the Sprint cancellations will result in some movements in our financial results, that are not typical for our business.	Transcript
CCI.N	2023-04-20T10:30:00Z	Revenue			Results for the first quarter were in line with our expectations and our full year 2023 outlook is unchanged, highlighted by an expectation for 5% organic tower revenue growth and accelerating small cell activity with the addition of 10,000 nodes during the year. .	Transcript
CCI.N	2023-03-09T11:00:00Z	Revenue			But talk about your confidence in your guidance, both near term and long term.	Transcript
CCI.N	2023-04-20T10:30:00Z	EBITDA			Our full year 2023 outlook remains unchanged and includes site rental revenue growth of 4%, adjusted EBITDA growth of 3% and AFFO growth of 4%. We expect the majority of the remaining $110 million to $120 million in accelerated payments to occur in the second quarter, and as a result, we continue to expect the second quarter to represent the high watermark for adjusted EBITDA and AFFO in 2023.	Transcript
CCI.N	2023-01-26T10:30:00Z	Revenue			And we expect to return to 3% growth as we exit 2023. Our expectations for nonrenewals and accelerated payments associated with this network rationalization activity are unchanged with approximately $30 million of new nonrenewals and $160 million to $170 million of accelerated payments during 2023. We expect to double the rate of small cell deployments this year to 10,000 nodes with over half colocated on existing fiber to meet the growing demand from our customers as 5G networks will require small cells at scale.	Transcript
COF.N	2023-02-14T14:25:00Z	Revenue			But the late fees are important source of revenue for Capital One. What are your thoughts as to the right way to move forward?	Transcript
ROP.N	2022-12-07T09:10:00Z	Revenue	6016416000	6016416000	And maybe just a quick follow-up to that. So it's one of many sort of built-in growth drivers in the business.	Transcript
ROP.N	2022-08-30T08:30:00Z	Revenue			For calendar 2023, we expect this business to have revenue in the $370 million range and EBITDA around $175 million, yielding EBITDA margins north of 47%. So we might have a little -- the company will have a little bit higher pricing for the next year or 2 and then revert back in the 4% range.	Transcript
ROP.N	2023-04-27T08:00:00Z	EBITDA			But for the second quarter, we're expecting it to be about the same, and then it will pick back up in the second half. Got it. I know you mentioned, obviously, it's impacting Q2. I mean, we thought EBITDA margins were in line with expectations in the first quarter, and we did have those implementations. When does that fully get running, that ramp?	Transcript
C.N	2023-04-14T11:00:00Z	Revenue	79000000000	78000000000	Despite recent events and the economic uncertainty that remains, our full year outlook for revenue and expenses remains unchanged. That's great. The one thing I did want to get a better sense of is how much of the sequential improvement that we saw in fees is a function of just partner payments being higher as credit continues to normalize.	Transcript
C.N	2022-09-27T04:00:27Z	Revenue			bootstrapped until the end of 2021, has rapidly grown at an average of 100%	Press Release
ODFL.OQ	2022-04-27T10:00:00Z	Revenue			This plan has helped us achieve a 10-year compound average growth rate in revenue and earnings per diluted share of approximately 11% and 24%, respectively. We will also maintain our focus on long-term opportunities for our business by continuing to execute on our long-term strategic plan.	Transcript
ODFL.OQ	2022-07-27T10:00:00Z	EBIT			Do you have an incremental margin target?	Transcript
A.N	2023-05-23T16:30:00Z	Revenue	7030000000	6930000000	Our updated guidance reflects a more constrained capital market, primarily impacting our instrument business.	Transcript
A.N	2022-11-21T16:30:00Z	EBIT			And despite the ongoing currency headwinds and a continued inflationary environment, we are expecting operating margin expansion for FY '23.	Transcript
GS.N	2023-01-17T09:30:00Z	Revenue			And so that obviously brings with it an upfront reserve build.	Transcript
GS.N	2022-01-18T09:30:00Z	Revenue			In the last 2 years, we have raised over $100 billion in commitments against our 5-year goal of $150 billion.	Transcript
MET.N	2022-02-03T09:00:00Z	Revenue			And excluding COVID impacts, and then grow by high single to low double digits in 2023 and 2024. Finally, for EMEA, we expect sales to grow mid- to high single digits over the near term. For Asia, we expect the recent sales momentum to continue and generate mid- to high single-digit growth over the near term. In Latin America, we expect adjusted PFOs to grow by high single digits over the near term. In addition, we expect journal account AUM to maintain mid-single-digit growth. Now let's look at the near-term guidance for our businesses outside the U.S. on Page 14. We are expecting mid-single-digit adjusted earnings growth when excluding the excess VII over plan of approximately $800 million post tax in 2021.	Transcript
MET.N	2023-05-04T09:00:00Z	Revenue			Taking participating contracts into account, the underlying PFO increase of approximately 5% was primarily due to solid growth across most products, including continued strong momentum in voluntary, and was within our 2023 target growth range of 4% to 6%.	Transcript
MET.N	2022-02-03T09:00:00Z	Revenue			And excluding COVID impacts, and then grow by high single to low double digits in 2023 and 2024. Finally, for EMEA, we expect sales to grow mid- to high single digits over the near term. For Asia, we expect the recent sales momentum to continue and generate mid- to high single-digit growth over the near term. In Latin America, we expect adjusted PFOs to grow by high single digits over the near term. In addition, we expect journal account AUM to maintain mid-single-digit growth. Now let's look at the near-term guidance for our businesses outside the U.S. on Page 14. We are expecting mid-single-digit adjusted earnings growth when excluding the excess VII over plan of approximately $800 million post tax in 2021.	Transcript
MET.N	2023-02-02T09:00:00Z	EBIT			Our Corporate & Other adjusted loss target is expected to remain at $650 million to $750 million after tax in 2023.	Transcript
MET.N	2022-02-03T09:00:00Z	Revenue			And excluding COVID impacts, and then grow by high single to low double digits in 2023 and 2024. Finally, for EMEA, we expect sales to grow mid- to high single digits over the near term. For Asia, we expect the recent sales momentum to continue and generate mid- to high single-digit growth over the near term. In Latin America, we expect adjusted PFOs to grow by high single digits over the near term. In addition, we expect journal account AUM to maintain mid-single-digit growth. Now let's look at the near-term guidance for our businesses outside the U.S. on Page 14. We are expecting mid-single-digit adjusted earnings growth when excluding the excess VII over plan of approximately $800 million post tax in 2021.	Transcript
WYNN.OQ	2023-05-09T16:30:00Z	Revenue			Looking forward, as you have seen, market-wide GGR momentum in Macau has been very impressive, building through the first quarter and accelerating into April. So we had the portions of the main floor on the East side closed at various points throughout Q1.	Transcript
WYNN.OQ	2023-05-09T16:30:00Z	EBITDA			And then just in terms of Macau, I know there was a couple of moving pieces in the quarter. But just as we think about this going forward and over the next few years, that would be helpful. Got it. I've talked a bit about this on prior calls. Is there any way to maybe quantify -- and I recognize that this is not something you would typically adjust for, but that mass hold in the quarter in terms of the impact to EBITDA as well as that construction disruption and just as we kind of think about in a normalized scenario going forward, that would be helpful. So we think that this will be a healthy balance of gaming-nongaming and that, that will allow us to provide a very full and high-quality experience and generate very healthy returns. Yes. Sure.	Transcript
PSA.N	2022-11-02T12:00:00Z	Revenue			And frankly, move-ins were quite strong in the quarter with move-in volumes were up 9%, move-in rates were up 3%. And so that's what I'd point you to. But as we look forward from here, our guidance would imply that we will exit the year with revenue growing at, call it, 10%, plus or minus, which sets us up really well heading into 2023. But that 3% is clearly a moderation from where we were earlier in the year and would anticipate that to continue to moderate through the fourth quarter. Just like how long do you have visibility into elevated rent growth? Like how long would you have visibility into kind of continued elevated realized rent growth just based on these factors and not like some of the other things like with a worsening of or any potential worsening of street rates or any of that? Recognizing it could be an uncertain environment into 2023, we'll be starting from a period of strength. So looking at what we're experiencing on move-in rent growth, we have seen the moderation in move-in rent growth as we move through the year that we've been anticipating and speaking to move-in rent growth.	Transcript
PSA.N	2023-05-03T16:05:00Z	EBIT			($ amounts in thousands, except per share data)	Press Release
PSA.N	2023-02-22T12:00:00Z	EBIT			Our non-same-store acquisition and development properties are again poised to be a strong contributor, growing from $448 million of NOI contribution in 2022 to $520 million at the midpoint. That leads to same-store NOI growth at the midpoint of 3.2%.	Transcript
MRNA.OQ	2023-05-04T08:00:00Z	Revenue			Additionally, we expect new sales in the U.S., Japan, European Union, Asia and Latin America. And we continue to expect additional orders from key markets. For INT cancer therapy, we expect to make additional Phase II update, launch of our Phase III study in adjuvant melanoma and expand into additional cancer types. Now as we turn to Slide 23, looking at the 2023 COVID deliveries, Today, we are reiterating a minimum of approximately $5 billion in COVID vaccine deliveries from current advanced purchase agreements. We expect to deliver the remaining approximately $3 billion in previously announced APAs in the second half of this year. We plan to file for approval for RSV vaccine and of Phase 303 flu study should be fully enrolled by this summer, and we expect data in Q4.	Transcript
MRNA.OQ	2023-02-23T08:00:00Z	Revenue			In addition, we are expecting sales from U.S. commercial market orders, EU, Japan and other countries.	Transcript
OGN.N						
NLSN.N^J22	2022-02-28T08:00:00Z	EBITDA	3636000000	3601800000	And for margins, from a timing perspective, we expect compression in the first half of the year and expansion in the second half, with first quarter margin contraction of a similar magnitude to the Q4 '21 contraction. The quarterly uneven as I described for Content will also play out in Q1 of this year with a challenging comparison.	Transcript
NLSN.N^J22	2022-07-27T06:30:20Z	Revenue	1560000000	1535000000	contingent on the closing of the Proposed Transaction (as described below).	Press Release
NLSN.N^J22	2022-07-27T06:30:20Z	EBIT			expansion in the fourth quarter as revenue growth accelerates, supported by half of the year, which includes year-over-year compression in the third	Press Release
NLSN.N^J22	2022-02-28T08:00:00Z	EBITDA			And for margins, from a timing perspective, we expect compression in the first half of the year and expansion in the second half, with first quarter margin contraction of a similar magnitude to the Q4 '21 contraction. The quarterly uneven as I described for Content will also play out in Q1 of this year with a challenging comparison.	Transcript
BK.N	2023-01-13T10:00:00Z	Revenue			We are expecting to deliver and are very committed to deliver year-on-year growth of about 4%, 4.5% constant currency.	Transcript
FAST.OQ	2023-04-13T10:00:00Z	Revenue			If you think about 2023, what are some of the key focus areas, the work that's still ahead of you for this year?	Transcript
LDOS.N	2022-08-02T08:00:00Z	Revenue	15100000000	14700000000	And obviously, I understand it takes time to get all the head count added and commercial aero [arguably] returns in 2024. But we see that as a big program that we've already won and should ramp up nicely in 2023. Can you just discuss some of the bigger drivers of next year's growth acceleration? I guess it's still a TBD given the kind of exposure that you guys have to widebody traffic. It sounds like the defense hardware pieces of Dynetics seem to be adding outsized lift. It's now fully out of any contribution for 2022. So maybe if you could tie together kind of what are your biggest uplifters into next year.	Transcript
LDOS.N	2023-02-15T14:05:00Z	Revenue	1585500000	1514100000	And then at the same time, we have won an award for international exams, which would be accretive. And then update us on the PACT awards and where they and airport security order prospects, they're picking up now that traffic is growing again? But overall, we expect the strength in our exam business to remain, and this goes back to where could there be upside. But we expect growth in margin in Defense '22 to '23. We expect PACT Act volume to increase throughout the year, which will help in our specific case to offset what we call the loss of District 6 or transition exams where the VA opened competition there.	Transcript
LDOS.N	2023-05-02T08:00:00Z	Revenue			We're maintaining our guidance from the Q4 call.	Transcript
LDOS.N	2023-02-15T14:05:00Z	EBITDA			Yes.	Transcript
LDOS.N	2023-02-15T14:05:00Z	EBITDA			Yes.	Transcript
LDOS.N	2023-05-02T08:00:00Z	EBITDA			Specifically, we expect 2023 revenues between $14.7 billion and $15.1 billion, adjusted EBITDA margin of 10.3% to 10.5%, non-GAAP diluted earnings per share between $6.40 and $6.80 and cash from operations at $700 million or greater.	Transcript
ORLY.OQ	2023-04-27T11:00:00Z	Revenue	15500000000	15200000000	Now we will cover some additional details on our first quarter results and guidance for the remainder of 2023. To wrap up my comments on sales, I would like to highlight our sales guidance and full year outlook.	Transcript
ORLY.OQ	2023-04-27T11:00:00Z	EBIT	3146500000	3009600000	Finally, we are maintaining our operating margin guidance range at 19.8% to 20.3% of sales.	Transcript
CSX.OQ	2023-05-24T08:35:00Z	Revenue			But on balance, we're seeing good positive revenue per unit growth largely due to the merchandise side.	Transcript
CSX.OQ	2022-04-20T16:30:00Z	EBIT			In the near term, we expect to continue to benefit from elevated export coal prices and higher fuel surcharge revenues.	Transcript
CFG.N	2023-01-17T09:00:00Z	Revenue			On the deposit side, we see 3% average deposit growth and a 2% to 3% spot deposit decline with cumulative deposit betas at year-end reaching the high 30s. We are targeting about $3 billion of spot auto runoff as we shift the portfolio towards products with more attractive risk-adjusted returns. We expect moderate loan growth with average loans up about 4% to 5%. We expect total average earning assets to be up 3% to 4%. We project moderate loan growth, partially offset by continued runoff in our auto book of close to $3 billion. With respect to our guidance for 2023, we assume a slowdown in economic growth to 1% for the year, 2 early Fed rate hikes and a Q4 cut and inflation getting below 3% by Q4.	Transcript
NI.N						
MO.N	2023-02-01T09:00:00Z	Revenue			When adjusted for trade inventory movements and calendar differences, we estimate that full year total oral tobacco segment volumes declined by an estimated 2%.	Transcript
MO.N	2023-02-01T09:00:00Z	Revenue			When adjusted for trade inventory movements and calendar differences, we estimate that full year total oral tobacco segment volumes declined by an estimated 2%.	Transcript
DD.N	2023-05-02T08:00:00Z	Revenue	12500000000	12300000000	These businesses are expected to grow at high single-digit rates over time and even faster in 2023 due to specific business wins in place. We expect them to generate revenues of about $500 million in 2023.	Transcript
DD.N	2023-02-07T08:00:00Z	Revenue	3100000000	3000000000	Can you just go over some of the guide framework?	Transcript
DD.N	2023-05-02T08:00:00Z	EBITDA			Ed, I wanted to follow up on your 300 basis point margin expansion opportunity for Spectrum to clarify. So they're on a very nice trajectory to achieve that average $110 million of EBITDA in 2023. We now expect full year net sales to be between $12.3 billion and $12.5 billion; operating EBITDA to be between $3 billion and $3.1 billion; and adjusted EPS to be between $3.55 and $3.70 per share.	Transcript
AEP.OQ	2023-02-23T09:00:00Z	Revenue			You will notice that we now expect residential sales to decrease by 0.5% in 2023 for the same reason.	Transcript
HOLX.OQ	2022-09-13T12:20:00Z	Revenue	4025000000	3925000000	And on Mobidiag, how are you thinking about sort of the revenue opportunity in fiscal '23?	Transcript
HOLX.OQ	2023-05-01T16:30:00Z	Revenue	1207500000	1177500000	Closing out non-COVID diagnostics, we expect blood revenue of slightly more than $30 million for the year. In terms of COVID revenue, we expect COVID assay sales to be approximately $25 million in the third quarter of 2023 and $245 million for the full year.	Transcript
HOLX.OQ	2023-05-01T16:30:00Z	Revenue			Closing out non-COVID diagnostics, we expect blood revenue of slightly more than $30 million for the year. In terms of COVID revenue, we expect COVID assay sales to be approximately $25 million in the third quarter of 2023 and $245 million for the full year.	Transcript
HOLX.OQ	2022-07-27T16:30:00Z	Revenue			We are confident despite the current turbulence, that our previously announced 5% to 7% annual organic revenue growth rate through 2025 remains an achievable target, provided the current chip headwind normalizes as we expect.	Transcript
HOLX.OQ	2022-07-27T16:30:00Z	EBIT			It's already been asked a lot about op margins for next year. We're still in that planning stages of how and when.	Transcript
HOLX.OQ	2022-09-13T12:20:00Z	EBIT			And are there any opportunities to drive margin leverage as well in the business? I think from a margin perspective, really spend is focused on getting the U.S. approval, which we expect in '25. So I think as we talked about on the revenue headwind, we expect that to -- as the revenue improves throughout the year, we expect that margin impact to lessen throughout the year, certainly, and hopefully, as we exit Q4, we're more at a normalized state. So less focus on margin improvement for that business in the near term, that will be more when it's available in the U.S.	Transcript
HOLX.OQ	2023-05-01T16:30:00Z	EBIT			For the full year, we continue to expect our non-GAAP gross margin percentage to be in the low 60s, and our non-GAAP operating margin percentage to be approximately 30%.	Transcript
BBY.N	2023-05-25T08:00:00Z	Revenue	45200000000	43800000000	After removing the estimated revenue from the 53rd week, the midpoint of our revenue guidance reflects a scenario where our growth, compared to fiscal '20, is slightly negative in the second quarter and regresses slightly more in the second half of this year. As a reminder, the fourth quarter of fiscal '24 contains an extra week. Furthermore, when using fiscal '20 as a comparison, you will see that our guidance implies revenue trends will further soften in the second quarter. Our guide implies comparable sales trends versus last year improve as we progress through the year. Starting with revenue, we expect Enterprise revenue in the range of $43.8 million to $45.2 billion and Enterprise comparable sales decline of 3% to 6%.	Transcript
BBY.N	2023-05-25T08:00:00Z	EBIT	1853200000	1620600000	As it relates to the extra week, we expect it to benefit our full year non-GAAP operating income rate by approximately 10 basis points. Moving on to full year profitability guidance, which is, Enterprise non-GAAP operating income rate in the range of 3.7% to 4.1%, and non-GAAP diluted earnings per share of $5.70 to $6.50.	Transcript
BBY.N	2022-05-22T08:00:00Z	EBIT			You're right.	Transcript
LHX.N	2023-04-27T16:05:00Z	Revenue	17800000000	17400000000	(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.l3harris.com%2Fresources%2F1q-2023-investor-letter&esheet=53388857&newsitemid=20230427005491&lan=en-US&anchor=Investor+Letter&index=1&md5=c7f964508eeaeaa1899f53874fc4c180) L3Harris Technologies (NYSE: LHX) today announced its first quarter fiscal	Press Release
LHX.N	2023-04-27T16:05:00Z	Revenue	2800000000	2700000000	(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.l3harris.com%2Fresources%2F1q-2023-investor-letter&esheet=53388857&newsitemid=20230427005491&lan=en-US&anchor=Investor+Letter&index=1&md5=c7f964508eeaeaa1899f53874fc4c180) L3Harris Technologies (NYSE: LHX) today announced its first quarter fiscal	Press Release
LHX.N	2023-04-28T08:30:00Z	Revenue			First quarter results, our differentiated winning strategy and the overall business environment led us to reaffirm our 2023 guidance with the recognition that record orders and strong revenue growth to date could support a bias towards the higher end of our revenue guidance range should these trends continue.	Transcript
LHX.N	2023-04-27T16:05:00Z	Revenue			(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.l3harris.com%2Fresources%2F1q-2023-investor-letter&esheet=53388857&newsitemid=20230427005491&lan=en-US&anchor=Investor+Letter&index=1&md5=c7f964508eeaeaa1899f53874fc4c180) L3Harris Technologies (NYSE: LHX) today announced its first quarter fiscal	Press Release
LHX.N	2023-04-27T16:05:00Z	EBIT			(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.l3harris.com%2Fresources%2F1q-2023-investor-letter&esheet=53388857&newsitemid=20230427005491&lan=en-US&anchor=Investor+Letter&index=1&md5=c7f964508eeaeaa1899f53874fc4c180) L3Harris Technologies (NYSE: LHX) today announced its first quarter fiscal year 2023 results in an Investor Letter	Press Release
LHX.N	2023-04-27T16:05:00Z	EBIT			(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.l3harris.com%2Fresources%2F1q-2023-investor-letter&esheet=53388857&newsitemid=20230427005491&lan=en-US&anchor=Investor+Letter&index=1&md5=c7f964508eeaeaa1899f53874fc4c180) L3Harris Technologies (NYSE: LHX) today announced its first quarter fiscal year 2023 results in an Investor Letter	Press Release
LHX.N	2023-04-27T16:05:00Z	EBIT			(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.l3harris.com%2Fresources%2F1q-2023-investor-letter&esheet=53388857&newsitemid=20230427005491&lan=en-US&anchor=Investor+Letter&index=1&md5=c7f964508eeaeaa1899f53874fc4c180) L3Harris Technologies (NYSE: LHX) today announced its first quarter fiscal year 2023 results in an Investor Letter	Press Release
LHX.N	2023-04-27T16:05:00Z	EBIT			(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.l3harris.com%2Fresources%2F1q-2023-investor-letter&esheet=53388857&newsitemid=20230427005491&lan=en-US&anchor=Investor+Letter&index=1&md5=c7f964508eeaeaa1899f53874fc4c180) L3Harris Technologies (NYSE: LHX) today announced its first quarter fiscal year 2023 results in an Investor Letter	Press Release
LHX.N	2023-04-27T16:05:00Z	EBIT			(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.l3harris.com%2Fresources%2F1q-2023-investor-letter&esheet=53388857&newsitemid=20230427005491&lan=en-US&anchor=Investor+Letter&index=1&md5=c7f964508eeaeaa1899f53874fc4c180) L3Harris Technologies (NYSE: LHX) today announced its first quarter fiscal year 2023 results in an Investor Letter	Press Release
APA.OQ						
IFF.N	2022-08-09T09:00:00Z	Revenue	12300000000	12300000000	And our fourth team is focused on building out our global shared service platform in [concept] with technology, to drive increased centralization and process standardization to drive efficiencies across our administrative and business support functions. First, this $250 million to $300 million annual impact is net of reinvestments that are targeted to strengthen our innovation pipeline, expand our commercial efforts across key products, customers and regions, deepen our technology and digital capabilities and strengthen our talent. In total, the combined programs are targeting a preliminary net annualized P&L impact of $250 million to $300 million that we expect to be achieved between 2023 and 2025. Secondly, the net savings will be slightly more skewed to 2024 and 2025. The third initiative is our economic profit team that is focused on leveraging improved technology and disciplined processes to optimize product mix, rationalize SKUs and enhance make versus buy decisions. We look forward to sharing more details with you at our Investor Day in December.	Transcript
IFF.N	2022-11-08T09:00:00Z	Revenue	2340000000	2340000000	And while it's still early in our planning process, we are targeting strong comparable currency-neutral sales growth in 2023 to be driven more predominantly by price with more modest EBITDA growth on a comparable currency-neutral basis as we reinvest in the business to accelerate sales momentum and drive long-term profitable growth.	Transcript
IFF.N	2023-05-09T09:00:00Z	Revenue			This change is largely related to energy and raw material pass-through price adjustments.	Transcript
IFF.N	2021-01-11T06:55:00Z	EBIT			That's up around 400 basis points from our 2020 pro forma. We also expect to see meaningful operating margin improvement for IFF moving forward, including an estimated adjusted EBITDA margin of approximately 26% in 2023.	Transcript
IFF.N	2022-06-01T08:00:00Z	EBITDA			One, on the top line revenue target that was outlined.	Transcript
IFF.N	2023-05-09T09:00:00Z	EBITDA			Foreign exchange headwinds are expected to continue to pressure sales and comparable currency-neutral adjusted operating EBITDA growth, which we now expect will adversely impact us 1% and 3%, respectively.	Transcript
STT.N	2023-02-14T11:05:00Z	Revenue			And with that, we think over time, that gets us to that fee revenue growth target that we have of about 4% to 5% per year.	Transcript
JCI.N	2023-02-01T08:30:00Z	Revenue			Our backlog grew double digits and remains at record level. We were pleased with our start of the year and are encouraged by the continued strength and resilience in our order and backlog.	Transcript
JCI.N	2023-05-09T10:30:00Z	Revenue			And then just how significant is the delta between the margin profile of what's in backlog versus what's flowing through revenue now we would assume the long cycle component has more price/cost benefits just because of the lag on inflationary pricing. Correct. It's now growing 10%. So if you look at -- let me give you the elements to enter the answer. Talk to us about that, talk to us about mix. The inflection point is going to be driven by the 2 points we mentioned earlier. The margin on orders on install is increasing sequentially every quarter.	Transcript
JCI.N	2023-02-22T15:30:00Z	EBIT			And with the improved velocity, the flow, the project flow and conversion is improving.	Transcript
JCI.N	2023-05-09T10:30:00Z	EBIT			You are talking about 100-plus basis point improvement year-on-year.	Transcript
FE.N	2023-02-02T17:55:02Z	Revenue			Additionally, FirstEnergy today announced it has increased its 2021-2025 billion from the $17 billion target established in 2021. Later this year, the company plans to provide an updated long-term growth forecast, which will include additional investments to support a more resilient and modern grid and long-term growth plan to nearly $18 billion, an increase of approximately $1 the transition to a low-carbon future. FirstEnergy plans to provide full year	Press Release
PNC.N	2022-12-06T13:00:00Z	Revenue	22176000000	21964800000	And what are you expecting for next year? Eventually, banks cook in a good margin, the Fed keeps going, betas become one. Like I'm befuddled by that competitor, whoever that's suppose to comment.	Transcript
VZ.N	2022-01-25T08:30:00Z	Revenue	48500000000	47000000000	Excluding the impact of the TracFone acquisition, wireless service revenue is expected to grow at least 3%.	Transcript
VZ.N	2023-04-25T06:50:26Z	Revenue			* Total wireless service revenue growth(2 3 )of 2.5 percent to 4.5 percent. For 2023, Verizon continues to expect the following: allocation of administrative and telco recovery charges which partly recover	Press Release
VZ.N	2022-03-08T11:00:00Z	EBITDA			And then with that revenue growth from a margin standpoint, we said we expect EBITDA to grow at or above the rate of revenue growth. But not -- we didn't just talk in percentage terms. One, revenue growth that gets to 4% by 2024. We said that would get to $124 billion by 2025.	Transcript
VZ.N	2023-04-25T08:30:00Z	EBITDA			We believe that the actions the teams are taking will grow the top line, driving both EBITDA and cash flow.	Transcript
NEM.N	2023-04-27T07:00:00Z	Revenue			2023 Outlook - Gold ((1)(2)) Outlook Estimate	Press Release
ROL.N	2023-04-27T08:30:00Z	Revenue			We expect this acquisition to add between $90 million and $100 million of revenue in 2023.	Transcript
ROL.N	2023-04-27T08:30:00Z	EBITDA			The acquisition should add $18 million to $20 million -- $22 million of EBITDA for the remainder of the year.	Transcript
ROL.N	2023-02-16T08:30:00Z	EBIT			We're not committing to necessarily a specific margin target, but we do see an opportunity to continue to improve our margin profile over the long term.	Transcript
KEY.N	2023-04-20T10:00:00Z	Revenue			And importantly, most of this growth has already occurred relative to 2022, so we don't expect material loan balance growth. And to your point, there's no question that the cost of raw material has gone up significantly. But as you and I have talked before, lending on a stand-alone business that's hard to return your cost of capital. Slide 18 updates our full year 2023 outlook. So I'm trying to reconcile you are more caution with your provisions with no change in your loan guidance whereas others have brought down their loan guidance that they tightened things up. The guidance is relative to our full year 2022 results. We expect average loans to grow between 6% and 9%. We're certainly not going to change our lending standards.	Transcript
GIS.N	2022-06-29T09:00:00Z	Revenue	3470364000	3438231000	I think we're expecting as a backdrop that the supply chain disruptions, to the extent they are foreseeable, will in the near term, not abate that much.	Transcript
GIS.N	2022-06-15T10:00:00Z	Revenue			And it's added over 1 point of growth for context. And our free cash flow conversion has been really, really good over the last number of years. And then to the extent that we need to shedding assets where somebody else is probably a better owner than we are and they're dilutive to our current growth. And within that model, we want to make sure that we're investing in activities that can help us achieve that model and generate the free cash flow that is necessary.	Transcript
GIS.N	2023-03-23T08:00:00Z	Revenue			We remain on track to deliver double-digit organic net sales growth for the Pet segment in the second half of fiscal 2023 with the back half segment operating profit margin ahead of our Q2 results.	Transcript
GIS.N	2023-02-21T08:00:00Z	Revenue			With a great team, a clear strategy and best-in-class execution, we expect North America Retail to generate consistent, profitable organic sales growth in the years ahead.	Transcript
GIS.N	2023-03-23T08:00:00Z	EBIT			We remain on track to deliver double-digit organic net sales growth for the Pet segment in the second half of fiscal 2023 with the back half segment operating profit margin ahead of our Q2 results.	Transcript
GIS.N	2022-06-29T07:00:00Z	EBIT			bottom-line growth profile over the long term. The company estimates the net	Press Release
GIS.N	2022-06-15T10:00:00Z	EBIT			And our free cash flow conversion has been really, really good over the last number of years. And the key is to make sure we're investing in some areas while deprioritizing others. And then combine that with the dividend, you get a really good return for shareholders. And within that model, we want to make sure that we're investing in activities that can help us achieve that model and generate the free cash flow that is necessary. But in the current environment, how is the company generally balancing investment needs to support growth strategy versus -- and I know you discussed those sustained, those are still being prioritized, but what's the process by which you balance those strategic investments with the need to deliver bottom line and free cash flow? It's actually invest to generate a return and then sometimes quitting activities that aren't generating the returns that we want in order to do things more like data and analytics that we think are going to be more important to us. So as I mentioned in the opening, you're in your quiet period, so we'll recognize that. So it's not just spend more, spend more, spend more. So that is our model. So yes, again, without giving guidance on next year, what I would say over the longer term, our -- we've been very clear that in our sales guidance growth is 2% to 3% inflationary period notwithstanding, which can lead to -- which leads to mid-single-digit operating profit growth and mid- to high single-digit EPS growth.	Transcript
GIS.N	2022-09-21T08:00:00Z	EBIT			As price-mix on the business outside of bakery flour did not keep pace with roughly 20% input cost inflation for the segment in Q1, we expect recent incremental SRM actions will help address this gap and improve our profit performance in the remainder of the year. Segment operating profit for the quarter was down 25%.	Transcript
GIS.N	2022-06-29T07:30:00Z	EBIT			And when looking at our performance compared to prepandemic levels in fiscal '19, our results are in line with or ahead of our long-term growth goals, including mid-single-digit growth in organic net sales and adjusted operating profit and high single-digit growth in adjusted diluted EPS. On the bottom line, though our gross and operating margins were below prior year levels, we were able to deliver constant currency growth of 2% on adjusted operating profit and 4% on adjusted diluted EPS.	Transcript
CMCSA.OQ	2023-04-27T08:30:00Z	Revenue			And we're pleased with the 4.5% year-over-year increase in ARPU in the quarter. Our second major growth opportunity- business services, which is approaching $10 billion in annual revenue, is growing at mid-single digits with newly reported margins just shy of 60% and delivering adjusted EBITDA growth in the high single-digit range.	Transcript
CMCSA.OQ	2023-04-27T08:30:00Z	EBITDA			Our second major growth opportunity- business services, which is approaching $10 billion in annual revenue, is growing at mid-single digits with newly reported margins just shy of 60% and delivering adjusted EBITDA growth in the high single-digit range. We continue to expect Peacock losses for the year to be around $3 billion, which we believe will be peak losses for Peacock and then begin to steadily improve.	Transcript
PFE.N	2023-01-31T06:45:00Z	Revenue	71000000000	67000000000	Excluding COVID-19 products, the Company continues to expect 7% to 9% forward to 2023, we expect strong topline growth of 7% to 9% excluding our	Press Release
PFE.N	2023-05-02T10:00:00Z	Revenue			On a total company basis, we continue to expect revenues of $67 billion to $71 billion, reflecting an operational decline of 31% at the midpoint, with 5% operational growth in our non-COVID revenues this quarter, we are on track to achieve our non-COVID revenue guidance of 7% to 9% operational growth for the full year.	Transcript
PFE.N	2023-05-02T10:00:00Z	EBIT			Looking ahead, as we exit this unprecedented period of anticipated launches, we would expect to achieve operating margin improvement over time.	Transcript
PFE.N	2022-12-12T13:00:00Z	Revenue			Additionally, we are well on track of achieving our target of $25 billion of risk-adjusted sales by 2030 generated through business development. Great. It certainly has peaks and troughs and it starts to peak, we see, during the winter months, but we also see that it continues to be with us year-round. So in terms of the COMIRNATY portion of combos and sort of moving forward, I think obviously, time is going to tell as the sort of the virus continues to evolve. Thanks for the question. That's excluding COVID-19 products and excluding the impact of FX.	Transcript
EIX.N	2022-05-01T16:30:00Z	Revenue			As shown on Page 8, our capital forecast continues to result in projected rate base growth of 7% to 9% from 2021 to 2025. The forecast reflects SCE's current view of the request to be made in GRC track 4, the 2025 GRC and other applications. We continue to see strong potential for SCE to continue deploying capital and achieving 7% to 9% rate base growth through 2025.	Transcript
NWS.OQ	2022-08-08T17:00:00Z	Revenue			As a reminder, over 75% of Dow Jones revenues are recurring or subscription-based, the majority digital, with a strong margin, and we feel confident of its growth trajectory leading into 2023. At News Media, we still expect higher content licensing revenue from our platform deals as we implement elements of the broader Google partnership, such as Subscribe with Google, and also benefit from our expanded Apple relationship.	Transcript
NWS.OQ	2023-02-09T17:00:00Z	Revenue			BINGE reached nearly 1.4 million paying subscribers in the quarter, and we'll be launching an advertising tier later this fiscal year as we seek to maximize Foxtel's revenue potential.	Transcript
NWS.OQ	2022-08-08T17:00:00Z	Revenue			As a reminder, over 75% of Dow Jones revenues are recurring or subscription-based, the majority digital, with a strong margin, and we feel confident of its growth trajectory leading into 2023. At News Media, we still expect higher content licensing revenue from our platform deals as we implement elements of the broader Google partnership, such as Subscribe with Google, and also benefit from our expanded Apple relationship.	Transcript
NWS.OQ	2022-08-08T17:00:00Z	EBIT			Our faith in its prospects has been shown by the acquisitions of Investor's Business Daily, OPIS and Base Chemicals, all of which we expect will contribute to revenue and profitability in the years ahead.	Transcript
NWS.OQ	2023-02-09T17:00:00Z	EBIT			Profitability will be skewed to the fourth quarter as we expect third quarter cost to be higher in local currency compared to the prior year given the contractual escalators and expanded content from the AFL and NRL. We are very encouraged by the year-to-date performance and continue to expect the Foxtel Group's profitability in local currency for the full year to be relatively stable.	Transcript
MU.OQ	2023-05-22T08:00:00Z	Revenue			But we are currently estimating a range of impact in the low single-digits percent of our company total revenue at the low end and high single-digit percentage of total company revenue at the high end. We expect bit growth to continue in the second half of calendar '23.	Transcript
MU.OQ	2022-11-29T16:10:00Z	EBITDA			So you saw that we went out to the debt markets and raised some additional liquidity to kind of ride this out and continue to make the right decisions.	Transcript
MU.OQ	2023-03-28T16:30:00Z	EBIT			We do project profitability to improve sequentially due to lower inventory write-downs and free cash flow to improve slightly, driven by reduced capital spend.	Transcript
UPS.N	2023-04-25T08:30:00Z	Revenue	97000000000	97000000000	We deal with both ground and air, as you know.	Transcript
UPS.N	2023-04-25T08:30:00Z	Revenue	12416000000	12416000000	We deal with both ground and air, as you know.	Transcript
UPS.N	2023-04-25T08:30:00Z	Revenue			We deal with both ground and air, as you know.	Transcript
UPS.N	2023-04-25T08:30:00Z	EBIT			And then the volumes were down -- the volume is down 3% for the year. Brian, just a couple of follow-ups on the guidance. How should we think about Q2? markets remain challenged.	Transcript
UPS.N	2023-04-25T08:30:00Z	EBIT			And then the volumes were down -- the volume is down 3% for the year. Brian, just a couple of follow-ups on the guidance. How should we think about Q2? markets remain challenged.	Transcript
UPS.N	2023-04-25T08:30:00Z	EBIT			And then the volumes were down -- the volume is down 3% for the year. Brian, just a couple of follow-ups on the guidance. How should we think about Q2? markets remain challenged.	Transcript
UPS.N	2023-04-25T08:30:00Z	EBIT			And then the volumes were down -- the volume is down 3% for the year. Brian, just a couple of follow-ups on the guidance. How should we think about Q2? markets remain challenged.	Transcript
TYL.N	2023-02-16T10:00:00Z	Revenue	1970000000	1935000000	The midpoint of our guidance implies organic growth of approximately 8%. We expect both GAAP and non-GAAP total revenues will be between $1.935 billion and $1.970 billion.	Transcript
TYL.N	2023-04-27T10:00:00Z	Revenue			And it's the same thing with flips from on-prem to the cloud. Any context you can provide, just around your view on that number is helpful. The commentary around the demand environment, RFP volume has remained consistently upbeat. There's -- we may sign it now, but there's a period of time where that transition takes place, so we don't get the uplift in the revenues immediately. What is the organic growth number not entirely reflecting relative to the demand backdrop, whether it's pipeline bookings or just general mix and transition impacts?	Transcript
TYL.N	2022-11-30T12:20:00Z	EBITDA			But what are some of the things that should be top of mind for investors as we're thinking through the growth margin profile near term, and then we can go into the longer term.	Transcript
TYL.N	2022-11-29T12:15:00Z	EBIT			And we've got some duplicate costs until we get out of -- completely out of our first data center and then our second data center over the next 2 to 3 years that are sort of elevating our cost right now. But we did say that for a number of reasons as we came into this year, we expected to see more of a margin -- more pressure on margins. So -- and maybe when we're talking about that, maybe we can also discuss how government customers and the typical traditional enterprise customers differ, right? So -- and then the bubble costs as well. So are you guys currently on track with 290 basis points of impact to FY '22 margins?	Transcript
TYL.N	2023-04-27T10:00:00Z	EBIT			And certainly, margins and our targets and broadly how we view the trajectory of one of the topics we'll be looking to address at the Investor Day, that things are rarely linear. And then the other question is, I know that you guys have been messaging about operating margins, troughing in 2022 before they expand in 2024. And then, in terms of the overall margin, we don't give quarterly guidance, so we didn't have a quarterly margin target out there. But generally, our expectation for the full year margins hasn't changed. So, I don't expect it to be linear. The first quarter did have good performance, good growth around the subscription revenues, as some of those revenues are coming online from deals we've signed in prior quarters and the pace at which those revenues hit can affect that somewhat.	Transcript
UNP.N	2023-04-20T08:45:00Z	Revenue			Here is our outlook for the rest of 2023 as we see it today.	Transcript
UNP.N	2023-04-20T07:45:04Z	EBIT			Maintaining 2023 Full Year Guidance	Press Release
BAC.N						
KMX.N	2022-04-12T09:00:00Z	Revenue			During our Analyst Day last May, we announced long-term targets of achieving 2 million combined retail and wholesale units sold and $33 billion of revenue in FY '26, up from $1.2 million and $19 billion, respectively, during FY '21. These ranges reflect the macro factors we [had] earlier that could result in ongoing volatility in consumer demand and vehicle pricing. Though we don't anticipate updating our targets annually, our strong performance in FY '22 has given us a new perspective on these targets that we believe is appropriate to share at this time. We're revising our FY '26 targets to reflect a range of 2 million to 2.4 million combined units with revenue between $33 billion and $45 billion.	Transcript
PARA.OQ	2023-02-16T08:30:00Z	EBITDA			And then on the Filmed Entertainment segment, we do expect slightly lower OIBDA on a year-over-year basis there, just given the timing of our film slate, which is a little more back-end loaded in '23 relative to '22. And then, of course, we're comping against '22, which included Top Gun, which was obviously a very large contributor. I think TV Media will also reflect the impact of a number of the cost savings initiatives that we started talking about on our last call as well as some of the benefits that we'll unlock from Showtime and Paramount+ in the back part of the year. Importantly, our focus on working capital optimization meant the year-over-year change in free cash flow in 2022 was better than the year-over-year change in OIBDA, a trend we expect will continue in 2023 as the gap between cash content spend and P&L content expense continues to narrow.	Transcript
PARA.OQ	2023-03-08T11:00:00Z	Revenue			Talk a little bit about the thought process there and how the product offering is going to change based on the changes you've announced?	Transcript
PARA.OQ	2022-02-15T16:15:00Z	EBIT			And longer term, our model suggests that the D2C segment will approach margins similar to our current TV Media business. Given these investments, we forecast D2C OIBDA losses will be greatest in 2023, but will improve in 2024 when our global D2C businesses will start to see the benefits of our full content slate, including Paramount Pay1 movies.	Transcript
PARA.OQ	2022-05-03T08:30:00Z	EBITDA			We continue to forecast D2C OIBDA losses will be greatest in 2023 and then improve in 2024.	Transcript
IP.N	2023-04-27T10:00:00Z	EBITDA	2500000000	2300000000	We are now projecting full year 2023 EBITDA for the company to be in the range of $2.3 billion to $2.5 billion.	Transcript
IP.N	2022-11-30T08:45:00Z	EBIT			Our commitment is to deliver $350 million to $400 million of incremental earnings through 2024. Through our Building a Better IP initiatives, we're focused on continuing to invest in projects to drive structural cost reduction through efficiency improvements and accelerating profitable growth. We set a target for 2022 of $220 million, and we will achieve that and probably the high end of that target.	Transcript
MDT.N	2023-01-09T12:00:00Z	Revenue			However, we expect that as we exit this fiscal year, over half of our China revenue will have been through VBP, and we expect to reach approximately 80% by the end of our FY '24, giving us a new, albeit lower revenue base to grow from going forward. Starting with our established market-leading businesses.	Transcript
MDT.N	2022-08-23T08:00:00Z	Revenue			As we look ahead for FX, I would say, keep in mind, it's only Q1 now. But if we look at next fiscal year, based on recent rates, we would expect the headwind next fiscal year to be similar to the headwind this fiscal year, again, if rates stay the same. In terms of FX, as you've seen, we've had the strengthening dollar continue to impact our reported revenue, just like it has for many of our peers.	Transcript
MMM.N	2023-04-25T09:00:00Z	Revenue			We continue to expect procedure volumes to improve as we progress through the year.	Transcript
MMM.N	2023-04-25T09:00:00Z	Revenue			As I mentioned, we aggressively managed cost, focused on serving customers while navigating end-market weakness, particularly in consumer-facing markets as we started the year. We expect organic sales volumes will improve as consumer retail and consumer electronics markets stabilize, China work through its COVID-related challenges as our year-on-year comps ease.	Transcript
MMM.N	2023-01-24T09:00:00Z	Revenue			Based on this outlook, we expect organic growth of minus 3% to flat, along with adjusted EPS of $8.50 to $9, and adjusted free cash flow conversion of 90% to 100%. This includes selling prices up low single digits Therefore, organic volumes are expected to be down low to mid-single digits for the year.	Transcript
MMM.N	2023-04-25T06:30:05Z	EBIT			"To strengthen 3M for the future, today we announced actions that will reduce chain structure, and streamline our go-to-market business models, which will	Press Release
MMM.N	2023-03-15T08:50:00Z	EBITDA			We have good margins, good EBITDA will continue to increase as we hopefully, supply chains stabilize.	Transcript
CZR.OQ	2023-05-02T17:00:00Z	Revenue			From an EBITDA perspective, our net revenues are now at a scale where we are able to roughly break even and cover the cost of our proprietary technology. Second, we expect to begin testing our in-house player account management system later this year, which will ultimately lead to a shared wallet that we anticipate rolling out in 2024. We expect that our year-over-year net revenues will continue to grow each quarter.	Transcript
CZR.OQ	2023-05-02T17:00:00Z	EBITDA			We remain on track to generate the 50% return on the $1.1 billion of cumulative losses that we generated as we launched the business.	Transcript
CZR.OQ	2023-02-21T17:00:00Z	EBIT			As of December 31, we had federal net operating loss carryforwards of $1.9 billion, which will continue to shield operating income in 2023 and well beyond.	Transcript
INTU.OQ	2022-11-29T16:30:00Z	Revenue	14317000000	14279000000	At the same time, we are reiterating our fiscal year 2023 revenue guidance for all other segments and reiterating our fiscal 2023 GAAP and non-GAAP operating income and earnings per share guidance. We are lowering our fiscal year 2023 revenue guidance for Credit Karma to a decline of 15% to 10% versus our previous guidance of 10% to 15% growth. We are reiterating our revenue expectations for all other segments and now expect total company revenue growth of 10% to 12% versus the previous range of 14% to 16%.	Transcript
INTU.OQ	2022-11-29T16:30:00Z	Revenue	5461000000	5441000000	At the same time, we are reiterating our fiscal year 2023 revenue guidance for all other segments and reiterating our fiscal 2023 GAAP and non-GAAP operating income and earnings per share guidance. We are lowering our fiscal year 2023 revenue guidance for Credit Karma to a decline of 15% to 10% versus our previous guidance of 10% to 15% growth. We are reiterating our revenue expectations for all other segments and now expect total company revenue growth of 10% to 12% versus the previous range of 14% to 16%.	Transcript
INTU.OQ	2023-05-23T16:00:00Z	Revenue			Twelve Months Ending July 31, 2023	Press Release
INTU.OQ	2023-05-23T16:00:00Z	Revenue			Twelve Months Ending July 31, 2023	Press Release
INTU.OQ	2023-05-23T16:00:00Z	EBIT			* GAAP operating income of $3.071 billion to $3.091 billion, growth of GAAP Â  Â  Â  Non-GAAP	Press Release
INTU.OQ	2022-08-23T16:30:00Z	EBIT			Can you talk to us about sort of the organic, if you will, or sort of like the fundamental margin improvement that you're expecting in the business in FY '23?	Transcript
INTU.OQ	2022-08-23T16:00:00Z	Revenue			Revenue $ 14,485 Â  Â  $ 14,700 Â  Â  $ â€” Â  $ 14,485 Â  $ 14,700	Press Release
INTU.OQ	2023-05-23T16:00:00Z	EBIT			PROJECTED GAAP REVENUE, OPERATING INCOME (LOSS), AND EPS TABLE E	Press Release
OKE.N	2022-05-04T11:00:00Z	Revenue	4725000000	4425000000	As natural gas prices have increased this year, ethane prices have kept pace, providing attractive ethane recovery economics in certain areas of our system. In the Gulf Coast, construction continues on our 125,000 barrel per day MB-5 fractionator in Mont Belvieu, which we now expect to be complete in the second quarter of 2023. In the Permian Basin, NGL volumes increased 23% year-over-year due to strong producer activity levels, which feed our West Texas NGL pipeline. International LPG demand remains strong, and we continue to expect both domestic and international ethane demand to continue to increase throughout 2022. MB-5 will increase our total system-wide fractionation capacity to more than 1 million barrels per day.	Transcript
OKE.N	2023-02-28T11:00:00Z	Revenue			In the natural gas liquids segment, we expect volume growth to be driven by strong producer levels, producer activity across our operations, continuing the momentum we saw from producers in 2022.	Transcript
OKE.N	2023-05-03T11:00:00Z	Revenue			We expect volumes to continue to grow in the spring and summer months.	Transcript
OKE.N	2023-02-28T11:00:00Z	EBITDA			Excluding the effect of the settlement and the third-party costs of $540 million, this still amounts to more than $4 billion double-digit earnings growth, which we referenced on our last earnings call.	Transcript
OKE.N	2023-02-27T16:15:06Z	EBITDA			expects to incur in 2023.	Press Release
OKE.N	2023-02-28T11:00:00Z	EBITDA			Excluding the effect of the settlement and the third-party costs of $540 million, this still amounts to more than $4 billion double-digit earnings growth, which we referenced on our last earnings call.	Transcript
OKE.N	2023-02-28T11:00:00Z	EBITDA			Excluding the effect of the settlement and the third-party costs of $540 million, this still amounts to more than $4 billion double-digit earnings growth, which we referenced on our last earnings call.	Transcript
ADP.OQ	2022-07-27T08:30:00Z	Revenue	17983147000	17818164000	Clearly, with the year-over-year parity to the dollar with a weaker pound and with about 20% of our ES segment revenue being generated outside the U.S. were factored in a fair amount of FX headwind for fiscal '23 of well over 1%.	Transcript
ADP.OQ	2022-09-07T13:00:00Z	Revenue			But once again, remember that's because of inflation. Otherwise, we would be targeting 150. So if we look at pricing a little bit, traditionally been a 0.5 point of growth for ADP historically. This year, we've talked about 100 to 150 basis points. Yes, I think it's -- to your initial comments, 50 basis points is what we would normally expect in a year from sales this year.	Transcript
ADP.OQ	2022-07-27T08:30:00Z	EBIT			Our adjusted EBIT margin was up 170 basis points, about in line with our expectations as leverage from strong revenue growth overcame higher selling expenses, PEO pass-throughs and growth investments like the sales head count growth Maria just mentioned.	Transcript
ADP.OQ	2022-09-07T13:00:00Z	EBIT			So float drives, 130 bps.	Transcript
EQIX.OQ	2023-01-04T17:30:00Z	Revenue	8275000000	8175000000	Right.	Transcript
EQIX.OQ	2023-05-03T17:30:00Z	Revenue	3715000000	3635000000	For the full year, we're raising our revenue guidance by $30 million and adjusted EBITDA guidance by $20 million, primarily due to favorable FX rates and lower integration costs.	Transcript
EQIX.OQ	2023-05-03T17:30:00Z	EBITDA			For the full year, we're raising our revenue guidance by $30 million and adjusted EBITDA guidance by $20 million, primarily due to favorable FX rates and lower integration costs.	Transcript
EQIX.OQ	2023-05-03T17:30:00Z	EBITDA			For the full year, we're raising our revenue guidance by $30 million and adjusted EBITDA guidance by $20 million, primarily due to favorable FX rates and lower integration costs.	Transcript
CHD.N	2022-09-06T12:45:00Z	Revenue	5751892000	5698136000	Trailing 12-month EBITDA is $45 million, trailing 12-month sales is $115 million, about 40% EBITDA margins, $130 million of sales in 2022 is the expectation, so that means about $150 million in 2023.	Transcript
CHD.N			645624000	621712000		
MTD.N	2022-11-03T17:00:00Z	Revenue	4115694450	4115694450	Based on market conditions today, we believe we will generate good sales growth for the remainder of the year and in 2023.	Transcript
MTD.N	2023-05-10T13:40:00Z	EBIT			We know how to take that and deliver mid-teens EPS growth.	Transcript
MTD.N	2022-11-30T11:20:00Z	EBIT			Is the guidance LRP assuming a little bit more activity on the M&A front? Like next year, operating margins is going to be much stronger than that.	Transcript
EBAY.OQ	2023-04-26T17:30:00Z	Revenue			This ranking model also enables us to evaluate the expected performance of multiple ad products alongside each other rather than making ad-serving decisions in silos.	Transcript
EBAY.OQ	2023-05-22T11:15:00Z	EBIT			And that is increasing the capacity for us to invest. The second thing I would say is that we are leaning into investment.	Transcript
EBAY.OQ	2022-06-01T08:00:00Z	EBIT			Again, eBay has, what I describe as best-in-class margins with a fortress balance sheet that really supports the investments in the business. And going through that margin to actually through sort of 2024, we'll continue to assess it for the long term. And this is probably a good time to weave in a question from the audience here. But again, when I think about top line growth, the operating leverage of that continues to provide. But in that Investor Day outlook, you pointed to low 30s, 31%, 32% operating margin by 2024. Is that the right end state for eBay? It frees up capacity for us to continue to invest in the business and then to continue to stimulate earnings growth at the bottom line. Or is that just a stepping stone given the reinvestment -- priority right now? So I'm very happy with the architecture that we laid out and very optimistic about the future potential for the company. We've really clearly laid out an architecture for the next couple of years. Yes, I'm not going to get ahead of myself.	Transcript
PEG.N	2023-02-21T11:00:00Z	Revenue			For '24, total nuclear generation is forecasted also to be approximately 31 terawatt hours and 55% to 60% hedged at an average price of $32 per megawatt hour. PCG is forecasting total baseload nuclear generation of approximately 31 terawatt hours for the full year of '23 hedged 95% to 100% at an average price of $31 per megawatt hour, an increase of about $4 per megawatt hour compared to '22.	Transcript
PEG.N	2022-10-31T11:00:00Z	Revenue			And in October, PSE&G filed its annual transmission formula rate update with FERC, which increases its annual transmission revenue requirement by $69 million effective January 1, 2023.	Transcript
PEG.N	2023-05-02T11:00:00Z	EBIT			For the full year 2023, PSE&G's forecast of non-GAAP operating earnings is unchanged at $1.5 billion to $1.525 billion.	Transcript
BIIB.OQ	2022-10-25T08:00:00Z	Revenue	9766464000	9562996000	We continue to expect a gradual launch of BYOOVIZ with more meaningful revenue contribution expected to begin in 2023.	Transcript
CTSH.OQ	2023-05-03T17:00:00Z	Revenue	19600000000	19200000000	And so the revenue growth, in this case, will be picking up.	Transcript
CTSH.OQ	2023-05-03T17:00:00Z	EBIT	2881200000	2726400000	Moving on to the adjusted operating margin.	Transcript
CTSH.OQ	2022-05-12T13:00:00Z	EBIT			And we've guided 20 to 40 basis points of margin expansion for the next 3 years, a little less this year because of labor and whatnot. I think in the coming 3 years, the fruit of that labor should become more apparent, stronger revenue growth, hopefully, now, out of a period of heavy investments and hopefully into a period of margin expansion. Well, speaking of still being in transition or in transformation, looking forward now, sort of resetting yourself after 3 years, what are the top priorities over the next 3 years?	Transcript
ALB.N	2023-05-03T16:15:03Z	Revenue	11500000000	9800000000	market pricing. Net sales are expected to increase 35% to 55% over prior year,	Press Release
ALB.N	2022-08-04T09:00:00Z	Revenue	4000000000	3300000000	Looking forward, we expect volumes to grow approximately 20% per year from 2022 to 2025 driven primarily by the ramp-up of new conversion assets.	Transcript
ALB.N	2023-05-03T16:15:03Z	Revenue			market pricing. Net sales are expected to increase 35% to 55% over prior year,	Press Release
ALB.N	2023-05-04T09:00:00Z	Revenue			The next item affecting margins is the accounting treatment of the MARBL joint venture. This is up 45% over the prior year at the midpoint. We still anticipate a 20% to 30% CAGR in Albemarle sales volumes between now and 2027, allowing us to maintain our leadership position and keep up with accelerated market demand. While lithium prices have pulled back, our team continues to focus on the themes that are within our control.	Transcript
ALB.N	2023-05-04T09:00:00Z	Revenue			The next item affecting margins is the accounting treatment of the MARBL joint venture. This is up 45% over the prior year at the midpoint. We still anticipate a 20% to 30% CAGR in Albemarle sales volumes between now and 2027, allowing us to maintain our leadership position and keep up with accelerated market demand. While lithium prices have pulled back, our team continues to focus on the themes that are within our control.	Transcript
ALB.N	2023-05-04T09:00:00Z	EBITDA			Adjusted EBITDA for Energy Storage is expected to be between $2.7 billion and $3.4 billion, essentially flat compared to 2022. Adjusted EBITDA is expected to be between $3.3 billion and $4 billion, reflecting a year-over-year growth of 5% at the midpoint. This reflects a full year EBITDA margin in the range of 34% to 35% for the total company.	Transcript
ALB.N	2023-05-03T16:15:03Z	EBITDA			2023 Ketjen Outlook	Press Release
ALB.N	2022-05-05T09:00:00Z	EBITDA			So I would say that our long-term view, as we laid out last year in our Investor Day, was in the mid-40s for the lithium business at mid-cycle pricing, so through the cycle.	Transcript
ALB.N	2023-05-03T16:15:03Z	EBITDA			Adjusted EBITDA Margin((a)) 37% - 40% 34% - 35% FY 2023 Guidance FY 2023 Guidance	Press Release
ALB.N	2023-05-04T09:00:00Z	EBITDA			Adjusted EBITDA for Energy Storage is expected to be between $2.7 billion and $3.4 billion, essentially flat compared to 2022. Adjusted EBITDA is expected to be between $3.3 billion and $4 billion, reflecting a year-over-year growth of 5% at the midpoint. This reflects a full year EBITDA margin in the range of 34% to 35% for the total company.	Transcript
ALB.N	2023-05-04T09:00:00Z	EBITDA			Adjusted EBITDA for Energy Storage is expected to be between $2.7 billion and $3.4 billion, essentially flat compared to 2022. Adjusted EBITDA is expected to be between $3.3 billion and $4 billion, reflecting a year-over-year growth of 5% at the midpoint. This reflects a full year EBITDA margin in the range of 34% to 35% for the total company.	Transcript
NCLH.N	2023-05-01T10:00:00Z	EBITDA	1950000000	1800000000	Adjusted EBITDA is still expected to be in the range of $1.8 billion to $1.95 billion, with the high end of our targeted range, representing record adjusted EBITDA for the company.	Transcript
NCLH.N	2023-05-01T07:30:00Z	Revenue			5.0 to 6.5%, both on a constant currency basis and compared to 2019. realized earlier than anticipated. Based on initiatives already identified and versus 2019. Looking ahead, full year guidanceÂ remains unchanged at Net Per	Press Release
NCLH.N	2023-05-01T10:00:00Z	EBIT			New hardware introductions generate excitement from those new to cruise and new to brand as well as with our loyal pass guests.	Transcript
NCLH.N	2022-11-08T10:00:00Z	EBITDA			On our current trajectory, each of these building blocks are expected to lead to record net yields and record adjusted EBITDA for the full year 2023.	Transcript
UDR.N	2023-03-06T15:40:00Z	Revenue			So we do expect that to translate into more new lease growth, and that gives us the confidence that our blended rate growth will continue to grow throughout leasing season.	Transcript
UDR.N	2023-04-27T12:00:00Z	EBIT			We expect to improve our efficiency, expand our NOI margin and create value for all UDR shareholders and stakeholders.	Transcript
DGX.N	2023-04-27T08:30:00Z	Revenue	8880000000	8780000000	Base business revenues are expected to be between $8.78 billion and $8.88 billion, COVID-19 testing revenues are expected to be between $150 million and $200 million. We have raised our base business revenue guidance to reflect stronger base volume trends and the recent close of the Newyork-Presbyterian transaction.	Transcript
DGX.N	2023-04-27T08:30:00Z	Revenue			The Haystack acquisition actually modestly improves on that as well. We have lowered our COVID-19 revenue guidance which now assumes very modest COVID-19 revenue following the end of the public health emergency in May.	Transcript
DGX.N	2023-04-27T08:30:00Z	EBIT			Just on the margin side.	Transcript
CBOE.Z	2023-05-05T08:30:00Z	Revenue			We're pleased with the overall performance of the category and even more excited by the numerous catalysts we expect to accelerate growth over the course of this year.	Transcript
CBOE.Z	2023-02-15T08:35:00Z	Revenue			And market environment where both the SPX and VIX options are really finding great use.	Transcript
CBOE.Z	2022-02-04T08:30:00Z	EBITDA			We anticipate a potential revenue offset for more than half of the expense in 2022, with an expectation that the additions are EBITDA-positive on a combined basis in year 2. The company plans to further update its guidance for 2022 after the acquisitions close, which is expected in the first half of this year.	Transcript
ETSY.OQ	2023-03-23T13:30:00Z	Revenue			We haven't given any -- well, we haven't given any guidance for the full year of 2023, and we specifically haven't given any guidance beyond the -- what we guided to for take rate for Q1.	Transcript
ETSY.OQ	2022-08-09T13:15:00Z	EBITDA			And you might -- some of you might recall that in 2019, we had an Investor Day and gave long-term guidance, and we said at scale, over a 5-year period, we would be 30% or higher.	Transcript
HIG.N	2023-02-03T09:00:00Z	Revenue			We expect workers' compensation to remain a highly profitable business and an important earnings contributor to The Hartford.	Transcript
HIG.N	2023-04-28T09:00:00Z	EBIT			As a reminder, from a seasonality perspective, we tend to experience higher underlying loss costs in the first quarter, so we would expect the margins lower than our full year estimate. Core earnings in the first quarter of $90 million and the 5.2% core earnings margin reflect lower group life and disability loss ratios and growth in fully insured premiums. Turning to Group Benefits.	Transcript
HIG.N	2023-04-28T09:00:00Z	Revenue			We have strong momentum across Commercial Lines, and I expect continued topline growth at highly profitable margins.	Transcript
HIG.N	2023-02-03T09:00:00Z	Revenue			We expect workers' compensation to remain a highly profitable business and an important earnings contributor to The Hartford.	Transcript
HIG.N	2023-02-03T09:00:00Z	EBIT			In homeowners, we expect earned pricing to generally keep pace with loss cost trends throughout 2023. Loss cost trends, primarily driven by severity, are expected to remain elevated during the first half of the year before returning to more normal levels in the second half. Loss costs are expected to be up slightly as long-term frequency and severity selections remain unchanged from 2022.	Transcript
HIG.N	2023-02-03T09:00:00Z	EBIT			In homeowners, we expect earned pricing to generally keep pace with loss cost trends throughout 2023. Loss cost trends, primarily driven by severity, are expected to remain elevated during the first half of the year before returning to more normal levels in the second half. Loss costs are expected to be up slightly as long-term frequency and severity selections remain unchanged from 2022.	Transcript
HIG.N	2023-04-27T16:15:00Z	EBIT			confident in achieving our ROE target of 14 to 15 percent.â€	Press Release
HIG.N	2023-02-03T09:00:00Z	EBIT			And in group disability, we expect some moderation of recent favorable incidence and recovery trends. However, we expect mortality trends will settle above prepandemic levels, and we are pricing business accordingly.	Transcript
VRSK.OQ	2022-12-07T09:30:00Z	Revenue	2630000000	2590000000	About 1% to 2% from cross-sell and upsell to existing customers, and then about another 1% to 2% from new products and adjacencies into less penetrated markets still in the insurance vertical. So thank you for the question, and so a couple of ways to kind of -- to think about the components of that organic growth rate.	Transcript
VRSK.OQ	2023-05-03T08:30:00Z	Revenue	1420000000	1370000000	But the strategic benefit for us that I believe we're really at the early stages of realizing is that through associating data sets that are now in a cloud format, our ability to tie those data sets together, to develop workflow software that is able to integrate that, to deliver that in a micro services context or an EPA context to our clients and integrate into those features expands the scope by which we can create value from those data sets. I think we will lap some of that exceptional growth, and that will probably serve as a bit of an offset in the later part of 2023. Now we will also continue to expect to see our cloud expenses grow as we integrate new data sets as we develop new solutions. We saw broad-based growth across most of our businesses with strength in core underwriting, property estimating solutions, extreme events, antifraud, life insurance solutions and many of our international businesses.	Transcript
VRSK.OQ	2023-05-03T07:15:00Z	EBITDA			2023 Financial Guidance EBITDA margin in the 53%-54% range and adjusted EPS in the range of	Press Release
VRSK.OQ	2022-12-07T09:30:00Z	EBITDA			About half of it can be achieved by headcount-related actions that can include spans and layers and operating more efficiently. And then longer term, where should we -- how should we think about the margin for this business in sort of, let's say, 5 years' time? And then the final 25% comes from third-party spend, procurement efficiencies and real estate also in that bucket. And we are working through that. Another 1/4 of it comes from IT and tech-related spend, including some savings associated with our transition to the cloud. I think we said on our last earnings call that we have delivered actions. If you just change the track from growth to sort of margin now, you talked about 300 to 500 basis points of margin expansion, I think, by 2024. It can also include global optimization in where we hire and where we locate our talent that's both included in that 50%. So we think we have a good road to our target there. So what's left to be done? So yes, our margin targets of 300 to 500 basis points off of a 50% to 51% baseline, achieving those by 2024 is something that I am very committed to here as CFO. The timing of it being realized in our P&L will happen gradually from now through to 2024. We also gave some color on the buckets, the categories of spend action that we're looking there. We are almost halfway there. We've actioned over 50% of that.	Transcript
VRSK.OQ	2023-05-03T07:15:00Z	EBITDA			2023 Financial Guidance EBITDA margin in the 53%-54% range and adjusted EPS in the range of	Press Release
AMT.N	2023-02-23T08:30:00Z	Revenue	6970000000	6860000000	Finally, in Africa, we expect a solid acceleration off of 2022 with expected organic tenant billings growth of approximately 9%. This includes colocation and amendment contributions of around 6% along with escalators of around 10% and expected 450 basis point increase from 2022 levels.	Transcript
AMT.N	2023-02-23T08:30:00Z	Revenue			Finally, in Africa, we expect a solid acceleration off of 2022 with expected organic tenant billings growth of approximately 9%. This includes colocation and amendment contributions of around 6% along with escalators of around 10% and expected 450 basis point increase from 2022 levels.	Transcript
AMT.N	2023-04-26T07:00:01Z	Revenue			measure cannot be calculated without unreasonable effort.	Press Release
AMT.N	2023-05-22T14:30:00Z	Revenue			And we haven't seen the market recover to that level yet. So we're cautious in terms of where we view India going in the long term.	Transcript
AMT.N	2023-04-26T07:00:01Z	Revenue			measure cannot be calculated without unreasonable effort.	Press Release
AMT.N	2023-02-23T08:30:00Z	Revenue			Lastly, as I mentioned in my earlier remarks, we anticipate a modest FX headwind of just under 1.5% to consolidated growth. Moving on to the details of Slide 7. At the midpoint of our outlook, we expect total property revenues of nearly $10.8 billion, representing growth of approximately 3% or approximately 4% absent the incremental reserves assumed for VIL in 2023. We also expect data centers to contribute roughly $55 million of growth in cash revenue to the property segment in 2023. We are guiding to approximately 4% organic tenant billings growth in 2023, including churn of around 4%, which is around 70 basis points lower than the 2022 churn rate.	Transcript
AMT.N	2022-03-14T09:35:00Z	Revenue			And we're seeing outsized escalators in Latin America. Because of the way it's contracted, we'll have very little churn, if any at all. But certainly, the long-term gross demand is going to be there. But the Indian government has stepped up and really have been much more supportive to the wireless segment, the telecom segment than it has in the past. But this year, we're looking at 9%, so really attractive. But we are seeing exactly what we expected to see. But we're seeing solid levels of gross growth, elevated churn because of a few -- just a few instances of churn there. It allowed the carriers to delay their interest and penalty fees on what we refer to adjusted gross revenue case that was in Europe, which is essentially a tax on adjusted gross revenue that goes back over a 15-year period. So Europe is really strong for us. So it helps them really shore up their balance sheet. So it's really good assets to build. So that really reduces the overall churn rate in that market at a time when we are seeing increased growth rates there. So that took a $7 billion liability off of Voda and basically delayed it for 4 years. So that's kind of where Latin America looks. So the escalators are jumping up into the upper single-digit rates in Latin America. So they are in the process of really kind of figuring that out. So we do think that, that market is turning a corner and turning a corner fairly rapidly. So we have the continuation of some of the Nextel churn coming through in Brazil. So we think Europe is really well positioned for many years of solid demand. So we think India is on the verge of some really good things. So we're excited about Europe. That is also because of a moderation in churn. That's a similar level to what we built in 2021. That's slightly down below where it was in 2021, down off of, I think, it was just under 8% in 2021. The churn rates are coming down to 5% or so in India, and we still see solid organic gross growth up in that 5% range as well, maybe a touch north of that. The integration is well in hand, and the growth rates look really strong across Europe. Then bouncing over to Latin America, we're going to see organic tenant billings growth rates in 2022 better than 6%. There are new entrants in Germany and some good activity around 4G densification and 5G deployment. There is less churn in the European market. There's more demand for these sites. They'll come, and they will go. They're also monetizing some of their noncore assets, which again will further strengthen their balance sheet. They're going to turn that into equity for the government and not pay it out. We are building 3,500, 3,600 sites in India in 2022. We couldn't be more happy with the acquisition we had done and the way that it's performing. We do think that will moderate and step back a little bit, so back into that 6% to 7% range by the time we get out to 2023. We have Telefonica kind of working through their MVNO strategy with AT&T in Mexico, so that's kind of delayed things there slightly. We think that, that they will get sure footing on their balance sheet, and they'll continue to build as well. We're going to be in positive territory for organic billings growth there in India for the first time in many years. We're happy to see them come back into positive territory for us when churn rates come down. We're projecting between 2% and 3% of organic tenant billings growth. We're still very cautious in terms of what we're projecting there.	Transcript
AMT.N	2023-04-26T08:30:00Z	EBITDA			We are reiterating our adjusted EBITDA outlook with a decline of approximately $25 million related to the Mexico Fiber sale, offset by $25 million from positive impacts of FX.	Transcript
AMT.N	2022-03-14T09:35:00Z	Revenue			And we're seeing outsized escalators in Latin America. Because of the way it's contracted, we'll have very little churn, if any at all. But certainly, the long-term gross demand is going to be there. But the Indian government has stepped up and really have been much more supportive to the wireless segment, the telecom segment than it has in the past. But this year, we're looking at 9%, so really attractive. But we are seeing exactly what we expected to see. But we're seeing solid levels of gross growth, elevated churn because of a few -- just a few instances of churn there. It allowed the carriers to delay their interest and penalty fees on what we refer to adjusted gross revenue case that was in Europe, which is essentially a tax on adjusted gross revenue that goes back over a 15-year period. So Europe is really strong for us. So it helps them really shore up their balance sheet. So it's really good assets to build. So that really reduces the overall churn rate in that market at a time when we are seeing increased growth rates there. So that took a $7 billion liability off of Voda and basically delayed it for 4 years. So that's kind of where Latin America looks. So the escalators are jumping up into the upper single-digit rates in Latin America. So they are in the process of really kind of figuring that out. So we do think that, that market is turning a corner and turning a corner fairly rapidly. So we have the continuation of some of the Nextel churn coming through in Brazil. So we think Europe is really well positioned for many years of solid demand. So we think India is on the verge of some really good things. So we're excited about Europe. That is also because of a moderation in churn. That's a similar level to what we built in 2021. That's slightly down below where it was in 2021, down off of, I think, it was just under 8% in 2021. The churn rates are coming down to 5% or so in India, and we still see solid organic gross growth up in that 5% range as well, maybe a touch north of that. The integration is well in hand, and the growth rates look really strong across Europe. Then bouncing over to Latin America, we're going to see organic tenant billings growth rates in 2022 better than 6%. There are new entrants in Germany and some good activity around 4G densification and 5G deployment. There is less churn in the European market. There's more demand for these sites. They'll come, and they will go. They're also monetizing some of their noncore assets, which again will further strengthen their balance sheet. They're going to turn that into equity for the government and not pay it out. We are building 3,500, 3,600 sites in India in 2022. We couldn't be more happy with the acquisition we had done and the way that it's performing. We do think that will moderate and step back a little bit, so back into that 6% to 7% range by the time we get out to 2023. We have Telefonica kind of working through their MVNO strategy with AT&T in Mexico, so that's kind of delayed things there slightly. We think that, that they will get sure footing on their balance sheet, and they'll continue to build as well. We're going to be in positive territory for organic billings growth there in India for the first time in many years. We're happy to see them come back into positive territory for us when churn rates come down. We're projecting between 2% and 3% of organic tenant billings growth. We're still very cautious in terms of what we're projecting there.	Transcript
AMT.N	2023-02-23T08:30:00Z	Revenue			Lastly, as I mentioned in my earlier remarks, we anticipate a modest FX headwind of just under 1.5% to consolidated growth. Moving on to the details of Slide 7. At the midpoint of our outlook, we expect total property revenues of nearly $10.8 billion, representing growth of approximately 3% or approximately 4% absent the incremental reserves assumed for VIL in 2023. We also expect data centers to contribute roughly $55 million of growth in cash revenue to the property segment in 2023. We are guiding to approximately 4% organic tenant billings growth in 2023, including churn of around 4%, which is around 70 basis points lower than the 2022 churn rate.	Transcript
AMT.N	2023-01-04T11:30:00Z	Revenue			And we have good visibility in terms of where they are in their own life cycles, what kinds of renewals we would expect. But right now, the carriers are really supporting that fixed wireless component element value proposition with additional infrastructure on our sites. I think if you're thinking about the opportunity at the edge, I still think that's a few years away. In the meantime, we're able to enjoy the kind of that interconnection cloud on-ramp rich marketplace. We're really looking to leverage the kind of that interconnection capability to really drive more value at that tower site that I talked about before that we have that exclusive right to be able to utilize. When we think about the data center business or why -- first of all, I think it's just a great infrastructure class.	Transcript
PYPL.OQ	2023-05-08T17:00:00Z	Revenue			First of all, obviously, we had a real strong start to the year. It was stronger than our expectations, but we just missed around 11% FXN revenue growth at 10.4%. It's still 150 basis points better than our expectations on that.	Transcript
PYPL.OQ	2023-05-16T10:00:00Z	EBIT			And our -- the growth of our unbranded business is what's going to help do that and the unbranded business is going to become a much higher margin business. And so the question we had earlier around is there an opportunity for you to continue to have attractive growth rates on the branded business? Go win that processing business because it is going to enable us to have a much more valuable branded business.	Transcript
PYPL.OQ	2023-03-02T15:30:00Z	EBIT			And so as we show strong performance in the book, we will have opportunity potentially to manage this program. And so our operating margin will be slightly impaired by virtue of running this program. But the discount will come through on our operating income.	Transcript
CAG.N	2023-04-05T09:30:00Z	EBIT			We expect adjusted operating margin of 15.5% to 15.6%, and we're increasing our expectations for adjusted EPS growth to range from $2.70 to $2.75.	Transcript
CAG.N	2022-10-06T09:30:00Z	Revenue			But we were very clear that we expect SG&A to be up greater than our sales growth for the full fiscal year '23. So we expect A&P to ramp up year to go. So we had given guidance that we expect A&P will grow above our organic net sales for the full year. We expect A&P will ramp up year to go.	Transcript
CAG.N	2022-07-14T09:30:00Z	EBIT			As I already noted, we expect our Refrigerated & Frozen and International segments to deliver operating margin improvement as fiscal '23 progresses. As Sean mentioned earlier, we expect to see operating margins expand in both our Refrigerated & Frozen and International segments in fiscal '23, as pricing actions catch up to the recent inflation.	Transcript
CAG.N	2022-07-14T09:30:00Z	EBIT			As I already noted, we expect our Refrigerated & Frozen and International segments to deliver operating margin improvement as fiscal '23 progresses. As Sean mentioned earlier, we expect to see operating margins expand in both our Refrigerated & Frozen and International segments in fiscal '23, as pricing actions catch up to the recent inflation.	Transcript
UHS.N	2023-02-28T09:00:00Z	Revenue	14314000000	14044000000	But those are the headwinds, I think, specifically on the acute side of the business that mainly sort of tend to suppress the margins.	Transcript
UHS.N	2023-04-26T09:00:00Z	Revenue	1753310000	1662050000	So if we see some moderation, it is certainly something that's been anticipated in our guidance.	Transcript
UHS.N	2023-02-28T09:00:00Z	EBITDA			But probably, at the end of the day, the 2023 forecast assumes slightly increased margins in the behavioral business.	Transcript
UHS.N	2023-04-26T09:00:00Z	EBIT			But generally, we were pleased with the first quarter results. Obviously, in this case, it would have been for better has there been any change. So as is our practice, we didn't address guidance in our press release, which means that we're maintaining our existing guidance.	Transcript
UHS.N	2023-02-27T16:16:08Z	EBITDA			2023 Operating Results Forecast: to $1.753 billion, as compared to our 2022 Adjusted EBITDA net of NCI of	Press Release
TFX.N	2023-05-04T08:00:00Z	Revenue	2975327220	2940207680	Considering the revised foreign exchange headwind, we expect reported revenue growth of 4.65% to 5.9% in 2023, implying a dollar range of $2.921 billion to $2.956 billion. Looking forward, we would expect growth in China to accelerate during the remainder of 2023. Of note, we maintained our pricing discipline in the first quarter and continue to expect at least 50 basis points of positive price year-over-year in 2023. We continue to expect all MSA revenues to cease at the end of 2023, implying no MSA revenue in 2024.	Transcript
TFX.N	2023-05-04T08:00:00Z	Revenue			Considering the revised foreign exchange headwind, we expect reported revenue growth of 4.65% to 5.9% in 2023, implying a dollar range of $2.921 billion to $2.956 billion. Looking forward, we would expect growth in China to accelerate during the remainder of 2023. Of note, we maintained our pricing discipline in the first quarter and continue to expect at least 50 basis points of positive price year-over-year in 2023. We continue to expect all MSA revenues to cease at the end of 2023, implying no MSA revenue in 2024.	Transcript
TFX.N	2023-03-07T13:40:00Z	EBIT			Our combination of growth drivers and diversified portfolio will help to provide consistency in growth while our continued focus on margin expansion and our revenue base will drive attractive free cash flow generation. We are confident that there are several levers to pull that will enhance our margins. We will continue to achieve margin and earning expansion. We will drive durable constant currency revenue growth, achieve margins and earning expansion, optimize our product portfolio and advance corporate social responsibility and an inclusive culture.	Transcript
TFX.N	2023-05-04T08:00:00Z	EBIT			All other elements of our adjusted financial guidance for 2023 remain unchanged, including our outlook for adjusted gross and operating margins.	Transcript
SYF.N	2023-02-14T16:05:00Z	Revenue			And I think the other thing, Moshe, I bring you to a back to some of the early guidance back in '14 and '15, we kind of said it was going to be 4.25% to 4.5%. Could you talk a little bit about the development of the RSA in this kind of path? Just talk about that here in the protection that affords for Synchrony?	Transcript
WAT.N	2023-05-16T16:15:01Z	Revenue	3194852700	3135413580	$1.8 billion total addressable market and 10-12% projected annual growth(i). growth and margin profile. Additionally, Waters expects to generate over $70	Press Release
WAT.N	2023-05-09T06:50:04Z	EBIT	967372000	945082000	Dr. Batra continued, "The acceleration of our growth strategy remains on	Press Release
WAT.N	2022-03-09T14:10:00Z	EBIT			And up to '23 -- 2022, '23, '24, maybe '24, you start to see early stages of turnaround. And we expect then these initiatives to pay back in that time frame, right? I'm going to do a quick one on margins. It again depends on, Dan, how quickly some of these things get traction. It's not a ton, but it's good enough to sort of get these initiatives started. Like when do you show that leverage? On the investment time horizon, we see over the next 2 to 3 years, significant investment, which is about -- in this case, if you do 50 basis points, it's for $15 million, $17 million. So I guess, how much -- how long do these reinvestments occur for? So if I were to compare apples-to-apples, yes, you should see margin expansion in 2025, '26, that time frame. So just one on margins. So you talked about 5% top line gets you north of 50 basis points, 50, 55 on operating margin, but you're investing. So you're showing less than that today.	Transcript
INCY.OQ	2023-05-10T13:40:00Z	Revenue			Can you talk about where you think the remaining legs of growth are either by indication or just by opportunity dollar-wise for upside from relative trends this year? We always provide a range of around $100 million between the low and the high end, especially earlier in the year.	Transcript
LRCX.OQ	2023-04-19T17:00:00Z	Revenue			And we will start recognizing revenues for these products in calendar 2023.	Transcript
IDXX.OQ	2023-03-02T10:00:00Z	Revenue	3700000000	3615000000	So I think that's reflected for the macro.	Transcript
IDXX.OQ	2023-05-02T08:30:00Z	Revenue	1091500000	1048350000	We're refining our full year outlook to incorporate our solid Q1 operating results and updated estimates for foreign exchange impacts.	Transcript
IDXX.OQ	2023-05-02T08:30:00Z	EBIT			This includes approximately 280 basis points in combined benefit from the $16 million Q1 customer contract resolution payment and the lapping of $80 million of discrete R&D investment in the second quarter of 2022.	Transcript
IDXX.OQ	2022-02-02T08:30:00Z	Revenue			We're well positioned to build on this strong financial performance in 2022.	Transcript
PPG.N	2023-04-21T08:00:00Z	Revenue			So as Tim pointed, there's a few factors that we're considering in the volumes forecast that's in the guide. Tim, just curious, in terms of the second half with the 10% EPS growth, I apologize if I missed this, but what do you expect for volumes?	Transcript
LKQ.OQ	2023-02-23T08:00:00Z	Revenue			Looking at Slide 7 in the presentation, you can see how we get from the 2022 actual EPS to our 2023 guidance. Operating performance is expected to generate growth of $0.24 relative to the 2022 results, mostly related to wholesale North America from volume growth in Europe due to margin improvement. We do expect a continuation of challenging conditions for specialty from softening demand for RV-related products and self-service related to commodity prices and input cost inflation.	Transcript
LKQ.OQ	2023-04-27T08:00:00Z	Revenue			We expect to see further declines in the RV market as recent industry reports project that full year 2023 wholesale shipments will be down about 34% year-over-year. We still expect reported organic parts and service revenue in the range of 6% to 8%, organic growth of 7.9% in Q1 includes an extra selling day in Europe, which we will give up in the balance of the year in addition to 1 fewer selling day in North America and Specialty in Q3.	Transcript
LKQ.OQ	2023-04-27T08:00:00Z	EBITDA			We remain optimistic about our previously disclosed expectation for full year margin expansion of 20 to 30 basis points in 2023. While we believe there will be some moderation in segment EBITDA margin in upcoming quarters as the benefits of the 2022 price increases fall away, the strong start to 2023 has improved our margin outlook to be in the 18s for the year.	Transcript
LKQ.OQ	2023-02-23T08:00:00Z	EBIT			I want to commend the Europe team for achieving this result despite the onset of the war on the Ukraine and significant macroeconomic headwinds and we are optimistic about incremental margin expansion of 20 to 30 basis points in 2023.	Transcript
LKQ.OQ	2023-02-23T08:00:00Z	EBITDA			As mentioned in prior quarters, we believe there will likely be some moderation in segment EBITDA margin in upcoming quarters as the benefits of the 2022 price increases fall away with the resulting EBITDA margin expected to be in the high 17%, low [18%] range for 2023.	Transcript
HES.N	2022-01-06T12:00:00Z	Revenue			And John, Liza 2, you had said you expected by the end of the first quarter, that still feel sounds like it's on track. And then Yellowtail, which is probably going to be a ship in the range of 250,000 barrels a day capacity, so it's going to be a bigger ship, bigger capital investment, but also a bigger resource and have returns, quite frankly, that are probably one of the best in the business compared to shale or compared to offshore. Payara, which is really Phase 3, that's on track for a 220,000 barrel a day ship. Remember, that ship is a 220,000 barrel a day capacity ship gross. So pretty meaningful. That's on track for oil in 2024. That's on track. Whole built top sites construction underway in Singapore.	Transcript
EOG.N	2023-02-23T16:15:10Z	Revenue			Guidance Range Guidance Range Midpoint Actual Actual Actual	Press Release
MAR.OQ	2023-05-02T07:00:23Z	Revenue	4540000000	4360000000	Owned, leased, and other revenue, net of direct expenses Approx. $80 $300 to $310	Press Release
MAR.OQ	2023-05-02T07:00:23Z	EBITDA			ADJUSTED EBITDA FORECAST	Press Release
TJX.N	2023-05-17T11:00:00Z	Revenue	53200000000	52700000000	As a reminder, our comp guidance will exclude expected sales from the 53rd week.	Transcript
TJX.N	2022-05-18T07:30:00Z	EBIT			traffic and sales. We remain focused on our long-term vision to become an	Press Release
MNST.OQ	2023-05-04T17:00:00Z	Revenue			April 2023 had 1 less selling day compared to April 2022. We estimate April 2023 sales, including the Alcohol Brand segment, to be approximately 7.2% higher than in April 2022 and 5.1% higher than in April 2022, excluding the Alcohol Brand segment. We estimate that on a foreign currency adjusted basis, including the Alcohol Brand segment, April 2023 sales were approximately 9.9% higher than the comparable April '22 sales and 7.9% higher than April 2022, excluding the Alcohol Brand segment.	Transcript
VMC.N	2023-02-16T11:00:00Z	Revenue	1950000000	1850000000	Considering these dynamics, we currently expect our Aggregates shipments to decline between 2% and 6% in 2023.	Transcript
VMC.N	2023-05-04T11:00:00Z	Revenue			How we should think about the flow through, especially with IIJA projects?	Transcript
VMC.N	2023-02-16T07:30:05Z	EBIT			our aggregates unit profitability and earnings growth in 2023."	Press Release
VMC.N	2023-05-04T11:00:00Z	EBITDA			On the heels of a strong 2022, in which adjusted EBITDA improved by 12%, we now expect to exceed that growth in 2023 with 14% to 20% improvement. Tom shared with you our increased adjusted EBITDA outlook for 2023. We got off to a solid start in the first quarter and now expect to deliver between $1.85 billion and $1.95 billion in adjusted EBITDA this year, a 14% to 20% improvement versus the prior year.	Transcript
EW.N	2023-04-26T17:00:00Z	Revenue	6000000000	6000000000	We now expect high single-digit underlying growth in 2023, driven by the adoption of our most advanced technologies and an increase in the overall heart valve surgeries.	Transcript
EW.N	2022-01-26T17:00:00Z	Revenue	1800000000	1680000000	We remain confident in this large global opportunity will double to $10 billion by 2028, which implies a compounded annual growth rate in the low double-digit range.	Transcript
EW.N	2022-12-08T08:01:03Z	EBIT			Adjusted Operating Margin ~30% -- Amount Underlying Growth Rate	Press Release
SBNY.OQ^C23	2023-01-17T08:00:00Z	Revenue			It would be difficult for us to expand our loans. Those are two newer business lines for us that we want to continue to see have growth and garner market share and market favor.	Transcript
FRC.N^E23	2023-01-13T10:00:00Z	Revenue			We continue to expect to deliver mid-teens loan growth for 2023. We will continue to deliver exceptional client service, grow new households and provide safe growth in 2023 and beyond.	Transcript
ALL.N	2023-05-18T08:19:00Z	Revenue			â€œAllstate continued to implement significant auto insurance rate actions as	Press Release
ALL.N	2023-02-02T09:00:00Z	EBIT			We expect to continue to pursue significant rate increases into 2023 to improve auto insurance margins to target levels.	Transcript
BMY.N	2022-02-04T06:59:00Z	Revenue	47082180000	47082180000	CAGR for our Continuing Business( )at constant exchange rates	Press Release
BMY.N	2023-01-09T10:30:00Z	Revenue			Second, with the line extensions for this new product portfolio that have already read out, we have significantly derisked the $25-plus billion in non-risk-adjusted long-term potential that we see for this portfolio.	Transcript
BMY.N	2022-01-10T07:30:00Z	EBIT			And we expect this portfolio of in-line growth drivers and new products will enable us to more than offset the impact of LOEs, grow our top line through 2025 and remain very profitable with operating margins in the low to mid-40s. Firstly, let's look at the outlook through 2025 on the left-hand side. I want to reiterate my confidence in our ability to grow through the Revlimid LOE, and this is driven by the exciting opportunity that we have to transform and strengthen our company with what we're calling our Continuing Business. Now secondly, looking to the post-Revlimid period on the right-hand side, as I told you in November, I expect '29 sales to be higher than 2025. Of course, on top of what we already have in-house today, our financial strength provides additional growth optionality through capacity for continued disciplined business development. We will continue to execute commercially and advance our pipeline, and we see multiple pathways to growth during this time frame.	Transcript
BMY.N	2022-02-04T06:59:00Z	EBIT			* Expects to maintain low- to mid-40s percent non-GAAP operating margin Reaffirms Long-Term Financial Targets long-term targets:	Press Release
APH.N	2023-01-25T13:00:00Z	Revenue			Based just down the street from us here in Meriden, Connecticut, RFS is a provider of interconnect and antenna products for the mobile networks market with expected sales of approximately $100 million in 2023. In addition, we're pleased to have signed an agreement for the acquisition of the North American hybrid and fiber optic cable and cable assembly as well as the global infrastructure antenna business of RFS at the end of the fourth quarter. This acquisition, which we anticipate will close by the end of the second quarter and thus is not included in our guidance, expands Amphenol's product offering and presence with mobile network service providers who are continuing to invest in their next-generation 5G networks.	Transcript
APH.N	2022-10-26T13:00:00Z	EBIT			And kind of with that, does the guided drop in Q4 operating margins really just reflect the volume deleverage into the fourth quarter? I know at least a part of that is price cost catch-up. I'm not going to necessarily kind of guide here to '23 in terms of operating margins, but what I could tell you is I do feel good about, again, as I said before, the overall performance of the team in being able to ultimately drive our incrementals at that 25% plus kind of operating leverage that we talk about and then ultimately, also being able to protect the bottom line, if the case may be that demand does drop in certain areas. So margins have realized a pretty nice sequential improvement both over the last 2 quarters. What is the expectation on price cost into Q4 and early 2023 to the extent you have visibility on price in the backlog and where inventory costs are running at?	Transcript
HON.OQ	2023-02-22T08:00:00Z	Revenue	37300000000	36500000000	And so the next thing for us is capital deployment. Half of that went into share repurchase, and we hope to push more of that into M&A. So we're going to keep executing on the organic side operationally and then now pivot more from a capital deployment standpoint. We did $8 billion of that last year. We promised $25 billion over 3 years.	Transcript
HON.OQ	2023-04-27T08:30:00Z	EBITDA	8429800000	8139500000	I'm excited about the new technologies and adjacencies we have unlocked through this latest transaction.	Transcript
HON.OQ	2023-04-27T08:30:00Z	Revenue			Given the positive signs from the supply chain and continued strength in our order book, we now expect Aero organic sales growth in the low double-digit range, an upgrade from our outlook last quarter of high single digits to low double-digit growth.	Transcript
HON.OQ	2023-04-27T08:30:00Z	Revenue			In Defense & Space, we passed the growth inflection point in 1Q, and we expect similar organic growth rates throughout the year as we convert our strong defense order book into sales. Looking ahead for Aerospace, demand across our end markets remain very encouraging. Now let's take a moment to walk through the second quarter and full year expectations by segment. Our expectation for the supply chain remains unchanged, modest, steady improvement each quarter. We expect modest sequential sales growth in the second quarter as flight hours continue to improve with particular strength in commercial aftermarket.	Transcript
HON.OQ	2023-04-27T08:30:00Z	EBIT			We now expect Aero segment margins to be flattish for the full year.	Transcript
HON.OQ	2023-02-02T08:30:00Z	EBIT			As you can see, segment profit will be the key driver of our earnings growth in '23, contributing $0.59 at the midpoint of our guidance range.	Transcript
HON.OQ	2023-04-27T08:30:00Z	EBIT			For full year 2023, we're upgrading our segment expectations -- our segment margin expectations by 10 basis points on the low end to a new range of 22.3% to 22.6% or 60 to 90 basis points of year-over-year expansion. So in total, we executed a strong first quarter with outperformance across all guided metrics and are raising our full year 2023 organic sales growth, segment margin and adjusted EPS guidance ranges.	Transcript
HON.OQ	2023-04-27T08:30:00Z	EBIT			We now expect Aero segment margins to be flattish for the full year.	Transcript
GPC.N	2022-11-01T13:00:00Z	Revenue	23421731380	22979811920	And if you look at NAPA, GPC over the last decade, our CAGR is somewhere in the 6% to 8% range.	Transcript
GPC.N	2023-04-20T11:00:00Z	EBIT			But we were not expecting margin declines in either segment for the year.	Transcript
GPC.N	2023-04-20T06:55:03Z	EBIT			"We are pleased with the solid start to 2023 and continue to expect another strong year of profitable growth. Our updated outlook for the full year	Press Release
MHK.N	2023-02-09T16:10:00Z	Revenue			increased. We are increasing our insulation sales and distribution in the U.K.	Press Release
MHK.N	2022-02-10T16:10:00Z	Revenue			profitability.â€	Press Release
MHK.N	2022-02-11T11:00:00Z	EBIT			And then with all that, we see the -- we think we're probably in the mid-cycle part of it. So it seems like there's plenty of room to grow. So we think we're in the right position for higher growth and margin expansion over the next few years. The residential markets are running at high rates, and what normally have when you get towards the cycle that -- we've overbuilt the residential housing. This time, we're still chasing it. Usually, the economy, and the industry, keep growing as we start raising rates at this point. We believe there are going to be more acquisition opportunities. We think there's more going to come into the marketplace over the next year or 2. We're well positioned with our balance sheet to take advantage of those. We'll have to see how they evolve. We're talking to several at the moment. We've talked about the commercial improving. You hear us continuing to invest in leading technologies to give us differentiation to improve the margins.	Transcript
MCHP.OQ	2023-03-07T09:50:00Z	Revenue			We're growing revenue organically at 10% to 15% per year.	Transcript
MCHP.OQ	2023-06-01T14:35:00Z	Revenue			And so we're pretty excited about what we can bring. Can you walk through what are the growth compositions of this versus your legacy business? These are energy preserving or gas house reduction type of tools or better and more energy-efficient tools. Unless there's a question in the audience, we will shift gears a little bit.	Transcript
MCHP.OQ	2022-08-02T17:00:00Z	EBIT			Our long-term operating expense model will continue to guide our investment actions to drive the long-term growth and profitability of our business.	Transcript
MCHP.OQ	2023-03-07T09:50:00Z	EBIT			Operating margin is a very similar story that our long-term non-GAAP target is about 45%.	Transcript
CAT.N	2023-01-31T08:30:00Z	Revenue			In Energy & Transportation, we expect sales growth due to strong order rates in most applications. We do expect service sales momentum to continue after reaching $22 billion in 2022.	Transcript
CAT.N	2023-04-27T08:30:00Z	Revenue			As I mentioned, we expect a strong top line for 2023, supported by price and higher sales to users, with healthy underlying end markets.	Transcript
CAT.N	2023-01-31T08:30:00Z	Revenue			In Energy & Transportation, we expect sales growth due to strong order rates in most applications. We do expect service sales momentum to continue after reaching $22 billion in 2022.	Transcript
CAT.N	2022-06-01T11:00:00Z	EBIT			Again, what we talk about is those adjusted operating profit margin targets, 300 to 600 basis points based on that reference period of 2010 to 2016. And the way we look at this is, we really don't talk about incremental margins quarter-to-quarter or year-to-year. Do you think you're going to be able to capture enough pricing this year to get you back to -- back on track to hitting your targets as we go into 2023? Having said that, we also, again, we see that our total addressable market is increasing. Okay. Our total addressable market is increasing, we'll maintain our margins, meet those margin targets, which should -- which will increase -- should increase our free cash flow (inaudible) to the top line. So at the Analyst Day a few weeks ago, you gave a guidance that implied incremental margins like the 30% to 40% range. So what we believe we will meet those targets this year, and we fully intend to meet them moving forward. We know we have to make increased investments in some products, but we believe, based on everything we see, again our intent is to invest more.	Transcript
CAT.N	2023-01-31T08:30:00Z	EBIT			We've updated our margin target scope to account for the impact of inflation on sales and costs, and we expect our 2023 adjusted operating margins to be within our updated range.	Transcript
PG.N	2023-04-21T08:30:00Z	Revenue	80988870000	80988870000	I would expect some level of negativity in terms of overall market volumes but certainly improving sequentially.	Transcript
ZTS.N	2023-05-04T08:30:00Z	Revenue	8725000000	8575000000	First, the new manufacturing facility in Georgia, is the investment based predominantly on increased forecast for current products or positive late-stage R&D progress for which we, at least on the outside, currently don't have visibility? Foreign exchange rates have been volatile over the quarter. Note that guidance reflects foreign exchange rates as of late April. Now moving on to guidance for the full year 2023. We'll give you more details, which we've been asked for around the pain opportunity and what we're expecting there.	Transcript
ZTS.N	2022-06-01T16:10:00Z	Revenue			But DRAXXIN, we expected about 20% impact in the first year and 20% in the second year. Or is there some innovation that's going to come out from Zoetis that helps the company recapture those normalized growth rates to mid-single digits as early as next year? We did a little bit better than what we thought in the first year, but we continue to track as we go into our second year here. We expected coming into the competitive situation for generic DRAXXIN and to some extent, Zoamix.	Transcript
STE.N			5354466120	5304887730		
BKR.OQ	2023-01-23T08:30:00Z	EBITDA	26000000000	24000000000	It sounds high. So just some additional color on that, that free cash conversion rate. We also saw cash consumption from inventory build in OFSE and gas tech equipment as we prepare for growth in '23.	Transcript
BKR.OQ	2023-01-23T08:30:00Z	EBITDA	3800000000	3600000000	Given this macro backdrop, we would expect OFSE revenue between $14.5 billion and $15.5 billion and EBITDA between $2.4 billion and $2.8 billion in 2023.	Transcript
BKR.OQ	2023-01-23T08:30:00Z	Revenue			Given this macro backdrop, we would expect OFSE revenue between $14.5 billion and $15.5 billion and EBITDA between $2.4 billion and $2.8 billion in 2023. The major factors driving this revenue range will be the pace of backlog conversion for gas tech equipment, growth in industrial tech driven by improving supply chain dynamics and the impact of any continued deferrals in maintenance activity or supply chain delays at gas tech services.	Transcript
BKR.OQ	2023-01-23T08:30:00Z	Revenue			Given this macro backdrop, we would expect OFSE revenue between $14.5 billion and $15.5 billion and EBITDA between $2.4 billion and $2.8 billion in 2023. The major factors driving this revenue range will be the pace of backlog conversion for gas tech equipment, growth in industrial tech driven by improving supply chain dynamics and the impact of any continued deferrals in maintenance activity or supply chain delays at gas tech services.	Transcript
BKR.OQ	2022-10-19T08:30:00Z	EBITDA			You announced this power gen acquisition from BRUSH.	Transcript
BKR.OQ	2022-10-19T08:30:00Z	EBIT			Importantly, a key driver of margin enhancement has been the continued improvement in our production chemicals business. This will be partially offset by expected declines across all our industrial businesses due to likely global economic weakness.	Transcript
BKR.OQ	2022-10-19T08:30:00Z	EBIT			Importantly, a key driver of margin enhancement has been the continued improvement in our production chemicals business. This will be partially offset by expected declines across all our industrial businesses due to likely global economic weakness.	Transcript
BKR.OQ	2022-10-19T08:30:00Z	EBIT			Importantly, a key driver of margin enhancement has been the continued improvement in our production chemicals business. This will be partially offset by expected declines across all our industrial businesses due to likely global economic weakness.	Transcript
BKR.OQ	2022-10-19T08:30:00Z	EBIT			Importantly, a key driver of margin enhancement has been the continued improvement in our production chemicals business. This will be partially offset by expected declines across all our industrial businesses due to likely global economic weakness.	Transcript
AFL.N	2023-02-14T09:40:00Z	Revenue			As a result, we expect sales in 2023 to be driven by the continued rollout of cancer insurance at Japan Post in April and then later, an introduction of the revised medical product.	Transcript
CPB.N	2022-06-15T04:30:00Z	Revenue	9418200000	9289770000	Again, I think most of the elements that we talked about at Investor Day were the things that I felt were areas that we had a lot of control over, right? Exactly where can you get to? Great. I think we've got about 3 minutes left. No. I mean not really. Yes or no?	Transcript
CPB.N	2023-03-14T13:00:00Z	Revenue	1381310000	1355370000	And then just on the consumer, some of the pressure that we've been hearing about, are you seeing any consumers that you wouldn't have seen otherwise? Any signs that the consumer is feeling that pinch and moving into the soup category? That's why again, I don't ever want to lose share, but if the soup category continues to grow mid- to high single digits, and we may be pressured at over 50% of the category, even if we're pressured a little bit on share, the net of that is still a pretty strong positive for the company.	Transcript
CPB.N	2022-06-15T04:30:00Z	EBIT			I don't know when that cloud is going to roll off.	Transcript
CPB.N	2023-03-08T07:15:00Z	EBIT			The full-year fiscal 2023 guidance is set forth in the table below:	Press Release
PTC.OQ	2023-04-26T16:01:06Z	Revenue	2140000000	2080000000	appropriately, balancing our momentum and outlook with macroeconomic	Press Release
PTC.OQ	2023-05-22T10:00:00Z	Revenue			Exactly how fast we've taken a fairly conservative view, so as to not get ahead of ourselves, but it should definitely be a growth driver that would either lift the growth rate of the company or offset other factors, macro or otherwise that might be slowing us down. Now a lot of times the new logo win is small and then expands from there. Obviously, the SaaS transition is one of those. Obviously, we've been through an inflationary period here where we could get away with quite aggressive price increases and people expected that actually.	Transcript
PTC.OQ	2019-02-12T16:20:00Z	EBIT			So I did that math exercise to help you understand that those goals, while incredibly attractive, aren't actually as hard as they sound.	Transcript
PTC.OQ	2022-11-02T17:00:00Z	EBIT			We expect the ongoing effect of these profitability initiatives to lead the further cash contribution margin expansion in fiscal '23.	Transcript
FITB.OQ	2023-05-22T09:00:01Z	Revenue	9062280000	8894460000	and full range of payment types. The business is growing at double digits and businesses. the annual revenue is projected to eclipse $130 million this year,	Press Release
FITB.OQ	2023-03-08T08:00:00Z	Revenue			From a balance sheet perspective, everything is exactly as advertised in terms of the guide, loans. Revenue, we're comfortable with the guide, reaffirmed the revenue guide.	Transcript
MSI.N	2023-05-04T17:00:00Z	Revenue	9775000000	9725000000	And as Jack mentioned, that growth will be even better in some of our power verticals, which represent over half of the composition of the revenue. And as markets move, we're positioned extremely well. For the full year, we are increasing both our revenue and EPS guidance. The revenue guidance reflects expectations for strong double-digit growth in the first half as well as continued growth in the second half of the year, which comes on top of the 15% growth we saw in the second half of last year.	Transcript
MSI.N	2023-05-22T08:40:00Z	Revenue			Now what we see sometimes is we're able to achieve supply better than the lead times.	Transcript
MSI.N	2023-05-04T16:10:00Z	Revenue			billion, and non-GAAP EPS of between $11.21 and $11.29 per share, up from its	Press Release
MSI.N	2023-02-09T17:00:00Z	EBIT			In terms of leverage, we saw the leverage that we expected in the second half of 2022 on the operating line, and we expect continued operating margin expansion in '23.	Transcript
MSI.N	2023-05-04T17:00:00Z	EBIT			For the full year, we expect operating margins in this segment to be comparable to last year to slightly down, driven by higher costs from acquisitions, primarily rate.	Transcript
XEL.OQ	2023-04-27T10:00:00Z	Revenue			We continue to expect annual electric sales growth of approximately 1% in 2023, driven by C&I sales, while we expect residential sales to be down slightly for the year.	Transcript
HSIC.OQ	2023-05-10T16:40:00Z	Revenue	13026410000	12773470000	And so there's still a large kind of unmet market that we think might be -- this price point is becoming a little more attractive as some of these other -- as medic -- as some of these others come in. You just don't see it in revenue -- in terms of revenue growth.	Transcript
HSIC.OQ	2023-05-09T10:00:00Z	EBIT	983360000	948240000	We expect lower non-GAAP operating margin of 10 to 15 basis points below the 2022 non-GAAP operating margin of 8.2% and this was largely a result of lower PPE products and COVID-19 test kit sales and profits.	Transcript
HSIC.OQ	2023-01-11T12:00:00Z	EBIT			And then looking into 2023, what's your framework for driving margin expansion? I think you're aware of our global e-commerce platform, which will be launching a pilot event in the U.K. in the early part of this year and then in the U.S. in the later part of this year in '23.	Transcript
ITW.N	2023-02-22T10:30:00Z	Revenue	16569280000	16250640000	We extrapolate into the year.	Transcript
ITW.N	2023-05-02T10:00:00Z	Revenue	4204853100	3961890100	So, you mentioned sequentially, you expect automotive margins to get better from here on.	Transcript
ITW.N	2023-02-22T10:30:00Z	EBIT			When it was 31% kind of before... You deliver organic growth at 35% to 40% incrementals, you can't help but continue to improve your margins.	Transcript
ITW.N	2023-05-02T08:00:01Z	EBIT			1.5 to 3.5 percent. Operating margin is projected to be in the range of 24.5	Press Release
GPS.N	2022-08-25T17:00:00Z	Revenue	15303680000	14835200000	That said, we continue to see a path towards delivering a mid-teens revenue CAGR over the long term as we capitalize on the continued secular shift and growth in the health and wellness categories broadly. We are quickly pivoting and reacting to meet her needs with performance lifestyle products while remaining true to our DNA.	Transcript
GPS.N	2023-05-25T16:15:07Z	EBIT			Fiscal 2023 Outlook consumer environment," said Katrina O'Connell, Executive Vice President and positioned to drive continued margin expansion and improved cash flow relative	Press Release
GPS.N	2022-05-26T17:00:00Z	EBIT			I guess just maybe putting together all the headwinds, can you quantify what you see as sort of transitory this year, whether it be airfreight or some of the Old Navy issue specifically, any incremental actions you're taking at SG&A?	Transcript
WST.N	2022-10-27T06:00:11Z	Revenue	2990000000	2965000000	Biologics market unit, to exceed our financial construct of 7% to 9% annual Mr. Green concluded, "We project our full-year 2023 base business, led by our	Press Release
WST.N	2023-04-27T09:00:00Z	Revenue	710400000	675050000	Net sales guidance also includes a reduction of $8 million, resulting from an expected divestiture of a European facility that produced standard Proprietary Product components. There are some key elements I want to bring your attention to as you review our guidance. There is an estimated full year 2023 tailwind of $15 million based on current foreign exchange rates compared to prior guidance of the 2023 headwind of $30 million.	Transcript
WST.N	2022-09-15T08:20:00Z	EBIT			And that would indicate that there will be an increase in margin. We're also looking at our cost base within our business to see, is that appropriate for 2023?	Transcript
WST.N	2023-04-27T09:00:00Z	EBIT			So going down, so was going to the mix shift next because obviously, that has accelerated recently. When you think about your forward model construct, are -- does that margin sort of look more like 150 basis points?	Transcript
ALK.N	2022-10-20T11:30:00Z	Revenue	10337800000	10149840000	We are tracking ahead of plan and are set to recognize approximately $135 million in incremental revenue on our long-term goal of $195 million.	Transcript
DFS.N	2023-04-20T08:00:00Z	Revenue			Following the strong first quarter performance, we are raising our expectations for loan growth this year to be low to mid-teens. Including on Slide 11 with our outlook.	Transcript
APTV.N	2023-05-04T06:45:04Z	EBITDA	19300000000	18700000000	Full Year 2023 Outlook	Press Release
APTV.N	2023-05-04T06:45:04Z	EBITDA	2745000000	2585000000	($ in millions)	Press Release
APTV.N	2023-05-04T08:00:00Z	Revenue	2080000000	1920000000	And accordingly, our full year financial outlook is unchanged from the guidance provided last quarter.	Transcript
APTV.N	2023-05-04T08:00:00Z	EBITDA			EBITDA and operating income of approximately $2.7 billion and $2 billion at the midpoints, respectively, and earnings per share of $4.25.	Transcript
APTV.N	2023-05-04T06:45:04Z	EBITDA			($ in millions)	Press Release
APTV.N	2023-05-04T06:45:04Z	EBIT			($ in millions) 2023 (1) Estimated Full Year Operating income $ 1,560 8.2 %	Press Release
APTV.N	2023-05-04T06:45:04Z	EBIT			($ in millions) 2023 (1) Estimated Full Year Operating income $ 1,560 8.2 %	Press Release
APTV.N	2023-05-04T08:00:00Z	EBIT			EBITDA and operating income of approximately $2.7 billion and $2 billion at the midpoints, respectively, and earnings per share of $4.25.	Transcript
APTV.N	2023-05-04T06:45:04Z	EBIT			(in millions, except per share amounts) Full Year 2023 2023 (1) Adjusted operating income $ 2,000 10.5 % Adjusted operating income $1,920 - $2,080 Estimated Full Year Full Year 2023 Outlook The Company's full year 2023 financial guidance is as follows:	Press Release
MPC.N	2023-01-31T11:00:00Z	Revenue			We have seen recovery in demand across all our products since coming out of the pandemic, and we anticipate further recovery in 2023, particularly as we expect consumers to adjust consumption patterns to lower retail fuel prices.	Transcript
MPC.N	2023-01-31T11:00:00Z	EBIT			Uncertainties remain around the pace and impact of China's recovery, the magnitude of a potential U.S. or global recession and the impact of Russian product sanctions.	Transcript
PGR.N	2023-02-28T09:30:00Z	EBIT			It's the most populous state. That's helpful.	Transcript
ZION.OQ	2023-04-19T17:30:00Z	Revenue			More immediately, we expect the recent acceleration of deposit repricing beta and balance sheet changes to reduce net interest income by about 7% in the second quarter when compared to the first quarter.	Transcript
WBD.OQ	2023-05-24T08:00:00Z	EBITDA	11500000000	11000000000	So help me think about what you're most excited about over the next year.	Transcript
WBD.OQ	2022-08-04T16:30:00Z	Revenue			So we anticipate adding more than 40 million incremental sales by 2025. You should also note that we estimate an additional overlap of around 4 million subscribers between the 2 services today.	Transcript
WBD.OQ	2022-09-13T12:15:00Z	EBIT			We have given guidance to breakeven in the U.S. for the D2C business in 2024, and we're targeting $1 billion of profit for the D2C business globally in 2025 despite the fact that we're going to be rolling out additional markets with associated start-up losses.	Transcript
WBD.OQ	2022-03-14T08:05:00Z	EBITDA			So feeling very good about the margin profile there. We're going to continue to manage this business across all territories, all different platforms, all exploitation windows. Is that likely to be enough to fund the company's global streaming ambitions?	Transcript
ICE.N	2023-05-04T08:30:00Z	Revenue			While we expect to continue to outperform the industry, if current cyclical conditions persist, we would expect recurring revenues to be towards the lower end of our mid- to high single-digit guidance range for the year.	Transcript
KMB.N	2022-10-25T10:00:00Z	Revenue	20578500000	20175000000	But just we see it looks like pulp is kind of flattening out in terms of market data, but there are industry participants that has sort of said otherwise. One, we remain at historical highs in the whole commodity and cost structure.	Transcript
KMB.N	2023-01-25T10:00:00Z	Revenue	2957210000	2904870000	At the same time, we expect our revenue management efforts will continue to positively impact this year.	Transcript
KMB.N	2022-01-26T10:00:00Z	EBIT			And I want to juxtapose that against your -- the strategic ambition to restore margins, and I'm really curious as to where you think you can get to on that objective by year-end. On the margins, my goal is to enhance margins over time, over the long term. So I guess I'm trying to get a little bit more depiction in my mind about what the kind of improvement curve looks like throughout the year as you slide south in 1Q and then build back, trying to get a sense of where you think like the exit rate is in '22 as a base case.	Transcript
KMB.N	2022-07-26T10:00:00Z	EBIT			And yes, absolutely, our targets and the way I've been looking at it are mid, long-term target margins for KCP remains unchanged at the high teens. I mean, we are aiming for that and we will get back. I was wondering if you can give some insights on to what you think is needed based on your early analysis of the business there to return to historically what is more of a mid- to high teens margins or whether that target even looks realistic anymore. In KCP, we saw some sequential deterioration there, again despite the top line. Nelson, you commented on margins being a key focus of yours going forward.	Transcript
SWKS.OQ	2023-01-05T14:05:00Z	Revenue			We're expecting to continue low double-digit CAGR extending -- actually, it will be a slow down this year compared to last year, but still double-digit growth in our timing portfolio for the data center and cloud applications as well.	Transcript
SWKS.OQ	2021-12-07T11:30:00Z	EBIT			And is that something that we can expect to be a tailwind for margins next year as some of those COVID-related costs hopefully start to abate? And one of the things that you've noted through the pandemic is you've taken on some additional cost to make sure that your customers were taken care of, and that's been a bit of a headwind to margins. And so we're excited about the opportunity as we're going forward. And the markets that we're in right now are the markets that you want to be in, they really are. And we think going into 2022, a lot of the stuff, a lot of these headwinds will abate. I'll pivot to margins a bit. The opportunity for us will continue to grow. When do those headwinds come off?	Transcript
EL.N	2023-05-03T09:30:00Z	Revenue	15966900000	15612080000	And so that's the cadence that we're seeing right now. In addition, higher inflation and currency volatility, as well as promotions in certain markets to alleviate high stock levels more than offset our price increases and further pressured our business margins. Or should we think about there still being a mismatch between sell-in, sell and being down and sell through into the first quarter of '24. So I heard your comments on encouraging progression on share and retail sales turning positive in Hainan and so on. So the pace of retail, which has been slower, again, than we expected this year, will determine how quickly we resume shipments.	Transcript
EL.N	2023-05-03T09:30:00Z	EBIT	2544946450	2491368630	Full year operating margin is forecasted to be approximately 11.1%, an 860 basis point contraction from the prior year period primarily due to the disruptions from COVID restrictions that not only impacted sales in Asia travel retail in Mainland China, but also resulted in increased obsolescence charges, discounts and promotional expenses.	Transcript
TSLA.OQ	2023-04-19T17:30:00Z	Revenue			Correct.	Transcript
TSLA.OQ	2023-01-25T17:30:00Z	EBIT			As the world transitions from an inflationary to deflationary environment, we expect a strong partnership with our suppliers on this journey as well. However, we believe our margins will remain healthy and industry-leading over the course of the year. In that, we've priced our products with a view towards a longer-term cost structure. Thus, there will be an impact on operating margin in the near term.	Transcript
EXR.N	2023-02-22T16:10:07Z	Revenue			Operating Income â€”	Press Release
EXR.N	2022-08-03T13:00:00Z	Revenue			And moving out of the store arena, everything else is growing really rapidly.	Transcript
EXR.N	2023-02-23T13:30:00Z	EBIT			Like last year, we have provided wider same-store revenue and NOI ranges to capture the different scenarios that we believe are possible given the unusual 2022 comparable. Same-store expenses have improved from 2022 levels at 5% to 6%, resulting in projected same-store NOI of 3% to 5.5%.	Transcript
IPGP.OQ	2023-05-02T10:00:00Z	Revenue			Although demand can fluctuate depending on the pipeline of projects and regional capacity additions. We expect the EV investment cycle to continue and e-mobility sales to remain strong in the next 3 to 5 years. With the strong pipeline of opportunities we are expecting our global sales force focused on e-mobility applications.	Transcript
SPGI.N	2022-03-01T08:00:00Z	Revenue	12552520000	12315680000	Or how diversified is that $350 million number? We outlined in our 2021 TCFD report that our revenue expectations from the ongoing development of ESG would grow at a 42% CAGR through 2025 to reach $380 million.	Transcript
SPGI.N	2022-02-28T16:26:50Z	EBITDA	5615098200	5392780000	the merger to be accretive to earnings by the end of 2023. The Company expects	Press Release
SPGI.N	2023-04-27T08:30:00Z	EBIT			All of this is reflected in our updated guidance. And we continue to expect margin expansion this year.	Transcript
SPGI.N	2022-05-03T08:30:00Z	Revenue			If you look back for the last decade, there's maybe 3 situations where the issuance environment was negative, and there were impacts on the Ratings revenue.	Transcript
SPGI.N	2023-05-15T07:00:12Z	Revenue			Despite economic headwinds, new vehicle sales are projected to surpass 14.5 more, prior to adjustments for inflation and other factors. The newest Channel	Press Release
SPGI.N	2023-02-09T08:30:00Z	Revenue			We expect expense growth to be below revenue growth in 2023.	Transcript
SPGI.N	2022-08-02T08:30:00Z	Revenue			As volumes continue to grow, we expect to see tailwinds in our Mobility segment across multiple product lines, including CARFAX and automotiveMastermind.	Transcript
SPGI.N	2023-02-09T08:30:00Z	EBIT			Beginning with Market Intelligence, we expect growth in the 6.5% to 8.5% range and margins between 34% and 35%. In Commodity Insights, we expect revenue growth in the 6.5% to 8.5% range and margin between 46% and 47%. In Indices, we expect revenue to be flat to up 2% with margins of 66% to 67%. Margins for Ratings are expected to be between 56% and 57%. We expect to expand operating margin to the range of 45.5% to 46.5%; diluted EPS, which excludes deal-related amortization, of $12.35 to $12.55, which is an 11% year-over-year increase from the midpoint.	Transcript
SPGI.N	2023-02-09T08:30:00Z	EBIT			We believe the strength and discipline shown in 2022 sets us up for a return to positive overall revenue growth and margin expansion in 2023.	Transcript
SPGI.N	2022-03-01T08:00:00Z	EBIT			The EBITA contributions from the combined revenue and cost synergies is expected to be approximately $810 million in 2026. We also continue to expect 200 basis points of average annual margin expansion through 2023. We also expect Market Intelligence to be one of the larger beneficiaries of cost synergies this year and next year so we expect a bit more margin expansion in MI than in other divisions. We continue to expect approximately $350 million in revenue synergies, but it is important to note that this is despite the estimated $35 million in revenue synergies lost from divestitures since we announced the merger. We expect to expand operating margin by approximately 130 basis points in 2022, though we still expect margin expansion to average approximately 200 basis points annually through next year.	Transcript
SPGI.N	2022-03-01T08:00:00Z	EBIT			The EBITA contributions from the combined revenue and cost synergies is expected to be approximately $810 million in 2026. We also continue to expect 200 basis points of average annual margin expansion through 2023. We also expect Market Intelligence to be one of the larger beneficiaries of cost synergies this year and next year so we expect a bit more margin expansion in MI than in other divisions. We continue to expect approximately $350 million in revenue synergies, but it is important to note that this is despite the estimated $35 million in revenue synergies lost from divestitures since we announced the merger. We expect to expand operating margin by approximately 130 basis points in 2022, though we still expect margin expansion to average approximately 200 basis points annually through next year.	Transcript
SPGI.N	2023-02-09T08:30:00Z	EBIT			Beginning with Market Intelligence, we expect growth in the 6.5% to 8.5% range and margins between 34% and 35%. In Commodity Insights, we expect revenue growth in the 6.5% to 8.5% range and margin between 46% and 47%. In Indices, we expect revenue to be flat to up 2% with margins of 66% to 67%. Margins for Ratings are expected to be between 56% and 57%. We expect to expand operating margin to the range of 45.5% to 46.5%; diluted EPS, which excludes deal-related amortization, of $12.35 to $12.55, which is an 11% year-over-year increase from the midpoint.	Transcript
SPGI.N	2023-02-09T08:30:00Z	EBIT			Beginning with Market Intelligence, we expect growth in the 6.5% to 8.5% range and margins between 34% and 35%. In Commodity Insights, we expect revenue growth in the 6.5% to 8.5% range and margin between 46% and 47%. In Indices, we expect revenue to be flat to up 2% with margins of 66% to 67%. Margins for Ratings are expected to be between 56% and 57%. We expect to expand operating margin to the range of 45.5% to 46.5%; diluted EPS, which excludes deal-related amortization, of $12.35 to $12.55, which is an 11% year-over-year increase from the midpoint.	Transcript
SPGI.N	2023-02-09T08:30:00Z	EBIT			Beginning with Market Intelligence, we expect growth in the 6.5% to 8.5% range and margins between 34% and 35%. In Commodity Insights, we expect revenue growth in the 6.5% to 8.5% range and margin between 46% and 47%. In Indices, we expect revenue to be flat to up 2% with margins of 66% to 67%. Margins for Ratings are expected to be between 56% and 57%. We expect to expand operating margin to the range of 45.5% to 46.5%; diluted EPS, which excludes deal-related amortization, of $12.35 to $12.55, which is an 11% year-over-year increase from the midpoint.	Transcript
SPGI.N	2023-02-09T08:30:00Z	EBIT			Beginning with Market Intelligence, we expect growth in the 6.5% to 8.5% range and margins between 34% and 35%. In Commodity Insights, we expect revenue growth in the 6.5% to 8.5% range and margin between 46% and 47%. In Indices, we expect revenue to be flat to up 2% with margins of 66% to 67%. Margins for Ratings are expected to be between 56% and 57%. We expect to expand operating margin to the range of 45.5% to 46.5%; diluted EPS, which excludes deal-related amortization, of $12.35 to $12.55, which is an 11% year-over-year increase from the midpoint.	Transcript
ADBE.OQ	2022-12-15T17:00:00Z	Revenue	19300000000	19100000000	In summary, for fiscal year '23, we're targeting: total Adobe revenue of $19.1 billion to $19.3 billion; Digital Media net new ARR of approximately $1.65 billion; Digital Media segment revenue of $13.9 billion to $14.0 billion; Digital Experience segment revenue of $4.925 billion to $5.025 billion; Digital Experience subscription revenue of $4.375 billion to $4.425 billion; tax rate of approximately 22% on a GAAP basis and 18.5% on a non-GAAP basis; GAAP earnings per share of $10.75 to $11.05 and non-GAAP earnings per share of $15.15 to $15.45.	Transcript
ADBE.OQ	2023-03-15T17:00:00Z	Revenue			For fiscal 2023, we are now targeting Digital Media net new ARR of approximately $1.70 billion, GAAP earnings per share of $10.85 to $11.15 and non-GAAP earnings per share of $15.30 to $15.60.	Transcript
ADBE.OQ	2023-03-21T14:30:00Z	EBIT			Does that make sense? When a lot of these underlying technologies were still pretty immature.	Transcript
ADBE.OQ	2022-12-15T17:00:00Z	Revenue			In summary, for fiscal year '23, we're targeting: total Adobe revenue of $19.1 billion to $19.3 billion; Digital Media net new ARR of approximately $1.65 billion; Digital Media segment revenue of $13.9 billion to $14.0 billion; Digital Experience segment revenue of $4.925 billion to $5.025 billion; Digital Experience subscription revenue of $4.375 billion to $4.425 billion; tax rate of approximately 22% on a GAAP basis and 18.5% on a non-GAAP basis; GAAP earnings per share of $10.75 to $11.05 and non-GAAP earnings per share of $15.15 to $15.45.	Transcript
ADSK.OQ	2023-05-25T17:00:00Z	Revenue	5460000000	5360000000	In some cases, we're going to be delivering significantly more value to certain types of customers, and we expect to charge for that value. Putting that all together, we still expect fiscal '24 revenue to be between $5.36 billion and $5.46 billion, up about 8% at the midpoint or about 13% at constant exchange rates and excluding the impact from Russia. We expect both initiatives to drive further conversion and growth in the second half of the year and beyond.	Transcript
ADSK.OQ	2023-05-25T17:00:00Z	EBIT			We expect non-GAAP operating margins to be similar to fiscal '23 levels, with constant currency margin improvement offset by FX headwinds.	Transcript
ADSK.OQ	2023-05-25T16:01:04Z	EBIT			FY24 Guidance Metrics FY24	Press Release
WRK.N	2023-05-04T08:30:00Z	Revenue	3600000000	3200000000	Our goal is to increase our vertical integration and reduce volatility from external paper sales. Our integration efforts here are well underway, and I am pleased to report that we expect to exceed our synergy targets. We expect a sequential volume improvement offset by the flow-through of previously published price decreases.	Transcript
WRK.N	2023-05-04T08:30:00Z	EBITDA			And then, I guess, on the benefit side, any kind of fixed cost reduction estimate or way to think about that? In terms of fiber, we expect a benefit of between $250 million and $300 million.	Transcript
WHR.N	2023-05-16T13:15:00Z	EBIT	19400000000	19400000000	Yes. Yes. Yes, I don't think our long-term perspective on North America has changed really much at all.	Transcript
WHR.N	2023-05-16T13:15:00Z	EBIT	1450000000	1450000000	Yes. Yes. Yes, I don't think our long-term perspective on North America has changed really much at all.	Transcript
WHR.N	2023-05-16T13:15:00Z	EBIT			Yes. Yes. Yes, I don't think our long-term perspective on North America has changed really much at all.	Transcript
WHR.N	2023-04-25T08:00:00Z	Revenue			Keep also in mind of the North America sales numbers, we also have Canada in there and KitchenAid small domestic and a small domestic appliance business in Q1, Q2, also we expected is still a little bit softer than the major domestic market.	Transcript
WHR.N	2023-03-06T09:50:00Z	Revenue			And then I've laid out on the slide where just talks about our goals are still the same as a company is we want to see 5% to 6% organic revenue growth.	Transcript
WHR.N	2023-05-16T13:15:00Z	EBIT			Yes. Yes. Yes, I don't think our long-term perspective on North America has changed really much at all.	Transcript
WHR.N	2023-01-31T08:00:00Z	EBIT			As our availability improves, we expect to participate in value-creating promotions partially offset by positive mix driven by a strong lineup of new product introductions.	Transcript
WHR.N	2023-01-31T08:00:00Z	EBIT			You talked about North America being at 14% by the end of the year.	Transcript
WHR.N	2023-04-24T16:05:06Z	EBIT			December 31, 2023 Reported measure ~$1,300 $13.00 - $15.00 Results classification Earnings before Earnings per Twelve Months Ending Whirlpool, for the twelve months ending December 31, 2023. Ongoing EBIT calculated by dividing EBIT by net sales. The earnings per diluted share GAAP interest & diluted share margin is calculated by dividing ongoing EBIT by net sales. EBIT margin is measure and ongoing measure are presented net of tax, while each adjustment is presented on a pre-tax basis. Our anticipated full-year GAAP tax rate is 19.0% taxes*	Press Release
WHR.N	2023-04-25T08:00:00Z	EBIT			Our market share gains, in particular in the U.S. builder segment, will continue throughout the year, coupled with early signs of a stronger U.S. housing market, we expect to see an improved revenue top line as the year progresses. So all part $130 million, $140 million. We remain confident in the structural strength of our North America business and continue to expect our actions to deliver very strong results, including approximately 100 basis points of sequential margin expansion in every quarter of 2023.	Transcript
WHR.N	2023-04-24T16:05:06Z	EBIT			Company's projections regarding the earnings of the Company's non wholly-owned	Press Release
FOXA.OQ	2023-05-09T08:30:00Z	Revenue			And so with another sort of 1/3 of our book due for renewal in fiscal '24 and a touch under 30% during fiscal '25, we feel pretty confident that we can continue to deliver pricing gains in subscribers. If the subscriber rate of attrition stays at the same level, we expect to post ongoing affiliate revenue growth for the company.	Transcript
FOXA.OQ	2022-11-01T08:30:00Z	EBITDA			Last year, we sort of across -- TUBI across the whole year was in the low 200s in terms of EBITDA deficit for the company.	Transcript
TT.N	2023-05-03T10:00:00Z	Revenue	17591200000	17431280000	Our Americas transport refrigeration business performed consistent with our expectations for the first quarter with mid-single-digit revenue growth.	Transcript
TT.N	2023-05-23T10:25:00Z	Revenue			And in the first quarter, we saw orders bookings down 1%. But right now, we're expecting to enter 2024 with a very strong backlog well in excess of $6 billion. Do we start eating into that backlog here? Do you want to -- sure go ahead. Right? So we did better than that versus the scenario. Thermo King, that's a little bit lumpy in terms of when order rates have occurred just given when we've selectively opened up the backlog and the order bookings.	Transcript
TT.N	2023-05-03T10:00:00Z	Revenue			Our Americas transport refrigeration business performed consistent with our expectations for the first quarter with mid-single-digit revenue growth.	Transcript
TT.N	2022-05-25T11:30:00Z	EBIT			Actually margins and then hopefully, we can have time for just a quick capital allocation question. But I would tell you that our long-range target is really to get 25% incrementals on good revenue growth. Going into 2023, I think you said back in the 25% organic incremental zone, is that still sort of the best thinking right now? I really want to see how we get through the next couple of quarters. So 25%, we still like over the long term. So let's see where the markets fall out on revenue growth, but long-term target we should get 25% incrementals. Start with 30% core, and then we save 5 points for that reinvestment back in the business, okay? The first part of your question on margins, we haven't really guided 2023 yet.	Transcript
TT.N	2022-08-03T10:00:00Z	Revenue			And when we come up with a guide for 2023, we can explain to you in a lot of detail as to what's happening.	Transcript
TSN.N	2023-05-08T09:00:00Z	EBIT	54000000000	53000000000	And in our International business, we remain committed to expanding globally in the fastest-growing protein consumption markets in the world.	Transcript
TSN.N	2023-05-08T09:00:00Z	EBIT			And in our International business, we remain committed to expanding globally in the fastest-growing protein consumption markets in the world.	Transcript
TSN.N	2023-05-08T09:00:00Z	Revenue			Now let's review our updated outlook for fiscal 2023.	Transcript
TSN.N	2023-02-06T09:00:00Z	EBITDA			And on an EBITDA basis, we look at something in the high single digits for that. We remain committed to our investment-grade rating and managing our net leverage ratio to be at or below 2x net debt to adjusted EBITDA over the long term, providing optionality for inorganic investment and additional return of cash to shareholders.	Transcript
TSN.N	2023-02-06T09:00:00Z	EBIT			It's been an investment.	Transcript
TSN.N	2022-11-14T06:55:00Z	EBIT			We anticipate improved results from our foreign operations in fiscal 2023.	Press Release
TSN.N	2023-05-08T09:00:00Z	EBIT			And in our International business, we remain committed to expanding globally in the fastest-growing protein consumption markets in the world.	Transcript
TSN.N	2023-05-08T09:00:00Z	EBIT			And in our International business, we remain committed to expanding globally in the fastest-growing protein consumption markets in the world.	Transcript
AKAM.OQ	2023-05-24T10:40:00Z	Revenue	3785000000	3740000000	Always tough to call a bottom in the CDN business. So it felt like there were 2 good things happening there.	Transcript
AKAM.OQ	2022-11-08T16:30:00Z	Revenue	1097650000	1047200000	The vast majority of our security revenue today is in the app and the API protection area.	Transcript
AKAM.OQ	2023-05-09T16:30:00Z	EBIT			The impact of these charges has been incorporated into our second quarter and full year 2023 guidance.	Transcript
LUV.N	2023-04-27T12:30:00Z	Revenue			As a reminder, second quarter 2022 operating revenues included approximately $300 million of additional breakage revenue, a higher-than-normal amount related to flight credits issued during the pandemic that were soon set to expire as well as our later policy change to eliminate flight credit expiration dates.	Transcript
LUV.N	2023-01-26T12:30:00Z	EBIT			And even with the first quarter headwinds, our 2023 plan continues to support solid profits with year-over-year margin expansion for full year 2023.	Transcript
TSCO.OQ	2023-04-27T10:00:00Z	Revenue	15300000000	15000000000	We continue to expect full year sales of $15 billion to $15.3 billion and project comparable store sales to increase 3.5% to 5.5%. We remain very confident in our sales guidance or in our earnings guidance for the year.	Transcript
TSCO.OQ	2023-04-27T06:55:00Z	EBIT	1575900000	1515000000	Fiscal 2023 Financial Outlook The Company confirmed its fiscal 2023 financial guidance, initially provided	Press Release
AON.N	2022-09-21T05:00:00Z	Revenue			And are there any misconceptions or misunderstandings about your business short term or long term in the investment community? I think 8% growth in the first half of the year, guidance of mid-single digit or greater than the second -- for the full year 2023, that would be one -- the biggest, I think, disconnect for us is free cash flow, as you know well. Maybe as you've talked to investors since earnings, what are the questions that come up a lot?	Transcript
AON.N	2023-04-28T08:30:00Z	EBIT			I was wondering if that means you expect more margin expansion over the balance of the year? It's us driving gross margin expansion net of investments.	Transcript
AON.N	2023-02-03T06:00:11Z	EBIT			impact of approximately $0.13 per share, or an approximately $39 million	Press Release
AMZN.OQ	2022-07-28T16:01:00Z	Revenue			* In India, Amazon raised its pledge to now enable $20 billion in cumulative Amazon announced a new pledge to help the more than 18,000 small and export sales by 2025. This pledge will support the objectives of the Italian exporters are on track to surpass $5 billion in cumulative exports. In Italy, exports by 2025. Since launching in 2015, Amazonâ€™s Global Selling program has grown to more than 100,000 exporters that are showcasing millions of Made in India products to customers worldwide through Amazonâ€™s store. Indian medium-sized businesses selling on Amazon reach â‚¬1.2 billion in annual	Press Release
AMZN.OQ	2022-07-26T07:00:08Z	EBIT			both in Canada and the U.S. We are on a journey with the goal of becoming a global leader in clean wellness with highly differentiated products, strong	Press Release
MS.N						
BRKb.N						
GOOG.OQ						
KR.N	2023-03-02T08:30:14Z	Revenue	5200000000	5000000000	competitive pricing and personalization, fresh products and a better shopping	Press Release
KR.N	2023-03-02T10:00:00Z	Revenue			We expect to grow revenue by continuing to invest in our customers through competitive pricing and personalization and providing fresh products and a better shopping experience across our store and digital ecosystem.	Transcript
KR.N	2022-09-20T13:00:00Z	EBIT			But I think from our perspective, what we feel really good about is the strategy that we developed was really making the investments that obviously do create some short-term pain around margin because we felt like the important thing was to win customer loyalty to build that digital business so that we can grow margin longer-term. Can we just clarify which margin you're talking about margin? Yes.	Transcript
KR.N	2023-03-02T10:00:00Z	EBIT			And then I would think of the sort of core supermarket business is really sort of continuing to grow year-over-year. So I think about it as the 53rd week adding, call it, $0.15 of earnings per share.	Transcript
BKNG.OQ	2022-08-03T16:30:00Z	Revenue			And any kind of medium-term outlook you can share?	Transcript
BKNG.OQ	2023-05-04T16:30:00Z	EBITDA			In terms of our outlook for the year, we are not updating our previous full year commentary at this time. Our strong bookings in the first 4 months of the year create the potential for some upside but we want to see how the next few months develop before considering any updated commentary.	Transcript
BKNG.OQ	2023-05-04T16:30:00Z	EBITDA			In terms of our outlook for the year, we are not updating our previous full year commentary at this time. It is also tied to your financial model because we made the comment last quarter or in February that we're obviously not targeting pre-COVID margin level because of the mix shift in the business for some of these new areas that we're now focused in but we do expect to be able to grow our EBITDA margin above the levels we're at in 2023 and the biggest driver, that would be continue to increase our direct mix.	Transcript
STZ.N	2022-12-06T10:15:00Z	Revenue			But ultimately, we continue to target top line organic growth of roughly 2% to 4% and operating margins of 28% to 29% over the medium term.	Transcript
STZ.N	2023-04-06T10:30:00Z	Revenue			We anticipate our full year fiscal '24 shipments and depletions to track each other closely, both on an absolute basis and in terms of the year-over-year comparison.	Transcript
STZ.N	2023-04-06T10:30:00Z	Revenue			We anticipate our full year fiscal '24 shipments and depletions to track each other closely, both on an absolute basis and in terms of the year-over-year comparison.	Transcript
STZ.N	2022-10-06T10:30:00Z	Revenue			So while on an absolute basis, we continue to expect our shipments for the remainder of this fiscal year to be relatively in line with depletions, we believe the more comparable indicator for growth for our beer brands in the second half will be the depletion rate.	Transcript
STZ.N	2022-10-06T10:30:00Z	EBIT			Looking forward, we are also confident that over the medium term, our Beer business remains well positioned to deliver 7% to 9% net sales growth and 39% to 40% operating margin, supported by the sustained momentum of our core brands, the steady progress of our brewing capacity additions and the continued development of our innovation lineup, including the momentum of our chelada brands, the recent launch of Fresca Mixed, the expansion of Modelo Oro from select test markets to the entire national market next year and the introduction of Corona nonalcoholic.	Transcript
STZ.N	2023-01-05T10:30:00Z	EBIT			And in fact, when considering our fiscal '20 through our currently anticipated fiscal '24 margins, we expect the average operating margin for that 5-year period to remain within our medium-term algorithm of 39% to 40%.	Transcript
STZ.N	2023-04-06T10:30:00Z	EBIT			The majority of these relate to year-over-year adjustments in our packaging and raw material costs, which, on average, represent a high single-digit increase in absolute terms for these inputs in the import portion of our beer business.	Transcript
ABBV.N	2023-04-27T09:00:00Z	Revenue	52400000000	52400000000	And for aesthetics, we now expect global revenue of approximately $5.3 billion, reflecting the better-than-expected recovery in China and stable economic trends in the U.S. At current rates, we expect foreign exchange to have a modest unfavorable impact on full year sales growth. First quarter results include continued robust performance from Skyrizi and Rinvoq, which remain on track to contribute more than $11 billion in combined sales this year. Longer term, we remain extremely confident in our ability to grow the aesthetics business and continue to expect to achieve total sales of more than $9 billion by the end of this decade. This guidance includes the following updated assumptions. We now expect Vraylar sales of approximately $2.7 billion, an increase of $200 million, reflecting strong prescription growth following the MDD approval. We now expect net revenues of approximately $52.4 billion, an increase of $400 million.	Transcript
ABBV.N	2023-03-15T13:35:00Z	EBIT	24440000000	24440000000	And that reduction is really driven by the fact we're continuing to invest in the business. I guess as we're going through the period now, what can you say about how you expect gross margins to evolve '23 and beyond. No, it's a fair question, especially in line of you said we've talked about operating margin and how we've seen we provided guidance of 47%, which is certainly a reduction from prior year. People are looking for those anchors.	Transcript
ABBV.N	2022-01-11T15:45:00Z	EBIT			And some of the prior margin comments you've made, do those still hold in terms of -- I don't know as you think about the investment seems to make in your business, can you manage those despite the '23 erosion you're expecting? And then as we return to growth very quickly, you'll start to see those operating margins expand once again. And what I've been saying is think of it in the 46% to 47% range as a trough level of operating margin, which still is top tier in our industry. We will see a decline in '23, given the U.S. Humira LOE.	Transcript
MA.N	2023-05-11T00:01:00Z	Revenue	25350180000	25127810000	return to office. With an uncertain economy providing some cross-market turbulence, mainland Chinaâ€™s reopening is expected to bolster growth	Press Release
MA.N	2022-04-26T09:00:00Z	EBIT			Can you just comment on kind of puts and takes there and what the long-term trajectory is for value-added services? Our teams are fully engaged and as we looked ahead in the guidance that Sachin gave, we assume a strong services growth. So that will continue. We are expecting our -- there's nothing to be said that there's anything changing on the growth rates of our business.	Transcript
XOM.N						
SWK.N	2022-05-12T13:00:00Z	Revenue	1700000000	1300000000	And we do think there's about a $300 million cyclical recovery revenue opportunity for this segment that plays out over some time frame in the next 2 to 4 years, depending on how quickly those industries recover. As we electrify those particular products over the next 3 to 5 years, we see that as a wonderful growth opportunity.	Transcript
SWK.N	2023-02-02T08:00:00Z	Revenue			In this case, we expect full year organic revenues to decline by mid-single digits with volume declines in both the tools and outdoor and industrial segments.	Transcript
SWK.N	2023-05-04T08:00:00Z	Revenue			If this scenario becomes the macro reality, we would expect full year organic revenues to decline by mid-single digits, with volume declines in both the Tools & Outdoor and industrial segments. The downside case reflects a deceleration of demand due to elevated recessionary pressures.	Transcript
SWK.N	2023-05-09T11:35:00Z	EBITDA			If you take the back half, annualize it, it's about $1.3 billion to $1.5 billion.	Transcript
SWK.N	2022-07-28T08:00:00Z	EBIT			Any major ramp-up in Q4 there?	Transcript
SWK.N	2023-02-02T08:00:00Z	EBIT			As a result, the under absorption of fixed manufacturing costs would continue to constrain first half 2023 operating margins to low single digits.	Transcript
SWK.N	2023-05-04T08:00:00Z	EBIT			The current pretax charges estimate was narrowed to $275 million to $325 million, with approximately 25% of these expenses being noncash.	Transcript
HRL.N	2023-02-28T17:00:00Z	Revenue	12925270180	12674294060	Before I give an overview of each new segment, there are 2 items of note: First, our legacy Jennie-O Turkey Store segment has been fully integrated into our 3 new segments.	Transcript
HRL.N	2023-03-02T09:30:00Z	Revenue			And then as we expect our international business to come back with some of those challenges abating, we do believe that we'll be able to deliver that top line.	Transcript
HRL.N	2023-03-02T09:30:00Z	EBIT			We expect unfavorable mix in the retail segment, short-term margin compression due to our immediate actions across the supply chain and for continued COVID-related disruption in China to negatively affect the second quarter.	Transcript
HRL.N	2022-11-30T09:00:00Z	Revenue			We do know that we're going to have some positive impact from pricing. We expect strong growth, foodservice and International.	Transcript
INTC.OQ	2023-04-27T17:00:00Z	Revenue			While we're encouraged by first quarter revenue and expect growth to improve sequentially through 2023, we're not satisfied with our financial results and remain focused on what we can control, our execution and the prioritization of our owners' capital toward our long-term goals.	Transcript
INTC.OQ	2023-04-27T17:00:00Z	EBIT			The client and data center-focused products from the former AXG business are now reported within our CCG and DCAI segments, respectively, and will have a dilutive effect on the operating margins of those businesses.	Transcript
TRMB.OQ	2023-05-03T08:00:00Z	Revenue	3935000000	3835000000	As such, we now expect full year revenue to be in the range of $3.835 billion to $3.935 billion. Our dealers reduced their inventories as expected in the first quarter of this year, and we estimate that dealer inventory reductions accounted for roughly $40 million or nearly half of our product revenue decline.	Transcript
TRMB.OQ	2023-02-08T08:00:00Z	Revenue	944400000	882050000	Revenues in the Geospatial segment are expected to decline for the year, with the highest levels of organic decline in the first quarter, as we lap strong numbers from the first quarter of 2022.	Transcript
TRMB.OQ	2023-05-03T08:00:00Z	EBITDA			From a margin perspective, we indicated that EBITDA margins would be about 30%. I still think that's the long-term trend, but we've lost a little bit of fixed cost leverage. It's just growing a little more slowly than we'd expect. It's still growing. Probably the simplest way to think about that for the year, Jerry, is Transporeon margins will be pretty close to the Trimble average this year and then higher as the business gets back to growth or higher levels of growth.	Transcript
TRMB.OQ	2023-05-03T08:00:00Z	Revenue			So you're looking for an acceleration in total ARR from 13% to 15% for the full year, just to put a finer point on that since obviously, mid-teens is a pretty wide range.	Transcript
TRMB.OQ	2023-05-03T08:00:00Z	Revenue			So you're looking for an acceleration in total ARR from 13% to 15% for the full year, just to put a finer point on that since obviously, mid-teens is a pretty wide range.	Transcript
TRMB.OQ	2023-05-03T08:00:00Z	Revenue			So you're looking for an acceleration in total ARR from 13% to 15% for the full year, just to put a finer point on that since obviously, mid-teens is a pretty wide range.	Transcript
TRMB.OQ	2023-02-08T08:00:00Z	EBITDA			Influenced by these revenue growth patterns, we expect operating and EBITDA margins to be relatively flat in the first half of the year and up in the second half.	Transcript
TRMB.OQ	2023-02-08T08:00:00Z	EBIT			Influenced by these revenue growth patterns, we expect operating and EBITDA margins to be relatively flat in the first half of the year and up in the second half. We expect a modest increase in operating margins, as we invest against our strategy in an environment where organic revenue growth is harder to come by. We expect margins to be stable in Buildings & Infrastructure and Resources and Utilities. We project growth in Transportation margins, while Geospatial margins will be down modestly for the year.	Transcript
TRMB.OQ	2023-02-08T08:00:00Z	EBIT			Influenced by these revenue growth patterns, we expect operating and EBITDA margins to be relatively flat in the first half of the year and up in the second half. We expect a modest increase in operating margins, as we invest against our strategy in an environment where organic revenue growth is harder to come by. We expect margins to be stable in Buildings & Infrastructure and Resources and Utilities. We project growth in Transportation margins, while Geospatial margins will be down modestly for the year.	Transcript
TRMB.OQ	2023-02-08T08:00:00Z	EBIT			Influenced by these revenue growth patterns, we expect operating and EBITDA margins to be relatively flat in the first half of the year and up in the second half. We expect a modest increase in operating margins, as we invest against our strategy in an environment where organic revenue growth is harder to come by. We expect margins to be stable in Buildings & Infrastructure and Resources and Utilities. We project growth in Transportation margins, while Geospatial margins will be down modestly for the year.	Transcript
TRMB.OQ	2023-05-03T08:00:00Z	EBIT			We expect non-GAAP operating margins to be in the range of 23% to 24%.	Transcript
TRMB.OQ	2023-02-08T08:00:00Z	EBIT			Influenced by these revenue growth patterns, we expect operating and EBITDA margins to be relatively flat in the first half of the year and up in the second half. We expect a modest increase in operating margins, as we invest against our strategy in an environment where organic revenue growth is harder to come by. We expect margins to be stable in Buildings & Infrastructure and Resources and Utilities. We project growth in Transportation margins, while Geospatial margins will be down modestly for the year.	Transcript
TRMB.OQ	2023-02-08T08:00:00Z	EBIT			Influenced by these revenue growth patterns, we expect operating and EBITDA margins to be relatively flat in the first half of the year and up in the second half. We expect a modest increase in operating margins, as we invest against our strategy in an environment where organic revenue growth is harder to come by. We expect margins to be stable in Buildings & Infrastructure and Resources and Utilities. We project growth in Transportation margins, while Geospatial margins will be down modestly for the year.	Transcript
WBA.OQ	2023-01-05T08:30:00Z	Revenue	137500000000	133500000000	While the U.S. performance was impacted by the anticipated COVID-19 headwinds, we do expect year-on-year performance to improve in the second half as the COVID headwind lessens and initiatives to drive script volume gain traction.	Transcript
WBA.OQ	2023-01-05T08:30:00Z	Revenue	5697630000	5646300000	While the U.S. performance was impacted by the anticipated COVID-19 headwinds, we do expect year-on-year performance to improve in the second half as the COVID headwind lessens and initiatives to drive script volume gain traction.	Transcript
WBA.OQ	2023-01-05T08:30:00Z	Revenue	4900000000	4700000000	While the U.S. performance was impacted by the anticipated COVID-19 headwinds, we do expect year-on-year performance to improve in the second half as the COVID headwind lessens and initiatives to drive script volume gain traction.	Transcript
WBA.OQ	2023-03-28T08:30:00Z	Revenue			Let's start with the core business. Through our focused investments, we have returned an incremental 500 stores to normal pharmacy operating hours. U.S. Pharmacy comp scripts grew 3.5%, excluding immunization exceeding our guidance of 3% growth and improving from 2.1% last quarter.	Transcript
WBA.OQ	2023-01-10T14:15:00Z	Revenue			Now moving to International. We expect significant second half momentum in U.S. Retail Pharmacy.	Transcript
WBA.OQ	2023-01-05T08:30:00Z	EBITDA			For the U.S. Healthcare segment, we expect sales of $6.5 billion to $7.3 billion and an adjusted EBITDA range from a loss of $50 million to positive $25 million. Shields Health Solutions and CareCentrix continue to perform well, which led to the accelerated acquisition of both entities. Shields closed on December 28, and CareCentrix is scheduled to close in the third quarter of fiscal '23. We continue to expect to exit fiscal '23 with positive adjusted EBITDA for the U.S. Healthcare segment.	Transcript
WBA.OQ	2022-11-09T14:00:00Z	EBIT			And then depending on the timing of an IPO of Village, that's the first time we'll expose the full financials. But we did give the numbers in the presentation.	Transcript
WBA.OQ	2022-10-13T08:30:00Z	EBIT			We expect adjusted operating income of $830 million to $870 million with strong constant currency growth of 26% to 32%.	Transcript
WBA.OQ	2023-01-05T08:30:00Z	EBIT			For U.S. retail pharmacy, we have raised our sales guidance by $500 million due to a better-than-expected first quarter, which benefited from brand inflation and broad-based retail strength.	Transcript
WBA.OQ	2023-01-05T08:30:00Z	EBITDA			For the U.S. Healthcare segment, we expect sales of $6.5 billion to $7.3 billion and an adjusted EBITDA range from a loss of $50 million to positive $25 million. Shields Health Solutions and CareCentrix continue to perform well, which led to the accelerated acquisition of both entities. Shields closed on December 28, and CareCentrix is scheduled to close in the third quarter of fiscal '23. We continue to expect to exit fiscal '23 with positive adjusted EBITDA for the U.S. Healthcare segment.	Transcript
WBA.OQ	2023-01-05T08:30:00Z	EBIT			For U.S. retail pharmacy, we have raised our sales guidance by $500 million due to a better-than-expected first quarter, which benefited from brand inflation and broad-based retail strength.	Transcript
DISCK.OQ^D22						
OMC.N	2023-03-07T12:50:00Z	Revenue			But it sounds like in your answer to the last question, you would maybe think that would be higher if this was a true normal year.	Transcript
OMC.N	2023-04-18T16:30:00Z	EBIT			And then, Phil, can you just confirm, I think you said for the margin guide at the higher end of the range? We expect to be at or close to the top of that range.	Transcript
GLW.N	2023-01-31T08:30:00Z	Revenue			My first question is about the guidance.	Transcript
GLW.N	2023-01-31T08:30:00Z	Revenue			My first question is about the guidance.	Transcript
GLW.N	2023-01-31T08:30:00Z	Revenue			My first question is about the guidance.	Transcript
GLW.N	2023-04-25T08:30:00Z	EBIT			Overall, our team demonstrated operational rigor during the quarter. We continue to make progress on improving our profitability by raising prices to help offset inflation and by adjusting our productivity ratios closer to historical levels, and we will continue to align our cost structure to successfully weather the demand environment.	Transcript
GLW.N	2022-07-26T08:30:00Z	Revenue			As we take a look at retail, what we say is we'd expect TV units to probably be down this year now especially given what has happened with the China shutdowns. But it could be flat. I was wondering if you can update us around your assumption for TV units for '22 and maybe initial look into '23. On Display, as you would have heard in our opening, we are -- we expect our volume to be in line with where our panel makers are taking their utilization and down some 15% in quarter 3. This is a pretty significant correction that we're working our way through.	Transcript
GLW.N	2022-12-08T12:50:00Z	Revenue			And then maybe just talk a little bit about auto glass, kind of where are you in the per vehicle. How are you guys doing there and design wins and moving that along? I think that unlike the environmental space is going to be a growth opportunity for us for sure, regardless of the number of cars made. It's a much smaller business, but we've won a lot of business and a lot of that will come -- kind of come online as new model years unfold.	Transcript
CRM.N	2023-05-31T16:05:00Z	Revenue	34700000000	34500000000	up ~10% Y/Y	Press Release
CRM.N	2023-05-31T16:05:00Z	EBIT	9369000000	9315000000	percentage of GAAP revenue. Non-GAAP operating margin is the proportion of â€œSalesforce significantly exceeded our non-GAAP margin target for the	Press Release
CRM.N	2023-05-31T16:05:00Z	EBIT			* Raises Full Year FY24 GAAP Operating Margin Guidance to ~11.4% and Non-GAAP Guidance Non-GAAP Operating Margin((2)) N/A Â  ~28.0% The following is a reconciliation of GAAP operating margin guidance to	Press Release
SBUX.OQ	2023-05-02T17:00:00Z	EBITDA	36120336000	35475330000	Lastly, despite the current interest rate environment, our balance sheet remains very healthy, supported by our strong cash flows and a measured financial policy targeting leverage below 3x lease-adjusted debt to EBITDA.	Transcript
SBUX.OQ	2023-05-02T17:00:00Z	Revenue			Third, as I discussed earlier, we expect China's average weekly sales to sequentially grow in Q3 and Q4, but at a more moderate pace.	Transcript
SBUX.OQ	2023-05-02T17:00:00Z	EBIT			Excluding the impairment, the segment's margin was nearly 40% for the quarter, and we continue to expect Channel Development's margin to normalize in the mid-40s range towards the end of the year. Note the quarterly margin shape in Q3 and Q4 is not expected to mirror the prior year. Regarding the shape of margin, we continue to expect sequential margin improvement in both Q3 and Q4. We expect Q3 margin near the prior year level, with Q4 expanding meaningfully over prior year as we lap the significant investments in wages and benefits.	Transcript
SBUX.OQ	2023-02-02T17:00:00Z	EBIT			And what I'm really trying to get at here is that if the China sales recovery gets back to '19 levels, does this allow you to return to the prior long-term operating margin target of 17% to 18%.	Transcript
SBUX.OQ	2023-05-02T17:00:00Z	EBIT			Excluding the impairment, the segment's margin was nearly 40% for the quarter, and we continue to expect Channel Development's margin to normalize in the mid-40s range towards the end of the year. Note the quarterly margin shape in Q3 and Q4 is not expected to mirror the prior year. Regarding the shape of margin, we continue to expect sequential margin improvement in both Q3 and Q4. We expect Q3 margin near the prior year level, with Q4 expanding meaningfully over prior year as we lap the significant investments in wages and benefits.	Transcript
ATO.N						
ETR.N	2023-02-16T11:00:00Z	Revenue			Note that we continue to sit squarely in the middle of our guidance range, and we do plan to use FLEX spending or FLEX levers that we have to continue to manage 2023, both from a weather potential effects as well as any other effects that come along. This is Kimberly. We executed on key deliverables throughout the year and once again increased our dividend by 6%.	Transcript
UA.N						
HAL.N	2023-04-25T09:00:00Z	Revenue			I will now turn the call back to Jeff. Let me provide you with some comments on how we see the second quarter unfolding.	Transcript
TFC.N	2023-01-19T08:00:00Z	Revenue	24647450000	24186750000	Going forward, loan growth will moderate from the robust levels in 2022 as clients respond to the impact of higher rates, high inflation and a slowing economy. In addition, we also expect growth in residential mortgage and prime auto to continue to slow as we focus our capital on higher return opportunities. Truist remains well positioned to advise clients across a range of economic scenarios given our broad capability, talented teammates and increased capacity post integration.	Transcript
ATVI.OQ	2023-02-06T16:05:00Z	EBIT			segment operating income for 2023. We also expect interest income to be significantly higher year-over-year in 2023 given the current rate	Press Release
TAP.N	2023-03-16T11:00:00Z	Revenue			Making the tough decisions around contract brewing, which is not necessarily beneficial for us for a variety of reasons and obviously, impacts in this instance, both volume and revenue was something we wanted to do.	Transcript
ABT.N	2023-01-25T09:00:00Z	Revenue			And I think we're going to continue to see strong performance in EPD. Based on current rates, we would expect exchange to have an unfavorable impact of approximately 1% on our reported full year sales, which includes an expected unfavorable impact of approximately 3% on our first quarter reported sales.	Transcript
ABT.N	2023-01-25T07:30:07Z	Revenue			sales of around $2.0 billion.	Press Release
ABT.N	2023-01-25T09:00:00Z	EBIT			I just want to make sure I understand what's baked in on the gross margin line.	Transcript
V.N	2023-04-25T17:00:00Z	Revenue			Client incentives growth is expected to be higher in the second half than it was in the first.	Transcript
YUM.N	2023-05-03T08:15:00Z	Revenue			To close, we're incredibly pleased with our results for the quarter.	Transcript
YUM.N	2023-02-08T08:15:00Z	EBIT			We expect Taco Bell company operated margins to be in line with full year 2022 margins, and we expect our 2023 G&A to be approximately $1.15 billion, in line with the guidance provided at Investor Day.	Transcript
YUM.N	2022-11-02T08:15:00Z	EBIT			As we mentioned on the past 2 quarterly calls, were it not for the loss of Russian profits, we would expect core operating profit growth to be high single digits this year, in line with our long-term growth outlook.	Transcript
LYV.N	2023-02-23T17:00:00Z	Revenue			A few other points on 2023.	Transcript
LYV.N	2023-05-04T17:00:00Z	Revenue			And then two, on this junk fee protection act, I believe there's a provision that the FTC can determine if mandatory ticketing fees are excessive.	Transcript
LYV.N	2023-02-23T16:07:04Z	Revenue			2023 OUTLOOK (as of mid-February, vs 2022): Positioned For Ongoing Growth, As	Press Release
LYV.N	2023-05-04T17:00:00Z	EBIT			As timing plays out, we anticipate that for the full year, variable expenses and margins will be in line with 2022. But these margins are ahead of our full year 2022 numbers, and we expect margins for the full year to continue being in the high 30s.	Transcript
LYV.N	2023-05-04T17:00:00Z	EBIT			As timing plays out, we anticipate that for the full year, variable expenses and margins will be in line with 2022. But these margins are ahead of our full year 2022 numbers, and we expect margins for the full year to continue being in the high 30s.	Transcript
JNPR.N	2023-01-31T16:15:01Z	Revenue	5778308000	5778308000	2023.â€ experience, continues to resonate across the markets we serve. We believe our	Press Release
JNPR.N	2022-12-14T09:00:00Z	EBIT			We do think we can deliver at least 100 basis points of operating margin and over time, get back to 20%-plus operating margins.	Transcript
JNPR.N	2022-12-07T12:15:00Z	EBIT			So this are the top priorities.	Transcript
RE.N	2023-02-09T08:00:00Z	Revenue			So one, it sounds like you're going to update premium guidance also in November? We see abundant opportunity to continue growing and diversifying our portfolio in all markets, focused on further growth in Asia and Europe, while capitalizing on the continuing market dislocation in Property. We're in a heightened risk environment.	Transcript
FTNT.OQ	2023-05-04T16:30:00Z	Revenue	5485000000	5425000000	For the full year, we expect billings in the range of $6.750 billion to $6.810 billion, which at the midpoint represents growth of 21%. Revenue in the range of $5.425 billion to $5.485 billion, which the midpoint represents growth of 23.5%. Service revenue, the rate of $3.370 billion, to $3.400 billion, which at the midpoint represents growth of 28%. The second quarter guidance assumes backlog decreases during the quarter. The service revenue guidance implies product revenue growth of 16%. This guidance assumes a low single-digit impact of billings growth from backlog.	Transcript
FTNT.OQ	2023-05-04T16:30:00Z	EBIT	1426100000	1356250000	Non-GAAP operating margin of 25% to 26%, non-GAAP earnings per share of $1.44 to $1.48, which assumes a share count of between 795 million and 805 million.	Transcript
DTE.N	2022-02-10T09:00:00Z	EBIT			Just for our models, is that still sort of how you're thinking about the growth through 2026 in those -- in the segments? Just, Jerry -- sorry, just in previous slides, you've had this -- Dave, this disclosure on earnings growth for segments, 7% to 8% for electric and then 9% for gas. We are targeting operating earnings of $90 million to $95 million in 2022, growing to $160 million to $170 million in 2026. What we see is we see higher growth in these early years, so '22 and '23 at electric and gas, that allow us to grow at 5% to 7% through the converts that come in this year, the $1.3 billion of convert.	Transcript
DTE.N	2023-02-23T09:00:00Z	Revenue			At Vantage, as we go through 2023, we will see the timings for the earnings is back-end loaded towards the third and fourth quarters as new already secured projects come online.	Transcript
DTE.N	2022-02-10T09:00:00Z	EBIT			Just for our models, is that still sort of how you're thinking about the growth through 2026 in those -- in the segments? Just, Jerry -- sorry, just in previous slides, you've had this -- Dave, this disclosure on earnings growth for segments, 7% to 8% for electric and then 9% for gas. We are targeting operating earnings of $90 million to $95 million in 2022, growing to $160 million to $170 million in 2026. What we see is we see higher growth in these early years, so '22 and '23 at electric and gas, that allow us to grow at 5% to 7% through the converts that come in this year, the $1.3 billion of convert.	Transcript
DTE.N	2022-02-10T09:00:00Z	EBIT			Just for our models, is that still sort of how you're thinking about the growth through 2026 in those -- in the segments? Just, Jerry -- sorry, just in previous slides, you've had this -- Dave, this disclosure on earnings growth for segments, 7% to 8% for electric and then 9% for gas. We are targeting operating earnings of $90 million to $95 million in 2022, growing to $160 million to $170 million in 2026. What we see is we see higher growth in these early years, so '22 and '23 at electric and gas, that allow us to grow at 5% to 7% through the converts that come in this year, the $1.3 billion of convert.	Transcript
HST.OQ	2023-05-04T16:30:00Z	EBITDA	5405000000	5266000000	BETHESDA, Md., May 04, 2023 (GLOBE NEWSWIRE) -- Â Host Hotels & Resorts, first quarter 2023 results. The investor presentation can be found on the	Press Release
HST.OQ	2023-05-04T16:30:00Z	Revenue	1625000000	1545000000	BETHESDA, Md., May 04, 2023 (GLOBE NEWSWIRE) -- Â Host Hotels & Resorts, https://www.hosthotels.com/investor-relations/investor-presentation.	Press Release
HST.OQ	2023-05-04T16:30:00Z	EBITDA	837775000	758304000	BETHESDA, Md., May 04, 2023 (GLOBE NEWSWIRE) -- Â Host Hotels & Resorts, first quarter 2023 results. The investor presentation can be found on the	Press Release
HST.OQ	2023-05-04T16:30:00Z	EBIT			first quarter 2023 results. The investor presentation can be found on the	Press Release
HST.OQ	2023-05-04T16:30:00Z	EBITDA			Investor Relations section on the Companyâ€™s website at	Press Release
IRM.N	2023-05-04T06:45:00Z	Revenue	5600000000	5500000000	2023 Guidance Â  Y/Y % Change at Midpoint	Press Release
IRM.N	2023-05-04T06:45:00Z	EBITDA	1975000000	1940000000	Iron Mountain affirmed full year 2023 guidance; details are summarized in the table below.	Press Release
IRM.N	2022-11-03T08:30:00Z	EBITDA			And with that, it's a fully-funded capital plan through EBITDA expansion and leverage within our target range.	Transcript
PEAK.N	2022-02-09T11:00:00Z	Revenue			92% exclude our newly announced Vantage project. And then maybe you could talk a little bit about how cap rates have also trended in your markets since rent growth has been so strong. And then second question is just on the life science rents that you talked about in the last year growing well over double digit, still a very low vacancy in those markets that you're in. And we expect our embedded $10-plus billion shadow development pipeline will be a key driver of our future growth. At the same time, when we look at the supply-demand fundamentals as well as our own portfolio, where we're essentially fully leased other than the normal frictional vacancy for downtime to build out TIs, we are expecting that the rent growth will be quite attractive in 2022. During the last 5 years, we delivered $1.4 billion of life science development at an average yield of 8%, which compares to stabilized cap rates for these Class A assets of 4% or less. For Class A space in the 3 core markets today are probably plus or minus 4%, depending upon the mark-to-market that exists at that building. Given the huge leasing demand and tight market conditions for high-quality life science products, we continue to see tenants commit to space before steel has even come out of the ground. I don't know that we would predict that that's going to continue in 2022. More recently, it's obviously been higher, double digits, approaching 20% in San Diego and Boston over the past year. On market rents, over the last decade in the 3 core markets, the compounded growth rate has been in the 7% range. Our active $1.6 billion life science and MOB pipeline is projected to provide a 7% weighted average yield on cost and a 74% pre-leased. So I guess I'm just wondering if you still think that the potential for rent growth over the next year is still over 10% for your markets? So certainly, pricing is strong. So if anything, that mark-to-market across our portfolio, looking forward probably grows rather than declines. So if anything, you'd expect a 100% purchase with full control to trade at even lower cap rates. So it's somewhere in that range, and there's been plenty of trades in that general range in the past quarter or 2, even for minority positions or noncontrolling interests. That's pretty high. With consideration to the scarcity and current pricing for well-located, stabilized life science and on-campus MOB properties, our development machine has become a growing part of our growth strategy in addition to accretive acquisitions.	Transcript
PEAK.N	2023-04-28T11:00:00Z	EBIT			Yes. Good question, and I'm glad you brought it up, Steve.	Transcript
PEAK.N	2023-02-08T11:00:00Z	EBIT			And then just on development contributions for guidance for '23, you guys give fantastic details so kudos to you, but just curious on how much development NOI should we expect to contribute in '23 and any sort of insights into at least currently, what would be incremental in '24, not to get ahead of our skis, but just curious of whatever details you can provide on development NOIs.	Transcript
FIS.N	2023-02-13T08:30:00Z	Revenue	14535000000	14285000000	The first of these headwinds has been a lack of new product investment, driving compression and attrition in our SMB subsegment, accounting for approximately 3 points of headwind in our Merchant guide. We're confident this is near term in nature and will be directly addressed with the successful spin of Worldpay as it transitions to a growth-oriented capital structure and investment philosophy.	Transcript
FIS.N	2022-02-15T08:30:00Z	Revenue	6100000000	5900000000	Based on our large and growing backlog as well as our expanding pipeline of new opportunities, we expect Banking to continue to grow high single digits in the midterm. In 2022, Banking will grow 6% or more due to approximately 200 basis points in grow overs. In summary, while we continue to see impacts from the pandemic in the short term, Merchant TAM is expected to grow 8% to 10% through the midterm, as shown on Slide 24. This is primarily due to lapping pandemic-related stimulus and expected lower termination fees.	Transcript
FIS.N	2023-05-22T15:50:00Z	Revenue			I expect backlog to mitigate. In fact, that's why as I gave guidance for banking for 2023, we had a lowered expectation around guidance. It might go negative here on us over the next couple of quarters and then come back out as we reposition ourselves and really focus on the selling.	Transcript
FIS.N	2023-04-27T08:00:00Z	Revenue			For the second quarter, we are anticipating banking organic revenue growth of 0% to 2%, which incorporates a continued reduction in nonrecurring revenue, and we remain confident in meeting or exceeding our organic growth outlook for the year.	Transcript
FIS.N	2023-04-27T08:00:00Z	EBITDA			With that in mind, for the year, we now anticipate consolidated organic revenue growth of 0% to 1%, adjusted EBITDA margins of 41.5% to 42.2% and adjusted earnings per share of $5.76 to $6.06.	Transcript
FIS.N	2023-02-13T08:30:00Z	EBITDA			Banking margins will improve throughout the year, with a return to margin expansion in the second half.	Transcript
FIS.N	2023-02-13T08:30:00Z	EBITDA			Banking margins will improve throughout the year, with a return to margin expansion in the second half.	Transcript
FIS.N	2023-02-13T08:30:00Z	EBITDA			As you know, these businesses are highly margin accretive on the right growth trajectory, highly recurring revenue generative.	Transcript
FIS.N	2023-02-13T08:30:00Z	EBITDA			Banking margins will improve throughout the year, with a return to margin expansion in the second half.	Transcript
DAL.N	2022-07-13T10:00:00Z	Revenue	54726000000	52445750000	And as we increase the mix of premium seats in our fleet, improve the display and sales channels and see progression in the recovery of business, premium will continue to grow. Premium continues to lead with load factors and yields higher than 2019. We expect more than 60% of revenue will come from premium products and non-ticket revenue sources by 2024. We're on track to receive over $5 billion in remuneration this year from American Express, and we remain confident in our 2024 target of $7 billion.	Transcript
DAL.N	2022-10-13T10:00:00Z	Revenue	6567120000	5244575000	As we get closer and closer to it, it looks like it's -- we may need to increase that as we get closer to '24. But I think 60%, as you pointed out, was our aspirational target. But obviously, your revenue guidance is pretty positive, but I do think it's a sequential decline in your yields. I think we're at 54% now, but the goal is to get to 60% by 2024. I think we're very, very confident in getting to 60% given that we've been less restored internationally, and internationally has actually a higher component of premium revenues and -- as well as the new fleets coming in and the continuation of growth at American Express and (inaudible). So I think the one that we're not confident with right now is cargo for 2024. That optimism is also reflected in GBTA's recent travel survey where 80% of respondents expect travel volumes to increase in 2023 compared to '22. We expect corporate sales recovery in the December quarter in the low to mid-80s at a system level. Yes.	Transcript
DAL.N	2023-03-14T08:00:00Z	EBIT			Our full year 2023, we're looking at revenue growth in the 15% to 20% range, an operating margin of 10% to 12%, EPS of $5 to $6 per share.	Transcript
DAL.N	2023-04-13T10:00:00Z	EBIT			We are reaffirming our full year guidance for operating margins of 10% to 12%, earnings of $5 to $6 per share and more than $2 billion of free cash flow.	Transcript
ROK.N	2023-02-22T09:45:00Z	Revenue	8900000000	8900000000	And what sort of -- to the extent it is a stand-alone business still, what kind of organic growth are you seeing? Or what should people expect at Plex? We haven't broken out the specific growth targets for that portion of Information Solutions & Connected Services, but we have said that, that's double digit as is the ARR growth and Plex business is practically all annual recurring revenue, and we see that as good double-digit growth this year.	Transcript
ROK.N	2023-04-27T08:30:00Z	Revenue	1913500000	1913500000	Also, as the largest pure play, we have an impressive record of earnings growth, and we expect that to continue given our unique market focus and differentiation. Our fiscal '23 guidance projects total reported sales growth of 14.5%. This is consistent with our expectations of improving component availability and the subsequent reduction in customer lead times. We are increasing our reported sales guidance to approximately $8.9 billion in fiscal '23 or 14.5% growth at the midpoint. With our current orders outlook, we anticipate exiting the year with backlog levels of around $5 billion, positioning us well for fiscal year '24.	Transcript
ROK.N	2023-05-09T10:15:00Z	EBIT			I'm not sure I'm ready to give guidance beyond '23. We're also seeing strength in the software portion of our business in Software & Control.	Transcript
ROK.N	2023-01-26T08:30:00Z	EBIT			That's more inclusive of everything.	Transcript
ROK.N	2023-04-27T08:30:00Z	EBIT			Our updated guidance now assumes full year core earnings conversion of close to 40%. This represents a 100 basis point increase versus our prior guidance, split evenly between price and cost.	Transcript
DOW.N	2022-01-27T06:00:05Z	Revenue			value for our shareholders."	Press Release
DOW.N	2022-04-21T08:00:00Z	Revenue			All combined, these investments represent a 70% increase in our industry-leading downstream alkoxylates capacity over the next several years, targeting high-value applications where we're delivering 10% to 15% annual growth rates. These expansions maintain our current carbon emissions levels and are backed by supply agreements with leading consumer brands across fast-growing end markets.	Transcript
DOW.N	2023-04-25T08:00:00Z	EBITDA			Or -- and does the cost reductions kind of bridge that gap?	Transcript
DOW.N	2023-03-14T08:50:00Z	EBIT			But we look at EBIT and we also look at cash flow.	Transcript
DOW.N	2023-03-14T08:50:00Z	EBITDA			I would say the one we landed on right now is looking at EBITDA, EBIT really, if you look at our -- our incentives are based on EBIT. We've -- I look at EBIT and EBITDA both, but we've said that we're going to keep our investments at or below D&A and so EBITDA and EBIT should move relatively similarly. When you think about how you manage Dow or how the Board looks at Dow, how does it try to get the incentives for management and the employees in the right place?	Transcript
PPL.N	2022-02-18T11:00:00Z	EBIT			So we have the next round of retirements, you may recall, in 2024.	Transcript
NTRS.OQ						
VFC.N	2022-05-19T16:00:00Z	Revenue			As we told you in January, we're committed to delivering the long-term algorithm for VF. Our performance in fiscal '22 and guidance for fiscal '23 clearly shows we're largely delivering on our commitment to high single-digit revenue growth and low double-digit operating earnings growth despite underperformance in our Vans business, headwinds through the supply chain, and finally, new and pronounced market challenges in one of our key growth markets, China, as well as macro events leading to a significant increase in inflation globally.	Transcript
VFC.N	2023-05-23T16:30:00Z	Revenue			And in both of those brands, we expect to grow, and we'll continue to see good performance in the Outdoor emerging brands and as we begin to even evolve our operating model there to accelerate value creation in those brands. We're going to see improving results in both Supreme and Dickies.	Transcript
VFC.N	2023-05-23T16:30:00Z	Revenue			In addition, we have an unfavorable brand mix in the quarter with a bigger (inaudible), which will have a disproportionate impact from U.S. wholesale as we expect the brand's revenue to be particularly affected by a continuation of lower wholesale sales in the spring season as we work to right size inventories. We expect EMEA to be resilient and generate profitable revenue growth in fiscal year '24 behind its hallmark execution strength. We expect growth in Europe for the year, although we do anticipate some deceleration considering our evolved view of macro pressures, and continued progressive improvement in China, which we've seen gain momentum in recent quarters and expect that to continue.	Transcript
VFC.N	2023-05-23T16:05:00Z	EBIT			* Operating margin expansion, driven by the higher gross margins supporting	Press Release
VFC.N	2023-05-23T16:30:00Z	EBIT			While gross margin is expected to be similar year-over-year in the quarter, SG&A will deleverage from the revenue decline, which will pressure operating margins.	Transcript
VFC.N	2023-05-23T16:05:00Z	EBITDA			We expect to improve our operating performance and financial results, an increasingly difficult near-term environment, particularly in US wholesale. generation, all of which supports our plan to de-lever. I remain confident VF	Press Release
ETN.N	2022-11-01T11:00:00Z	Revenue			Third, we're benefiting from the aerospace industry growth cycle, which, over the next several years, will continue to accelerate.	Transcript
ETN.N	2023-05-02T11:00:00Z	Revenue			And we're increasing Aerospace 200 basis points to 10% to 12% from 8% to 10%.	Transcript
ETN.N	2022-11-01T11:00:00Z	Revenue			Third, we're benefiting from the aerospace industry growth cycle, which, over the next several years, will continue to accelerate.	Transcript
ETN.N	2022-03-15T12:30:00Z	EBIT			And the goal is, let's do more of the good stuff, less of the stuff that's marginal, and that's the way we continue to evolve the portfolio, and that's the way, quite frankly, that we continue to expand the margins inside of the company. And what's the margin of safety in your forecast? Maybe you can sort of talk about what are the drivers of your higher targets? So you raised your medium-term targets. They're chasing targets that are pretty considerably higher, about 150 basis points higher than what we set at the corporate level.	Transcript
ETN.N	2023-05-02T11:00:00Z	EBIT			As a reminder, this is a 70 basis point increase at the midpoint from our 2022 all-time record margin. For segment margins, we're raising our guidance range for Electrical Americas by 20 basis points to a revised range of 23.3% to 23.7%, which reflects the continued strong momentum that we have in this business.	Transcript
CVX.N	2022-02-28T11:00:00Z	EBITDA			But as you know, depending on what -- whether it exists or at what level it's at, we'd expect markets to rebalance -- to compensate some forward. But if you go through LCFS, credits, are down a little bit.	Transcript
LNC.N	2023-02-09T10:00:00Z	Revenue			I guess for you or Randy, can you help give us any sense of the magnitude of that item specifically, and if that's something that could potentially be dealt with, with internal reinsurance? Ryan, I'll not get into the specifics of any particular product. The improved rate environment, coupled with our proven track record of delivering positive flows, positions Retirement to continue to deliver strong results going forward.	Transcript
LNC.N	2023-05-02T16:30:00Z	EBIT			At current interest rates, we expect the deal to have an immaterial and initial impact on stockholders' equity ex-AOCI. Let me now turn to the financial impacts on a GAAP basis. Overall, we remain confident in our ability to drive profitable long-term growth, particularly as we look to 2024 and beyond. We expect the transaction to impact adjusted operating income by approximately $150 million on an annual basis or a negative quarterly run rate impact of $30 million to $35 million in our Life Insurance business and $5 million in our annuities business.	Transcript
CI.N	2023-05-10T12:20:00Z	Revenue	188000000000	188000000000	And then the services business is like 10% of Evernorth.	Transcript
CI.N	2022-11-03T08:30:00Z	Revenue	7360000000	7360000000	One good example of this is our recently announced partnership with Centene that will deliver greater prescription drug affordability and access for their approximately 20 million customers starting in January of 2024. This mutually beneficial partnership will bring significant revenue and will be financially accretive over the course of the multiyear contract term.	Transcript
CI.N	2023-05-10T12:20:00Z	Revenue			We increased our revenue outlook by $1 billion for the year as well and also increased our Cigna Healthcare medical customer growth expectation to be at least 1.3 million customers off of where we started the year.	Transcript
CI.N	2023-05-10T12:20:00Z	Revenue			And then the services business is like 10% of Evernorth.	Transcript
CI.N	2022-08-04T08:30:00Z	EBIT			With our increased 2022 outlook, we're now projecting for the profit margin in Cigna Healthcare to run in the high 8%, just south of 9% relative to our long-term margin goal of 9% to 10%.	Transcript
CI.N	2022-06-14T14:20:00Z	EBIT			But that gives us opportunity on a multiyear basis to creep up towards the midpoint of the 9% to 10% all-in Cigna Healthcare range.	Transcript
CI.N	2023-05-10T12:20:00Z	EBIT			If you think of Evernorth, in aggregate, delivers 4% to 4.5% margins, which we -- again, we think are competitive, sustainable in a variety of scenarios. So I mentioned 4% to 4.5% margins for Evernorth.	Transcript
CI.N	2023-05-05T06:00:04Z	EBIT			December 31, 2023	Press Release
ACN.N	2022-12-21T07:59:00Z	Revenue	68369678550	66521849400	consumers to easily find and access content.â€ drive revenue for media companies, while delivering experiences that enable said Imran Shah, a managing director with Accentureâ€™s Communications, Media â€œThe future of the media industry is moving toward aggregated platforms,â€	Press Release
ACN.N	2023-02-02T10:14:00Z	Revenue	9688784180	9379580770	(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.accenture.com%2Fus-en%2Finsights%2Flife-sciences%2Fnewscienceecon&esheet=53298604&newsitemid=20230201006099&lan=en-US&anchor=expected+to+drive+81+percent+of+biopharma+revenue+growth&index=3&md5=90af016eb04292855cd1b1a2c6949522)	Press Release
ACN.N	2023-03-23T08:00:00Z	EBIT			We expect business optimization actions to impact fiscal '23 GAAP operating margin by 120 basis points and EPS by $0.96.	Transcript
ACN.N	2023-03-23T08:00:00Z	EBIT			For adjusted operating margin, we expect fiscal year '23 to be 15.3% to 15.5%, a 10 to 30 basis point expansion over fiscal '22 results.	Transcript
XYL.N	2023-05-04T09:00:00Z	Revenue	6018980000	5963760000	This increase in our outlook is driven by continued robust demand for our AMI solutions and earlier improvements in chip supply through 2023 as seen in quarter 1, allowing for backlog execution. Utilities, which makes up the largest end market, continues to be healthy, and we now expect growth in low teens in 2023, up from high single digits.	Transcript
XYL.N	2023-05-04T09:00:00Z	EBITDA	1083416400	1043658000	We expect second quarter EBITDA margin to be in the range of 17.5% to 18%, which represents over 100 basis points of improvement versus the prior year, driven by higher volumes and continued price realization and productivity gains.	Transcript
XYL.N	2022-08-02T09:00:00Z	EBITDA			And so that took a more mechanical meaning this time around.	Transcript
HAS.OQ	2022-10-18T06:30:00Z	Revenue	5798133000	5680999000	* For the full-year, on a constant currency basis and excluding the music business which was sold in 2021, we expect revenue to decline mid-single including our plan to drive accelerated growth and profit over the next five scripted TV and film releases move to the first quarter of 2023. Adjusted	Press Release
HAS.OQ	2022-10-18T06:30:00Z	Revenue	1173100000	1173100000	* For the full-year, on a constant currency basis and excluding the music business which was sold in 2021, we expect revenue to decline mid-single including our plan to drive accelerated growth and profit over the next five scripted TV and film releases move to the first quarter of 2023. Adjusted	Press Release
HAS.OQ	2023-04-27T06:30:00Z	Revenue			2022. Guidance will be updated upon completion of the sale process of our	Press Release
HAS.OQ	2023-05-22T11:20:00Z	Revenue			And Hasbro is a $2 billion business in that, that generates 30% operating profit today. And I certainly think we're going to be able to drive our bottom line profitability a lot more aggressively. And we see by reorienting on operational excellence, the ability to significantly improve our profitability in our toy business, such that if you look out 3 to 5 years for Hasbro, we probably will have better-than-average toy and game growth prospects, call it, mid-single digits but probably in the 9% to 10% range in terms of operating profit growth by focusing and scaling our business, by leaning into games and leaning into higher-margin play opportunities. Because if you look at businesses like games, games is a $2 billion business for Hasbro. Looking out, we see that games business growing significantly. The games industry has generally been growing at a mid-single-digit to upper single-digit growth CAGR.	Transcript
HAS.OQ	2023-04-27T08:30:00Z	Revenue			As we continue to invest in Wizards of the Coast, operating profit declined 28% due to higher product costs, product development, personnel costs, advertising expense and costs supporting the return of organized play. Looking at our segments, Wizards of the Coast and Digital Gaming revenue increased 14% in constant currency. Tabletop revenues were up 13% behind popular MAGIC: THE GATHERING releases.	Transcript
HAS.OQ	2022-10-18T06:30:00Z	EBIT			meet our objectives. We are focused on selling through inventory and managing	Press Release
HAS.OQ	2022-10-04T12:00:00Z	EBIT			During todayâ€™s event, Hasbro provided an overview of its long-term outlook Financial Outlook	Press Release
HAS.OQ	2023-02-16T08:30:00Z	EBIT			Also, as we continue to invest for future growth and expand our universe of Beyond products, we expect adjusted operating profit margin in the high 30% range. For the full year 2023, we expect entertainment revenue to increase low single digits, and adjusted operating profit margin is expected to increase slightly from 8.6% in 2022.	Transcript
HAS.OQ	2023-04-27T08:30:00Z	EBIT			As we continue to invest in Wizards of the Coast, operating profit declined 28% due to higher product costs, product development, personnel costs, advertising expense and costs supporting the return of organized play. We continue to expect full year operating profit margin for the segment in the high 30% range, which reflects investment for future growth and expansion of our Universes Beyond products.	Transcript
HAS.OQ	2023-04-27T06:30:00Z	EBIT			* For the full-year 2023, we expect revenue to increase low-single digits and	Press Release
ENPH.OQ	2023-04-25T16:30:00Z	Revenue			We expect to ship 50,000 net in USA microinverters to customers this quarter.	Transcript
SO.N	2023-02-16T13:00:00Z	Revenue			Included in our 2023 guidance is an assumption of retail electric sales growth of 0% to 1%.	Transcript
CTLT.N	2022-02-01T08:15:00Z	Revenue	4875000000	4625000000	And our Oral and Specialty Delivery and Clinical Supply Services segment are also slated to grow in the mid- to high single digits at attractive margin profiles. And so -- but I will fall short from providing the specifics about this one. As highlighted last quarter, we opened new CSS facilities in San Diego, California and Shiga, Japan in the first half of this fiscal year and expect them to be long-term growth drivers for the segment. But have you seen any -- or can you just walk us through your ability to absorb the impact by moving customer projects to elsewhere in the network from Brussels? Finally, our Clinical Supply Services segment posted high single-digit net revenue and EBITDA growth compared to the second quarter of fiscal 2021. However, we all need to appreciate the tough customers. I believe, from other contexts, we're to believe that maybe that's a 6- or 7-month time frame. I can confirm that we're only going to restart this facility where we are satisfied meeting with the highest standards of quality and compliance. I can only share that we have deployed a significant amount of resources, internal and external experts, in my comment to this. I guess kind of two aspects of this question as well, one being the time frame that you expect this facility to be impacted as you remediate the issues. If you could confirm that. In addition to our positive organic performance, we received a strong boost from the first quarterly contribution from Bettera, which added more than 20 percentage points of net revenue growth to the segment. In fact, we have public disclosures that have been made around relationships with several key customers that extend through the fiscal '23 time frame. In terms of what the revenue profile of COVID looks like after 2024, we haven't -- sorry, after 2023, we haven't talked about that specifically, but we did clarify on today's call, Dave, that it's expected to be a significantly lower contributor in the outer years of our long-term target, especially with regards to fiscal '26. It did require some engineering a high-filtration system, which are ongoing. It sounds like the financial impact from the shutdown is clearly fairly manageable. Just a follow up on Dave's line of questioning there, Tom. My follow-up question, maybe a good seque, Alessandro, you touched on the 483. Our second biggest segment, Softgel and Oral Technologies, is now up to 6% to 8% with improved margins following the acquisition of Bettera. So the size of Catalent's battleship, if you will, gives us just the ability to absorb these types of normal course challenges that come up from time to time when you operate in a highly regulated space. So to answer your question, we have been able to absorb this. So with the first part of the question, look, we, of course, plan, work very, very hard and strive not to have these situations, and we expect from us surely the highest level of excellence. Specifically, they have way more data point than just one 483. The Bettera acquisition was an important factor in leading us to raise this segment's long-term net revenue growth rate to 6% to 8% and improving its margin profile. The investment is ongoing there. They experience and observe the performance of Catalent and add values We have said that we do expect our COVID revenue to continue to contribute into our fiscal '23 year. We operate over 50 sites across the globe, manufacturing over 7,000 products across 1,000 different customers. We said from the start that this was not a material financial contributor or impact for the company, and I think that's seen by the robust guidance we've put forth here for the remainder of the fiscal year.	Transcript
CTLT.N	2022-02-01T08:15:00Z	Revenue	4350000000	4250000000	And our Oral and Specialty Delivery and Clinical Supply Services segment are also slated to grow in the mid- to high single digits at attractive margin profiles. And so -- but I will fall short from providing the specifics about this one. As highlighted last quarter, we opened new CSS facilities in San Diego, California and Shiga, Japan in the first half of this fiscal year and expect them to be long-term growth drivers for the segment. But have you seen any -- or can you just walk us through your ability to absorb the impact by moving customer projects to elsewhere in the network from Brussels? Finally, our Clinical Supply Services segment posted high single-digit net revenue and EBITDA growth compared to the second quarter of fiscal 2021. However, we all need to appreciate the tough customers. I believe, from other contexts, we're to believe that maybe that's a 6- or 7-month time frame. I can confirm that we're only going to restart this facility where we are satisfied meeting with the highest standards of quality and compliance. I can only share that we have deployed a significant amount of resources, internal and external experts, in my comment to this. I guess kind of two aspects of this question as well, one being the time frame that you expect this facility to be impacted as you remediate the issues. If you could confirm that. In addition to our positive organic performance, we received a strong boost from the first quarterly contribution from Bettera, which added more than 20 percentage points of net revenue growth to the segment. In fact, we have public disclosures that have been made around relationships with several key customers that extend through the fiscal '23 time frame. In terms of what the revenue profile of COVID looks like after 2024, we haven't -- sorry, after 2023, we haven't talked about that specifically, but we did clarify on today's call, Dave, that it's expected to be a significantly lower contributor in the outer years of our long-term target, especially with regards to fiscal '26. It did require some engineering a high-filtration system, which are ongoing. It sounds like the financial impact from the shutdown is clearly fairly manageable. Just a follow up on Dave's line of questioning there, Tom. My follow-up question, maybe a good seque, Alessandro, you touched on the 483. Our second biggest segment, Softgel and Oral Technologies, is now up to 6% to 8% with improved margins following the acquisition of Bettera. So the size of Catalent's battleship, if you will, gives us just the ability to absorb these types of normal course challenges that come up from time to time when you operate in a highly regulated space. So to answer your question, we have been able to absorb this. So with the first part of the question, look, we, of course, plan, work very, very hard and strive not to have these situations, and we expect from us surely the highest level of excellence. Specifically, they have way more data point than just one 483. The Bettera acquisition was an important factor in leading us to raise this segment's long-term net revenue growth rate to 6% to 8% and improving its margin profile. The investment is ongoing there. They experience and observe the performance of Catalent and add values We have said that we do expect our COVID revenue to continue to contribute into our fiscal '23 year. We operate over 50 sites across the globe, manufacturing over 7,000 products across 1,000 different customers. We said from the start that this was not a material financial contributor or impact for the company, and I think that's seen by the robust guidance we've put forth here for the remainder of the fiscal year.	Transcript
CTLT.N	2022-02-01T08:15:00Z	Revenue	775000000	725000000	And our Oral and Specialty Delivery and Clinical Supply Services segment are also slated to grow in the mid- to high single digits at attractive margin profiles. And so -- but I will fall short from providing the specifics about this one. As highlighted last quarter, we opened new CSS facilities in San Diego, California and Shiga, Japan in the first half of this fiscal year and expect them to be long-term growth drivers for the segment. But have you seen any -- or can you just walk us through your ability to absorb the impact by moving customer projects to elsewhere in the network from Brussels? Finally, our Clinical Supply Services segment posted high single-digit net revenue and EBITDA growth compared to the second quarter of fiscal 2021. However, we all need to appreciate the tough customers. I believe, from other contexts, we're to believe that maybe that's a 6- or 7-month time frame. I can confirm that we're only going to restart this facility where we are satisfied meeting with the highest standards of quality and compliance. I can only share that we have deployed a significant amount of resources, internal and external experts, in my comment to this. I guess kind of two aspects of this question as well, one being the time frame that you expect this facility to be impacted as you remediate the issues. If you could confirm that. In addition to our positive organic performance, we received a strong boost from the first quarterly contribution from Bettera, which added more than 20 percentage points of net revenue growth to the segment. In fact, we have public disclosures that have been made around relationships with several key customers that extend through the fiscal '23 time frame. In terms of what the revenue profile of COVID looks like after 2024, we haven't -- sorry, after 2023, we haven't talked about that specifically, but we did clarify on today's call, Dave, that it's expected to be a significantly lower contributor in the outer years of our long-term target, especially with regards to fiscal '26. It did require some engineering a high-filtration system, which are ongoing. It sounds like the financial impact from the shutdown is clearly fairly manageable. Just a follow up on Dave's line of questioning there, Tom. My follow-up question, maybe a good seque, Alessandro, you touched on the 483. Our second biggest segment, Softgel and Oral Technologies, is now up to 6% to 8% with improved margins following the acquisition of Bettera. So the size of Catalent's battleship, if you will, gives us just the ability to absorb these types of normal course challenges that come up from time to time when you operate in a highly regulated space. So to answer your question, we have been able to absorb this. So with the first part of the question, look, we, of course, plan, work very, very hard and strive not to have these situations, and we expect from us surely the highest level of excellence. Specifically, they have way more data point than just one 483. The Bettera acquisition was an important factor in leading us to raise this segment's long-term net revenue growth rate to 6% to 8% and improving its margin profile. The investment is ongoing there. They experience and observe the performance of Catalent and add values We have said that we do expect our COVID revenue to continue to contribute into our fiscal '23 year. We operate over 50 sites across the globe, manufacturing over 7,000 products across 1,000 different customers. We said from the start that this was not a material financial contributor or impact for the company, and I think that's seen by the robust guidance we've put forth here for the remainder of the fiscal year.	Transcript
CTLT.N	2023-05-19T08:15:00Z	Revenue			This is a segment where we expected a strong growth as we started the year, modified our expectations to much more modest growth in November and February, and now tracking to flat organic revenue growth for the full year.	Transcript
CTLT.N	2023-05-19T08:15:00Z	Revenue			The revenue accounting treatment for complex products with long production cycles will continue to be recognized on a percentage of completion basis when contract terminology determines our work related to commercial activity. These issues drove our EBITDA reduction in our reduced revised guidance to be greater than our revenue reduction due to the following dynamics. When I look at the overall picture, and notwithstanding the fact that we entered into this fiscal year with more ambitious expectations for our top line growth.	Transcript
CTLT.N	2022-11-01T08:15:00Z	EBIT			And look, I think our margins are looking to be flat this current year in the new guidance in comparison to where they were in the prior year. Yes. No, good question, Dave. Your margin forecast for the new guidance is essentially the same as the old guidance.	Transcript
CTLT.N	2022-02-01T08:15:00Z	EBIT			The Bettera acquisition was an important factor in leading us to raise this segment's long-term net revenue growth rate to 6% to 8% and improving its margin profile. They're not material, full disclosure, at this point in time in the overall map of the company. We did want to just highlight the fact that we will see these -- some additional costs here as a result of the remediation efforts that will have an adverse impact in the margin profile of the business in the second half of the year, primarily in the third quarter.	Transcript
CTLT.N	2022-02-01T08:15:00Z	EBITDA			As highlighted last quarter, we opened new CSS facilities in San Diego, California and Shiga, Japan in the first half of this fiscal year and expect them to be long-term growth drivers for the segment. Finally, our Clinical Supply Services segment posted high single-digit net revenue and EBITDA growth compared to the second quarter of fiscal 2021.	Transcript
CTLT.N	2023-05-19T08:15:00Z	EBITDA			We are now reducing our fiscal '23 net revenue guidance to a range from $4.25 billion to $4.35 billion, and we are reducing our adjusted EBITDA guidance to range from $725 million to $775 million.	Transcript
CTLT.N	2022-06-07T13:00:00Z	EBITDA			Our long-term target you see on this page now by fiscal '26 is greater than $7.5 billion of revenue for the consolidated company at EBITDA margins of approximately 30%.	Transcript
VNO.N	2022-02-15T10:00:00Z	Revenue			Other than Hotel Penn's income, we still expect to recover most of the income from our variable businesses in 2022 with the full return in 2023.	Transcript
CTXS.OQ^J22						
DISH.OQ	2023-02-23T12:00:00Z	Revenue			And I've got a follow-up. And anything I'm missing and your latest thoughts would be helpful. And then obviously, we're looking at retail wireless and the network co to finance some of that business. I think it is in next year, and we'll look to refinance that with hopefully an equity component. So that's the big picture answer.	Transcript
LUMN.N	2022-12-01T12:20:00Z	Revenue	4800000000	4600000000	But yes, I do think given the quality of the product and the ability to do marketing behind that as we get to scale, that probably gives us more tailwinds than headwinds.	Transcript
LUMN.N	2023-05-02T16:01:06Z	EBITDA			below:	Press Release
LUMN.N	2022-12-01T12:20:00Z	EBITDA			So those are... We talked about CapEx being in about the same neighborhood that we guided this year.	Transcript
NRG.N	2023-05-04T09:00:00Z	EBITDA	3250000000	3010000000	Finally, we are updating our 2023 guidance ranges to include Vivint and the alignment of adjusted EBITDA between our 2 companies.	Transcript
NRG.N	2023-05-04T07:10:00Z	Revenue			from capitalizing proceeds received from installation and equipment and then return the unit to service by the end of the second quarter of 2023. The	Press Release
NRG.N	2022-12-06T08:00:00Z	EBITDA			For NRG, we are using the midpoint of the 2023 guidance recently released, while for Vivint, since they have not issued yet 2023 guidance, we are using its 2022 EBITDA as a baseline for the pro forma calculation and the consistent estimate of its equivalent free cash flow before growth, assuming the transaction closes on January 1, 2023. On Slide 21, you can find a summary of the pro forma combined 2023 key financial metrics and 2025 equivalent run rate for the combined businesses. We now expect to deliver $835 million of incremental EBITDA in 2025, a 60% increase from our baseline. We told you we were going to launch several test-and-learn initiatives to validate our assumptions and determine the right business model and go-to-market strategy. Well, this highly accretive transaction provides the certainty on how we're going to achieve these goals and win.	Transcript
NRG.N	2023-02-16T07:00:01Z	EBITDA			Adjusted EBITDA(a) $2,270 - $2,470 expects to achieve 2.50x to 2.75x corporate net debt to adjusted EBITDA by	Press Release
MKTX.OQ	2023-01-25T10:00:00Z	Revenue			And with respect to the post trade, that continues to be a mid-single-digit growth rate. But the good news for the 2023 outlook, we think that the growth rates will be in the 10% to 12% range for information services on a constant currency basis, and we hope to do better than that. Just thinking about 2023 and what -- as you think about infoservices and post trade, what are the kind of good growth rates or appropriate growth rate to think about for the next 12 months or beyond? Wanted to follow up on just the nontransactional revenue.	Transcript
LMT.N	2023-04-18T07:29:03Z	EBIT	66000000000	65000000000	(in millions) 2023 Outlook (in millions, except per share data) 2023 Outlook(1) Business segment operating profit (non-GAAP) ~$7,255 - $7,355 Business segment operating profit(2, 3) ~$7,255 - $7,355	Press Release
LMT.N	2023-04-18T11:00:00Z	EBIT	7355000000	7255000000	And so, we're just dealing with a 1-year type of a trough, I would say.	Transcript
LMT.N	2023-04-18T11:00:00Z	Revenue			However, we anticipate little to no revenue impact from any potential delivery delay, and therefore, no material adverse effect on our 2023 P&L.	Transcript
LMT.N	2022-10-18T11:00:00Z	EBIT			2023, we'll see a step down from where they are this year in 2022. The other thing I just have to also mention is that where we see the margin pressure next year, a lot of that is driven at MFC.	Transcript
LMT.N	2023-03-16T10:30:00Z	EBIT			And I think there was a little bit of confusion in terms of how to read that because you think that, that much margin pressure suggests potential for -- maybe there's a zero-margin program that's actually sizable enough to drive the whole segment margin down that much. And so the only thing that we have there is for the timing, we'll see that over the next 5 years, it's possible based on facts and circumstances that we may have to do a pull forward loss based on -- based on the situation. Is that -- was that kind of the right takeaway for people to have about that? It's actually negative margin for -- it's a program that's in development today. Maybe to stay on the topic of missiles and prior control. So we've got protection there. The development part of it was -- is cost plus.	Transcript
LMT.N	2023-04-18T07:29:03Z	EBIT			Consolidated operating profit (GAAP) ~$8,345 - $8,445	Press Release
DLR.N	2023-04-27T17:00:00Z	EBITDA	5600000000	5500000000	We are also affirming our full year adjusted EBITDA guidance of $2.7 billion at the midpoint as the downward adjustment in our overall revenue guidance is purely due to lower utility expenses, driven by lower spot electricity rates that are passed on directly to our customers.	Transcript
DLR.N	2023-04-27T17:00:00Z	Revenue	2725000000	2675000000	The lag between signings and commencements in the quarter was 16 months, principally due to a few larger long-term leases that require buildouts. We expect the remaining $200-plus million of commencements in 2023 to be somewhat evenly weighted throughout the balance of the year.	Transcript
DLR.N	2023-03-06T08:00:00Z	EBIT			And curious if you could unpack where that incremental utilization is coming from. And that has to do with -- we've been chopping a lot of wood on our renewals. And we believe that will be an incremental step-up in the less than a megawatt category. One of the other points, I think you referenced this earlier when you're discussing the business, so one of the other points that you're, I think, guiding on this year is higher utilization in 2023. We've been selling out of places where we have less pricing power, even on the larger footprint side, and the pricing panel continues to move in our favor.	Transcript
DLR.N	2023-04-27T17:00:00Z	EBIT			We also made meaningful progress on the turn in our fundamentals during the quarter, providing strong support to the organic operating metrics supporting our full year guidance, including cash and GAAP re-leasing spreads over 3%, same-capital cash NOI growth of 3% to 4% and year-end portfolio occupancy between 85% and 86%.	Transcript
PSX.N	2023-05-03T07:00:00Z	EBITDA			Phillips 66 is executing its NGL growth strategy to build its generate an incremental $1 billion of annual adjusted EBITDA. In addition, including the impact from the merger transaction last year, is expected to	Press Release
PSX.N	2023-03-02T12:00:00Z	Revenue			We actually gave guidance on $800 million to $900 million on turnarounds last year, which is a pretty heavy year for us, honestly. We came in below the low end of that guidance in the $700 million number.	Transcript
PSX.N	2022-11-01T12:00:00Z	EBITDA			And certainly, the piece that we control, we know we'll be moving, and we'll provide details next week. But we'll be more focused on what we're doing to drive our mid-cycle going forward. What the -- has the market mid-cycle moved, it has our ability to generate EBITDA move.	Transcript
PSX.N	2023-03-02T12:00:00Z	EBITDA			And every dollar per barrel on gasoline is $320 million of EBITDA a year. Every dollar diesel is $280 million a year. Every dollar on Canadian heavy is $100 million a year. We do believe it will be higher, but that's the baseline that you can utilize.	Transcript
SCHW.N	2023-04-17T09:00:00Z	Revenue			Second, although the volume of client cash allocation activity has exceeded the expectations embedded in the financial scenario we shared a few months ago, as Walt mentioned, we are seeing signs of the pace beginning to moderate, and we continue to expect a resumption of deposit growth in 2023.	Transcript
DXC.N	2023-05-18T17:00:00Z	Revenue			And what you've seen when you go look at Page 14 of our deck, the security is -- that's a business that is pretty stable for us.	Transcript
DXC.N	2023-05-18T17:00:00Z	EBIT			Free cash flow of $900 million. We have driven roughly the same level of revenue in constant currency, excluding dispositions for all 4 quarters in FY '23, which positions us to continue improving our revenue performance in FY '24.	Transcript
DXC.N	2021-11-03T17:00:00Z	EBIT			This gives us confidence that we will achieve our FY '24 double-digit margin guidance.	Transcript
SNPS.OQ	2023-05-17T17:00:00Z	Revenue	5843773300	5792957880	Based on continued strong design activity and high confidence in our business, we are raising our full year revenue guidance range to between $5.79 billion and $5.83 billion.	Transcript
SNPS.OQ	2023-05-17T16:05:05Z	EBIT			14-15%, non-GAAP operating margin accretion of 150 basis points to 34.5%, and business. We are raising our full year guidance and expect revenue growth of non-GAAP earnings per share growth of 21-22%."	Press Release
SNPS.OQ	2022-03-09T12:30:00Z	EBIT			And then maybe -- you mentioned margins. But Synopsys has this larger IP portfolio. Can you walk us through how the IP portfolio may or may not -- could that be -- like how does that come into play relative to other software companies that may not have that IP kind of mix? IP, the business that Jason is referring to, roughly 20%-ish of the overall revenues, growing in the mid-teens, very profitable. It's a little bit more resource intensive. It's more a very profitable business. It's not a royalty business like ARM, but it's still very profitable, right? Let me put it into context. Margins are right now around the 10% range and improving over time. Of that $4.8 billion of revenue, 10% is roughly the Software Integrity business. Right. So on the margin side, obviously, you're seeing top line strength, which enables you to drive leverage. That's our emerging growth business of 15% to 20% growth long term. This year, we're on track to do roughly $4.8 billion in revenues at the midpoint of guidance, about 32% operating margins and then EPS growth in the mid-teens.	Transcript
J.N	2022-11-21T10:00:00Z	Revenue	16265880000	15967420000	We continue to target double-digit revenue growth on a constant currency basis with operating margins returning to above 20% throughout 2023, driven by improved utilization.	Transcript
J.N	2022-11-21T06:40:06Z	Revenue	1470000000	1420000000	On a net revenue basis the difference between these two scenarios is approximately $430 million.	Press Release
J.N	2021-11-23T10:00:00Z	Revenue			Looking beyond 2022, we expect our strong organic growth to result in approximately $10 per share of adjusted EPS in fiscal year 2025.	Transcript
J.N	2023-02-07T10:00:00Z	Revenue			In CMS, we continue to deliver a strong base of recurring revenue with a growing new business pipeline. Our backlog and sales pipeline remains robust across a diverse set of customers. So we see improving, they're at a point in time where some of the wins that they've had, which are a little bit higher margin are yet to kind of get into the burn. We expect net revenue growth to accelerate materially in the second half of our fiscal year as we start to see growth from our investments in sales, data solutions and technology offerings.	Transcript
J.N	2023-05-09T10:00:00Z	Revenue			We continue to expect net revenue growth to accelerate in the second half of our fiscal year as we start to see growth from our investments in sales, data solutions and technology offerings. We continue to expect revenue growth in British pounds to remain near or above 10% during the second half of fiscal 2023.	Transcript
J.N	2023-05-09T10:00:00Z	Revenue			We continue to expect net revenue growth to accelerate in the second half of our fiscal year as we start to see growth from our investments in sales, data solutions and technology offerings. We continue to expect revenue growth in British pounds to remain near or above 10% during the second half of fiscal 2023.	Transcript
J.N	2023-02-07T10:00:00Z	Revenue			In CMS, we continue to deliver a strong base of recurring revenue with a growing new business pipeline. Our backlog and sales pipeline remains robust across a diverse set of customers. So we see improving, they're at a point in time where some of the wins that they've had, which are a little bit higher margin are yet to kind of get into the burn. We expect net revenue growth to accelerate materially in the second half of our fiscal year as we start to see growth from our investments in sales, data solutions and technology offerings.	Transcript
J.N	2023-05-09T10:00:00Z	EBIT			As a result, we expect Divergent's quarterly margins to approach 10% as we near the end of the fiscal year as scale begins to further mitigate the impact of the continued investments for growth. We expect operating margins to improve in the second half of fiscal 2023, with full year CMS margins expected to approach 8% on a full year basis as we convert on an IDIQ pipeline of higher-margin opportunities.	Transcript
J.N	2023-05-09T10:00:00Z	EBIT			As a result, we expect Divergent's quarterly margins to approach 10% as we near the end of the fiscal year as scale begins to further mitigate the impact of the continued investments for growth. We expect operating margins to improve in the second half of fiscal 2023, with full year CMS margins expected to approach 8% on a full year basis as we convert on an IDIQ pipeline of higher-margin opportunities.	Transcript
J.N	2022-11-21T10:00:00Z	EBIT			As I transition to Jacobs' Executive Chair, I'm excited and confident about the next phase of our strategy: Boldly Moving Forward. We expect modest adjusted operating profit margin expansion in fiscal 2023, driven by a combination of a higher margin revenue mix and lower employee-related costs.	Transcript
J.N	2023-05-09T10:00:00Z	EBIT			As a result, we expect Divergent's quarterly margins to approach 10% as we near the end of the fiscal year as scale begins to further mitigate the impact of the continued investments for growth. We expect operating margins to improve in the second half of fiscal 2023, with full year CMS margins expected to approach 8% on a full year basis as we convert on an IDIQ pipeline of higher-margin opportunities.	Transcript
J.N	2023-05-09T10:00:00Z	EBITDA			Due to our continued momentum across our business, we feel confident in our ability to reach our previously stated objectives and narrow our outlook for FY '23 adjusted EBITDA to a range of $1.42 billion to $1.47 billion and adjusted EPS to $7.25 to $7.45.	Transcript
J.N	2023-05-09T10:00:00Z	EBIT			As a result, we expect Divergent's quarterly margins to approach 10% as we near the end of the fiscal year as scale begins to further mitigate the impact of the continued investments for growth. We expect operating margins to improve in the second half of fiscal 2023, with full year CMS margins expected to approach 8% on a full year basis as we convert on an IDIQ pipeline of higher-margin opportunities.	Transcript
J.N	2023-05-09T10:00:00Z	EBIT			As a result, we expect Divergent's quarterly margins to approach 10% as we near the end of the fiscal year as scale begins to further mitigate the impact of the continued investments for growth. We expect operating margins to improve in the second half of fiscal 2023, with full year CMS margins expected to approach 8% on a full year basis as we convert on an IDIQ pipeline of higher-margin opportunities.	Transcript
SIVB.OQ^C23	2023-01-19T18:00:00Z	Revenue			And that's all included in our net interest income guidance and in the interest-bearing deposit beta guidance. And the reason for that is that mortgage spreads continue to come in. Just last one for me. The premium amortization that you guys talked about for the first quarter here, you have it down a little bit, but it's predicated on a 3.75% tenure, which is a 10-year obviously, a little bit lower today, with incremental pressure on that number if it's, at the 10-year, finishes 50 bps lower.	Transcript
AVY.N	2023-04-26T13:00:00Z	Revenue			We also expect volume to recover post the inventory reductions as well and particularly in apparel, our volumes to rebound in the normal fashion that we would expect post these inventory reductions and as sentiment around the end of the year and particularly around holiday is stronger.	Transcript
AVY.N	2023-04-26T13:00:00Z	Revenue			We also expect volume to recover post the inventory reductions as well and particularly in apparel, our volumes to rebound in the normal fashion that we would expect post these inventory reductions and as sentiment around the end of the year and particularly around holiday is stronger.	Transcript
AVY.N	2023-02-02T06:45:00Z	Revenue			to continue our long track record of earnings growth in 2023, including	Press Release
AVY.N	2023-04-26T06:45:00Z	EBITDA			* The company anticipates label destocking to be largely complete by mid-year,	Press Release
AVY.N	2023-04-26T13:00:00Z	EBITDA			We expect adjusted EBITDA margin to improve sequentially throughout 2023.	Transcript
